id,adj.P.Val.xBirA.Cre.over.NoBirA,AveExpr.xBirA.Cre.over.NoBirA,Log.P.Value.xBirA.Cre.over.NoBirA,logFC.xBirA.Cre.over.NoBirA,P.Value.xBirA.Cre.over.NoBirA,t.xBirA.Cre.over.NoBirA,Amanda_newDatabase..126.126.127.128.129.130.131..NoBirA_6.multimedian,Amanda_newDatabase..128.126.127.128.129.130.131..NoBirA_4.multimedian,Amanda_newDatabase..129.126.127.128.129.130.131..NoBirA_5.multimedian,Amanda_newDatabase..127.126.127.128.129.130.131..BirA.Cre_3.multimedian,Amanda_newDatabase..130.126.127.128.129.130.131..BirA.Cre_2.multimedian,Amanda_newDatabase..131.126.127.128.129.130.131..BirA.Cre_1.multimedian,id.query,id.mapped,id.concat,accession_number,geneSymbol,numColumnsProteinObserved,numSpectraProteinObserved,numPepsUnique,numPepsUniqueSubgroupSpecificCI,accession_numbers,species,protein_mw,percentCoverage,groupNum,subgroupNum,scoreUnique,scoreUniqueSubgroupSpecificCI,orfCategory,sequenceLength,entry_name,cellular_component,biological_process,molecular_function,Amanda_newDatabase.unique_peptides,Amanda_newDatabase.numSpectra,Amanda_newDatabase.totalIntensity,Amanda_newDatabase.pct_cov
E9Q414,0.604460486,-0.02875,4.101129623,0.2555,0.388943965,0.928661363,-0.4825,-0.207,0.22,0.212,-0.11,0.195,E9Q414,Apob,E9Q414_Apob,E9Q414,Apob,1,1087,250,250,E9Q414,MOUSE,510791.9,51.4,1,1.1,3841.73,3841.73,,4505,Apolipoprotein B-100,extracellular region|cytoplasm|endoplasmic reticulum|Golgi apparatus|plasma membrane|vesicle membrane|actin cytoskeleton|vesicle lumen|mature chylomicron|very-low-density lipoprotein particle|low-density lipoprotein particle|intermediate-density lipoprotein particle|chylomicron|neuronal cell body|extracellular exosome|,in utero embryonic development|lipid metabolic process|triglyceride mobilization|spermatogenesis|nervous system development|cholesterol metabolic process|fertilization|response to virus|response to carbohydrate|post-embryonic development|response to selenium ion|positive regulation of gene expression|positive regulation of macrophage derived foam cell differentiation|positive regulation of lipid storage|positive regulation of cholesterol storage|lipid catabolic process|triglyceride catabolic process|cholesterol transport|sperm motility|response to lipopolysaccharide|cholesterol efflux|low-density lipoprotein particle remodeling|low-density lipoprotein particle clearance|lipoprotein metabolic process|lipoprotein biosynthetic process|lipoprotein catabolic process|cholesterol homeostasis|lipoprotein transport|regulation of cholesterol biosynthetic process|artery morphogenesis|cellular response to tumor necrosis factor|cellular response to prostaglandin stimulus|,phospholipid binding|heparin binding|cholesterol transporter activity|lipase binding|low-density lipoprotein particle receptor binding|,250,1087,1.13E+12,51.4%
P01027,0.315406172,-0.09575,10.15797667,0.578166667,0.096427817,1.969906794,-0.7755,-0.188,-0.191,0.192,-0.107,0.495,P01027,C3,P01027_C3,P01027,C3,1,1123,179,156,P01027|P01027-2|Q2UVX4|G3X7A5,MOUSE,188021,88.2,2,2.1,2935.15,2624.27,,1663,Complement C3,extracellular space|extracellular exosome|blood microparticle|,"positive regulation of type IIa hypersensitivity|positive regulation of protein phosphorylation|positive regulation of activation of membrane attack complex|tolerance induction|fatty acid metabolic process|inflammatory response|complement activation|complement activation, alternative pathway|complement activation, classical pathway|blood coagulation|positive regulation of vascular endothelial growth factor production|positive regulation of glucose transport|regulation of triglyceride biosynthetic process|positive regulation of lipid storage|negative regulation of endopeptidase activity|response to magnesium ion|response to estradiol|response to progesterone|positive regulation of G-protein coupled receptor protein signaling pathway|positive regulation of angiogenesis|positive regulation of developmental growth|positive regulation of phagocytosis|response to glucocorticoid|positive regulation of ERK1 and ERK2 cascade|positive regulation of apoptotic cell clearance|",endopeptidase inhibitor activity|protein binding|lipid binding|C5L2 anaphylatoxin chemotactic receptor binding|cofactor binding|,180,1123,3.95E+12,88.2%
A0A0F6QNP7,0.174726314,-0.25775,15.86810269,1.343,0.025893439,3.460361,,-1.265,,-0.017,-0.066,0.317,A0A0F6QNP7,NotFound,A0A0F6QNP7_NotFound,A0A0F6QNP7,C3,1,1,25,1,A0A0F6QNP7,BOVIN,188719.1,9.4,2,2.2,329.19,6.23,,1661,Complement component 3,,,,1,1,11900000,0.6%
Q61838,0.555101425,-0.11475,4.774939855,0.316833333,0.333047375,1.052747207,-0.7935,-0.149,0.123,-0.024,0.075,0.08,Q61838,NotFound,Q61838_NotFound,Q61838,Pzp,1,2114,146,141,Q61838,MOUSE,167218.8,73.9,3,3.1,2637.49,2559.86,,1495,Pregnancy zone protein,extracellular region|extracellular space|,embryo implantation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|protein complex binding|,146,2114,9.17E+13,73.9%
F1MI18,0.425473432,0.798916667,7.021109564,-1.309166667,0.198558756,-1.448206582,1.1515,2.572,0.637,1.938,-0.906,-0.599,F1MI18,NotFound,F1MI18_NotFound,F1MI18,,1,5,9,4,F1MI18|F1MJK3,BOVIN,167182.2,6.9,3,3.2,102.8,25.17,,1478,Uncharacterized protein,,,,4,5,120000000,3.9%
A0A087WSN6,0.758326556,0.756583333,2.104406305,-0.429833333,0.615969728,-0.529223248,2.5565,0.425,-0.067,0.734,1.324,-0.433,A0A087WSN6,Fn1,A0A087WSN6_Fn1,A0A087WSN6,Fn1,1,488,113,113,A0A087WSN6|B9EHT6|A0A087WR50|Q3UHL6|P11276|B7ZNJ1|A0A087WS56|Q4KL80,MOUSE,256658.4,59.1,4,4.1,1819.32,1819.32,,2296,Fibronectin,fibrinogen complex|proteinaceous extracellular matrix|basement membrane|basal lamina|extracellular space|endoplasmic reticulum-Golgi intermediate compartment|apical plasma membrane|extracellular matrix|extracellular exosome|blood microparticle|extracellular matrix|,"regulation of protein phosphorylation|cell-substrate junction assembly|cell adhesion|cell-matrix adhesion|calcium-independent cell-matrix adhesion|positive regulation of cell proliferation|positive regulation of gene expression|positive regulation of peptidase activity|peptide cross-linking|integrin activation|substrate adhesion-dependent cell spreading|endodermal cell differentiation|wound healing|positive regulation of axon extension|positive regulation of fibroblast proliferation|regulation of ERK1 and ERK2 cascade|positive regulation of substrate-dependent cell migration, cell attachment to substrate|negative regulation of transforming growth factor-beta secretion|",protease binding|integrin binding|protein binding|peptidase activator activity|,113,488,3.79E+11,59.1%
P06684,0.315406172,-0.161416667,10.11393677,0.4895,0.097410623,1.962587349,-0.6375,-0.123,-0.458,0.278,-0.044,0.016,P06684,Hc,P06684_Hc,P06684,C5,1,530,117,117,P06684|A0A0J9YUU3,MOUSE,190586.2,56.2,5,5.1,1757.91,1757.91,,1680,Complement C5,membrane attack complex|extracellular space|extracellular exosome|,"in utero embryonic development|inflammatory response|complement activation, alternative pathway|complement activation, classical pathway|positive regulation of vascular endothelial growth factor production|negative regulation of macrophage chemotaxis|negative regulation of endopeptidase activity|cytolysis|positive regulation of angiogenesis|positive regulation of chemokine secretion|activation of mitophagy in response to mitochondrial depolarization|",endopeptidase inhibitor activity|,117,530,7.19E+11,56.2%
P28665,0.745307288,0.005583333,2.299802656,0.2015,0.588870413,0.571201141,-0.7275,0.04,0.402,0.329,-0.09,0.08,P28665,Mug1,P28665_Mug1,P28665,Mug1,1,702,103,50,P28665,MOUSE,166721,61.1,6,6.1,1699.07,904.45,,1476,Murinoglobulin-1,extracellular space|,embryo implantation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,103,702,1.54E+12,61.1%
P28666,0.604895102,-0.0513,4.087057174,0.32325,0.390206305,0.940504528,0.0685,-0.559,,-0.153,0.011,0.376,P28666,Mug2,P28666_Mug2,P28666,Mug2,1,16,54,9,P28666,MOUSE,163805.4,34.1,6,6.2,783.79,109.44,,1451,Murinoglobulin-2,extracellular space|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,9,16,364000000,7.0%
A0A0N4SVU1,0.529819388,-0.010916667,5.122017819,0.285833333,0.307466793,1.115243605,-0.4475,-0.005,-0.009,0.386,0.014,-0.004,A0A0N4SVU1,NotFound,A0A0N4SVU1_NotFound,A0A0N4SVU1,Gm7298,1,3,36,1,A0A0N4SVU1,MOUSE,166767.7,23.6,6,6.3,505.96,8.37,,1476,Predicted gene 7298,,,,1,3,79800000,1.2%
Q921I1,0.477611329,-0.049916667,5.941971566,0.459833333,0.254567433,1.261904249,-0.9975,0.003,0.155,0.251,0.279,0.01,Q921I1,Trf,Q921I1_Trf,Q921I1,Tf,1,890,84,81,Q921I1|E9Q035|E9Q939|Q29443,MOUSE,78890.5,80.3,7,7.1,1538.39,1487.32,,697,Serotransferrin,extracellular space|endosome|early endosome|late endosome|coated pit|basal plasma membrane|cell surface|membrane|cytoplasmic membrane-bounded vesicle|apical plasma membrane|vesicle coat|endocytic vesicle|vesicle|basal part of cell|perinuclear region of cytoplasm|recycling endosome|extracellular exosome|blood microparticle|dense body|,"iron ion transport|cellular iron ion homeostasis|actin filament organization|activation of JUN kinase activity|ferric iron transport|osteoclast differentiation|positive regulation of phosphorylation|positive regulation of bone resorption|positive regulation of transcription, DNA-templated|SMAD protein signal transduction|ERK1 and ERK2 cascade|positive regulation of cell motility|",protein binding|ferric iron binding|ferric iron transmembrane transporter activity|,84,890,1.4E+13,80.3%
Q2HJF0,0.940910696,0.4109,0.373973915,-0.053083333,0.917492681,-0.109046313,1.0245,-0.139,,0.797,0.431,-0.059,Q2HJF0,NotFound,Q2HJF0_NotFound,Q2HJF0,LOC525947,1,10,8,5,Q2HJF0,BOVIN,70893.5,4.8,7,7.2,83.43,32.36,,622,Serotransferrin-like,,,,5,10,5510000000,1.4%
P01029,0.745307288,0.05925,2.324124199,0.168166667,0.585581813,0.576002726,-0.3445,-0.131,0.401,0.196,-0.11,0.344,P01029,C4b,P01029_C4b,P01029,C4b,1,519,105,105,P01029|E1BH06|P01030|F1MVK1,MOUSE,194566.4,57.5,8,8.1,1513.92,1513.92,,1738,Complement C4-B,extracellular space|,"inflammatory response|complement activation, classical pathway|negative regulation of endopeptidase activity|innate immune response|",endopeptidase inhibitor activity|,105,519,6.89E+11,57.5%
E9Q8I0,0.612149353,-0.044916667,3.967632024,0.333833333,0.401085348,0.904673461,-0.6265,-0.369,0.36,-0.15,-0.076,0.592,E9Q8I0,Cfh,E9Q8I0_Cfh,E9Q8I0,Cfh,1,456,89,72,E9Q8I0|P06909|D6RGQ0|E9Q8H9|A0A0A6YVP8,MOUSE,145947.1,72.1,9,9.1,1469.82,1205.88,,1252,Complement factor H,extracellular exosome|blood microparticle|,regulation of complement activation|,complement component C3b binding|heparin binding|heparan sulfate proteoglycan binding|,89,456,1.34E+12,72.1%
E9Q8B5,0.456433733,-0.065416667,6.339493204,0.604166667,0.232300786,1.331106488,0.0665,0.085,-1.254,0.244,-0.152,0.618,E9Q8B5,Gm4788,E9Q8B5_Gm4788,E9Q8B5,Gm4788,1,11,49,4,E9Q8B5|E9Q8B6,MOUSE,102688.5,63.2,9,9.2,786.52,70.24,,879,Predicted gene 4788,,,,4,11,7540000000,6.8%
E9PUM5,0.437741736,0.0485,6.712902621,0.674,0.213161976,1.48198317,,-0.457,,0.157,-0.107,0.601,E9PUM5,NotFound,E9PUM5_NotFound,E9PUM5,Gm4788,1,1,46,1,E9PUM5,MOUSE,94467.4,63.9,9,9.3,733.15,16.87,,808,Predicted gene 4788,,,,1,1,6480000,2.5%
Q4LDF6,0.509872886,-0.1033,5.458741243,0.334916667,0.284528566,1.198439152,-0.4745,-0.134,,0.192,-0.108,0.008,Q4LDF6,Cfhr2,Q4LDF6_Cfhr2,Q4LDF6,Cfhr2,1,8,16,4,Q4LDF6|Q61405,MOUSE,39129.7,57.8,9,9.4,290.43,68.45,,332,Complement factor H-related 2,,,,4,8,561000000,14.1%
P20918,0.45009248,0.04925,6.439587654,0.6155,0.227008038,1.348406103,-0.7395,0.482,-0.518,1.01,0.1,-0.039,P20918,Plg,P20918_Plg,P20918,Plg,1,623,85,85,P20918,MOUSE,93544.9,83,10,10.1,1418.1,1418.1,,812,Plasminogen,extracellular region|extracellular space|cell surface|extrinsic component of plasma membrane|extrinsic component of external side of plasma membrane|plasma lipoprotein particle|intracellular membrane-bounded organelle|extracellular exosome|blood microparticle|,blood coagulation|negative regulation of cell-substrate adhesion|negative regulation of angiogenesis|extracellular matrix disassembly|tissue regeneration|fibrinolysis|myoblast differentiation|muscle cell cellular homeostasis|tissue remodeling|proteolysis involved in cellular protein catabolic process|negative regulation of fibrinolysis|positive regulation of fibrinolysis|trophoblast giant cell differentiation|labyrinthine layer blood vessel development|mononuclear cell migration|,fibronectin binding|serine-type endopeptidase activity|receptor binding|protein domain specific binding|apolipoprotein binding|,85,623,4.03E+12,83.0%
E9PZD8,0.886819929,0.091083333,0.997432726,0.1165,0.79479793,0.272130797,-0.7605,0.048,0.811,0.211,0.248,-0.011,E9PZD8,Cp,E9PZD8_Cp,E9PZD8,Cp,1,543,75,1,E9PZD8|Q61147,MOUSE,125007.5,59,11,11.1,1370.51,17.49,,1086,Ceruloplasmin,extracellular space|lysosomal membrane|extracellular exosome|blood microparticle|,copper ion transport|cellular iron ion homeostasis|oxidation-reduction process|,ferroxidase activity|copper ion binding|chaperone binding|,75,543,1.76E+12,59.0%
G3X8Q5,0.745307288,0.14375,2.291356726,0.229,0.590016732,0.585001778,,-0.028,,0.226,0.405,-0.028,G3X8Q5,Cp,G3X8Q5_Cp,G3X8Q5,Cp,1,3,75,1,G3X8Q5|G3X9T8,MOUSE,124936.5,58.9,11,11.2,1364.63,11.61,,1085,Ceruloplasmin,extracellular space|lysosomal membrane|extracellular exosome|blood microparticle|,copper ion transport|cellular iron ion homeostasis|oxidation-reduction process|,ferroxidase activity|copper ion binding|chaperone binding|,1,3,58600000,1.0%
B8JJN0,0.697521707,0.014583333,3.052829623,0.2195,0.495127488,0.72614012,-0.4895,-0.095,0.299,0.43,-0.084,0.027,B8JJN0,NotFound,B8JJN0_NotFound,B8JJN0,Gm20547,1,372,86,61,B8JJN0|B8JJM5|P04186|B8JJM6|F6XQ00,MOUSE,144605,52.4,12,12.1,1337.16,955.56,,1276,Predicted gene 20547,,proteolysis|,serine-type endopeptidase activity|,86,372,6.11E+11,52.4%
P21180,0.890329957,0.15625,0.878061794,-0.0605,0.816946884,-0.241868984,0.2575,0.022,0.28,0.422,-0.136,0.092,P21180,C2,P21180_C2,P21180,C2,1,29,35,10,P21180|P21180-2|B8JJN2|B8JJM9,MOUSE,85995.1,45.9,12,12.2,512.78,131.18,,760,Complement C2,extracellular exosome|,"proteolysis|complement activation|complement activation, classical pathway|response to nutrient|innate immune response|positive regulation of apoptotic cell clearance|",serine-type endopeptidase activity|metal ion binding|,10,29,18200000000,15.2%
P07724,0.514652785,-0.11875,5.351898209,0.3255,0.291615215,1.15618471,-0.7225,-0.228,0.106,0.022,0.06,0.05,P07724,Alb,P07724_Alb,P07724,Alb,1,608,70,67,P07724,MOUSE,70745.2,91.4,13,13.1,1190.54,1140.76,,608,Serum albumin,extracellular region|extracellular space|nucleus|cytoplasm|myelin sheath|protein complex|extracellular exosome|blood microparticle|,retina homeostasis|transport|cellular response to starvation|hemolysis by symbiont of host erythrocytes|negative regulation of apoptotic process|maintenance of mitochondrion location|,DNA binding|fatty acid binding|drug binding|toxic substance binding|pyridoxal phosphate binding|metal ion binding|chaperone binding|oxygen binding|,70,608,5.85E+12,91.4%
P02769,0.2717339,0.498916667,11.36117972,-2.753166667,0.07309405,-2.177541411,0.6235,4.892,0.111,-0.853,-0.969,-0.811,P02769,NotFound,P02769_NotFound,P02769,ALB,1,21,10,7,P02769,BOVIN,71289,15.6,13,13.2,130.24,80.46,,607,Serum albumin,,,,7,21,4600000000,10.2%
O88783,0.509872886,0.030583333,5.440411138,0.272166667,0.285732003,1.171860508,-0.2735,0.006,-0.049,0.36,0.172,-0.032,O88783,F5,O88783_F5,O88783,F5,1,215,74,74,O88783,MOUSE,248366.9,34.5,14,14.1,1085.6,1085.6,,2183,Coagulation factor V,extracellular space|membrane|platelet alpha granule|extracellular vesicle|,blood coagulation|blood circulation|platelet activation|,copper ion binding|,74,215,52800000000,34.5%
E9PVD2,0.724389671,0.04175,2.738912846,0.153833333,0.532241477,0.662583076,-0.0315,-0.039,-0.035,0.388,-0.092,0.06,E9PVD2,Itih4,E9PVD2_Itih4,E9PVD2,Itih4,1,284,60,1,E9PVD2|A0A0R4J1N1|E9Q5L2,MOUSE,104757.7,63.4,15,15.1,914.88,24.1,,941,"Inter alpha-trypsin inhibitor, heavy chain 4",cytoplasm|plasma membrane|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|calcium ion binding|hyaluronic acid binding|,60,284,5.08E+11,63.4%
A6X935,0.745307288,0.2475,2.286123529,-0.17875,0.590728123,-0.574212554,0.5705,0.139,,0.431,0.162,-0.065,A6X935,Itih4,A6X935_Itih4,A6X935,Itih4,1,7,60,1,A6X935|A6X935-2,MOUSE,104828.7,63.4,15,15.2,914.19,23.41,,942,"Inter alpha-trypsin inhibitor, heavy chain 4",cytoplasm|plasma membrane|extracellular exosome|blood microparticle|,acute-phase response|negative regulation of endopeptidase activity|hyaluronan metabolic process|response to cytokine|,serine-type endopeptidase inhibitor activity|protein binding|calcium ion binding|hyaluronic acid binding|,1,7,2690000000,2.3%
Q9DBD0,0.586005351,0.041583333,4.420579416,0.2575,0.361361648,0.987984697,-0.4005,-0.049,0.188,0.361,0.166,-0.016,Q9DBD0,1300017J02Rik,Q9DBD0_1300017J02Rik,Q9DBD0,Ica,1,302,57,57,Q9DBD0|D3YY36,MOUSE,78761.2,66.8,16,16.1,914.29,914.29,,700,Inhibitor of carbonic anhydrase,extracellular space|,negative regulation of catalytic activity|,enzyme inhibitor activity|iron ion binding|,57,302,7.23E+11,66.8%
P06728,0.203138841,-0.254416667,14.33336721,0.686833333,0.036869163,2.674182439,-0.7105,-0.247,-0.836,0,0.244,0.023,P06728,Apoa4,P06728_Apoa4,P06728,Apoa4,1,535,51,51,P06728,MOUSE,45028.2,85.8,17,17.1,858.62,858.62,,395,Apolipoprotein A-IV,extracellular region|extracellular space|cytosol|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|cell surface|,innate immune response in mucosa|cholesterol biosynthetic process|lipid transport|response to lipid hydroperoxide|leukocyte cell-cell adhesion|cholesterol metabolic process|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|removal of superoxide radicals|triglyceride catabolic process|regulation of intestinal cholesterol absorption|neuron projection regeneration|regulation of cholesterol transport|cholesterol efflux|phospholipid efflux|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|negative regulation of plasma lipoprotein particle oxidation|response to stilbenoid|lipoprotein metabolic process|cholesterol homeostasis|hydrogen peroxide catabolic process|reverse cholesterol transport|multicellular organismal lipid catabolic process|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|positive regulation of lipoprotein lipase activity|lipid homeostasis|protein-lipid complex assembly|triglyceride homeostasis|,copper ion binding|lipid binding|cholesterol binding|antioxidant activity|cholesterol transporter activity|phosphatidylcholine binding|protein homodimerization activity|phosphatidylcholine-sterol O-acyltransferase activator activity|,51,535,9.38E+12,85.8%
P21614,0.617264385,-0.015416667,3.891498043,0.328166667,0.408178566,0.890253252,-0.8895,0.062,0.289,0.35,0.127,-0.031,P21614,Gc,P21614_Gc,P21614,Gc,1,228,47,47,P21614,MOUSE,55196.9,89.2,18,18.1,841.06,841.06,,476,Vitamin D-binding protein,extracellular space|cytosol|axon|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|,female pregnancy|lactation|response to nutrient levels|response to estradiol|vitamin D metabolic process|vitamin transport|,actin binding|vitamin transporter activity|calcidiol binding|,47,228,3.81E+11,89.2%
Q5SWU9,0.174726314,1.080583333,16.28763603,-1.7845,0.023509121,-3.033100113,1.5155,2.007,2.396,1.387,-0.703,-0.119,Q5SWU9,Acaca,Q5SWU9_Acaca,Q5SWU9,Acaca,1,110,65,55,Q5SWU9|Q5SWU9-2,MOUSE,266849.4,30.1,19,19.1,823.39,688.64,,2345,Acetyl-CoA carboxylase 1,nucleolus|cytoplasm|mitochondrion|cytosol|actin cytoskeleton|extracellular exosome|,tissue homeostasis|acetyl-CoA metabolic process|lipid metabolic process|fatty acid biosynthetic process|multicellular organismal protein metabolic process|protein homotetramerization|lipid homeostasis|cellular response to prostaglandin E stimulus|malonyl-CoA biosynthetic process|,acetyl-CoA carboxylase activity|biotin carboxylase activity|protein binding|ATP binding|metal ion binding|,65,110,6810000000,30.1%
E9Q4Z2,0.153374531,1.33775,17.56216863,-1.6635,0.017530049,-3.266964515,2.1505,2.3,2.058,1.537,-0.411,0.392,E9Q4Z2,Acacb,E9Q4Z2_Acacb,E9Q4Z2,Acacb,1,7,17,7,E9Q4Z2,MOUSE,278141.4,7.9,19,19.2,196.21,61.46,,2448,Acetyl-CoA carboxylase 2,nucleus|mitochondrion|endomembrane system|membrane|,acetyl-CoA metabolic process|fatty acid biosynthetic process|positive regulation of lipid storage|negative regulation of fatty acid oxidation|protein homotetramerization|positive regulation of heart growth|malonyl-CoA biosynthetic process|,acetyl-CoA carboxylase activity|biotin carboxylase activity|ATP binding|metal ion binding|,7,7,114000000,3.3%
Q8K0E8,0.597174093,0.84125,4.254905829,-1.3445,0.375413095,-0.958559853,4.1105,-0.295,0.725,-0.446,2.187,-1.234,Q8K0E8,Fgb,Q8K0E8_Fgb,Q8K0E8,Fgb,1,200,51,51,Q8K0E8|F1MAV0|P02676,MOUSE,55436.4,79.2,20,20.1,823.22,823.22,,481,Fibrinogen beta chain,fibrinogen complex|extracellular space|cell cortex|external side of plasma membrane|cell surface|platelet alpha granule|extracellular exosome|blood microparticle|extracellular vesicle|,"cell-matrix adhesion|signal transduction|plasminogen activation|positive regulation of heterotypic cell-cell adhesion|fibrinolysis|induction of bacterial agglutination|cellular protein complex assembly|cellular response to leptin stimulus|innate immune response|positive regulation of vasoconstriction|positive regulation of exocytosis|positive regulation of protein secretion|protein polymerization|response to calcium ion|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|cellular response to interleukin-1|blood coagulation, fibrin clot formation|positive regulation of peptide hormone secretion|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|negative regulation of endothelial cell apoptotic process|","structural molecule activity|protein binding, bridging|chaperone binding|receptor binding|cell adhesion molecule binding|",51,200,1.73E+11,79.2%
Q80YQ1,0.728945731,-0.01875,2.683094121,-0.6445,0.539126386,-0.651734124,2.6295,-0.604,-1.115,-0.387,-0.153,-0.483,Q80YQ1,Thbs1,Q80YQ1_Thbs1,Q80YQ1,Thbs1,1,193,56,56,Q80YQ1|P35441,MOUSE,133681.8,49.3,21,21.1,822.52,822.52,,1171,Thrombospondin-1,fibrinogen complex|extracellular space|external side of plasma membrane|cell surface|secretory granule|extracellular matrix|platelet alpha granule|extracellular exosome|extracellular matrix|,activation of MAPK activity|negative regulation of endothelial cell proliferation|negative regulation of cell-matrix adhesion|sprouting angiogenesis|chronic inflammatory response|negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|negative regulation of dendritic cell antigen processing and presentation|outflow tract morphogenesis|endocardial cushion development|growth plate cartilage development|inflammatory response|immune response|cell cycle arrest|cell adhesion|response to glucose|positive regulation of endothelial cell migration|negative regulation of endothelial cell migration|negative regulation of plasma membrane long-chain fatty acid transport|negative regulation of nitric oxide mediated signal transduction|negative regulation of cGMP-mediated signaling|negative regulation of plasminogen activation|positive regulation of fibroblast migration|positive regulation of cell-substrate adhesion|cell migration|negative regulation of angiogenesis|peptide cross-linking|positive regulation of blood coagulation|positive regulation of cell migration|positive regulation of transforming growth factor beta receptor signaling pathway|regulation of cGMP metabolic process|response to magnesium ion|negative regulation of interleukin-12 production|negative regulation of fibroblast growth factor receptor signaling pathway|positive regulation of phosphorylation|response to drug|positive regulation of tumor necrosis factor biosynthetic process|positive regulation of macrophage activation|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of blood vessel endothelial cell migration|negative regulation of blood vessel endothelial cell migration|engulfment of apoptotic cell|positive regulation of translation|positive regulation of angiogenesis|blood vessel morphogenesis|positive regulation of chemotaxis|response to calcium ion|positive regulation of protein kinase B signaling|negative regulation of fibrinolysis|cellular response to nitric oxide|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors|positive regulation of endothelial cell apoptotic process|positive regulation of reactive oxygen species metabolic process|negative regulation of endothelial cell chemotaxis|,phosphatidylserine binding|fibronectin binding|integrin binding|calcium ion binding|heparin binding|fibroblast growth factor binding|low-density lipoprotein particle binding|laminin binding|extracellular matrix binding|fibrinogen binding|collagen V binding|,56,193,91700000000,49.3%
P32261,0.699470325,0.186416667,3.015001985,0.2505,0.499458952,0.718959352,-0.5055,0.165,0.524,0.521,0.447,-0.033,P32261,Serpinc1,P32261_Serpinc1,P32261,Serpinc1,1,327,54,54,P32261|A0A0A6YX49|A0A0A6YXS8,MOUSE,52516.1,67,22,22.1,814.04,814.04,,465,Antithrombin-III,extracellular space|extracellular exosome|blood microparticle|,"response to nutrient|blood coagulation|negative regulation of endopeptidase activity|negative regulation of inflammatory response|regulation of blood coagulation, intrinsic pathway|",protease binding|serine-type endopeptidase inhibitor activity|heparin binding|,54,327,1.12E+12,67.0%
P19221,0.401922334,-0.10675,7.687452886,0.554833333,0.170315711,1.560626727,-0.6805,0.216,-0.688,0.549,-0.109,0.072,P19221,F2,P19221_F2,P19221,F2,1,283,48,48,P19221|H7BX99,MOUSE,71693.8,57.6,23,23.1,768.82,768.82,,618,Prothrombin,extracellular space|cytosol|extracellular matrix|extracellular exosome|blood microparticle|,positive regulation of protein phosphorylation|proteolysis|acute-phase response|cell surface receptor signaling pathway|positive regulation of cell proliferation|regulation of cell shape|response to wounding|regulation of gene expression|positive regulation of phosphatidylinositol 3-kinase signaling|response to inactivity|platelet activation|positive regulation of blood coagulation|positive regulation of cell growth|positive regulation of collagen biosynthetic process|fibrinolysis|negative regulation of proteolysis|negative regulation of astrocyte differentiation|positive regulation of release of sequestered calcium ion into cytosol|cytosolic calcium ion homeostasis|thrombin receptor signaling pathway|cellular response to mechanical stimulus|positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway|positive regulation of reactive oxygen species metabolic process|,serine-type endopeptidase activity|receptor binding|calcium ion binding|protein binding|peptidase activity|thrombospondin receptor activity|,48,283,7.11E+11,57.6%
Q61702,0.51497654,-0.020416667,5.339632573,0.3935,0.292439978,1.154776396,-0.8435,0.062,0.13,0.404,0.138,-0.013,Q61702,Itih1,Q61702_Itih1,Q61702,Itih1,1,218,47,2,Q61702,MOUSE,101521.5,50.8,24,24.1,763.37,29.72,,907,Inter-alpha-trypsin inhibitor heavy chain H1,extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,47,218,2.78E+11,50.8%
F8WJ05,0.32515976,0.0179,9.584747581,0.978583333,0.11003358,1.948882458,-1.2335,0.095,,0.718,0.489,0.021,F8WJ05,Itih1,F8WJ05_Itih1,F8WJ05,Itih1,1,4,46,2,F8WJ05,MOUSE,102089.1,50.9,24,24.2,747.87,18.52,,911,Inter-alpha-trypsin inhibitor heavy chain H1,extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,2,4,497000000,4.0%
P26262,0.817095546,0.119416667,1.624960063,0.253166667,0.687866238,0.42215907,-1.1515,-0.055,1.185,0.395,0.356,-0.013,P26262,Klkb1,P26262_Klkb1,P26262,Klkb1,1,242,45,45,P26262|P04187,MOUSE,73492.3,65.8,25,25.1,751.27,751.27,,638,Plasma kallikrein,extracellular space|extracellular exosome|,inflammatory response|blood coagulation|plasminogen activation|fibrinolysis|positive regulation of fibrinolysis|liver regeneration|,serine-type endopeptidase activity|,45,242,3.83E+11,65.8%
Q00623,0.477427431,-0.068416667,5.983538842,0.478833333,0.252142536,1.269248579,-1.0545,-0.06,0.191,0.319,0.173,0.021,Q00623,Apoa1,Q00623_Apoa1,Q00623,Apoa1,1,746,44,44,Q00623,MOUSE,30615,81.4,26,26.1,706.1,706.1,,264,Apolipoprotein A-I,extracellular region|extracellular space|nucleus|cytosol|cell surface|endocytic vesicle|cytoplasmic vesicle|very-low-density lipoprotein particle|high-density lipoprotein particle|discoidal high-density lipoprotein particle|spherical high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|extracellular vesicle|,regulation of protein phosphorylation|endothelial cell proliferation|negative regulation of cytokine secretion involved in immune response|phospholipid metabolic process|phosphatidylcholine biosynthetic process|cholesterol biosynthetic process|G-protein coupled receptor signaling pathway|integrin-mediated signaling pathway|response to nutrient|cholesterol metabolic process|glucocorticoid metabolic process|negative regulation of tumor necrosis factor-mediated signaling pathway|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|negative regulation of very-low-density lipoprotein particle remodeling|protein oxidation|peptidyl-methionine modification|triglyceride catabolic process|lipid storage|regulation of intestinal cholesterol absorption|cholesterol transport|adrenal gland development|organ regeneration|regulation of Cdc42 protein signal transduction|cholesterol efflux|phospholipid efflux|negative regulation of heterotypic cell-cell adhesion|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|positive regulation of Rho protein signal transduction|lipoprotein biosynthetic process|response to drug|cholesterol homeostasis|blood vessel endothelial cell migration|response to estrogen|reverse cholesterol transport|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|negative regulation of interleukin-1 beta secretion|negative regulation of inflammatory response|protein stabilization|negative chemotaxis|positive regulation of lipoprotein lipase activity|vitamin transport|positive regulation of hydrolase activity|negative regulation of hydrolase activity|positive regulation of stress fiber assembly|phospholipid homeostasis|negative regulation of lipase activity|negative regulation of cell adhesion molecule production|negative regulation of response to cytokine stimulus|triglyceride homeostasis|cholesterol import|positive regulation of substrate adhesion-dependent cell spreading|protein localization|axon regeneration|,beta-amyloid binding|lipid transporter activity|protein binding|phospholipid binding|phospholipid transporter activity|high-density lipoprotein particle binding|lipid binding|cholesterol binding|cholesterol transporter activity|enzyme binding|phosphatidylcholine binding|apolipoprotein receptor binding|apolipoprotein A-I receptor binding|identical protein binding|chemorepellent activity|lipase inhibitor activity|phosphatidylcholine-sterol O-acyltransferase activator activity|high-density lipoprotein particle receptor binding|lipoprotein particle binding|cholesterol transporter activity|,44,746,1.3E+14,81.4%
E9PV24,0.586005351,0.690916667,4.387134178,-1.417833333,0.364155256,-0.983101339,4.3435,-0.281,0.137,-0.635,1.773,-1.192,E9PV24,Fga,E9PV24_Fga,E9PV24,Fga,1,214,53,53,E9PV24|E9PV24-2|P02672|A5PJE3,MOUSE,88169.4,55.5,27,27.1,705.71,705.71,,789,Fibrinogen alpha chain,fibrinogen complex|extracellular space|rough endoplasmic reticulum|cell cortex|external side of plasma membrane|cell surface|platelet alpha granule|extracellular exosome|blood microparticle|extracellular vesicle|,"protein complex assembly|acute-phase response|cell-matrix adhesion|signal transduction|blood coagulation|plasminogen activation|response to estradiol|response to genistein|positive regulation of heterotypic cell-cell adhesion|fibrinolysis|induction of bacterial agglutination|response to morphine|cellular protein complex assembly|innate immune response|positive regulation of vasoconstriction|positive regulation of exocytosis|response to cycloheximide|positive regulation of protein secretion|protein polymerization|response to calcium ion|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|cellular response to interleukin-6|cellular response to organic cyclic compound|blood coagulation, common pathway|blood coagulation, fibrin clot formation|positive regulation of peptide hormone secretion|liver regeneration|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|cellular response to granulocyte colony-stimulating factor|negative regulation of endothelial cell apoptotic process|","structural molecule activity|protein binding, bridging|receptor binding|cell adhesion molecule binding|",53,214,3.65E+11,55.5%
Q61129,0.520433101,-0.068416667,5.237086584,0.2955,0.299427264,1.135779462,-0.5765,-0.176,0.104,0.063,0.158,0.017,Q61129,Cfi,Q61129_Cfi,Q61129,Cfi,1,209,41,41,Q61129,MOUSE,69541.5,59.8,28,28.1,695.91,695.91,,603,Complement factor I,extracellular space|membrane|extracellular exosome|,"proteolysis|receptor-mediated endocytosis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|scavenger receptor activity|metal ion binding|,41,209,3.41E+11,59.8%
P20029,0.434899442,-0.090916667,6.774949696,0.361833333,0.210138211,1.403406326,-0.5375,0.067,-0.345,0.249,0.059,-0.038,P20029,Hspa5,P20029_Hspa5,P20029,Hspa5,1,179,44,41,P20029,MOUSE,72534.8,54.5,29,29.1,674.84,638.53,,655,78 kDa glucose-regulated protein,extracellular region|nucleus|mitochondrion|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum membrane|smooth endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|plasma membrane|focal adhesion|cell surface|membrane|integral component of endoplasmic reticulum membrane|midbody|endoplasmic reticulum chaperone complex|melanosome|myelin sheath|extracellular exosome|COP9 signalosome|,ER overload response|activation of signaling protein activity involved in unfolded protein response|cerebellum structural organization|cerebellar Purkinje cell layer development|substantia nigra development|positive regulation of cell migration|negative regulation of transforming growth factor beta receptor signaling pathway|positive regulation of protein ubiquitination|response to endoplasmic reticulum stress|maintenance of protein localization in endoplasmic reticulum|positive regulation of embryonic development|cellular response to glucose starvation|negative regulation of apoptotic process|proteolysis involved in cellular protein catabolic process|cellular response to antibiotic|cellular response to interleukin-4|toxin transport|,glycoprotein binding|protein binding|ATP binding|ATPase activity|enzyme binding|protein domain specific binding|ubiquitin protein ligase binding|ribosome binding|unfolded protein binding|misfolded protein binding|,44,179,1.25E+11,54.5%
P63017,0.221392282,0.304083333,13.36836597,-0.796833333,0.046042978,-2.508604424,0.1365,0.857,1.114,-0.012,-0.233,-0.038,P63017,Hspa8,P63017_Hspa8,P63017,Hspa8,1,26,19,16,P63017|Q504P4|P17156|P16627|P17879|Q61696,MOUSE,71098,27.8,29,29.2,215.7,179.39,,646,Heat shock cognate 71 kDa protein,Prp19 complex|extracellular space|intracellular|nucleus|spliceosomal complex|nucleolus|cytosol|plasma membrane|focal adhesion|membrane|ribonucleoprotein complex|melanosome|myelin sheath|extracellular exosome|blood microparticle|ubiquitin ligase complex|,"transcription, DNA-templated|mRNA processing|protein folding|RNA splicing|protein refolding|negative regulation of transcription, DNA-templated|ATP metabolic process|positive regulation of mRNA splicing, via spliceosome|chaperone mediated protein folding requiring cofactor|regulation of cell cycle|clathrin coat disassembly|negative regulation of fibril organization|","G-protein coupled receptor binding|protein binding|ATP binding|ATPase activity|enzyme binding|MHC class II protein complex binding|heat shock protein binding|ubiquitin protein ligase binding|ATPase activity, coupled|poly(A) RNA binding|unfolded protein binding|C3HC4-type RING finger domain binding|",16,26,635000000,25.0%
A0A0R4J038,0.232788104,-0.133416667,12.97639425,0.594166667,0.050391882,2.441966091,-0.6475,-0.156,-0.488,0.299,0.182,0.01,A0A0R4J038,Kng1,A0A0R4J038_Kng1,A0A0R4J038,Kng1,1,255,37,32,A0A0R4J038|O08677|D3YTY9|O08677-3|B99909|P01044|P01045,MOUSE,74183.9,51.5,30,30.1,651.49,583.81,,661,Kininogen-1,,,,37,255,1.69E+12,51.5%
Q6S9I0,0.331936472,-0.12025,9.248553061,0.529833333,0.118889827,1.818767709,-0.5035,0.007,-0.659,0.467,-0.013,-0.02,Q6S9I0,Kng2,Q6S9I0_Kng2,Q6S9I0,Kng2,1,86,28,24,Q6S9I0|Q6S9I3|Q6S9I2|E0CYI5,MOUSE,48970.3,56.5,30,30.2,458.75,399.07,,433,Kininogen 2,extracellular space|cytosol|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|,cysteine-type endopeptidase inhibitor activity|receptor binding|,24,86,50700000000,51.9%
P06683,0.214239872,-0.21975,13.73262897,0.6155,0.042338659,2.570838259,-0.7995,-0.359,-0.424,0.002,0.247,0.015,P06683,C9,P06683_C9,P06683,C9,1,169,41,41,A0A0R4J032|P06683,MOUSE,63256.4,65.5,31,31.1,648.47,648.47,,548,Complement component C9,membrane attack complex|cytoplasm|plasma membrane|extracellular exosome|blood microparticle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",,41,169,2.51E+11,65.5%
A0A0R4J0I1,0.592000093,-0.09525,4.316900533,0.249166667,0.370092212,0.96883458,-0.5515,-0.194,0.086,-0.097,0.126,0.059,A0A0R4J0I1,Serpina3k,A0A0R4J0I1_Serpina3k,A0A0R4J0I1,Serpina3k,1,791,32,22,A0A0R4J0I1|P07759,MOUSE,46900.1,66.5,32,32.1,637.37,432.25,,418,MCG1051009,,,,32,791,9.45E+12,66.5%
G3X8T9,0.742574146,-0.08625,2.566754009,0.259166667,0.553763847,0.627616735,0.1235,0.301,-1.072,0.219,-0.045,-0.044,G3X8T9,Serpina3n,G3X8T9_Serpina3n,G3X8T9,Serpina3n,1,14,30,2,G3X8T9|Q6P4P1|D3Z451,MOUSE,46936.4,53.8,32,32.2,473.66,43.82,,418,"Serine (Or cysteine) peptidase inhibitor, clade A, member 3N, isoform CRA_a",extracellular region|extracellular space|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,2,14,13400000000,6.6%
Q91WP6,0.232788104,0.2313,13.00805394,-0.687416667,0.050025865,-2.571416049,0.6465,0.641,,-0.163,0.162,-0.13,Q91WP6,NotFound,Q91WP6_NotFound,Q91WP6,Serpina3n,1,1,30,1,Q91WP6|Q5I2A0|F2Z405,MOUSE,46888.3,54.3,32,32.3,451.23,7.37,,418,Serine protease inhibitor A3N,extracellular region|extracellular space|extracellular exosome|blood microparticle|,acute-phase response|negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,1,1,9690000,4.3%
Q03734,0.573179417,0.48325,4.571160997,-0.417833333,0.349046992,-1.017002536,0.4165,0.173,1.487,0.545,0.311,-0.033,Q03734,Serpina3m,Q03734_Serpina3m,Q03734,Serpina3m,1,47,23,12,Q03734,MOUSE,47234.5,54,32,32.4,419.26,195.01,,418,Serine protease inhibitor A3M,extracellular space|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,12,47,28400000000,31.8%
P29621,0.48709819,-0.1375,5.78351239,0.342083333,0.264027255,1.258000577,-0.5045,-0.181,,-0.015,-0.108,0.121,P29621,Serpina3c,P29621_Serpina3c,P29621,Serpina3c,1,15,15,10,P29621|Q80X76,MOUSE,46936.4,40.7,32,32.5,213.56,124.36,,417,Serine protease inhibitor A3C,extracellular space|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,10,15,1460000000,29.7%
Q8K182,0.480243199,-0.04275,5.867664255,0.370166667,0.25896053,1.24690233,-0.3755,-0.487,0.179,0.05,-0.095,0.472,Q8K182,C8a,Q8K182_C8a,Q8K182,C8a,1,180,43,43,Q8K182|A2A997|A2A998,MOUSE,67733.7,65.4,33,33.1,636.16,636.16,,587,Complement component C8 alpha chain,membrane attack complex|extracellular exosome|blood microparticle|,"complement activation|complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",complement binding|protein complex binding|,43,180,1.91E+11,65.4%
E9Q6D8,0.651504812,0.06975,3.53593362,0.309833333,0.44300297,0.822060262,-0.4325,-0.357,0.534,-0.016,0.695,-0.005,E9Q6D8,NotFound,E9Q6D8_NotFound,E9Q6D8,C6,1,118,40,40,E9Q6D8|Q91X70,MOUSE,108049.4,46.8,34,34.1,631.6,631.6,,931,Complement component 6,membrane attack complex|extracellular exosome|,in utero embryonic development|immune response|,,40,118,30600000000,46.8%
P42703,0.214239872,-0.137416667,13.66989369,1.402833333,0.042954694,2.570728362,-0.4055,-0.369,-1.742,-0.25,0.785,1.157,P42703,Lifr,P42703_Lifr,P42703,Lifr,1,207,42,3,P42703,MOUSE,123883.7,36.5,35,35.1,627.03,35.48,,1092,Leukemia inhibitory factor receptor,plasma membrane|integral component of membrane|receptor complex|extracellular exosome|,positive regulation of cell proliferation|negative regulation of muscle cell apoptotic process|response to organic cyclic compound|cytokine-mediated signaling pathway|organ regeneration|response to cytokine|oncostatin-M-mediated signaling pathway|neuron projection morphogenesis|leukemia inhibitory factor signaling pathway|ciliary neurotrophic factor-mediated signaling pathway|,leukemia inhibitory factor receptor activity|ciliary neurotrophic factor receptor binding|protein binding|growth factor binding|cytokine binding|protein heterodimerization activity|ciliary neurotrophic factor receptor activity|oncostatin-M receptor activity|,42,207,3.54E+11,36.5%
P42703-2,0.745307288,0.667083333,2.346485095,-0.2995,0.582574526,-0.581273327,0.9785,1.448,0.024,-0.264,0.78,1.036,P42703,Lifr,P42703-2_Lifr,P42703-2,Lifr,1,11,40,2,P42703-2,MOUSE,82255.7,52.9,35,35.2,604.54,35.46,,1092,Isoform 2 of Leukemia inhibitory factor receptor,plasma membrane|integral component of membrane|receptor complex|extracellular exosome|,positive regulation of cell proliferation|negative regulation of muscle cell apoptotic process|response to organic cyclic compound|cytokine-mediated signaling pathway|organ regeneration|response to cytokine|oncostatin-M-mediated signaling pathway|neuron projection morphogenesis|leukemia inhibitory factor signaling pathway|ciliary neurotrophic factor-mediated signaling pathway|,leukemia inhibitory factor receptor activity|ciliary neurotrophic factor receptor binding|protein binding|growth factor binding|cytokine binding|protein heterodimerization activity|ciliary neurotrophic factor receptor activity|oncostatin-M receptor activity|,2,11,10200000000,3.7%
E9PUU8,0.434899442,-0.323916667,6.777599624,0.753833333,0.21001003,1.406552291,-0.0375,-0.164,-1.901,-0.018,0.183,-0.006,E9PUU8,NotFound,E9PUU8_NotFound,E9PUU8,Pkhd1l1,1,80,49,49,E9PUU8|Q80ZA4|F8WH29|Q80ZA4-2,MOUSE,469488.1,13.3,36,36.1,620.9,620.9,,4249,Fibrocystin-L,cilium|,,protein binding|,49,80,6570000000,13.3%
Q07968,0.899330297,0.03425,0.782316198,0.0755,0.83515749,0.217416271,-0.3985,-0.276,0.664,-0.022,0.243,-0.005,Q07968,F13b,Q07968_F13b,Q07968,F13b,1,179,39,39,Q07968,MOUSE,78476.1,54.4,37,37.1,599.4,599.4,,669,Coagulation factor XIII B chain,extracellular region|,blood coagulation|,,39,179,1.51E+11,54.4%
P01872,0.604460486,0.119916667,4.115982828,0.3435,0.387616019,0.932601535,-0.0325,-0.357,0.234,-0.098,0.961,0.012,P01872,NotFound,P01872_NotFound,P01872,Ighm,1,221,36,35,P01872|P01872-2|P04221,MOUSE,50655.7,61.8,38,38.1,592.48,572.81,,454,Ig mu chain C region,"extracellular space|plasma membrane|external side of plasma membrane|integral component of membrane|B cell receptor complex|immunoglobulin complex, circulating|perinuclear region of cytoplasm|",activation of MAPK activity|humoral immune response mediated by circulating immunoglobulin|immunoglobulin mediated immune response|antigen processing and presentation|positive regulation of B cell proliferation|positive regulation of MAPK cascade|early endosome to late endosome transport|positive regulation of endocytosis|positive regulation of peptidyl-tyrosine phosphorylation|defense response to Gram-negative bacterium|B cell receptor signaling pathway|positive regulation of B cell activation|,antigen binding|transmembrane signaling receptor activity|protein binding|immunoglobulin receptor binding|identical protein binding|,36,221,7.84E+11,61.8%
P03988,0.890329957,0.03475,0.901437257,0.110333333,0.812561562,0.253279121,,-0.048,,-0.306,0.23,0.263,P03988,NotFound,P03988_NotFound,P03988,,1,1,2,1,P03988,RABIT,50581.1,6.9,38,38.2,30.89,11.22,,458,Ig mu chain C region secreted form,,,,1,1,6630000,4.8%
Q60841,0.377571059,-0.115583333,8.279255435,0.409833333,0.148619042,1.657215761,-0.2405,-0.332,-0.389,-0.249,0.295,0.222,Q60841,Reln,Q60841_Reln,Q60841,Reln,1,101,47,47,Q60841|Q60841-2|Q60841-3,MOUSE,394505.8,13.6,39,39.1,589.9,589.9,,3461,Reelin,proteinaceous extracellular matrix|extracellular space|cytoplasm|dendrite|,"cell morphogenesis involved in differentiation|neuron migration|proteolysis|cell adhesion|axon guidance|central nervous system development|brain development|learning|long-term memory|associative learning|glial cell differentiation|regulation of gene expression|positive regulation of neuron projection development|positive regulation of phosphatidylinositol 3-kinase signaling|dendrite development|cell migration|peptidyl-tyrosine phosphorylation|spinal cord patterning|ventral spinal cord development|hippocampus development|cerebral cortex tangential migration|layer formation in cerebral cortex|cerebral cortex development|forebrain development|positive regulation of TOR signaling|positive regulation of CREB transcription factor activity|protein localization to synapse|reelin-mediated signaling pathway|positive regulation of protein kinase activity|response to pain|positive regulation of peptidyl-tyrosine phosphorylation|regulation of behavior|regulation of synaptic transmission|positive regulation of small GTPase mediated signal transduction|positive regulation of synaptic transmission, glutamatergic|long-term synaptic potentiation|positive regulation of dendritic spine morphogenesis|positive regulation of protein tyrosine kinase activity|positive regulation of synapse maturation|postsynaptic density assembly|N-methyl-D-aspartate receptor clustering|postsynaptic density protein 95 clustering|receptor localization to synapse|lateral motor column neuron migration|positive regulation of long-term synaptic potentiation|positive regulation of lateral motor column neuron migration|regulation of N-methyl-D-aspartate selective glutamate receptor activity|positive regulation of excitatory postsynaptic membrane potential|positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity|",protein binding|serine-type peptidase activity|metal ion binding|lipoprotein particle receptor binding|very-low-density lipoprotein particle receptor binding|,47,101,7780000000,13.6%
G3X977,0.512767633,0.027083333,5.390049472,0.3545,0.289064695,1.162947168,-0.5375,0.263,-0.176,0.504,0.141,-0.032,G3X977,Itih2,G3X977_Itih2,G3X977,Itih2,1,211,37,37,G3X977|Q61703,MOUSE,106758.8,40.3,40,40.1,586.51,586.51,,950,"Inter-alpha trypsin inhibitor, heavy chain 2",extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,37,211,5.23E+11,40.3%
D3YXF5,0.174726314,-0.368083333,16.01492818,0.796833333,0.02503267,2.968933592,-0.9125,-0.376,-1.011,-0.118,0.196,0.013,D3YXF5,C7,D3YXF5_C7,D3YXF5,C7,1,105,37,37,D3YXF5,MOUSE,96587.9,42.1,41,41.1,567.22,567.22,,845,Complement component 7,membrane attack complex|extracellular exosome|,immune response|,,37,105,22200000000,42.1%
P08113,0.254188227,-0.593416667,12.11546334,1.1675,0.061440348,2.304915797,-0.8575,-0.408,-2.266,-0.162,0.132,0.001,P08113,Hsp90b1,P08113_Hsp90b1,P08113,Hsp90b1,1,100,44,42,P08113|E9PX27,MOUSE,92759.4,44.2,42,42.1,564.41,529.41,,802,Endoplasmin,extracellular region|nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum membrane|cytosol|plasma membrane|focal adhesion|membrane|midbody|extracellular matrix|endoplasmic reticulum chaperone complex|melanosome|perinuclear region of cytoplasm|extracellular exosome|,"response to hypoxia|protein folding|ER-associated ubiquitin-dependent protein catabolic process|retrograde protein transport, ER to cytosol|actin rod assembly|negative regulation of apoptotic process|regulation of phosphoprotein phosphatase activity|cellular response to ATP|",RNA binding|protein binding|ATP binding|protein phosphatase binding|virion binding|low-density lipoprotein particle receptor binding|unfolded protein binding|,44,100,23200000000,44.2%
P11499,0.44527584,0.4247,6.527242245,-1.020916667,0.222472213,-1.396800581,0.0115,2.063,,-0.655,0.43,0.274,P11499,Hsp90ab1,P11499_Hsp90ab1,P11499,Hsp90ab1,1,2,7,2,P11499,MOUSE,83622,9.2,42,42.2,77.09,18.8,,724,Heat shock protein HSP 90-beta,intracellular|cytoplasm|mitochondrion|cytosol|cell surface|membrane|inclusion body|basolateral plasma membrane|apical plasma membrane|brush border membrane|melanosome|extracellular exosome|COP9 signalosome|,"placenta development|protein folding|response to salt stress|virion attachment to host cell|positive regulation of protein binding|negative regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of protein import into nucleus, translocation|negative regulation of neuron apoptotic process|positive regulation of nitric oxide biosynthetic process|positive regulation of cell size|regulation of interferon-gamma-mediated signaling pathway|regulation of type I interferon-mediated signaling pathway|cellular response to interleukin-4|cellular response to organic cyclic compound|positive regulation of protein serine/threonine kinase activity|fibril organization|",UTP binding|CTP binding|double-stranded RNA binding|protein binding|ATP binding|GTP binding|sulfonylurea receptor binding|kinase binding|protein kinase binding|MHC class II protein complex binding|nitric-oxide synthase regulator activity|TPR domain binding|dATP binding|ion channel binding|poly(A) RNA binding|unfolded protein binding|,2,2,23700000,3.0%
P07901,0.047034419,0.7245,26.6008762,-5.982,0.00218732,-7.191178147,,5.211,,-0.092,-1.812,-0.409,P07901,Hsp90aa1,P07901_Hsp90aa1,P07901,Hsp90aa1,1,1,4,1,P07901,MOUSE,85185.7,5.4,42,42.3,27.7,4.41,,733,Heat shock protein HSP 90-alpha,intracellular|nucleus|nucleoplasm|cytoplasm|mitochondrion|cytosol|membrane|ruffle membrane|melanosome|myelin sheath|extracellular exosome|,nitric oxide biosynthetic process|response to unfolded protein|response to cold|protein refolding|protein import into mitochondrial outer membrane|positive regulation of nitric oxide biosynthetic process|positive regulation of cytotoxic T cell differentiation|regulation of catalytic activity|chaperone-mediated protein complex assembly|,protein binding|ATP binding|ATPase activity|MHC class II protein complex binding|nitric-oxide synthase regulator activity|TPR domain binding|identical protein binding|protein homodimerization activity|poly(A) RNA binding|GTPase binding|unfolded protein binding|,1,1,725000,1.2%
Q91ZX7,0.509872886,0.186083333,5.490217302,-0.4475,0.282473863,-1.182521012,0.3145,-0.215,1.13,-0.068,-0.038,-0.007,Q91ZX7,Lrp1,Q91ZX7_Lrp1,Q91ZX7,Lrp1,1,72,47,47,A0A0R4J0I9|Q91ZX7|Q3U5J2|Q9JI18|A2API5|E9Q202|Q3TES0|A0A0N4SWH8|D6RHQ8,MOUSE,523675.1,11.9,43,43.1,563.24,563.24,,4545,Prolow-density lipoprotein receptor-related protein 1,nucleolus|cytoplasm|lysosomal membrane|integral component of plasma membrane|coated pit|focal adhesion|membrane|receptor complex|perinuclear region of cytoplasm|,receptor-mediated endocytosis|cholesterol metabolic process|positive regulation of cholesterol efflux|negative regulation of smooth muscle cell migration|negative regulation of Wnt signaling pathway|positive regulation of lipid transport|regulation of cholesterol transport|regulation of phospholipase A2 activity|regulation of actin cytoskeleton organization|aorta morphogenesis|apoptotic cell clearance|beta-amyloid clearance|negative regulation of platelet-derived growth factor receptor-beta signaling pathway|,calcium ion binding|protein binding|protein complex binding|apolipoprotein binding|poly(A) RNA binding|,47,72,7540000000,11.9%
P09103,0.210808617,-0.21675,14.13509851,0.768166667,0.038591366,2.639972085,-0.5835,-0.194,-1.025,0.269,0.25,-0.017,P09103,P4hb,P09103_P4hb,P09103,P4hb,1,98,42,42,P09103|P05307|A6H7J6|E9Q8G8,MOUSE,57456.8,66.6,44,44.1,558.57,558.57,,509,Protein disulfide-isomerase,endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum-Golgi intermediate compartment|focal adhesion|external side of plasma membrane|procollagen-proline 4-dioxygenase complex|endoplasmic reticulum chaperone complex|melanosome|extracellular exosome|,protein folding|peptidyl-proline hydroxylation to 4-hydroxy-L-proline|response to endoplasmic reticulum stress|cell redox homeostasis|cellular response to hypoxia|regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|,protein disulfide isomerase activity|integrin binding|protein binding|enzyme binding|poly(A) RNA binding|protein heterodimerization activity|procollagen-proline 4-dioxygenase activity|peptidyl-proline 4-dioxygenase activity|,42,98,27500000000,66.6%
Q91WP0,0.271366626,-0.186416667,11.4482325,0.478833333,0.071643493,2.184837491,-0.6145,-0.41,-0.253,0.086,0.048,0.025,Q91WP0,Masp2,Q91WP0_Masp2,Q91WP0,Masp2,1,180,39,39,Q91WP0|Q91WP0-2,MOUSE,76998.6,53.2,45,45.1,556.57,556.57,,685,Mannan-binding lectin serine protease 2,extracellular exosome|,"complement activation, lectin pathway|proteolysis|complement activation, classical pathway|",complement component C4b binding|serine-type endopeptidase activity|calcium ion binding|protein binding|peptidase activity|calcium-dependent protein binding|,39,180,1.9E+11,53.2%
Q00897,0.766031211,0.047583333,2.022431867,0.2055,0.627706771,0.511310529,-0.7605,-0.085,0.68,0.298,0.149,0.004,Q00897,Serpina1d,Q00897_Serpina1d,Q00897,Serpina1d,1,234,32,10,Q00897,MOUSE,46168.7,65.8,46,46.1,552.17,174.82,,413,Alpha-1-antitrypsin 1-4,extracellular region|extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|identical protein binding|,32,234,1.65E+12,65.8%
P22599,0.940910696,0.197083333,0.357445939,-0.0895,0.920991042,-0.103506578,-1.4145,0.05,2.09,0.352,0.127,-0.022,P22599,Serpina1b,P22599_Serpina1b,P22599,Serpina1b,1,40,30,9,P22599,MOUSE,46145,64.8,46,46.2,541.85,155.97,,413,Alpha-1-antitrypsin 1-2,extracellular region|extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,in utero embryonic development|protein N-linked glycosylation|acute-phase response|negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|protein binding|identical protein binding|,9,40,1.01E+11,21.7%
A0A0A0MQA3,0.512767633,0.0695,5.396810044,-0.302916667,0.288615064,-1.187029473,0.2945,0.208,,0.025,-0.172,-0.008,A0A0A0MQA3,Serpina1a,A0A0A0MQA3_Serpina1a,A0A0A0MQA3,Serpina1a,1,2,30,2,A0A0A0MQA3|P07758,MOUSE,49023.3,61.6,46,46.3,499.34,22.52,,436,Alpha-1-antitrypsin 1-1,extracellular region|extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,protein N-linked glycosylation|negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|protein binding|identical protein binding|,2,2,23400000,11.9%
A0A0R4J0X5,0.178749926,0.598083333,15.5904799,-0.9135,0.027602728,-2.893700199,0.6845,0.879,1.601,0.34,-0.013,0.097,A0A0R4J0X5,Serpina1c,A0A0R4J0X5_Serpina1c,A0A0R4J0X5,Serpina1c,1,31,28,1,A0A0R4J0X5,MOUSE,46024.7,63.6,46,46.4,505.41,25.66,,413,Alpha-1-antitrypsin 1-3,,,,1,31,2440000000,7.2%
Q00898,0.724389671,0.083916667,2.740718091,0.744833333,0.532020284,0.663592471,-0.1235,1.771,-2.513,-0.569,1.009,0.929,Q00898,Serpina1e,Q00898_Serpina1e,Q00898,Serpina1e,1,9,22,3,Q00898,MOUSE,46118.8,33.6,46,46.5,333.31,44.6,,413,Alpha-1-antitrypsin 1-5,extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|identical protein binding|,3,9,829000000,8.7%
P98064,0.377571059,-0.216083333,8.299318914,0.406833333,0.147934037,1.660570095,-0.5355,-0.588,-0.135,-0.179,-0.004,0.145,P98064,Masp1,P98064_Masp1,P98064,Masp1,1,127,35,15,P98064,MOUSE,81621.4,54.6,47,47.1,548.78,237.77,,704,Mannan-binding lectin serine protease 1,extracellular space|,"complement activation, lectin pathway|proteolysis|",serine-type endopeptidase activity|calcium ion binding|protein homodimerization activity|calcium-dependent protein binding|,35,127,33700000000,54.6%
P98064-2,0.752055167,-0.126583333,2.195775106,0.231833333,0.603146052,0.549013789,-0.9445,-0.364,0.581,-0.168,0.13,0.006,P98064,Masp1,P98064-2_Masp1,P98064-2,Masp1,1,18,27,7,P98064-2,MOUSE,83984.9,40.1,47,47.2,414.38,103.37,,704,Isoform 2 of Mannan-binding lectin serine protease 1,extracellular space|,"complement activation, lectin pathway|proteolysis|",serine-type endopeptidase activity|calcium ion binding|protein homodimerization activity|calcium-dependent protein binding|,7,18,2670000000,9.2%
Q8BH35,0.254188227,-0.182416667,12.01336284,0.538833333,0.062901893,2.279498982,-0.4825,-0.265,-0.608,0.066,-0.099,0.294,Q8BH35,C8b,Q8BH35_C8b,Q8BH35,C8b,1,127,34,34,Q8BH35|Q8BH35-2,MOUSE,68053.9,54.6,48,48.1,529.75,529.75,,589,Complement component C8 beta chain,membrane attack complex|extracellular space|extracellular exosome|extracellular vesicle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",protein complex binding|,34,127,56600000000,54.6%
O08601-2,0.612529252,0.065083333,3.949547892,0.231166667,0.40275896,0.90016555,-0.2755,0.197,-0.073,0.438,0.144,-0.04,O08601,Mttp,O08601-2_Mttp,O08601-2,Mttp,1,76,36,36,O08601-2|O08601,MOUSE,101433.7,36.3,49,49.1,529.36,529.36,,894,Isoform 2 of Microsomal triglyceride transfer protein large subunit,endoplasmic reticulum|rough endoplasmic reticulum|Golgi apparatus|basolateral plasma membrane|brush border membrane|microvillus membrane|membrane-bounded vesicle|receptor complex|,protein lipidation|lipid metabolic process|triglyceride metabolic process|lipid transport|circadian rhythm|cholesterol metabolic process|lipoprotein metabolic process|cholesterol homeostasis|lipoprotein transport|response to calcium ion|,lipid transporter activity|protein binding|lipid binding|apolipoprotein binding|protein heterodimerization activity|,36,76,9120000000,36.3%
Q91X72,0.940910696,0.242916667,0.399238095,0.0475,0.912170852,0.115118344,0.8195,-0.307,0.145,0.021,0.851,-0.072,Q91X72,Hpx,Q91X72_Hpx,Q91X72,Hpx,1,162,34,34,Q91X72,MOUSE,52058.5,53,50,50.1,526.84,526.84,,460,Hemopexin,extracellular space|extracellular exosome|blood microparticle|,positive regulation of immunoglobulin production|positive regulation of humoral immune response mediated by circulating immunoglobulin|transport|hemoglobin metabolic process|heme metabolic process|positive regulation of tyrosine phosphorylation of Stat1 protein|regulation of protein metabolic process|positive regulation of response to interferon-gamma|positive regulation of interferon-gamma-mediated signaling pathway|,heme binding|metal ion binding|,34,162,1.55E+11,53.0%
Q06890,0.899330297,0.275416667,0.798518339,-0.0635,0.832047588,-0.22151519,0.3035,0.082,0.536,0.656,0.128,-0.053,Q06890,Clu,Q06890_Clu,Q06890,Clu,1,172,33,33,Q06890,MOUSE,52282.3,45.7,51,51.1,521.16,521.16,,448,Clusterin,extracellular space|intracellular|nucleus|cytoplasm|mitochondrion|endoplasmic reticulum|cytosol|extracellular matrix|mitochondrial membrane|spherical high-density lipoprotein particle|chromaffin granule|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|neurofibrillary tangle|apical dendrite|extracellular matrix|,cell morphogenesis|microglial cell activation|response to virus|protein import|central nervous system myelin maintenance|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|negative regulation of protein homooligomerization|positive regulation of tumor necrosis factor production|positive regulation of apoptotic process|positive regulation of nitric oxide biosynthetic process|protein stabilization|positive regulation of NF-kappaB transcription factor activity|chaperone-mediated protein complex assembly|response to misfolded protein|chaperone-mediated protein folding|microglial cell proliferation|intrinsic apoptotic signaling pathway|regulation of beta-amyloid clearance|regulation of neuron death|positive regulation of neuron death|positive regulation of beta-amyloid formation|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage|negative regulation of beta-amyloid formation|regulation of neuronal signal transduction|positive regulation of tau-protein kinase activity|positive regulation of neurofibrillary tangle assembly|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of intrinsic apoptotic signaling pathway|,protein binding|ubiquitin protein ligase binding|misfolded protein binding|ATPase activity|,33,172,4.44E+11,45.7%
Q01339,0.96490813,0.176583333,0.204090772,-0.027166667,0.954093469,-0.060057268,-0.5915,0.094,1.068,0.362,0.144,-0.017,Q01339,Apoh,Q01339_Apoh,Q01339,Apoh,1,196,33,33,Q01339,MOUSE,39930.4,70.7,52,52.1,497.06,497.06,,345,Beta-2-glycoprotein 1,extracellular space|cell surface|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|extracellular matrix|,"negative regulation of endothelial cell proliferation|triglyceride metabolic process|blood coagulation, intrinsic pathway|negative regulation of endothelial cell migration|negative regulation of angiogenesis|regulation of blood coagulation|negative regulation of blood coagulation|organ regeneration|plasminogen activation|negative regulation of myeloid cell apoptotic process|negative regulation of smooth muscle cell apoptotic process|positive regulation of lipoprotein lipase activity|regulation of fibrinolysis|negative regulation of fibrinolysis|",glycoprotein binding|phospholipid binding|heparin binding|lipid binding|identical protein binding|lipoprotein lipase activator activity|,33,196,7.35E+11,70.7%
E9QPD7,0.14994666,1.19975,18.14423686,-1.8255,0.015331206,-3.376008969,2.1995,1.992,2.146,1.438,-0.627,0.05,E9QPD7,Pcx,E9QPD7_Pcx,E9QPD7,Pcx,1,76,38,38,E9QPD7|G5E8R3|Q05920,MOUSE,130571.1,34.8,53,53.1,484.29,484.29,,1179,Pyruvate carboxylase,mitochondrion|,pyruvate metabolic process|gluconeogenesis|negative regulation of gene expression|viral RNA genome packaging|positive regulation by host of viral release from host cell|,DNA binding|biotin carboxylase activity|pyruvate carboxylase activity|ATP binding|biotin binding|metal ion binding|,38,76,10700000000,34.8%
Q8VCU2,0.888540941,0.19225,0.939067224,-0.2005,0.805551439,-0.257487314,-0.8025,-0.421,2.101,0.251,0.015,0.01,Q8VCU2,Gpld1,Q8VCU2_Gpld1,Q8VCU2,Gpld1,1,120,32,32,Q8VCU2|O70362,MOUSE,94192.4,44.2,54,54.1,480.09,480.09,,842,Glycosylphosphatidylinositol specific phospholipase D1,proteinaceous extracellular matrix|extracellular space|intracellular|cytoplasm|lysosomal membrane|intracellular membrane-bounded organelle|extracellular exosome|,cell migration involved in sprouting angiogenesis|complement receptor mediated signaling pathway|GPI anchor release|negative regulation of cell proliferation|insulin receptor signaling pathway|response to glucose|positive regulation of endothelial cell migration|cellular response to insulin stimulus|cellular response to drug|positive regulation of apoptotic process|positive regulation of cytolysis|positive regulation of membrane protein ectodomain proteolysis|cellular response to calcium ion|cellular response to cholesterol|cellular response to triglyceride|cellular response to pH|regulation of cellular response to insulin stimulus|,glycosylphosphatidylinositol phospholipase D activity|phospholipase D activity|protein binding|,32,120,63100000000,44.2%
O89020,0.315406172,-0.32575,10.21188667,0.852166667,0.095238234,1.984722003,-0.3855,-0.206,-1.664,0.194,0.111,-0.004,O89020,Afm,O89020_Afm,O89020,Afm,1,127,35,35,O89020|O89020-3|O89020-2,MOUSE,71317.7,53.6,55,55.1,472.88,472.88,,608,Afamin,extracellular space|extracellular exosome|blood microparticle|,vitamin transport|,vitamin E binding|,35,127,64400000000,53.6%
Q19LI2,0.878945326,0.721083333,1.064476423,0.2425,0.782622551,0.288792462,0.2805,0.077,1.442,-0.179,2.626,0.08,Q19LI2,A1bg,Q19LI2_A1bg,Q19LI2,A1bg,1,176,30,30,Q19LI2,MOUSE,57237.7,66,56,56.1,470.14,470.14,,512,Alpha-1B-glycoprotein,extracellular region|extracellular space|extracellular exosome|blood microparticle|,,,30,176,6.96E+11,66.0%
E9PWQ3,0.861013543,-0.01725,1.226253194,-0.0775,0.75400579,-0.328089238,-0.0695,-0.107,0.241,-0.235,-0.057,0.124,E9PWQ3,NotFound,E9PWQ3_NotFound,E9PWQ3,Col6a3,1,62,39,39,E9PWQ3|J3QQ16|A0A087WS16,MOUSE,355522.7,12.7,57,57.1,463.78,463.78,,3284,"Collagen, type VI, alpha 3",proteinaceous extracellular matrix|collagen trimer|extracellular space|extracellular matrix|sarcolemma|extracellular exosome|extracellular vesicle|extracellular matrix|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,39,62,4800000000,12.7%
Q8CG16,0.878945326,0.014416667,1.072026148,0.1005,0.781263231,0.29055159,-0.5105,-0.2,0.603,0.245,-0.059,0.008,Q8CG16,C1ra,Q8CG16_C1ra,Q8CG16,C1ra,1,88,31,29,Q8CG16|Q8CFG9,MOUSE,81555.2,53.3,58,58.1,461.63,433.28,,707,Complement C1r-A subcomponent,extracellular exosome|blood microparticle|,"proteolysis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|calcium ion binding|,31,88,22900000000,53.3%
Q3UZ09,0.153374531,0.406083333,17.5517447,-0.782833333,0.017572175,-3.246721374,1.0825,0.555,0.755,0.108,-0.074,0.01,Q3UZ09,C1rl,Q3UZ09_C1rl,Q3UZ09,C1rl,1,24,14,12,Q3UZ09,MOUSE,54233.1,26.5,58,58.2,144.43,116.08,,482,Complement C1r subcomponent-like protein,extracellular space|extracellular exosome|,"proteolysis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|,12,24,1550000000,22.1%
Q8CG14,0.328865496,-0.490916667,9.431217725,1.159833333,0.113993012,1.854144033,-0.7395,-0.031,-2.442,0.259,0.002,0.006,Q8CG14,C1s1,Q8CG14_C1s1,Q8CG14,C1sa,1,96,26,26,Q8CG14|E9Q6C2|A0A1W2P7F1|Q8CFG8,MOUSE,78396.6,48.4,59,59.1,457.61,457.61,,688,Complement C1s-A subcomponent,extracellular exosome|blood microparticle|,"proteolysis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|calcium ion binding|identical protein binding|,26,96,25900000000,48.4%
P13020,0.841448046,0.102583333,1.427315019,-0.105166667,0.719893907,-0.37596585,-0.0945,-0.061,0.621,0.023,0.141,-0.014,P13020,Gsn,P13020_Gsn,P13020,Gsn,1,84,31,31,P13020|P13020-2,MOUSE,86339.4,38.5,60,60.1,447.98,447.98,,780,Gelsolin,ruffle|podosome|extracellular region|extracellular space|cytoplasm|cytosol|plasma membrane|focal adhesion|sarcoplasm|lamellipodium|actin cap|cortical actin cytoskeleton|myelin sheath|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|nucleus|focal adhesion|cortical actin cytoskeleton|,"phagocytosis, engulfment|aging|positive regulation of gene expression|oligodendrocyte development|striated muscle atrophy|vesicle-mediated transport|actin filament polymerization|protein destabilization|tissue regeneration|sequestering of actin monomers|actin nucleation|response to ethanol|negative regulation of viral entry into host cell|phosphatidylinositol-mediated signaling|actin filament severing|barbed-end actin filament capping|positive regulation of actin nucleation|response to folic acid|actin filament capping|cilium morphogenesis|cellular response to cadmium ion|regulation of podosome assembly|actin filament reorganization|renal protein absorption|hepatocyte apoptotic process|positive regulation of keratinocyte apoptotic process|regulation of wound healing, spreading of epidermal cells|regulation of establishment of T cell polarity|regulation of plasma membrane raft polarization|regulation of receptor clustering|positive regulation of protein processing in phagocytic vesicle|amyloid fibril formation|positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|",actin binding|calcium ion binding|protein binding|protein domain specific binding|myosin II binding|,31,84,62500000000,38.5%
B2RPV6,0.641826969,0.42275,3.655209226,-0.474833333,0.431001794,-0.845097812,1.4395,-0.534,1.075,0.175,0.537,-0.156,B2RPV6,Mmrn1,B2RPV6_Mmrn1,B2RPV6,Mmrn1,1,74,36,36,B2RPV6|G3UVV6|A0A0N4SVL8,MOUSE,137358.3,30.8,61,61.1,443.73,443.73,,1210,Multimerin-1,extracellular region|,,,36,74,7090000000,30.8%
Q8BPB5,0.838918339,0.174416667,1.459397553,-0.130833333,0.714595447,-0.383615141,0.1335,-0.263,0.849,0.021,0.285,0.021,Q8BPB5,Efemp1,Q8BPB5_Efemp1,Q8BPB5,Efemp1,1,94,27,27,Q8BPB5,MOUSE,57234.1,59.2,62,62.1,442.07,442.07,,493,EGF-containing fibulin-like extracellular matrix protein 1,proteinaceous extracellular matrix|extracellular space|extracellular exosome|extracellular matrix|,"regulation of transcription, DNA-templated|epidermal growth factor receptor signaling pathway|peptidyl-tyrosine phosphorylation|negative regulation of chondrocyte differentiation|",epidermal growth factor-activated receptor activity|epidermal growth factor receptor binding|calcium ion binding|growth factor activity|,27,94,63200000000,59.2%
Q61508,0.951678117,0.789083333,0.302507297,-0.072166667,0.932715664,-0.088096005,2.0415,0.381,0.053,0.342,2.196,-0.279,Q61508,Ecm1,Q61508_Ecm1,Q61508,Ecm1,1,91,31,31,Q61508|F8WI14|Q61508-2,MOUSE,64485.6,59.9,63,63.1,429.32,429.32,,559,Extracellular matrix protein 1,proteinaceous extracellular matrix|extracellular space|extracellular matrix|extracellular exosome|,ossification|angiogenesis|positive regulation of endothelial cell proliferation|negative regulation of cytokine-mediated signaling pathway|regulation of type 2 immune response|regulation of transcription from RNA polymerase II promoter|inflammatory response|signal transduction|negative regulation of peptidase activity|negative regulation of bone mineralization|biomineral tissue development|positive regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of angiogenesis|regulation of T cell migration|,protease binding|signal transducer activity|interleukin-2 receptor binding|protein C-terminus binding|enzyme binding|laminin binding|,31,91,43200000000,59.9%
Q5XQN5,0.318473122,0.312083333,10.01969039,-2.0255,0.099547638,-1.952563772,3.3405,1.488,-0.854,-1.17,-0.417,-0.515,Q5XQN5,NotFound,Q5XQN5_NotFound,Q5XQN5,KRT5,1,106,36,23,Q5XQN5|Q922U2|P07744|P11679|Q99M73|Q9DCV7|P19246,BOVIN,63107,41,64,64.1,411.21,256.89,,601,"Keratin, type II cytoskeletal 5",,,,37,106,77600000000,41.0%
P50446,0.199303152,0.68875,14.64078743,-2.8015,0.034349566,-2.739738518,3.7525,2.505,0.011,-1.405,-1.045,0.314,P50446,Krt6a,P50446_Krt6a,P50446,Krt6a,1,11,22,7,P50446|Q9Z331|Q3UV11|Q6IFZ8,MOUSE,59676.4,30.9,64,64.2,246.89,72.15,,553,"Keratin, type II cytoskeletal 6A",keratin filament|extracellular exosome|,morphogenesis of an epithelium|Wnt signaling pathway|keratinization|wound healing|intermediate filament organization|,structural molecule activity|,7,11,3660000000,11.0%
Q3TTY5,0.32515976,0.36025,9.62591636,-1.185166667,0.108995449,-1.886705444,2.3225,0.433,0.103,-0.632,0.101,-0.166,Q3TTY5,Krt2,Q3TTY5_Krt2,Q3TTY5,Krt2,1,42,15,9,Q3TTY5,MOUSE,71377.9,12.3,64,64.3,169.71,101.92,,707,"Keratin, type II cytoskeletal 2 epidermal",extracellular space|nucleus|Golgi apparatus|membrane|keratin filament|extracellular exosome|,keratinization|keratinocyte activation|keratinocyte proliferation|keratinocyte migration|,structural molecule activity|,9,42,40900000000,9.0%
Q3UV17,0.194325351,0.46075,14.9226036,-2.618166667,0.032191383,-2.789307082,3.8145,1.407,0.088,-1.293,-0.558,-0.694,Q3UV17,Krt76,Q3UV17_Krt76,Q3UV17,Krt76,1,7,12,1,Q3UV17,MOUSE,63357,13.8,64,64.4,150.76,17.6,,594,"Keratin, type II cytoskeletal 2 oral",nucleus|keratin filament|extracellular exosome|,epidermis development|sebaceous gland development|,structural molecule activity|,1,7,40500000000,1.5%
Q6IFZ6,0.31416078,0.152916667,10.29596261,-2.045833333,0.09341223,-1.998794394,3.5235,0.456,-0.452,-0.835,-0.542,-1.233,Q6IFZ6,Krt77,Q6IFZ6_Krt77,Q6IFZ6,Krt77,1,4,10,3,Q6IFZ6|Q6IFZ9,MOUSE,61414.7,12,64,64.5,107.56,30.97,,572,"Keratin, type II cytoskeletal 1b",cytoskeleton|keratin filament|extracellular exosome|,,structural molecule activity|,3,4,150000000,5.7%
Q8VED5,0.266783375,0.251583333,11.54274328,-2.1385,0.070101235,-2.20812692,3.3215,1.273,-0.632,-1.106,-0.616,-0.731,Q8VED5,Krt79,Q8VED5_Krt79,Q8VED5,Krt79,1,7,10,1,Q8VED5,MOUSE,57836.6,10.3,64,64.6,102.21,19.85,,531,"Keratin, type II cytoskeletal 79",keratin filament|extracellular exosome|,,structural molecule activity|enzyme binding|,1,7,3110000000,2.2%
Q6NXH9,0.315406172,0.51075,10.19000823,-2.1375,0.095719226,-1.981060583,3.5005,2.089,-0.851,-0.746,-0.321,-0.607,Q6NXH9,Krt73,Q6NXH9_Krt73,Q6NXH9,Krt73,1,6,9,3,Q6NXH9,MOUSE,59538,11.1,64,64.7,101.29,24.01,,539,"Keratin, type II cytoskeletal 73",nucleus|keratin filament|extracellular exosome|,activation of mitophagy in response to mitochondrial depolarization|,structural molecule activity|,3,6,15200000000,4.0%
P04104,0.477427431,-0.013416667,5.95380302,-1.723833333,0.253874861,-1.264055523,3.4905,1.179,-2.124,-1.203,-0.617,-0.806,P04104,Krt1,P04104_Krt1,P04104,Krt1,1,18,8,4,P04104,MOUSE,66118.3,6.4,64,64.8,108.62,59.05,,637,"Keratin, type II cytoskeletal 1",extracellular space|nucleus|plasma membrane|membrane|extracellular matrix|keratin filament|extracellular exosome|blood microparticle|,"complement activation, lectin pathway|retina homeostasis|negative regulation of inflammatory response|establishment of skin barrier|",structural molecule activity|carbohydrate binding|,4,18,61000000000,2.0%
Q9R0H5,0.852168246,0.841,1.3095742,0.373333333,0.739677793,0.356859933,,0.561,,2.172,-0.211,0.842,Q9R0H5,Krt71,Q9R0H5_Krt71,Q9R0H5,Krt71,1,1,7,1,Q9R0H5,MOUSE,57895,10.1,64,64.9,88.05,8.21,,524,"Keratin, type II cytoskeletal 71",cytoplasm|keratin filament|extracellular exosome|,hair follicle morphogenesis|intermediate filament organization|,structural molecule activity|,1,1,1520000,2.2%
Q6IME9,0.745307288,-0.266083333,2.37214761,-0.975833333,0.579142237,-0.586720549,3.3025,0.884,-3.521,-1.022,-0.424,-0.816,Q6IME9,Krt72,Q6IME9_Krt72,Q6IME9,Krt72,1,2,5,1,Q6IME9,MOUSE,57262.8,7.3,64,64.1,62.07,15.75,,520,"Keratin, type II cytoskeletal 72",keratin filament|extracellular exosome|,,structural molecule activity|,1,2,8300000,2.3%
Q9ESB3,0.723082565,0.18825,2.76889554,0.274166667,0.528579658,0.669370632,-0.4485,0.289,0.313,1.038,-0.048,-0.014,Q9ESB3,Hrg,Q9ESB3_Hrg,Q9ESB3,Hrg,1,149,25,25,A0A0R4J039|Q9ESB3,MOUSE,60131.6,42.8,65,65.1,402.8,402.8,,525,Histidine-rich glycoprotein,extracellular region|vesicle|endolysosome|phagolysosome membrane|,angiogenesis|positive regulation of immune response to tumor cell|chemotaxis|negative regulation of cell adhesion|negative regulation of cell proliferation|regulation of gene expression|regulation of platelet activation|negative regulation of lamellipodium assembly|negative regulation of endopeptidase activity|response to organic cyclic compound|heme transport|negative regulation of angiogenesis|platelet activation|regulation of blood coagulation|negative regulation of cell growth|regulation of actin cytoskeleton organization|negative regulation of cell adhesion mediated by integrin|regulation of transcription from RNA polymerase II promoter in response to iron|fibrinolysis|positive regulation of apoptotic process|regulation of protein complex assembly|negative regulation of blood vessel endothelial cell migration|regulation of peptidyl-tyrosine phosphorylation|defense response to fungus|positive regulation of focal adhesion assembly|negative regulation of fibrinolysis|heme export|negative regulation of vascular endothelial growth factor signaling pathway|positive regulation of blood vessel remodeling|negative regulation of endothelial cell chemotaxis|,serine-type endopeptidase inhibitor activity|cysteine-type endopeptidase inhibitor activity|receptor binding|protein binding|heparin binding|zinc ion binding|immunoglobulin binding|heme binding|heparan sulfate proteoglycan binding|metal ion binding|,25,149,4.86E+11,42.8%
P97290,0.555101425,-0.029083333,4.772961647,0.282833333,0.333199112,1.052388468,-0.5525,-0.035,0.076,0.307,0.055,-0.025,P97290,Serping1,P97290_Serping1,P97290,Serping1,1,110,26,26,P97290|A2ATR8,MOUSE,55868.8,38.8,66,66.1,381.91,381.91,,504,Plasma protease C1 inhibitor,extracellular space|extracellular exosome|blood microparticle|,"negative regulation of complement activation, lectin pathway|complement activation, classical pathway|aging|blood coagulation|negative regulation of endopeptidase activity|fibrinolysis|innate immune response|",serine-type endopeptidase inhibitor activity|,26,110,91700000000,38.8%
Q61247,0.233962779,-0.114916667,12.88054849,0.6905,0.051516358,2.425720138,-0.5685,-0.055,-0.757,0.366,0.353,-0.028,Q61247,Serpinf2,Q61247_Serpinf2,Q61247,Serpinf2,1,134,24,24,Q61247,MOUSE,55199.1,39.9,67,67.1,380.87,380.87,,491,Alpha-2-antiplasmin,fibrinogen complex|extracellular space|cell surface|extracellular exosome|blood microparticle|,regulation of blood vessel size by renin-angiotensin|acute-phase response|response to organic substance|negative regulation of plasminogen activation|negative regulation of endopeptidase activity|collagen fibril organization|positive regulation of collagen biosynthetic process|positive regulation of cell differentiation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of JNK cascade|blood vessel morphogenesis|positive regulation of smooth muscle cell proliferation|positive regulation of stress fiber assembly|negative regulation of fibrinolysis|positive regulation of ERK1 and ERK2 cascade|positive regulation of transforming growth factor beta production|,protease binding|serine-type endopeptidase inhibitor activity|protein homodimerization activity|,24,134,3.75E+11,39.9%
A2A7A7,0.932038361,0.04725,0.476644576,-0.049833333,0.896056805,-0.136377909,-0.2925,-0.292,0.801,0.008,-0.107,0.166,A2A7A7,H6pd,A2A7A7_H6pd,A2A7A7,H6pd,1,71,27,27,A2A7A7|Q8CFX1,MOUSE,90478.8,36,68,68.1,372.92,372.92,,797,GDH/6PGL endoplasmic bifunctional protein,mitochondrion|,glucose metabolic process|pentose-phosphate shunt|oxidation-reduction process|response to alcohol|,glucose-6-phosphate dehydrogenase activity|6-phosphogluconolactonase activity|carbohydrate binding|NADP binding|,27,71,15400000000,36.0%
Q9JKR6,0.759970158,0.11275,2.063536369,-0.288166667,0.621793765,-0.520311445,-0.4965,-0.229,1.496,-0.163,0.061,0.008,Q9JKR6,Hyou1,Q9JKR6_Hyou1,Q9JKR6,Hyou1,1,65,28,28,Q9JKR6|E0CYZ2,MOUSE,111407.3,30.6,69,69.1,368.82,368.82,,999,Hypoxia up-regulated protein 1,extracellular region|endoplasmic reticulum lumen|focal adhesion|membrane|endoplasmic reticulum chaperone complex|extracellular exosome|,response to ischemia|response to endoplasmic reticulum stress|negative regulation of apoptotic process|cellular response to hypoxia|negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway|negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway|,ATP binding|,28,65,6510000000,30.6%
Q3UER8,0.664485431,0.923583333,3.402910039,-1.065833333,0.456782015,-0.796161885,3.6255,-0.183,0.927,-0.436,2.649,-1.041,Q3UER8,Fgg,Q3UER8_Fgg,Q3UER8,Fgg,1,106,26,26,Q3UER8|Q8VCM7|P12799|F1MGU7|Q3SZZ9,MOUSE,51033.2,55.7,70,70.1,365.71,365.71,,443,Fibrinogen gamma chain,fibrinogen complex|extracellular space|cell cortex|external side of plasma membrane|cell surface|platelet alpha granule|extracellular exosome|blood microparticle|,"cell-matrix adhesion|signal transduction|protein secretion|plasminogen activation|positive regulation of heterotypic cell-cell adhesion|fibrinolysis|cellular protein complex assembly|positive regulation of vasoconstriction|positive regulation of exocytosis|positive regulation of protein secretion|protein polymerization|response to calcium ion|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|blood coagulation, fibrin clot formation|positive regulation of peptide hormone secretion|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|negative regulation of endothelial cell apoptotic process|","receptor binding|structural molecule activity|protein binding, bridging|cell adhesion molecule binding|",26,106,1.14E+11,55.7%
F8VQ07,0.669813064,0.006083333,3.305739047,0.209166667,0.467117454,0.776267306,-0.4635,-0.028,0.196,0.312,0.047,-0.027,F8VQ07,5830473C10Rik,F8VQ07_5830473C10Rik,F8VQ07,5830473C10Rik,1,63,29,29,F8VQ07|A0A0J9YV75,MOUSE,72340.4,41.7,71,71.1,360.29,360.29,,620,RIKEN cDNA 5830473C10 gene,extracellular space|,transport|,,29,63,6460000000,41.7%
Q9QWK4,0.745307288,0.119583333,2.357623329,0.224833333,0.581082327,0.583639171,0.4565,-0.208,-0.227,-0.179,0.89,-0.015,Q9QWK4,Cd5l,Q9QWK4_Cd5l,Q9QWK4,Cd5l,1,101,24,24,Q9QWK4,MOUSE,40345.4,57.1,72,72.1,353.12,353.12,,352,CD5 antigen-like,membrane|extracellular exosome|blood microparticle|,receptor-mediated endocytosis|apoptotic process|,scavenger receptor activity|,24,101,1.82E+11,57.1%
Q8BH61,0.890329957,1.16025,0.876970712,-0.227166667,0.817152152,-0.241761334,2.3225,0.816,0.683,0.49,2.959,-0.309,Q8BH61,F13a1,Q8BH61_F13a1,Q8BH61,F13a1,1,74,24,24,Q8BH61,MOUSE,83719.2,28.4,73,73.1,353.01,353.01,,732,Coagulation factor XIII A chain,cytoplasm|blood microparticle|,blood coagulation|peptide cross-linking|,protein-glutamine gamma-glutamyltransferase activity|metal ion binding|,24,74,14400000000,28.4%
A2AS37,0.291894959,-0.053416667,10.89240932,0.528833333,0.081425244,2.092095203,-0.4605,-0.161,-0.332,0.533,0.119,-0.019,A2AS37,AI182371,A2AS37_AI182371,A2AS37,AI182371,1,82,22,22,A2AS37,MOUSE,40887.3,52.2,74,74.1,350.48,350.48,,356,Expressed sequence AI182371,extracellular region|,inflammatory response|complement activation|negative regulation of endopeptidase activity|,endopeptidase inhibitor activity|,22,82,76900000000,52.2%
P26928,0.408398537,-0.35025,7.434030146,0.7545,0.180549789,1.518457482,-0.3665,-0.006,-1.81,0.119,-0.049,0.011,P26928,Mst1,P26928_Mst1,P26928,Mst1,1,67,27,27,P26928|E0CXN0,MOUSE,83185.1,39.1,75,75.1,349.98,349.98,,716,Hepatocyte growth factor-like protein,extracellular exosome|,proteolysis|spermatogenesis|embryo implantation|sperm motility|,serine-type endopeptidase activity|,27,67,13400000000,39.1%
P49182,0.289535283,-0.05475,10.94709187,0.552166667,0.080406436,2.101206558,-0.5525,-0.23,-0.21,0.567,0.09,0.007,P49182,Serpind1,P49182_Serpind1,P49182,Serpind1,1,108,24,24,P49182,MOUSE,54781,47.6,76,76.1,349.56,349.56,,478,Heparin cofactor 2,extracellular space|extracellular exosome|,blood coagulation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|heparin binding|,24,108,96900000000,47.6%
Q01279,0.699470325,0.063416667,3.022680152,0.259166667,0.498576707,0.720674879,-0.2345,-0.459,0.495,-0.242,0.5,0.321,Q01279,Egfr,Q01279_Egfr,Q01279,Egfr,1,77,25,25,Q01279|Q9WVF5,MOUSE,138274.2,18,77,77.1,343.23,343.23,,1210,Epidermal growth factor receptor,"Golgi membrane|intracellular|nucleus|cytoplasm|endosome|endoplasmic reticulum membrane|plasma membrane|focal adhesion|cell surface|endosome membrane|membrane|integral component of membrane|basolateral plasma membrane|endocytic vesicle|early endosome membrane|nuclear membrane|receptor complex|membrane raft|perinuclear region of cytoplasm|multivesicular body, internal vesicle lumen|",cell morphogenesis|embryonic placenta development|positive regulation of protein phosphorylation|hair follicle development|signal transduction|cell surface receptor signaling pathway|epidermal growth factor receptor signaling pathway|salivary gland morphogenesis|learning or memory|cell proliferation|positive regulation of cell proliferation|epidermis development|single organismal cell-cell adhesion|peptidyl-tyrosine phosphorylation|cerebral cortex cell migration|signal transduction by protein phosphorylation|positive regulation of cell migration|positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle|positive regulation of catenin import into nucleus|regulation of cell proliferation|negative regulation of protein catabolic process|positive regulation of phosphorylation|negative regulation of apoptotic process|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of DNA repair|positive regulation of DNA replication|positive regulation of transcription from RNA polymerase II promoter|protein autophosphorylation|positive regulation of fibroblast proliferation|digestive tract morphogenesis|positive regulation of epithelial cell proliferation|regulation of peptidyl-tyrosine phosphorylation|regulation of nitric-oxide synthase activity|positive regulation of protein kinase B signaling|morphogenesis of an epithelial fold|response to UV-A|positive regulation of ERK1 and ERK2 cascade|cellular response to amino acid stimulus|cellular response to epidermal growth factor stimulus|cellular response to estradiol stimulus|,chromatin binding|protein tyrosine kinase activity|receptor signaling protein tyrosine kinase activity|signal transducer activity|transmembrane signaling receptor activity|epidermal growth factor-activated receptor activity|protein binding|ATP binding|kinase activity|enzyme binding|protein phosphatase binding|ubiquitin protein ligase binding|identical protein binding|protein heterodimerization activity|actin filament binding|nitric-oxide synthase regulator activity|,25,77,30600000000,18.0%
Q8BHN3-2,0.849755878,0.002583333,1.328121285,0.0895,0.736525642,0.352507629,-0.2395,-0.216,0.329,0.053,0.109,-0.02,Q8BHN3,Ganab,Q8BHN3-2_Ganab,Q8BHN3-2,Ganab,1,54,28,28,Q8BHN3-2|Q8BHN3|Q8BHN3-3,MOUSE,109858.4,28.7,78,78.1,336.6,336.6,,944,Isoform 2 of Neutral alpha-glucosidase AB,endoplasmic reticulum|Golgi apparatus|membrane|glucosidase II complex|melanosome|extracellular exosome|,N-glycan processing|,"protein binding|glucosidase activity|carbohydrate binding|glucan 1,3-alpha-glucosidase activity|poly(A) RNA binding|",28,54,6080000000,28.7%
Q8R121,0.407329798,0.00375,7.556244156,0.359833333,0.175539794,1.535883307,-0.3295,-0.2,0.001,0.207,0.363,-0.019,Q8R121,Serpina10,Q8R121_Serpina10,Q8R121,Serpina10,1,79,23,23,Q8R121|Q8R121-2,MOUSE,51910.6,46.8,79,79.1,330.79,330.79,,448,Protein Z-dependent protease inhibitor,extracellular space|extracellular exosome|,blood coagulation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|heparin binding|,23,79,25100000000,46.8%
P14211,0.477427431,-0.248916667,5.971420013,0.463166667,0.252847113,1.267068332,-1.1235,-0.486,0.168,-0.029,-0.034,0.011,P14211,Calr,P14211_Calr,P14211,Calr,1,69,24,24,P14211,MOUSE,48164.8,46.3,80,80.1,330.5,330.5,,416,Calreticulin,acrosomal vesicle|extracellular region|extracellular space|nucleus|cytoplasm|endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|Golgi apparatus|cytosol|polysome|focal adhesion|external side of plasma membrane|membrane|extracellular matrix|sarcoplasmic reticulum lumen|MHC class I peptide loading complex|phagocytic vesicle|perinuclear region of cytoplasm|extracellular exosome|,"negative regulation of transcription from RNA polymerase II promoter|peptide antigen assembly with MHC class I protein complex|protein export from nucleus|cell cycle arrest|spermatogenesis|positive regulation of cell proliferation|positive regulation of gene expression|negative regulation of translation|cortical actin cytoskeleton organization|response to estradiol|negative regulation of intracellular steroid hormone receptor signaling pathway|response to testosterone|protein localization to nucleus|regulation of meiotic nuclear division|response to drug|negative regulation of neuron differentiation|positive regulation of DNA replication|positive regulation of cell cycle|negative regulation of transcription, DNA-templated|negative regulation of retinoic acid receptor signaling pathway|positive regulation of phagocytosis|protein stabilization|cardiac muscle cell differentiation|chaperone-mediated protein folding|cellular response to lithium ion|cellular response to organic substance|cellular senescence|positive regulation of substrate adhesion-dependent cell spreading|positive regulation of dendritic cell chemotaxis|",glycoprotein binding|mRNA binding|integrin binding|iron ion binding|calcium ion binding|protein binding|carbohydrate binding|ubiquitin protein ligase binding|peptide binding|hormone binding|poly(A) RNA binding|androgen receptor binding|unfolded protein binding|,24,69,32100000000,46.3%
P39039,0.413719377,-0.16275,7.3406319,0.492166667,0.184474699,1.500290759,-1.0215,0.008,-0.213,0.186,0.018,0.046,P39039,Mbl1,P39039_Mbl1,P39039,Mbl1,1,115,20,20,P39039|P39039-2|A0A2C9F2B6,MOUSE,25852,66.9,81,81.1,307.81,307.81,,239,Mannose-binding protein A,collagen trimer|extracellular space|,"complement activation, lectin pathway|complement activation, classical pathway|negative regulation of growth of symbiont in host|positive regulation of phagocytosis|defense response to Gram-positive bacterium|protein homotetramerization|killing by host of symbiont cells|protein homotrimerization|",protease binding|calcium ion binding|mannose binding|polysaccharide binding|protein homodimerization activity|calcium-dependent protein binding|phosphatidylinositol-4-phosphate binding|,20,115,5.27E+11,66.9%
P08226,0.641826969,-0.028416667,3.652331467,0.214833333,0.431287482,0.843578326,-0.3045,-0.142,0.039,-0.245,0.207,0.275,P08226,Apoe,P08226_Apoe,P08226,Apoe,1,75,24,24,P08226,MOUSE,35923,58.8,82,82.1,306.67,306.67,,311,Apolipoprotein E,extracellular region|extracellular space|nucleus|endoplasmic reticulum|Golgi apparatus|cytosol|membrane|extracellular matrix|very-low-density lipoprotein particle|low-density lipoprotein particle|intermediate-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|extracellular vesicle|,negative regulation of endothelial cell proliferation|response to dietary excess|lipid metabolic process|triglyceride metabolic process|cholesterol biosynthetic process|cholesterol catabolic process|cellular calcium ion homeostasis|receptor-mediated endocytosis|response to oxidative stress|G-protein coupled receptor signaling pathway|nitric oxide mediated signal transduction|cholesterol metabolic process|regulation of gene expression|negative regulation of platelet activation|positive regulation of cholesterol esterification|positive regulation of cholesterol efflux|long-chain fatty acid transport|protein import|virion assembly|triglyceride catabolic process|cGMP-mediated signaling|negative regulation of blood coagulation|regulation of axon extension|positive regulation of cGMP biosynthetic process|regulation of cholesterol transport|regulation of Cdc42 protein signal transduction|positive regulation of low-density lipoprotein particle receptor catabolic process|cholesterol efflux|phospholipid efflux|very-low-density lipoprotein particle remodeling|low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|chylomicron remnant clearance|high-density lipoprotein particle clearance|very-low-density lipoprotein particle clearance|lipoprotein metabolic process|lipoprotein biosynthetic process|lipoprotein catabolic process|vasodilation|cholesterol homeostasis|negative regulation of MAP kinase activity|negative regulation of neuron apoptotic process|negative regulation of blood vessel endothelial cell migration|reverse cholesterol transport|positive regulation by host of viral process|negative regulation of cholesterol biosynthetic process|positive regulation of lipid biosynthetic process|artery morphogenesis|negative regulation of inflammatory response|positive regulation of nitric-oxide synthase activity|positive regulation of membrane protein ectodomain proteolysis|negative regulation of lipid biosynthetic process|maintenance of location in cell|lipid homeostasis|fatty acid homeostasis|positive regulation of dendritic spine development|negative regulation of dendritic spine development|cardiovascular system development|negative regulation of cholesterol efflux|alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering|N-methyl-D-aspartate receptor clustering|regulation of beta-amyloid clearance|regulation of neuron death|negative regulation of neuron death|positive regulation of neuron death|negative regulation of postsynaptic membrane organization|positive regulation of postsynaptic membrane organization|negative regulation of presynaptic membrane organization|positive regulation of presynaptic membrane organization|positive regulation of beta-amyloid formation|negative regulation of beta-amyloid formation|regulation of tau-protein kinase activity|negative regulation of dendritic spine maintenance|positive regulation of dendritic spine maintenance|positive regulation of phospholipid efflux|positive regulation of neurofibrillary tangle assembly|negative regulation of phospholipid efflux|negative regulation of lipid transport across blood brain barrier|positive regulation of lipid transport across blood brain barrier|protein localization|axon regeneration|,beta-amyloid binding|lipid transporter activity|protein binding|phospholipid binding|heparin binding|lipid binding|cholesterol binding|antioxidant activity|cholesterol transporter activity|identical protein binding|protein homodimerization activity|metal chelating activity|tau protein binding|low-density lipoprotein particle receptor binding|phosphatidylcholine-sterol O-acyltransferase activator activity|very-low-density lipoprotein particle receptor binding|lipoprotein particle binding|,24,75,33300000000,58.8%
P00920,0.870047744,0.314916667,1.126924665,-0.143833333,0.771449556,-0.304164053,-0.2985,0.139,1.32,0.472,-0.146,0.403,P00920,Car2,P00920_Car2,P00920,Ca2,1,51,18,18,P00920|A0A0A6YX78|P00921,MOUSE,29146.1,66.5,83,83.1,306.31,306.31,,260,Carbonic anhydrase 2,extracellular space|cytoplasm|cytosol|plasma membrane|microvillus|basolateral plasma membrane|axon|myelin sheath|apical part of cell|extracellular exosome|,"kidney development|morphogenesis of an epithelium|one-carbon metabolic process|regulation of pH|response to pH|response to zinc ion|carbon dioxide transport|positive regulation of synaptic transmission, GABAergic|positive regulation of cellular pH reduction|angiotensin-activated signaling pathway|odontogenesis of dentin-containing tooth|response to estrogen|regulation of anion transport|positive regulation of osteoclast differentiation|positive regulation of bone resorption|secretion|regulation of intracellular pH|cellular response to fluid shear stress|positive regulation of dipeptide transmembrane transport|regulation of chloride transport|",arylesterase activity|carbonate dehydratase activity|zinc ion binding|,18,51,8390000000,66.5%
Q3U3V1,0.235410501,-0.31925,12.72818325,0.905166667,0.053355805,2.409085478,-0.7115,-0.16,-1.444,0.35,0.055,-0.005,Q3U3V1,F10,Q3U3V1_F10,Q3U3V1,F10,1,75,20,20,Q3U3V1|O88947|D3Z215|D3Z521,MOUSE,56680.8,40.9,84,84.1,305.63,305.63,,493,Coagulation factor X,extracellular region|membrane|intracellular membrane-bounded organelle|,proteolysis|blood coagulation|positive regulation of protein kinase B signaling|,serine-type endopeptidase activity|calcium ion binding|phospholipid binding|,20,75,69400000000,40.9%
Q64726,0.394562768,0.020083333,7.850588305,0.431833333,0.164036755,1.585396572,-0.2765,0.107,-0.418,0.512,0.241,-0.045,Q64726,Azgp1,Q64726_Azgp1,Q64726,Azgp1,1,63,21,21,Q64726,MOUSE,35559.5,53.7,85,85.1,300.68,300.68,,307,Zinc-alpha-2-glycoprotein,extracellular space|nucleus|plasma membrane|MHC class I protein complex|extracellular exosome|,detection of chemical stimulus involved in sensory perception of bitter taste|retina homeostasis|antigen processing and presentation of peptide antigen via MHC class I|immune response|cell adhesion|regulation of multicellular organism growth|,glycoprotein binding|peptide antigen binding|,21,63,31600000000,53.7%
P23953,0.351568198,-0.279416667,8.895017428,0.736166667,0.128972838,1.764412767,-0.4825,0.003,-1.463,0.315,-0.045,-0.004,P23953,Ces1c,P23953_Ces1c,P23953,Ces1c,1,58,20,12,P23953|Q8VCT4|E9PYP1,MOUSE,61339.9,34.1,86,86.1,296.6,187.34,,554,Carboxylesterase 1C,extracellular space|endoplasmic reticulum lumen|,metabolic process|,"hydrolase activity, acting on ester bonds|carboxylic ester hydrolase activity|",20,58,17000000000,34.1%
D3Z5G7,0.711200332,0.225416667,2.8705504,-0.2875,0.516350926,-0.690107621,-0.2405,0.141,1.207,0.286,-0.013,-0.028,D3Z5G7,Ces1b,D3Z5G7_Ces1b,D3Z5G7,Ces1b,1,11,16,7,D3Z5G7,MOUSE,62538.2,31.3,86,86.2,224.92,99.04,,567,Carboxylic ester hydrolase,,metabolic process|,hydrolase activity|,7,11,774000000,17.6%
Q8VCC2,0.216362079,-0.0395,13.59790172,1.158,0.043672678,2.912598341,,-0.908,,0.259,0.479,0.012,Q8VCC2,Ces1g,Q8VCC2_Ces1g,Q8VCC2,Ces1,1,1,4,1,Q8VCC2,MOUSE,63078.1,7.4,86,86.3,55.01,10.07,,565,Liver carboxylesterase 1,endoplasmic reticulum lumen|,metabolic process|,carboxylic ester hydrolase activity|,1,1,10700000,2.1%
Q8BK48,0.524335469,-0.038583333,5.193366362,0.2625,0.302456808,1.127987109,-0.4235,-0.017,-0.069,0.137,0.175,-0.034,Q8BK48,Ces2e,Q8BK48_Ces2e,Q8BK48,Ces2e,1,70,20,15,Q8BK48|F6Z9B9|Q08ED5|Q149K3,MOUSE,62716,39.1,87,87.1,295.77,229.97,,559,Pyrethroid hydrolase Ces2e,endoplasmic reticulum|,metabolic process|,carboxylic ester hydrolase activity|,20,70,14100000000,39.1%
Q91WG0,0.811118777,0.112416667,1.669711936,-0.202166667,0.680814515,-0.43240016,-0.7825,0.539,0.884,0.171,-0.092,-0.045,Q91WG0,Ces2c,Q91WG0_Ces2c,Q91WG0,Ces2c,1,15,14,7,Q91WG0,MOUSE,62753.8,26.7,87,87.2,193.78,97.8,,561,Acylcarnitine hydrolase,endoplasmic reticulum|intracellular membrane-bounded organelle|,metabolic process|,acylcarnitine hydrolase activity|,7,15,506000000,13.5%
Q8QZR3,0.216362079,-0.2367,13.55258846,0.672583333,0.044130734,2.675483722,-0.7085,-0.572,,0.089,-0.009,0.017,Q8QZR3,Ces2a,Q8QZR3_Ces2a,Q8QZR3,Ces2a,1,12,10,5,Q8QZR3|Q8QZR3-2,MOUSE,62395.6,17.7,87,87.3,133.23,69.99,,558,Pyrethroid hydrolase Ces2a,,,carboxylic ester hydrolase activity|,5,12,575000000,10.2%
Q6PDB7,0.590971393,0.01675,4.33311361,-0.724833333,0.36871316,-0.97309417,-0.0505,2.02,-0.832,0.011,-0.639,-0.409,Q6PDB7,Ces2b,Q6PDB7_Ces2b,Q6PDB7,Ces2b,1,1,9,1,Q6PDB7,MOUSE,62211.2,16,87,87.4,113.1,7.68,,556,Carboxylic ester hydrolase,,metabolic process|,hydrolase activity|,1,1,16900000,2.5%
Q61704,0.580131828,0.31925,4.476517434,-0.491833333,0.356737083,-0.999603298,0.1705,-0.107,1.632,0.254,-0.021,-0.013,Q61704,Itih3,Q61704_Itih3,Q61704,Itih3,1,63,22,22,Q61704,MOUSE,99698.3,25.3,88,88.1,294.79,294.79,,889,Inter-alpha-trypsin inhibitor heavy chain H3,extracellular exosome|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,22,63,25700000000,25.3%
A11111,0.353902242,-0.222083333,8.755099701,0.5075,0.133195646,1.736634257,-0.9255,-0.058,-0.444,0.161,-0.05,-0.016,A11111,NotFound,A11111_NotFound,A11111,,1,47,19,19,A11111|P06709,MOUSE,39099.5,69.3,89,89.1,287.99,287.99,,,BirAG3ER,,,,19,47,1.93E+11,69.3%
P63260,0.641826969,-0.000916667,3.660940256,-0.590833333,0.430433411,-0.846200495,0.4135,1.629,-1.159,-0.28,-0.474,-0.135,P63260,Actg1,P63260_Actg1,P63260,Actg1,1,58,20,1,P63260|G3UYG0|B1ATY1|Q8BFZ3|V9GXQ2,MOUSE,42134.4,49.6,90,90.1,287.72,23.1,,375,"Actin, cytoplasmic 2",extracellular space|nucleus|cytosol|plasma membrane|focal adhesion|actin cytoskeleton|membrane|myofibril|filamentous actin|costamere|myelin sheath|extracellular exosome|blood microparticle|dense body|,retina homeostasis|sarcomere organization|response to calcium ion|platelet aggregation|,structural constituent of cytoskeleton|protein binding|ATP binding|ubiquitin protein ligase binding|identical protein binding|,20,58,19900000000,49.6%
P60710,0.480058772,0.1575,5.889438656,-0.815416667,0.257665418,-1.280491074,-0.3485,1.642,,-0.036,-0.355,-0.115,P60710,Actb,P60710_Actb,P60710,Actb,1,3,20,1,P60710|E9Q1F2,MOUSE,42078.3,49.6,90,90.2,285.05,20.43,,375,"Actin, cytoplasmic 1",nuclear chromatin|extracellular space|cytosol|plasma membrane|focal adhesion|membrane|ribonucleoprotein complex|cortical cytoskeleton|NuA4 histone acetyltransferase complex|cytoplasmic ribonucleoprotein granule|myelin sheath|protein complex|extracellular exosome|MLL5-L complex|blood microparticle|dense body|,retina homeostasis|substantia nigra development|ATP-dependent chromatin remodeling|platelet aggregation|,protein binding|ATP binding|kinesin binding|Tat protein binding|identical protein binding|nitric-oxide synthase binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding|,1,3,224000000,4.5%
P68134,0.468259994,0.3445,6.179833321,-0.66125,0.240999792,-1.333587082,1.4255,0.057,,0.401,-0.14,-0.021,P68134,Acta1,P68134_Acta1,P68134,Acta1,1,4,16,3,P68134|P68033|P62737|P63268,MOUSE,42392.6,39.5,90,90.3,215.77,28.71,,377,"Actin, alpha skeletal muscle",stress fiber|extracellular space|cytoplasm|striated muscle thin filament|actin filament|actin cytoskeleton|sarcomere|lamellipodium|filopodium|protein complex|cell body|extracellular exosome|blood microparticle|,response to mechanical stimulus|response to extracellular stimulus|response to lithium ion|positive regulation of gene expression|cell growth|skeletal muscle thin filament assembly|skeletal muscle fiber adaptation|response to steroid hormone|skeletal muscle fiber development|mesenchyme migration|,protein binding|ATP binding|,3,4,872000000,12.9%
E9Q557,0.328865496,0.273083333,9.420930314,-1.946166667,0.114263354,-1.852423421,3.0965,1.744,-1.102,-1.081,-0.427,-0.592,E9Q557,Dsp,E9Q557_Dsp,E9Q557,Dsp,1,45,31,31,E9Q557|E9PZW0,MOUSE,335359.7,9.6,91,91.1,284.66,284.66,,2883,Desmoplakin,cornified envelope|nucleus|cytoplasm|plasma membrane|cell-cell junction|fascia adherens|intercalated disc|membrane|basolateral plasma membrane|desmosome|extracellular exosome|intermediate filament|,desmosome organization|ventricular compact myocardium morphogenesis|single organismal cell-cell adhesion|peptide cross-linking|keratinocyte differentiation|adherens junction organization|wound healing|skin development|intermediate filament cytoskeleton organization|intermediate filament organization|protein localization to adherens junction|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|regulation of ventricular cardiac muscle cell action potential|,"protein kinase C binding|structural molecule activity|protein binding|protein binding, bridging|poly(A) RNA binding|cell adhesion molecule binding|scaffold protein binding|",31,45,1180000000,9.6%
Q07456,0.32515976,-0.119916667,9.767242427,0.4565,0.10550566,1.904977321,-0.5305,-0.388,-0.126,0.321,0,0.004,Q07456,Ambp,Q07456_Ambp,Q07456,Ambp,1,62,18,18,Q07456,MOUSE,39941.4,48.7,92,92.1,280.99,280.99,,349,Protein AMBP,extracellular space|plasma membrane|cell surface|intracellular membrane-bounded organelle|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|protein-chromophore linkage|protein catabolic process|protein maturation|,serine-type endopeptidase inhibitor activity|IgA binding|heme binding|small molecule binding|protein homodimerization activity|,18,62,59600000000,48.7%
P97298,0.302686697,-0.38975,10.54506354,0.984833333,0.08820509,2.040510914,-0.7285,-0.051,-1.867,0.231,0.087,-0.01,P97298,Serpinf1,P97298_Serpinf1,P97298,Serpinf1,1,61,17,17,P97298|E9PWS2,MOUSE,46290.3,51,93,93.1,276.77,276.77,,417,Pigment epithelium-derived factor,extracellular region|basement membrane|extracellular space|melanosome|axon hillock|perinuclear region of cytoplasm|extracellular exosome|extracellular matrix|,kidney development|aging|short-term memory|response to acidic pH|negative regulation of endothelial cell migration|negative regulation of gene expression|negative regulation of endopeptidase activity|positive regulation of neuron projection development|negative regulation of angiogenesis|ovulation cycle|response to arsenic-containing substance|negative regulation of inflammatory response|positive regulation of neurogenesis|retina development in camera-type eye|negative regulation of epithelial cell proliferation involved in prostate gland development|cellular response to cobalt ion|cellular response to retinoic acid|cellular response to glucose stimulus|cellular response to dexamethasone stimulus|negative regulation of neuron death|,serine-type endopeptidase inhibitor activity|,17,61,13000000000,51.0%
O70165,0.533851106,-0.115916667,5.061225554,0.4225,0.311800958,1.105980095,-1.0355,-0.21,0.264,-0.014,0.325,-0.025,O70165,Fcna,O70165_Fcna,O70165,Fcn1,1,66,18,18,O70165,MOUSE,36868.4,38.9,94,94.1,272.41,272.41,,334,Ficolin-1,collagen trimer|extrinsic component of external side of plasma membrane|blood microparticle|,cell surface pattern recognition receptor signaling pathway|G-protein coupled receptor signaling pathway|recognition of apoptotic cell|negative regulation of viral entry into host cell|defense response to virus|negative regulation of RNA biosynthetic process|positive regulation of interleukin-8 secretion|,antigen binding|protein binding|signaling pattern recognition receptor activity|carbohydrate binding|metal ion binding|carbohydrate derivative binding|,18,66,65200000000,38.9%
P70389,0.600490317,0.132083333,4.220286512,-0.3695,0.378417619,-0.952108164,-0.0585,-0.104,1.113,-0.197,-0.015,0.054,P70389,Igfals,P70389_Igfals,P70389,Igfals,1,47,21,21,A0A0R4J0S2|P70389,MOUSE,67757.5,39.6,95,95.1,268.23,268.23,,603,Insulin-like growth factor-binding protein complex acid labile subunit,nucleoplasm|insulin-like growth factor ternary complex|extracellular exosome|,cell adhesion|,,21,47,5130000000,39.6%
P41317,0.170432716,-0.584916667,16.56129241,1.385166667,0.022073478,3.082774635,-1.2745,-0.435,-2.123,0.164,0.149,0.01,P41317,Mbl2,P41317_Mbl2,P41317,Mbl2,1,77,16,16,P41317,MOUSE,26356,59,96,96.1,264.96,264.96,,244,Mannose-binding protein C,collagen trimer|extracellular space|,"complement activation, lectin pathway|complement activation, classical pathway|negative regulation of growth of symbiont in host|innate immune response|negative regulation of viral process|positive regulation of phagocytosis|defense response to Gram-positive bacterium|killing by host of symbiont cells|",receptor binding|calcium ion binding|mannose binding|calcium-dependent protein binding|,16,77,1.52E+11,59.0%
P16294,0.140805649,-0.2843,18.98372677,1.009083333,0.012636515,3.802361438,-1.0185,-0.761,,0.23,0.12,0.008,P16294,F9,P16294_F9,P16294,F9,1,55,16,16,P16294,MOUSE,54289.1,42,97,97.1,264.2,264.2,,471,Coagulation factor IX,extracellular space|extracellular exosome|,proteolysis|blood coagulation|zymogen activation|,endopeptidase activity|serine-type endopeptidase activity|calcium ion binding|peptidase activity|,16,55,37800000000,42.0%
Q03311,0.322790308,-0.724583333,9.895302239,1.709833333,0.102440049,1.931757334,-0.7755,-0.311,-3.652,0.178,0.227,-0.014,Q03311,Bche,Q03311_Bche,Q03311,Bche,1,50,18,18,Q03311,MOUSE,68974.5,27.3,98,98.1,263.72,263.72,,603,Cholinesterase,nuclear envelope lumen|endoplasmic reticulum|endoplasmic reticulum lumen|membrane|blood microparticle|,learning|negative regulation of cell proliferation|neuroblast differentiation|choline metabolic process|response to drug|response to alkaloid|negative regulation of synaptic transmission|response to glucocorticoid|response to folic acid|,acetylcholinesterase activity|cholinesterase activity|choline binding|identical protein binding|,18,50,15100000000,27.3%
Q9JHH6,0.888683038,0.255083333,0.932411257,0.099833333,0.806786968,0.255808994,-0.1385,-0.193,0.947,0.407,0.535,-0.027,Q9JHH6,Cpb2,Q9JHH6_Cpb2,Q9JHH6,Cpb2,1,58,18,18,Q9JHH6,MOUSE,49269,36.7,99,99.1,263.13,263.13,,422,Carboxypeptidase B2,extracellular space|cell|extracellular exosome|,positive regulation of extracellular matrix constituent secretion|proteolysis|blood coagulation|response to heat|negative regulation of plasminogen activation|response to drug|fibrinolysis|negative regulation of fibrinolysis|cellular response to glucose stimulus|liver regeneration|negative regulation of hepatocyte proliferation|,carboxypeptidase activity|metallocarboxypeptidase activity|zinc ion binding|,18,58,26600000000,36.7%
Q02819,0.44527584,-0.18825,6.507813675,0.3685,0.223469693,1.35767168,-0.2685,-0.114,-0.735,-0.244,0.152,0.08,Q02819,Nucb1,Q02819_Nucb1,Q02819,Nucb1,1,40,21,21,Q02819|A0A1C7CYU3,MOUSE,53407.7,44.4,100,100.1,262.31,262.31,,459,Nucleobindin-1,extracellular space|nucleus|early endosome|rough endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|Golgi-associated vesicle|cis-Golgi network|trans-Golgi network|microtubule cytoskeleton|membrane|Golgi cisterna membrane|extracellular exosome|extrinsic component of Golgi membrane|lumenal side of Golgi membrane|,response to cisplatin|regulation of protein targeting|,G-protein alpha-subunit binding|DNA binding|calcium ion binding|,21,40,3260000000,44.4%
P35917,0.40834567,-0.171916667,7.451486333,0.3365,0.179825537,1.518215386,-0.1775,-0.417,-0.426,-0.146,0.128,0.007,P35917,Flt4,P35917_Flt4,P35917,Flt4,1,35,19,19,P35917,MOUSE,155124.7,15.7,101,101.1,261.04,261.04,,1363,Vascular endothelial growth factor receptor 3,nucleus|cytoplasm|plasma membrane|integral component of plasma membrane|receptor complex|,positive regulation of protein phosphorylation|positive regulation of endothelial cell proliferation|vasculature development|lymph vessel development|lymphangiogenesis|sprouting angiogenesis|positive regulation of cell proliferation|positive regulation of vascular endothelial growth factor production|positive regulation of endothelial cell migration|peptidyl-tyrosine phosphorylation|cellular response to vascular endothelial growth factor stimulus|vascular endothelial growth factor signaling pathway|negative regulation of apoptotic process|positive regulation of MAPK cascade|positive regulation of JNK cascade|protein autophosphorylation|vascular endothelial growth factor receptor signaling pathway|blood vessel morphogenesis|regulation of blood vessel remodeling|positive regulation of ERK1 and ERK2 cascade|positive regulation of protein kinase C signaling|,transmembrane receptor protein tyrosine kinase activity|vascular endothelial growth factor-activated receptor activity|protein binding|ATP binding|growth factor binding|protein phosphatase binding|,19,35,2650000000,15.7%
P29699,0.899330297,0.012083333,0.783630153,0.0885,0.834904852,0.217827478,-0.7565,-0.069,0.729,0.124,0.046,-0.001,P29699,Ahsg,P29699_Ahsg,P29699,Ahsg,1,86,17,17,P29699,MOUSE,38123.7,63.1,102,102.1,255.32,255.32,,345,Alpha-2-HS-glycoprotein,extracellular space|extracellular exosome|blood microparticle|,ossification|acute-phase response|negative regulation of endopeptidase activity|negative regulation of bone mineralization|regulation of inflammatory response|positive regulation of phagocytosis|,cysteine-type endopeptidase inhibitor activity|,17,86,2.16E+11,63.1%
O70570,0.890329957,-0.018083333,0.887534489,0.0575,0.815166927,0.244275596,0.2175,-0.193,-0.165,0.043,-0.122,0.111,O70570,Pigr,O70570_Pigr,O70570,Pigr,1,35,18,18,O70570,MOUSE,86309.5,27.2,103,103.1,253.96,253.96,,771,Polymeric immunoglobulin receptor,extracellular space|plasma membrane|integral component of membrane|receptor complex|extracellular exosome|,detection of chemical stimulus involved in sensory perception of bitter taste|retina homeostasis|immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor|epidermal growth factor receptor signaling pathway|Fc receptor signaling pathway|receptor clustering|,polymeric immunoglobulin receptor activity|,18,35,2440000000,27.2%
P00761,0.016614818,0.79225,37.81129957,-2.525166667,0.000165527,-8.312860864,2.5545,1.609,2.001,-0.53,-0.506,-0.375,P00761,NotFound,P00761_NotFound,P00761,,1,275,14,13,P00761|B99908,PIG,25093.7,64,104,104.1,251.12,234.92,,231,Trypsin,,,,14,275,4.01E+13,64.0%
B99907,0.034155407,0.697083333,29.9104484,-1.866166667,0.001020834,-5.940957217,2.2075,1.364,1.319,-0.125,-0.251,-0.332,B99907,NotFound,B99907_NotFound,B99907,,1,46,5,4,B99907,PromTArt7,5560.1,98,104,104.2,101.82,85.62,,50,"Promega trypsin artifact 2 K to R mods +28 (2239.1, 2914)(1987, 2003) [Sus scrofa]",,,,4,46,46900000000,98.0%
P29788,0.742574146,0.236916667,2.546512067,-0.245833333,0.556350898,-0.623395872,0.3005,-0.29,1.069,0.371,-0.037,0.008,P29788,Vtn,P29788_Vtn,P29788,Vtn,1,86,16,16,P29788,MOUSE,55646.8,34.5,105,105.1,246.52,246.52,,478,Vitronectin,proteinaceous extracellular matrix|extracellular space|extracellular matrix|extracellular exosome|blood microparticle|extracellular matrix|,receptor-mediated endocytosis|immune response|cell-matrix adhesion|positive regulation of cell-substrate adhesion|negative regulation of endopeptidase activity|positive regulation of smooth muscle cell migration|extracellular matrix organization|positive regulation of protein binding|cell adhesion mediated by integrin|endodermal cell differentiation|positive regulation of receptor-mediated endocytosis|oligodendrocyte differentiation|positive regulation of peptidyl-tyrosine phosphorylation|smooth muscle cell-matrix adhesion|,scavenger receptor activity|integrin binding|heparin binding|polysaccharide binding|extracellular matrix binding|,16,86,1.7E+11,34.5%
Q61730-2,0.952269268,0.09975,0.294295588,-0.032166667,0.934480926,-0.085778005,-0.3695,-0.119,0.836,0.308,-0.107,0.05,Q61730,Il1rap,Q61730-2_Il1rap,Q61730-2,Il1rap,1,42,19,19,Q61730-2|Q61730-3|E9Q6I2|Q61730|G3UY13,MOUSE,42194.2,44.1,106,106.1,245.79,245.79,,570,Isoform 2 of Interleukin-1 receptor accessory protein,extracellular region|plasma membrane|membrane|integral component of membrane|,inflammatory response|cytokine-mediated signaling pathway|interleukin-2 biosynthetic process|innate immune response|,signal transducer activity|interleukin-1 receptor activity|protein binding|,19,42,5900000000,44.1%
A0A0A6YXW6,0.368361036,-0.011416667,8.484833803,0.746166667,0.141747896,1.695645303,-0.4355,-0.344,-0.374,-0.173,-0.054,1.312,A0A0A6YXW6,NotFound,A0A0A6YXW6_NotFound,A0A0A6YXW6,Igha,1,65,12,3,A0A0A6YXW6,MOUSE,42869.8,39,107,107.1,243.25,52.76,,389,Immunoglobulin heavy constant alpha (Fragment),,,,12,65,77600000000,39.0%
P01878,0.745307288,0.3705,2.318363806,0.344666667,0.586359032,0.592206279,,0.112,,0.407,-0.084,1.047,P01878,NotFound,P01878_NotFound,P01878,,1,2,10,1,P01878,MOUSE,37616.9,40.4,107,107.2,197.17,6.68,,344,Ig alpha chain C region,,,antigen binding|immunoglobulin receptor binding|,1,2,30200000,6.3%
P70375,0.78213603,0.246083333,1.895356283,-0.3375,0.646344968,-0.48323546,-0.5295,-0.258,2.032,0.079,0.141,0.012,P70375,F7,P70375_F7,P70375,F7,1,74,19,19,P70375,MOUSE,51701.8,36.9,108,108.1,242.95,242.95,,446,Coagulation factor VII,extracellular region|extracellular space|vesicle|,positive regulation of leukocyte chemotaxis|proteolysis|blood coagulation|circadian rhythm|positive regulation of platelet-derived growth factor receptor signaling pathway|positive regulation of blood coagulation|organ regeneration|response to vitamin K|response to estrogen|positive regulation of positive chemotaxis|positive regulation of protein kinase B signaling|response to growth hormone|,glycoprotein binding|serine-type endopeptidase activity|receptor binding|calcium ion binding|,19,74,22400000000,36.9%
Q06194,0.425473432,-0.354083333,6.95022251,0.7375,0.201826296,1.4360995,-0.0685,-0.236,-1.864,-0.059,0.124,-0.021,Q06194,F8,Q06194_F8,Q06194,F8,1,32,21,21,Q06194|B2RRC9,MOUSE,267560.2,8.5,109,109.1,242.2,242.2,,2319,Coagulation factor VIII,extracellular space|,acute-phase response|platelet activation|oxidation-reduction process|,copper ion binding|oxidoreductase activity|,21,32,1980000000,8.5%
Q9QWL7,0.233962779,0.385916667,12.79838102,-2.339166667,0.052500314,-2.421066643,3.4235,1.693,-0.45,-1.287,-0.541,-0.523,Q9QWL7,Krt17,Q9QWL7_Krt17,Q9QWL7,Krt17,1,74,20,6,Q9QWL7|Q9D312|Q8CCX5|Q8CCX5-2|Q99PS0,MOUSE,48446.3,33.9,110,110.1,239.59,73.93,,433,"Keratin, type I cytoskeletal 17",cytoplasm|intermediate filament|extracellular exosome|cell periphery|,morphogenesis of an epithelium|signal transduction|positive regulation of cell growth|hair follicle morphogenesis|keratinization|intermediate filament organization|positive regulation of translation|positive regulation of hair follicle development|,structural molecule activity|protein binding|MHC class II receptor activity|MHC class II protein binding|,21,74,2.29E+11,33.9%
Q61781,0.037628867,0.47825,28.8203637,-1.515833333,0.00131209,-5.660770945,1.5165,1.303,0.889,-0.378,-0.407,-0.054,Q61781,Krt14,Q61781_Krt14,Q61781,Krt14,1,3,20,3,Q61781|Q9Z320|Q8VCW2,MOUSE,53208.4,35.7,110,110.2,236.5,29.07,,484,"Keratin, type I cytoskeletal 14",intracellular|nucleus|cytoplasm|intermediate filament|keratin filament|extracellular exosome|cell periphery|,aging|response to zinc ion|response to ionizing radiation|epithelial cell differentiation|hair cycle|intermediate filament bundle assembly|,structural molecule activity|protein binding|keratin filament binding|,3,3,13800000,7.2%
Q6IFX2,0.767713886,-0.25275,2.006307345,-0.9565,0.630041658,-0.507769088,3.3285,1.509,-4.161,-1.322,-0.426,-0.445,Q6IFX2,Krt42,Q6IFX2_Krt42,Q6IFX2,Krt42,1,8,20,5,Q6IFX2,MOUSE,50474.5,30.5,110,110.3,214.31,46.8,,452,"Keratin, type I cytoskeletal 42",cytoplasm|intermediate filament|,,structural molecule activity|,5,8,1270000000,7.3%
Q9Z2K1,0.233962779,0.386083333,12.77890199,-2.380166667,0.052736318,-2.417740993,3.3695,1.893,-0.534,-1.315,-0.729,-0.368,Q9Z2K1,Krt16,Q9Z2K1_Krt16,Q9Z2K1,Krt16,1,11,15,6,Q9Z2K1,MOUSE,52004.9,23.6,110,110.4,181.07,82.81,,469,"Keratin, type I cytoskeletal 16",nucleus|cytoskeleton|intermediate filament|extracellular exosome|,morphogenesis of an epithelium|inflammatory response|aging|keratinocyte differentiation|negative regulation of cell migration|keratinization|hair cycle|innate immune response|intermediate filament cytoskeleton organization|keratinocyte migration|establishment of skin barrier|,structural constituent of cytoskeleton|protein binding|,6,11,2660000000,11.5%
P08730,0.926538247,0.60225,0.519975282,0.154833333,0.887161061,0.148148647,1.2445,1.239,-0.909,-0.446,-0.229,2.714,P08730,Krt13,P08730_Krt13,P08730,Krt13,1,4,14,3,P08730|P08730-2,MOUSE,48095.6,19.6,110,110.5,151.6,25.83,,437,"Keratin, type I cytoskeletal 13",nucleus|keratin filament|intermediate filament cytoskeleton|extracellular exosome|,cytoskeleton organization|response to radiation|tongue morphogenesis|cellular response to retinoic acid|,structural molecule activity|protein binding|,3,4,462000000,5.9%
O77727,0.463190313,0.285083333,6.251142549,-1.1155,0.237074992,-1.315803343,2.6345,0.667,-0.773,-0.566,-0.004,-0.248,O77727,NotFound,O77727_NotFound,O77727,KRT15,1,16,12,4,O77727,SHEEP,48769.2,18.3,110,110.6,153.11,49.61,,453,"Keratin, type I cytoskeletal 15",,,,4,16,9220000000,5.7%
P02535,0.279931124,0.32575,11.13272084,-1.886833333,0.077042065,-2.139113845,3.1305,1.049,-0.372,-1.001,-0.193,-0.659,P02535,Krt10,P02535_Krt10,P02535,Krt10,1,33,11,7,P02535|P02535-2|A2A513|P02535-3,MOUSE,57940,16.6,110,110.7,167.52,109.55,,570,"Keratin, type I cytoskeletal 10",keratin filament|,epithelial cell differentiation|cellular response to calcium ion|,structural molecule activity|protein binding|,7,33,1.06E+11,11.7%
B1AQ77,0.174726314,0.7949,15.93944457,-2.166416667,0.02547156,-3.172449754,1.7075,2.482,,1.041,-0.972,-0.284,B1AQ77,Krt15,B1AQ77_Krt15,B1AQ77,Krt15,1,1,9,1,B1AQ77|Q61414,MOUSE,49664.3,11.4,110,110.8,110.68,7.38,,456,"Keratin 15, isoform CRA_a",nucleus|intermediate filament|extracellular exosome|,activation of mitophagy in response to mitochondrial depolarization|,structural molecule activity|scaffold protein binding|,1,1,32700000,3.9%
P19001,0.261353624,0.228416667,11.77856851,-1.9715,0.066396188,-2.247920532,3.0125,1.18,-0.55,-1.026,-0.65,-0.596,P19001,Krt19,P19001_Krt19,P19001,Krt19,1,2,6,1,P19001,MOUSE,44541,11.4,110,110.9,76.3,9.39,,403,"Keratin, type I cytoskeletal 19",intermediate filament|plasma membrane|dystrophin-associated glycoprotein complex|Z disc|sarcolemma|costamere|extracellular exosome|cell periphery|terminal web|,Notch signaling pathway|response to estrogen|sarcomere organization|cell differentiation involved in embryonic placenta development|,protein binding|structural constituent of muscle|protein complex binding|,1,2,45800000,2.9%
Q9BGM5,0.254188227,0.264916667,11.97277867,-2.1445,0.063492457,-2.280754357,3.3675,1.071,-0.427,-1.047,-0.485,-0.89,Q9BGM5,NotFound,Q9BGM5_NotFound,Q9BGM5,KRT25,1,7,2,1,Q9BGM5,SHEEP,49883,4,110,110.1,31.83,17.44,,450,"Keratin, type I cytoskeletal 25",,,,1,7,18600000000,2.0%
Q9CQF9,0.641826969,-0.082916667,3.647134662,0.189833333,0.431803873,0.842579995,0.0475,-0.205,-0.376,0.038,0.012,-0.014,Q9CQF9,Pcyox1,Q9CQF9_Pcyox1,Q9CQF9,Pcyox1,1,37,17,17,Q9CQF9|A0A0N4SWD3,MOUSE,56721.9,40.3,111,111.1,238.91,238.91,,505,Prenylcysteine oxidase,lysosome|vacuolar membrane|plasma membrane|very-low-density lipoprotein particle|extracellular exosome|,prenylated protein catabolic process|prenylcysteine catabolic process|oxidation-reduction process|chloride transmembrane transport|,prenylcysteine oxidase activity|chloride-transporting ATPase activity|,17,37,2950000000,40.3%
P08607,0.804951873,0.15675,1.722231097,-0.234833333,0.672631017,-0.444349796,-0.3005,-0.319,1.442,-0.018,-0.123,0.259,P08607,C4bp,P08607_C4bp,P08607,C4bpa,1,51,15,15,P08607|E9PUZ8,MOUSE,53006.2,32.4,112,112.1,238.41,238.41,,469,C4b-binding protein,extracellular region|,"complement activation, classical pathway|innate immune response|",protein binding|,15,51,23900000000,32.4%
Q9DBB9,0.167167113,-0.297416667,16.76550145,0.8435,0.021059587,3.103502293,-0.4475,-0.564,-1.146,0.215,0.14,0.018,Q9DBB9,Cpn2,Q9DBB9_Cpn2,Q9DBB9,Cpn2,1,71,16,16,Q9DBB9,MOUSE,61333.9,34.1,113,113.1,236.74,236.74,,547,Carboxypeptidase N subunit 2,extracellular exosome|blood microparticle|,,,16,71,37200000000,34.1%
Q9R1E6-2,0.604460486,0.057083333,4.156938839,0.315166667,0.3839778,0.939478315,0.0365,0.148,-0.486,0.743,-0.049,-0.05,Q9R1E6,Enpp2,Q9R1E6-2_Enpp2,Q9R1E6-2,Enpp2,1,33,18,18,Q9R1E6-2|G3UXY9|Q9R1E6-3|Q9R1E6,MOUSE,106969.5,23.8,114,114.1,236.63,236.63,,862,Isoform 2 of Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,extracellular space|integral component of plasma membrane|,receptor-mediated endocytosis|chemotaxis|immune response|phospholipid catabolic process|positive regulation of epithelial cell migration|regulation of cell migration|phosphatidylcholine catabolic process|regulation of angiogenesis|positive regulation of peptidyl-tyrosine phosphorylation|nucleic acid phosphodiester bond hydrolysis|positive regulation of lamellipodium morphogenesis|,nucleic acid binding|phosphodiesterase I activity|nucleotide diphosphatase activity|lysophospholipase activity|scavenger receptor activity|calcium ion binding|zinc ion binding|polysaccharide binding|alkylglycerophosphoethanolamine phosphodiesterase activity|,18,33,3470000000,23.8%
P46412,0.128577811,-0.542916667,19.50451479,1.171166667,0.011208526,3.615406872,-1.1975,-0.567,-1.621,0.05,-0.052,0.13,P46412,Gpx3,P46412_Gpx3,P46412,Gpx3,1,119,17,17,P46412|P21765,MOUSE,25581.2,48.2,115,115.1,233.57,233.57,,226,Glutathione peroxidase 3,extracellular space|extracellular exosome|,response to oxidative stress|hydrogen peroxide catabolic process|protein homotetramerization|oxidation-reduction process|,glutathione peroxidase activity|selenium binding|,17,119,3E+11,48.2%
Q9Z0Z4,0.407329798,-0.42975,7.544398891,0.8055,0.176019228,1.537163616,-0.1355,-0.359,-2.003,-0.06,-0.026,0.005,Q9Z0Z4,Heph,Q9Z0Z4_Heph,Q9Z0Z4,Heph,1,30,18,18,Q9Z0Z4|Q9Z0Z4-2|A2AI62,MOUSE,130576.7,19.3,116,116.1,232.18,232.18,,1157,Hephaestin,intracellular|integral component of membrane|basolateral plasma membrane|perinuclear region of cytoplasm|,copper ion transport|iron ion transport|cellular iron ion homeostasis|oxidation-reduction process|,ferroxidase activity|copper ion binding|ferrous iron binding|,18,30,1900000000,19.3%
Q6GQT1,0.379086692,-0.147416667,8.235498864,0.466833333,0.150123995,1.649898264,-0.5885,-0.631,0.077,-0.063,0.102,0.219,Q6GQT1,A2m,Q6GQT1_A2m,Q6GQT1,A2m,1,76,19,15,Q6GQT1|K4JBR5|K4JF13|K4JB97,MOUSE,165776,13.7,117,117.1,229.1,184.95,,1474,Alpha-2-macroglobulin-P,extracellular exosome|blood microparticle|,"negative regulation of complement activation, lectin pathway|female pregnancy|negative regulation of endopeptidase activity|stem cell differentiation|",protease binding|serine-type endopeptidase inhibitor activity|receptor binding|protein binding|growth factor binding|enzyme binding|interleukin-8 binding|interleukin-1 binding|peptidase inhibitor activity|tumor necrosis factor binding|calcium-dependent protein binding|,21,76,6.88E+12,13.7%
Q7SIH1,0.742574146,0.1323,2.479953176,0.16675,0.564943066,0.615921142,-0.0365,0.101,,0.38,0.018,0.199,Q7SIH1,NotFound,Q7SIH1_NotFound,Q7SIH1,A2M,1,2,8,2,Q7SIH1|K4JR81|K4JDS3|K4JDR8|K4JBA2|R9QSM8,BOVIN,169056.4,5.8,117,117.2,74.56,9.58,,1510,Alpha-2-macroglobulin,,,,2,2,107000000,2.6%
Q9JJN5,0.611417348,0.559083333,3.990465011,-0.772833333,0.39898218,-0.908986409,-0.1785,0.077,2.938,0.332,0.197,-0.011,Q9JJN5,Cpn1,Q9JJN5_Cpn1,Q9JJN5,Cpn1,1,43,15,15,Q9JJN5|Q2KJ83,MOUSE,52129.7,37.4,118,118.1,225.56,225.56,,457,Carboxypeptidase N catalytic chain,extracellular space|,proteolysis|bradykinin catabolic process|response to glucocorticoid|,carboxypeptidase activity|metallocarboxypeptidase activity|zinc ion binding|,15,43,9900000000,37.4%
P33587,0.353357975,-0.35975,8.820496053,1.0295,0.131205003,1.751929699,-0.3405,-0.11,-2.173,0.473,0.01,-0.018,P33587,Proc,P33587_Proc,P33587,Proc,1,31,15,15,P33587,MOUSE,53186.4,38,119,119.1,224.62,224.62,,460,Vitamin K-dependent protein C,extracellular space|,proteolysis|blood coagulation|negative regulation of blood coagulation|negative regulation of apoptotic process|,calcium ion binding|peptidase activity|,15,31,3210000000,38.0%
P01898,0.886819929,0.080416667,0.992440497,0.1105,0.795712078,0.27088339,-0.6645,-0.05,0.79,0.311,0.128,-0.032,P01898,H2-Q10,P01898_H2-Q10,P01898,H2-Q10,1,58,14,8,P01898|G3UXE9|E9Q0G4|A7VMS6|V9GXR0|V9GXI4|Q05A75|G3UZL7|A0A0B4J1G3,MOUSE,37478.5,40.6,120,120.1,224.24,130.21,,325,"H-2 class I histocompatibility antigen, Q10 alpha chain",endoplasmic reticulum|Golgi apparatus|Golgi medial cisterna|plasma membrane|cell surface|membrane|phagocytic vesicle membrane|MHC class I protein complex|extracellular exosome|endoplasmic reticulum exit site|integral component of lumenal side of endoplasmic reticulum membrane|,antigen processing and presentation of peptide antigen via MHC class I|immune response|,receptor binding|beta-2-microglobulin binding|peptide antigen binding|T cell receptor binding|poly(A) RNA binding|TAP binding|,14,58,18700000000,40.6%
Q8HWB2,0.330192854,-0.293916667,9.356987674,0.7045,0.115958138,1.841728246,-0.6655,0.046,-1.319,0.139,0.071,-0.035,Q8HWB2,H2-Q4,Q8HWB2_H2-Q4,Q8HWB2,H2-Q4,1,7,13,4,Q8HWB2|P01899|O19441|E9PX63|P01900|P01902|P14427|P01895-2,MOUSE,39902.4,34.7,120,120.2,169.16,50.5,,354,"Histocompatibility 2, Q region locus 4",endoplasmic reticulum|Golgi apparatus|Golgi medial cisterna|plasma membrane|cell surface|membrane|MHC class I protein complex|extracellular exosome|endoplasmic reticulum exit site|,antigen processing and presentation of peptide antigen via MHC class I|immune response|,receptor binding|beta-2-microglobulin binding|peptide antigen binding|T cell receptor binding|poly(A) RNA binding|TAP binding|,4,7,259000000,12.1%
P79568,0.392487589,-0.0885,7.956591502,0.585416667,0.160081391,1.649790702,-0.8335,-0.046,,0.353,0.131,-0.047,P79568,H2-Q6,P79568_H2-Q6,P79568,H2-Q6,1,2,5,2,P79568|P14429|E9QJR9|E9PWT4|P14431|P14426|P04223|P04223-2|L7N260|P01901|Q3TH01|P03991|P06339,MOUSE,37691.1,16.2,120,120.3,65.3,13.07,,326,Class Ib MHC antigen Qa-2,endoplasmic reticulum|Golgi apparatus|Golgi medial cisterna|plasma membrane|cell surface|membrane|MHC class I protein complex|extracellular exosome|endoplasmic reticulum exit site|,antigen processing and presentation of peptide antigen via MHC class I|immune response|,receptor binding|beta-2-microglobulin binding|peptide antigen binding|T cell receptor binding|poly(A) RNA binding|TAP binding|,2,2,17900000,3.6%
E0CZ58,0.916739094,0.06875,0.633739139,-0.094833333,0.864223529,-0.17860761,1.2475,-0.151,-0.748,0.201,-0.053,-0.084,E0CZ58,Prg4,E0CZ58_Prg4,E0CZ58,Prg4,1,30,16,16,E0CZ58|Q9JM99|Q9JM99-2|E9QQ17|Q9JM99-3|E9QQ18|Q9JM99-4|A0A0R4J207|Q9JM99-5,MOUSE,135831.6,14.5,121,121.1,221.07,221.07,,1221,Proteoglycan 4,extracellular space|cytoplasm|,receptor-mediated endocytosis|immune response|peptide cross-linking|regulation of cell proliferation|negative regulation of interleukin-6 biosynthetic process|hematopoietic stem cell proliferation|,scavenger receptor activity|polysaccharide binding|,16,30,6570000000,14.5%
A0A0A6YVP0,0.468259994,-0.241583333,6.172281486,0.683833333,0.241419225,1.3021165,0.1085,-0.111,-1.748,0.054,0.249,-0.002,A0A0A6YVP0,NotFound,A0A0A6YVP0_NotFound,A0A0A6YVP0,Ighg2b,1,41,16,14,A0A0A6YVP0|P01867|P01867-2|P01865|P01863,MOUSE,45094.4,46.6,122,122.1,217.94,185.23,,405,Immunoglobulin heavy constant gamma 2B (Fragment),"extracellular space|immunoglobulin complex, circulating|","positive regulation of type IIa hypersensitivity|positive regulation of type I hypersensitivity|humoral immune response mediated by circulating immunoglobulin|phagocytosis, recognition|phagocytosis, engulfment|complement activation, classical pathway|immunoglobulin mediated immune response|positive regulation of phagocytosis|positive regulation of immune response|",antigen binding|,16,41,7100000000,46.6%
F6TQW2,0.503645659,-0.0935,5.601259299,0.32125,0.275343019,1.224630389,-0.4155,-0.157,,-0.041,0.128,0.018,F6TQW2,NotFound,F6TQW2_NotFound,F6TQW2,Ighg2c,1,26,12,10,F6TQW2|P01864,MOUSE,44892.5,32.9,122,122.2,191.84,159.13,,404,Immunoglobulin heavy constant gamma 2C (Fragment),"extracellular space|immunoglobulin complex, circulating|",humoral immune response mediated by circulating immunoglobulin|immunoglobulin mediated immune response|antibacterial humoral response|defense response to bacterium|,antigen binding|,10,26,4690000000,28.2%
A8DUK4,0.864716947,0.146583333,1.174110543,0.150833333,0.763113165,0.315687028,-0.8675,0.449,0.632,0.595,-0.215,0.286,A8DUK4,Hbb-bs,A8DUK4_Hbb-bs,A8DUK4,Hbb-bs,1,92,12,4,A8DUK4|P02081|P02104|D4QBB3|P02070|P06642|P06643,MOUSE,15804.8,89.7,123,123.1,215.7,67.24,,147,Beta-globin,hemoglobin complex|,oxygen transport|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,13,92,1.89E+11,89.7%
P02088,0.985814665,1.63225,0.072877549,0.0275,0.983359335,0.02175688,2.4215,2.218,0.216,0.75,4.286,-0.098,P02088,Hbb-b1,P02088_Hbb-b1,P02088,Hbb-b1,1,9,11,3,P02088,MOUSE,15954,88.4,123,123.2,199.89,47.41,,147,Hemoglobin subunit beta-1,hemoglobin complex|myelin sheath|,oxygen transport|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,3,9,10400000000,25.8%
P02089,0.910370636,0.9579,0.698573671,0.238583333,0.851417619,0.197437769,-0.0905,1.72,,0.479,3.087,-0.406,P02089,Hbb-b2,P02089_Hbb-b2,P02089,Hbb-b2,1,18,11,5,P02089,MOUSE,15992.1,77.5,123,123.3,181.25,88.18,,147,Hemoglobin subunit beta-2,hemoglobin complex|,oxygen transport|positive regulation of myeloid cell differentiation|regulation of erythrocyte differentiation|erythrocyte development|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,5,18,2740000000,35.3%
P68368,0.604460486,0.371416667,4.137795907,-0.366833333,0.385674042,-0.9366896,0.6945,1.039,-0.069,0.325,-0.292,0.531,P68368,Tuba4a,P68368_Tuba4a,P68368,Tuba4a,1,29,18,4,P68368|Q9JJZ2|Q3UX10,MOUSE,50665.2,42.1,124,124.1,214.83,45.52,,448,Tubulin alpha-4A chain,cytoplasm|microtubule|extracellular exosome|,microtubule-based process|metabolic process|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|,18,29,2810000000,42.1%
P05213,0.242548931,0.3071,12.42415215,-1.596916667,0.057224866,-2.474838286,0.3145,2.216,,-0.086,-0.772,-0.137,P05213,Tuba1b,P05213_Tuba1b,P05213,Tuba1b,1,4,17,3,P05213|P68369|P68373|P05214,MOUSE,50835.4,39.6,124,124.2,211.09,41.78,,451,Tubulin alpha-1B chain,cytosol|microtubule|cytoplasmic microtubule|myelin sheath|extracellular exosome|,microtubule cytoskeleton organization|protein folding|protein polymerization|cellular response to interleukin-4|,double-stranded RNA binding|GTPase activity|structural constituent of cytoskeleton|protein binding|GTP binding|ubiquitin protein ligase binding|,3,4,98100000,9.7%
P55065,0.926538247,0.17375,0.519258542,-0.048833333,0.887307486,-0.147880397,-0.0515,-0.162,0.808,0.128,0.321,-0.001,P55065,Pltp,P55065_Pltp,P55065,Pltp,1,37,14,14,P55065|A2A5K2,MOUSE,54680.3,40.1,125,125.1,213.67,213.67,,493,Phospholipid transfer protein,extracellular space|,lipid metabolic process|lipid transport|vitamin E biosynthetic process|positive regulation of cholesterol efflux|sperm motility|high-density lipoprotein particle remodeling|,lipid binding|,14,37,7690000000,40.1%
Q08761,0.916739094,0.032583333,0.653852432,0.092166667,0.860230342,0.183929035,-0.8995,-0.152,1.011,0.171,0.095,-0.03,Q08761,Pros1,Q08761_Pros1,Q08761,Pros1,1,46,17,17,Q08761,MOUSE,76987.1,28.1,126,126.1,213.16,213.16,,675,Vitamin K-dependent protein S,extracellular space|protein complex|extracellular exosome|blood microparticle|,blood coagulation|response to lipopolysaccharide|fibrinolysis|positive regulation of phagocytosis|,calcium ion binding|protein complex binding|,17,46,12000000000,28.1%
Q9EQH2,0.302686697,-0.444083333,10.5565759,0.956833333,0.087971584,2.042439817,-0.4055,-0.417,-1.945,0.155,-0.073,0.021,Q9EQH2,Erap1,Q9EQH2_Erap1,Q9EQH2,Erap1,1,27,19,19,Q9EQH2,MOUSE,107167.8,22.2,127,127.1,209.86,209.86,,930,Endoplasmic reticulum aminopeptidase 1,extracellular region|extracellular space|cytoplasm|endoplasmic reticulum lumen|endoplasmic reticulum membrane|membrane|integral component of membrane|extracellular exosome|,immune system process|proteolysis|membrane protein ectodomain proteolysis|positive regulation of angiogenesis|,aminopeptidase activity|interleukin-6 receptor binding|tumor necrosis factor receptor binding|peptidase activity|metalloexopeptidase activity|zinc ion binding|,19,27,1550000000,22.2%
Q9R098,0.611683281,-0.11275,3.980296318,0.350833333,0.399917463,0.907066296,0.1905,0.024,-1.079,0.037,0.184,-0.033,Q9R098,Hgfac,Q9R098_Hgfac,Q9R098,Hgfac,1,30,15,15,Q9R098,MOUSE,72905.8,25.7,128,128.1,208.45,208.45,,653,Hepatocyte growth factor activator,extracellular space|cytoplasm|rough endoplasmic reticulum|,proteolysis|,serine-type endopeptidase activity|,15,30,2650000000,25.7%
P28653,0.038106411,0.706416667,28.57786167,-2.138166667,0.001387439,-5.658801742,2.4905,1.181,1.655,-0.514,-0.251,-0.323,P28653,Bgn,P28653_Bgn,P28653,Bgn,1,27,15,15,P28653,MOUSE,42094.9,46.3,129,129.1,207.66,207.66,,369,Biglycan,proteinaceous extracellular matrix|intracellular|cell surface|transport vesicle|sarcolemma|extracellular exosome|extracellular matrix|,blood vessel remodeling|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|,glycosaminoglycan binding|extracellular matrix binding|,15,27,6470000000,46.3%
Q06770,0.303768038,-0.398583333,10.49261467,1.071833333,0.089276783,2.031724209,-0.6465,-0.102,-2.055,0.371,0.049,-0.008,Q06770,Serpina6,Q06770_Serpina6,Q06770,Serpina6,1,47,13,13,Q06770,MOUSE,44939.5,31.9,130,130.1,207.6,207.6,,397,Corticosteroid-binding globulin,extracellular space|extracellular exosome|,transport|glucocorticoid metabolic process|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|steroid binding|,13,47,48100000000,31.9%
P70663,0.838298347,-0.064416667,1.475325609,0.112833333,0.711979418,0.387211333,0.2615,-0.022,-0.602,-0.075,0.075,-0.024,P70663,Sparcl1,P70663_Sparcl1,P70663,Sparcl1,1,37,16,16,P70663,MOUSE,73141.8,26.4,131,131.1,205.81,205.81,,650,SPARC-like protein 1,proteinaceous extracellular matrix|extracellular space|extracellular exosome|,signal transduction|,calcium ion binding|,16,37,2270000000,26.4%
Q8VDD5,0.232788104,0.56375,13.00418164,-2.6295,0.050070489,-2.456252093,4.1145,-0.236,1.757,-0.869,-1.069,-0.315,Q8VDD5,Myh9,Q8VDD5_Myh9,Q8VDD5,Myh9,1,22,20,20,Q8VDD5|Q6URW6-3|Q6URW6|K3W4R2|Q6URW6-2|O08638|E9QPE7|O08638-2|Q3UH59|Q5SV64|Q61879|F2Z494,MOUSE,227566.2,12.1,132,132.1,205.65,205.65,,1960,Myosin-9,stress fiber|ruffle|uropod|nucleus|cytoplasm|actomyosin contractile ring|cytosol|plasma membrane|brush border|cell-cell adherens junction|cell cortex|actin cytoskeleton|membrane|myosin complex|myosin II complex|cortical cytoskeleton|cell leading edge|cleavage furrow|actomyosin|protein complex|extracellular exosome|myosin II filament|immunological synapse|spindle|plasma membrane|focal adhesion|COP9 signalosome|integrin complex|neuromuscular junction|,"meiotic spindle organization|cell morphogenesis involved in differentiation|cytokinesis|angiogenesis|in utero embryonic development|establishment of T cell polarity|membrane protein ectodomain proteolysis|phagocytosis, engulfment|cell adhesion|myoblast fusion|regulation of cell shape|protein transport|single organismal cell-cell adhesion|actin filament-based movement|platelet formation|monocyte differentiation|actomyosin structure organization|actin cytoskeleton reorganization|uropod organization|blood vessel endothelial cell migration|establishment of meiotic spindle localization|platelet aggregation|negative regulation of actin filament severing|positive regulation of protein processing in phagocytic vesicle|actin filament polymerization|actin filament capping|",microfilament motor activity|actin binding|protein binding|calmodulin binding|ATP binding|ATPase activity|protein domain specific binding|actin-dependent ATPase activity|protein homodimerization activity|protein anchor|ADP binding|poly(A) RNA binding|actin filament binding|,20,22,413000000,12.1%
P82198,0.742574146,-0.03325,2.471708575,0.1525,0.566016566,0.607175865,0.0725,-0.154,-0.247,-0.11,-0.119,0.358,P82198,Tgfbi,P82198_Tgfbi,P82198,Tgfbi,1,33,16,16,P82198|Q3UXJ2,MOUSE,75223.3,23.4,133,133.1,205.56,205.56,,683,Transforming growth factor-beta-induced protein ig-h3,proteinaceous extracellular matrix|basement membrane|extracellular space|trans-Golgi network|extracellular exosome|extracellular matrix|,angiogenesis|chondrocyte differentiation|cell adhesion|extracellular matrix organization|,collagen binding|cell adhesion molecule binding|extracellular matrix binding|,16,33,1330000000,23.4%
Q9R0E2,0.782484456,-0.047083333,1.884181807,0.1075,0.648010166,0.480353149,-0.2385,0.125,-0.189,-0.059,0.07,0.009,Q9R0E2,Plod1,Q9R0E2_Plod1,Q9R0E2,Plod1,1,37,21,20,Q9R0E2|A8Y5E6,MOUSE,84164,31,134,134.1,203.43,195.1,,728,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",rough endoplasmic reticulum membrane|extracellular exosome|,response to hypoxia|epidermis development|peptidyl-lysine hydroxylation|cellular response to hormone stimulus|oxidation-reduction process|,ferrous iron binding|procollagen-lysine 5-dioxygenase activity|L-ascorbic acid binding|peptide binding|,21,37,1330000000,31.0%
Q9R0E1,0.838498897,0.195416667,1.467923457,-0.266166667,0.713193956,-0.3857772,-0.1945,-0.716,1.896,-0.103,0.172,0.118,Q9R0E1,Plod3,Q9R0E1_Plod3,Q9R0E1,Plod3,1,11,7,6,Q9R0E1,MOUSE,85491.3,11.8,134,134.2,55.26,46.93,,741,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",rough endoplasmic reticulum membrane|extracellular exosome|,in utero embryonic development|endothelial cell morphogenesis|protein localization|neural tube development|collagen fibril organization|cellular response to hormone stimulus|vasodilation|epidermis morphogenesis|oxidation-reduction process|lung morphogenesis|basement membrane assembly|,iron ion binding|procollagen-lysine 5-dioxygenase activity|L-ascorbic acid binding|procollagen glucosyltransferase activity|,6,11,378000000,10.5%
O35930,0.81017246,0.0577,1.681230047,0.111583333,0.67901129,0.439001763,0.0085,-0.027,,0.153,0.173,-0.019,O35930,Gp1ba,O35930_Gp1ba,O35930,Gp1ba,1,30,14,14,O35930,MOUSE,80567.4,20.2,135,135.1,202.69,202.69,,734,Platelet glycoprotein Ib alpha chain,plasma membrane|integral component of plasma membrane|cell surface|membrane|extracellular exosome|anchored component of external side of plasma membrane|,cell morphogenesis|cell adhesion|blood coagulation|hemostasis|fibrinolysis|,,14,30,3850000000,20.2%
Q8CG19,0.394562768,0.46025,7.848529773,-0.649166667,0.164114526,-1.588577746,0.7285,0.134,1.492,-0.044,0.504,-0.053,Q8CG19,Ltbp1,Q8CG19_Ltbp1,Q8CG19,Ltbp1,1,19,13,13,Q8CG19|Q8CG19-2|Q8CG19-3|Q61810|F8VQ06|Q61810-2,MOUSE,195158.2,10.1,136,136.1,202.07,202.07,,1712,Latent-transforming growth factor beta-binding protein 1,microfibril|proteinaceous extracellular matrix|extracellular matrix|protein complex|extracellular matrix|,transforming growth factor beta receptor signaling pathway|,calcium ion binding|transforming growth factor beta binding|microfibril binding|,13,19,421000000,10.1%
O54782,0.669813064,0.21275,3.312697575,-0.2375,0.46636961,-0.777633915,-0.0705,0.256,0.809,-0.061,0.318,0.025,O54782,Man2b2,O54782_Man2b2,O54782,Man2b2,1,40,16,16,O54782,MOUSE,115835.7,18.3,137,137.1,201.18,201.18,,1018,Epididymis-specific alpha-mannosidase,extracellular exosome|,mannose metabolic process|,alpha-mannosidase activity|zinc ion binding|carbohydrate binding|,16,40,6510000000,18.3%
P16858,0.889361503,0.37825,0.917198419,-0.143166667,0.809618005,-0.251966496,0.8215,1.181,-0.653,0.708,-0.329,0.541,P16858,Gapdh,P16858_Gapdh,P16858,Gapdh,1,33,14,14,A0A0A0MQF6|P16858|A0A1D5RLD8|S4R1W1|P10096|Q64467|S4R2G5|A0A0R4J0X7|V9GX06|V9GXA7,MOUSE,36094.6,44.7,138,138.1,200.69,200.69,,333,Glyceraldehyde-3-phosphate dehydrogenase,nucleus|cytoplasm|cytosol|microtubule cytoskeleton|myelin sheath|GAIT complex|,microtubule cytoskeleton organization|glucose metabolic process|glycolytic process|negative regulation of translation|peptidyl-cysteine S-trans-nitrosylation|protein stabilization|neuron apoptotic process|oxidation-reduction process|,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity|protein binding|microtubule binding|enzyme binding|peptidyl-cysteine S-nitrosylase activity|NADP binding|NAD binding|,14,33,2620000000,44.7%
P00687,0.745307288,-0.03475,2.348360471,0.1295,0.582323012,0.581151382,-0.2675,0.096,-0.127,0.13,-0.02,-0.02,P00687,Amy1,P00687_Amy1,P00687,Amy1,1,32,15,15,P00687|P00688|E9PV85|Q3MHH8,MOUSE,58327.3,32,139,139.1,199.32,199.32,,511,Alpha-amylase 1,extracellular space|extracellular exosome|,carbohydrate catabolic process|,alpha-amylase activity|calcium ion binding|amylase activity|chloride ion binding|,15,32,5010000000,32.0%
P27773,0.411435344,-0.46675,7.377457321,0.918833333,0.182917083,1.508858224,-0.4705,-0.013,-2.295,-0.075,0.102,-0.049,P27773,Pdia3,P27773_Pdia3,P27773,Pdia3,1,26,16,16,P27773|A5D7E8|P38657,MOUSE,57133.7,31.8,140,140.1,197.96,197.96,,505,Protein disulfide-isomerase A3,nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|focal adhesion|cell surface|melanosome|myelin sheath|extracellular exosome|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|positive regulation of extrinsic apoptotic signaling pathway|,protein disulfide isomerase activity|protein binding|poly(A) RNA binding|,16,26,1910000000,31.8%
Q5I012,0.708905418,-0.32875,2.905145946,0.528166667,0.512254056,0.697126956,0.1575,0.424,-2.36,-0.049,-0.145,0,Q5I012,Slc38a10,Q5I012_Slc38a10,Q5I012,Slc38a10,1,23,13,13,Q5I012|J3QNE8|Q5I012-2|Q5I012-3|Q5I012-4,MOUSE,117762.2,19,141,141.1,195.97,195.97,,1090,Putative sodium-coupled neutral amino acid transporter 10,Golgi apparatus|integral component of membrane|,amino acid transmembrane transport|sodium ion transport|bone development|,amino acid transmembrane transporter activity|,13,23,6060000000,19.0%
Q9QXC1,0.351568198,-0.1387,8.888839464,0.60675,0.129156436,1.816064089,-0.8275,-0.178,,0.339,-0.087,0.06,Q9QXC1,Fetub,Q9QXC1_Fetub,Q9QXC1,Fetub,1,44,14,14,Q9QXC1|Q6YJU1,MOUSE,43567.8,28.6,142,142.1,195.89,195.89,,388,Fetuin-B,extracellular region|extracellular space|extracellular exosome|,single fertilization|binding of sperm to zona pellucida|negative regulation of endopeptidase activity|,cysteine-type endopeptidase inhibitor activity|metalloendopeptidase inhibitor activity|,14,44,31400000000,28.6%
Q61207,0.185498955,-0.44525,15.32570357,1.0705,0.029337942,2.860642853,-0.8285,-0.456,-1.657,-0.151,0.367,0.054,Q61207,Psap,Q61207_Psap,Q61207,Psap,1,43,13,13,Q61207|J3QPG5|K3W4L3|Q8BFQ1|E9PZ00,MOUSE,63303.9,30.5,143,143.1,192.92,192.92,,557,Prosaposin,extracellular space|nucleoplasm|nucleolus|mitochondrion|lysosome|Golgi apparatus|intracellular membrane-bounded organelle|extracellular exosome|,sphingolipid metabolic process|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway|regulation of lipid metabolic process|regulation of MAPK cascade|positive regulation of MAPK cascade|developmental growth|prostate gland growth|epithelial cell differentiation involved in prostate gland development|cellular response to organic substance|negative regulation of hydrogen peroxide-induced cell death|,G-protein coupled receptor binding|,13,43,7550000000,30.5%
Q9R097,0.32515976,-0.0555,9.592749045,0.52875,0.10983104,1.942369978,-0.4675,-0.278,,0.325,0.169,-0.026,Q9R097,Spint1,Q9R097_Spint1,Q9R097,Spint1,1,24,15,15,Q9R097,MOUSE,58358.6,30.9,144,144.1,186.73,186.73,,507,Kunitz-type protease inhibitor 1,extracellular space|plasma membrane|extracellular exosome|,neural tube closure|embryonic placenta development|negative regulation of endopeptidase activity|extracellular matrix organization|branching involved in labyrinthine layer morphogenesis|placenta blood vessel development|,serine-type endopeptidase inhibitor activity|,15,24,1220000000,30.9%
Q3U9N4,0.679041452,-0.183416667,3.217810315,0.454166667,0.476671261,0.759742911,0.4335,0.096,-1.761,-0.007,0.163,-0.025,Q3U9N4,Grn,Q3U9N4_Grn,Q3U9N4,Grn,1,34,13,13,Q3U9N4|P28798,MOUSE,70037.8,27.4,145,145.1,186.13,186.13,,602,Granulins,extracellular space|mitochondrion|cell surface|intracellular membrane-bounded organelle|extracellular exosome|,blastocyst hatching|embryo implantation|response to estradiol|chondrocyte proliferation|synaptic vesicle endocytosis|positive regulation of epithelial cell proliferation|male mating behavior|positive regulation of dendritic spine development|neural precursor cell proliferation|,poly(A) RNA binding|,13,34,2370000000,27.4%
Q3UTR7,0.639634553,0.250916667,3.712423718,-0.245833333,0.425360961,-0.855099417,0.0515,0.392,0.678,0.475,-0.072,-0.019,Q3UTR7,Agt,Q3UTR7_Agt,Q3UTR7,Agt,1,46,12,12,Q3UTR7|P11859,MOUSE,52954.5,31.3,146,146.1,185.76,185.76,,482,Angiotensinogen,extracellular space|cytoplasm|extracellular exosome|blood microparticle|,"ovarian follicle rupture|blood vessel development|branching involved in ureteric bud morphogenesis|kidney development|regulation of systemic arterial blood pressure by circulatory renin-angiotensin|angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure|renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure|renin-angiotensin regulation of aldosterone production|regulation of renal output by angiotensin|regulation of heart rate|brain renin-angiotensin system|renal system process|angiotensin-mediated drinking behavior|positive regulation of extracellular matrix constituent secretion|cellular sodium ion homeostasis|cell-matrix adhesion|G-protein coupled receptor signaling pathway|activation of phospholipase C activity|activation of NF-kappaB-inducing kinase activity|female pregnancy|aging|excretion|establishment of blood-nerve barrier|regulation of blood pressure|negative regulation of cell proliferation|response to cold|response to salt stress|regulation of gene expression|positive regulation of activation of JAK2 kinase activity|positive regulation of endothelial cell migration|positive regulation of cardiac muscle hypertrophy|positive regulation of gene expression|positive regulation of cholesterol esterification|negative regulation of endopeptidase activity|regulation of norepinephrine secretion|positive regulation of phosphatidylinositol 3-kinase signaling|artery smooth muscle contraction|response to muscle activity involved in regulation of muscle adaptation|negative regulation of angiogenesis|extracellular matrix organization|negative regulation of cell growth|peristalsis|positive regulation of cellular protein metabolic process|positive regulation of superoxide anion generation|positive regulation of peptidyl-serine phosphorylation|negative regulation of tissue remodeling|catenin import into nucleus|positive regulation of renal sodium excretion|positive regulation of multicellular organism growth|vasodilation|hormone metabolic process|drinking behavior|regulation of apoptotic process|positive regulation of MAPK cascade|negative regulation of neuron apoptotic process|positive regulation of nitric oxide biosynthetic process|positive regulation of fatty acid biosynthetic process|positive regulation of epidermal growth factor receptor signaling pathway|positive regulation of transcription, DNA-templated|positive regulation of vasodilation|positive regulation of organ growth|astrocyte activation|fibroblast proliferation|positive regulation of fibroblast proliferation|regulation of long-term neuronal synaptic plasticity|smooth muscle cell proliferation|cytokine secretion|regulation of inflammatory response|positive regulation of peptidyl-tyrosine phosphorylation|smooth muscle cell differentiation|negative regulation of neurotrophin TRK receptor signaling pathway|stress-activated MAPK cascade|regulation of calcium ion transport|regulation of transmission of nerve impulse|cell growth involved in cardiac muscle cell development|positive regulation of protein tyrosine kinase activity|ERK1 and ERK2 cascade|uterine smooth muscle contraction|cellular response to mechanical stimulus|positive regulation of branching involved in ureteric bud morphogenesis|positive regulation of protein kinase C activity|regulation of extracellular matrix assembly|positive regulation of membrane hyperpolarization|positive regulation of gap junction assembly|regulation of cardiac conduction|positive regulation of extrinsic apoptotic signaling pathway|",serine-type endopeptidase inhibitor activity|hormone activity|sodium channel regulator activity|type 1 angiotensin receptor binding|type 2 angiotensin receptor binding|,12,46,17500000000,31.3%
P07309,0.379259998,-1.17475,8.206285289,2.7735,0.151137234,1.648846179,-0.9125,-0.184,-6.588,0.419,0.236,-0.019,P07309,Ttr,P07309_Ttr,P07309,Ttr,1,54,13,13,P07309,MOUSE,15889.7,61.2,147,147.1,184.6,184.6,,147,Transthyretin,extracellular space|protein complex|extracellular exosome|,retinol metabolic process|thyroid hormone transport|,hormone activity|protein binding|identical protein binding|protein heterodimerization activity|thyroid hormone binding|,13,54,58400000000,61.2%
Q8CIF4,0.932038361,0.158583333,0.486837397,-0.0625,0.89395624,-0.139157393,-0.3065,-0.284,1.16,0.221,0.159,0.002,Q8CIF4,Btd,Q8CIF4_Btd,Q8CIF4,Btd,1,47,11,11,A0A0R4J131|Q8CIF4,MOUSE,58952,24.4,148,148.1,184.08,184.08,,520,Biotinidase,extracellular space|nucleolus|perikaryon|apical part of cell|extracellular exosome|,biotin metabolic process|,biotinidase activity|,11,47,12000000000,24.4%
G3X8T3,0.425473432,-0.100416667,6.947045361,0.3955,0.201973999,1.432739809,-0.2625,0.062,-0.694,0.105,0.222,-0.035,G3X8T3,Ctsa,G3X8T3_Ctsa,G3X8T3,Ctsa,1,43,12,12,G3X8T3|P16675,MOUSE,56352.8,27.2,149,149.1,183.12,183.12,,492,Carboxypeptidase,nucleoplasm|mitochondrion|membrane|intracellular membrane-bounded organelle|extracellular exosome|,proteolysis|,serine-type carboxypeptidase activity|protein binding|,12,43,6470000000,27.2%
P45700,0.968031615,0.059916667,0.168485562,-0.013166667,0.961947663,-0.049738058,-0.1655,-0.099,0.464,-0.005,0.186,-0.021,P45700,Man1a,P45700_Man1a,P45700,Man1a1,1,31,19,19,P45700|A0A1W2P6N0,MOUSE,73502.6,30.6,150,150.1,182.78,182.78,,655,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA",Golgi membrane|cytoplasm|endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|membrane|integral component of membrane|extracellular exosome|,N-glycan processing|,"mannosyl-oligosaccharide 1,2-alpha-mannosidase activity|calcium ion binding|",19,31,1670000000,30.6%
Q60590,0.888540941,0.036916667,0.950713206,0.0655,0.803394177,0.260235126,-0.0425,-0.249,0.304,-0.082,0.231,0.06,Q60590,Orm1,Q60590_Orm1,Q60590,Orm1,1,36,12,7,Q60590|J3JRU4|Q63805,MOUSE,24008.9,33.8,151,151.1,181.9,109.51,,207,Alpha-1-acid glycoprotein 1,extracellular space|,regulation of immune system process|transport|acute-phase response|,,12,36,23900000000,33.8%
P07361,0.963454267,-0.34775,0.216112533,0.078833333,0.951456082,0.063512913,2.5295,-2.104,-1.587,-0.723,-0.355,0.153,P07361,Orm2,P07361_Orm2,P07361,Orm2,1,7,9,4,P07361,MOUSE,23957.1,28.5,151,151.2,118.16,45.77,,207,Alpha-1-acid glycoprotein 2,extracellular space|,regulation of immune system process|transport|acute-phase response|,,4,7,478000000,12.5%
Q3UEL9,0.752963149,0.232916667,2.170375428,0.248166667,0.606683882,0.543530313,0.8035,0.076,-0.553,0.88,-0.192,0.383,Q3UEL9,Serpina7,Q3UEL9_Serpina7,Q3UEL9,Serpina7,1,35,14,14,Q3UEL9|P61939|Q8BII9,MOUSE,48364.8,29.3,152,152.1,181.59,181.59,,426,Thyroxine-binding globulin,extracellular space|extracellular exosome|,aging|post-embryonic development|negative regulation of endopeptidase activity|response to vitamin A|response to prostaglandin E|response to drug|response to peptide hormone|response to corticosterone|thyroid hormone transport|,serine-type endopeptidase inhibitor activity|hormone binding|,14,35,4130000000,29.3%
P11680,0.32515976,-0.05525,9.606239044,0.541166667,0.109490413,1.878223971,-0.7365,-0.164,-0.077,0.162,0.488,-0.004,P11680,Cfp,P11680_Cfp,P11680,Cfp,1,58,12,12,P11680,MOUSE,52836.7,32.5,153,153.1,181.53,181.53,,464,Properdin,extracellular region|extracellular matrix|,"complement activation, alternative pathway|",,12,58,90100000000,32.5%
P16301,0.293171081,-0.342083333,10.85411899,1.112833333,0.082146318,2.092328568,-0.8125,0.066,-1.949,0.451,0.219,-0.027,P16301,Lcat,P16301_Lcat,P16301,Lcat,1,55,11,11,P16301,MOUSE,50088.2,29.6,154,154.1,180.71,180.71,,438,Phosphatidylcholine-sterol acyltransferase,extracellular space|high-density lipoprotein particle|extracellular exosome|,phospholipid metabolic process|phosphatidylcholine biosynthetic process|cholesterol metabolic process|cholesterol transport|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|cholesterol esterification|lipoprotein biosynthetic process|cholesterol homeostasis|reverse cholesterol transport|response to copper ion|response to glucocorticoid|regulation of high-density lipoprotein particle assembly|,phosphatidylcholine-sterol O-acyltransferase activity|phospholipase A2 activity|apolipoprotein A-I binding|,11,55,90000000000,29.6%
P47879,0.800209948,0.15875,1.760854812,0.1085,0.666675536,0.452727022,-0.0225,0.149,0.187,0.471,0.201,-0.033,P47879,Igfbp4,P47879_Igfbp4,P47879,Igfbp4,1,43,13,13,P47879|H3BLB7,MOUSE,28947.5,48.8,155,155.1,179.07,179.07,,254,Insulin-like growth factor-binding protein 4,extracellular space|,regulation of cell growth|inflammatory response|regulation of glucose metabolic process|regulation of growth|positive regulation of MAPK cascade|positive regulation of insulin-like growth factor receptor signaling pathway|type B pancreatic cell proliferation|,insulin-like growth factor binding|insulin-like growth factor I binding|insulin-like growth factor II binding|,13,43,16300000000,48.8%
Q61805,0.916739094,0.144916667,0.640286721,-0.047833333,0.862921576,-0.180218596,0.0685,-0.004,0.442,0.434,-0.097,0.026,Q61805,Lbp,Q61805_Lbp,Q61805,Lbp,1,32,14,14,Q61805|A2AC65,MOUSE,53282.7,28.4,156,156.1,179.01,179.01,,481,Lipopolysaccharide-binding protein,extracellular space|cell surface|extracellular exosome|,"liver development|leukocyte chemotaxis involved in inflammatory response|macrophage activation involved in immune response|acute-phase response|opsonization|lipopolysaccharide transport|lipopolysaccharide-mediated signaling pathway|detection of molecule of bacterial origin|response to lipopolysaccharide|negative regulation of tumor necrosis factor production|positive regulation of chemokine production|positive regulation of interleukin-6 production|positive regulation of interleukin-8 production|positive regulation of tumor necrosis factor production|positive regulation of toll-like receptor 4 signaling pathway|positive regulation of tumor necrosis factor biosynthetic process|positive regulation of macrophage activation|negative regulation of growth of symbiont in host|innate immune response|defense response to Gram-negative bacterium|defense response to Gram-positive bacterium|positive regulation of phagocytosis, engulfment|positive regulation of respiratory burst involved in inflammatory response|cellular response to lipopolysaccharide|cellular response to lipoteichoic acid|positive regulation of neutrophil chemotaxis|regulation of membrane permeability|",lipopolysaccharide binding|receptor binding|lipoteichoic acid binding|,14,32,2410000000,28.4%
Q8VCG4,0.394562768,-0.0275,7.869877949,0.45875,0.163309784,1.633867633,-0.3335,-0.272,,0.191,-0.09,0.367,Q8VCG4,C8g,Q8VCG4_C8g,Q8VCG4,C8g,1,55,11,11,Q8VCG4|Q9DAC2,MOUSE,22678.7,62.3,157,157.1,176.6,176.6,,202,Complement component C8 gamma chain,membrane attack complex|extracellular exosome|blood microparticle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",complement binding|retinol binding|protein complex binding|,11,55,23400000000,62.3%
O09164,0.36473875,0.265583333,8.555952646,-0.405166667,0.139445574,-1.703428687,0.4145,0.252,0.738,0.184,0,0.005,O09164,Sod3,O09164_Sod3,O09164,Sod3,1,31,10,10,O09164,MOUSE,27733.7,44.2,158,158.1,176.57,176.57,,251,Extracellular superoxide dismutase [Cu-Zn],extracellular space|nucleus|cytoplasm|Golgi lumen|trans-Golgi network|extracellular exosome|extracellular matrix|,response to hypoxia|removal of superoxide radicals|response to copper ion|oxidation-reduction process|,superoxide dismutase activity|copper ion binding|protein binding|zinc ion binding|,10,31,11400000000,44.2%
P29533,0.758326556,0.18475,2.099460991,-0.340166667,0.616671533,-0.528146887,-0.3235,-0.445,1.833,-0.115,0.159,0,P29533,NotFound,P29533_NotFound,P29533,Vcam1,1,25,15,15,P29533|Q3UPN1|P29533-2,MOUSE,82457.1,22.1,159,159.1,176.49,176.49,,739,Vascular cell adhesion protein 1,podosome|extracellular space|early endosome|endoplasmic reticulum|Golgi apparatus|microvillus|external side of plasma membrane|cell surface|integral component of membrane|filopodium|anchored component of membrane|apical part of cell|extracellular exosome|alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex|cell periphery|,cell adhesion|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|leukocyte cell-cell adhesion|cell-matrix adhesion|heart development|amine metabolic process|viral process|positive regulation of T cell proliferation|leukocyte tethering or rolling|oxidation-reduction process|embryonic placenta morphogenesis|chorio-allantoic fusion|visceral serous pericardium development|cellular response to glucose stimulus|,integrin binding|primary amine oxidase activity|cell adhesion molecule binding|,15,25,1060000000,22.1%
Q02566,0.669813064,-0.208916667,3.347772078,-1.3955,0.462618283,-0.785360944,0.4015,4.242,-3.177,-0.844,-1.086,-0.79,Q02566,Myh6,Q02566_Myh6,Q02566,Myh6,1,21,17,4,Q02566|Q5SX39|Q5SX40|G3UW82|P13542|B1AR69,MOUSE,224360.2,9.4,160,160.1,174.76,43.64,,1938,Myosin-6,stress fiber|nucleoplasm|cytoplasm|mitochondrion|muscle myosin complex|focal adhesion|myosin complex|myofibril|Z disc|myosin filament|,in utero embryonic development|regulation of the force of heart contraction|regulation of heart rate|muscle contraction|striated muscle contraction|adult heart development|visceral muscle development|regulation of heart contraction|regulation of blood pressure|response to heat|actin filament-based movement|muscle filament sliding|myofibril assembly|BMP signaling pathway|regulation of ATPase activity|sarcomere organization|ATP metabolic process|cardiac muscle fiber development|atrial cardiac muscle tissue morphogenesis|ventricular cardiac muscle tissue morphogenesis|cardiac muscle contraction|canonical Wnt signaling pathway|regulation of heart growth|,microfilament motor activity|actin binding|protein binding|calmodulin binding|ATP binding|ATPase activity|protein kinase binding|actin-dependent ATPase activity|calcium-dependent ATPase activity|protein homodimerization activity|protein heterodimerization activity|,18,21,9310000000,9.4%
Q91Z83,0.174726314,0.8685,16.15457671,-4.447083333,0.024240542,-3.217389415,1.2545,5.819,,-0.691,-1.462,-0.578,Q91Z83,Myh7,Q91Z83_Myh7,Q91Z83,Myh7,1,1,15,1,Q91Z83,MOUSE,223673.7,8.2,160,160.2,148.98,12.52,,1935,Myosin-7,stress fiber|nucleoplasm|cytoplasm|muscle myosin complex|focal adhesion|myosin complex|myofibril|Z disc|myosin filament|,response to reactive oxygen species|regulation of the force of heart contraction|regulation of heart rate|skeletal muscle contraction|muscle contraction|striated muscle contraction|adult heart development|regulation of the force of skeletal muscle contraction|transition between fast and slow fiber|muscle filament sliding|regulation of slow-twitch skeletal muscle fiber contraction|ATP metabolic process|ventricular cardiac muscle tissue morphogenesis|cardiac muscle contraction|,microfilament motor activity|actin binding|calmodulin binding|ATP binding|ATPase activity|actin-dependent ATPase activity|protein homodimerization activity|protein heterodimerization activity|,1,1,7730000,0.8%
P13541,0.023108713,0.2645,32.39909784,-4.303333333,0.000575559,-9.964791262,,3.492,,-0.494,-1.117,-0.823,P13541,Myh3,P13541_Myh3,P13541,Myh3,1,1,5,1,P13541,MOUSE,224870.7,2.9,160,160.3,42.07,5.96,,1940,Myosin-3,myosin complex|myofibril|myosin filament|contractile fiber|extracellular exosome|,skeletal muscle contraction|ATP metabolic process|,"microfilament motor activity|calmodulin binding|ATP binding|ATPase activity, coupled|actin filament binding|",1,1,33700000,1.0%
P16882-2,0.242548931,-0.1457,12.49561056,0.732583333,0.056290997,2.474612027,-0.7895,-0.381,,0.084,0.368,-0.01,P16882,Ghr,P16882-2_Ghr,P16882-2,Ghr,1,39,10,10,P16882-2|P16882|Q3UP14,MOUSE,34617.4,36.7,161,161.1,174.72,174.72,,650,Isoform 2 of Growth hormone receptor,extracellular region|extracellular space|nucleus|plasma membrane|integral component of plasma membrane|cell surface|integral component of membrane|extrinsic component of membrane|receptor complex|growth hormone receptor complex|,allantoin metabolic process|citrate metabolic process|2-oxoglutarate metabolic process|succinate metabolic process|oxaloacetate metabolic process|isoleucine metabolic process|valine metabolic process|creatine metabolic process|fatty acid metabolic process|endocytosis|cytokine-mediated signaling pathway|taurine metabolic process|response to estradiol|cellular response to hormone stimulus|regulation of multicellular organism growth|positive regulation of multicellular organism growth|multicellular organismal metabolic process|creatinine metabolic process|insulin-like growth factor receptor signaling pathway|positive regulation of peptidyl-tyrosine phosphorylation|growth hormone receptor signaling pathway|,growth hormone receptor activity|protein binding|peptide hormone binding|growth factor binding|protein homodimerization activity|,11,39,39100000000,36.7%
Q02257,0.327678383,0.240416667,9.468935529,-1.9075,0.113007287,-1.860452324,2.9795,1.725,-1.122,-0.968,-0.484,-0.688,Q02257,Jup,Q02257_Jup,Q02257,Jup,1,27,16,16,Q02257|Q02248|E9Q6A9,MOUSE,82541,26.3,162,162.1,173.95,173.95,,745,Junction plakoglobin,nucleus|cytoplasm|cytosol|intermediate filament|plasma membrane|cell-cell junction|cell-cell adherens junction|focal adhesion|intercalated disc|membrane|catenin complex|Z disc|desmosome|protein-DNA complex|extracellular exosome|gamma-catenin-TCF7L2 complex|,desmosome assembly|cell adhesion|signal transduction|single organismal cell-cell adhesion|cell migration|adherens junction assembly|regulation of cell proliferation|positive regulation of protein import into nucleus|regulation of cell fate specification|skin development|detection of mechanical stimulus|positive regulation of sequence-specific DNA binding transcription factor activity|cellular response to indole-3-methanol|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|establishment of protein localization to plasma membrane|regulation of ventricular cardiac muscle cell action potential|positive regulation of transcription from RNA polymerase II promoter|,transcription coactivator activity|signal transducer activity|structural molecule activity|protein binding|protein phosphatase binding|alpha-catenin binding|cadherin binding|cell adhesion molecule binding|nuclear hormone receptor binding|,16,27,1060000000,26.3%
Q63880,0.800204643,-0.096583333,1.77031343,0.117166667,0.665225145,0.454859511,-0.5285,-0.014,0.077,-0.12,-0.064,0.07,Q63880,Ces3a,Q63880_Ces3a,Q63880,Ces3a,1,37,13,6,Q63880|Q63880-2,MOUSE,63715.9,23.4,163,163.1,172.68,88.57,,571,Carboxylesterase 3A,endoplasmic reticulum lumen|extracellular exosome|,metabolic process|,carboxylic ester hydrolase activity|,13,37,5190000000,23.4%
Q8VCU1,0.935838029,-1E-04,0.45073213,0.036083333,0.901419164,0.130297149,0.1655,-0.209,,-0.114,0.094,0.063,Q8VCU1,Ces3b,Q8VCU1_Ces3b,Q8VCU1,Ces3b,1,4,10,3,Q8VCU1|Q8VCU1-2,MOUSE,63751.2,16.2,163,163.2,120.33,36.22,,571,Carboxylesterase 3B,endoplasmic reticulum lumen|extracellular exosome|,metabolic process|,carboxylic ester hydrolase activity|,3,4,315000000,5.7%
Q91WU0,0.438545613,-0.43175,6.683082237,0.7375,0.214630668,1.390333325,-0.4745,0.032,-1.959,-0.081,-0.043,-0.065,Q91WU0,Ces1f,Q91WU0_Ces1f,Q91WU0,Ces1f,1,24,14,14,Q91WU0,MOUSE,62010.5,33.1,164,164.1,172.65,172.65,,561,Carboxylesterase 1F,lipid particle|cytosol|,short-chain fatty acid catabolic process|,hydrolase activity|,14,24,79500000000,33.1%
P28654,0.034505297,0.66175,29.68889765,-2.698833333,0.001074262,-5.948391066,2.9515,1.308,1.774,-0.817,-0.539,-0.707,P28654,Dcn,P28654_Dcn,P28654,Dcn,1,38,14,14,P28654,MOUSE,40150.6,34.1,165,165.1,171.85,171.85,,354,Decorin,collagen type VI trimer|extracellular space|extracellular matrix|,kidney development|placenta development|skeletal muscle tissue development|aging|response to mechanical stimulus|positive regulation of autophagy|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|response to lipopolysaccharide|wound healing|,collagen binding|glycosaminoglycan binding|poly(A) RNA binding|protein N-terminus binding|extracellular matrix binding|,14,38,9880000000,34.1%
P12399,0.40834567,-0.1685,7.446843282,0.387916667,0.180017892,1.558199154,-0.4015,-0.401,,-0.082,0.014,0.028,P12399,Ctla2a,P12399_Ctla2a,P12399,Ctla2a,1,45,11,11,P12399|A0A286YDF0|A0A286YD17|P12400|A0A0R4J245,MOUSE,16053.8,59.8,166,166.1,168.96,168.96,,137,Protein CTLA-2-alpha,extracellular space|lysosome|dendrite|,negative regulation of protein processing|regulation of regulatory T cell differentiation|negative regulation of inflammatory response|proteolysis involved in cellular protein catabolic process|,cysteine-type endopeptidase activity|,11,45,72500000000,59.8%
A0A075B5T3,0.44527584,-0.04075,6.572814137,0.3315,0.220149948,1.368823881,-0.1885,-0.236,-0.195,-0.072,0.451,-0.004,A0A075B5T3,NotFound,A0A075B5T3_NotFound,A0A075B5T3,Ighv6-6,1,42,12,7,A0A075B5T3,MOUSE,13464,81.5,167,167.1,168.07,104.48,,119,Immunoglobulin heavy variable 6-6 (Fragment),,,,12,42,48100000000,81.5%
A0A075B5T2,0.236594809,-0.1525,12.68259243,0.79375,0.053918867,2.509812896,-0.6865,-0.571,,-0.207,0.453,0.249,A0A075B5T2,NotFound,A0A075B5T2_NotFound,A0A075B5T2,Ighv6-3,1,20,10,5,A0A075B5T2,MOUSE,13430,56.7,167,167.2,136.41,75.25,,118,Immunoglobulin heavy variable 6-3 (Fragment),,,,5,20,9960000000,26.2%
P01801,,1.188333333,,,,,,,,-0.179,1.999,1.745,P01801,NotFound,P01801_NotFound,P01801,,1,1,9,1,P01801|P01796|P01799|P01797|P01802|P01800|P01803,MOUSE,12924.2,58.2,167,167.3,109.35,4.2,,115,Ig heavy chain V-III region J606,,,antigen binding|,1,1,24000000,13.0%
P01798,0.906482719,0.4229,0.730818443,-0.095583333,0.845119564,-0.205946897,0.1885,0.772,,0.255,1.051,-0.152,P01798,NotFound,P01798_NotFound,P01798,,1,1,5,1,P01798,MOUSE,12761.1,36.2,167,167.4,64.53,6.51,,113,Ig heavy chain V-III region E109,,,antigen binding|,1,1,4500000,7.9%
A0A0A6YWU3,0.407329798,0.1925,7.547002927,1.069583333,0.175913718,1.581104724,-0.7815,-0.117,,0.2,-0.133,1.794,A0A0A6YWU3,NotFound,A0A0A6YWU3_NotFound,A0A0A6YWU3,Ighv6-7,1,2,4,1,A0A0A6YWU3,MOUSE,13943.6,24.3,167,167.5,47.87,15.11,,119,Immunoglobulin heavy variable V6-7 (Fragment),,,,1,2,30900000,7.5%
P00760,0.015825163,0.805416667,38.60269315,-2.7895,0.000137953,-8.598864281,2.8115,1.916,1.873,-0.706,-0.528,-0.534,P00760,NotFound,P00760_NotFound,P00760,,1,31,10,10,P00760,BOVIN,26469.4,50.8,168,168.1,166.69,166.69,,246,Cationic trypsin,,,,10,31,14900000000,50.8%
O08795-2,0.379259998,-0.06675,8.209472961,0.366166667,0.151026342,1.645544566,-0.3965,-0.138,-0.215,0.125,0.263,-0.039,O08795,Prkcsh,O08795-2_Prkcsh,O08795-2,Prkcsh,1,28,14,14,O08795-2|O08795,MOUSE,60528.5,18.3,169,169.1,165.9,165.9,,521,Isoform 2 of Glucosidase 2 subunit beta,endoplasmic reticulum|,in utero embryonic development|liver development|N-glycan processing|nitrogen compound metabolic process|negative regulation of neuron projection development|protein heterooligomerization|renal system development|,RNA binding|protein kinase C binding|calcium ion binding|protein binding|ion channel binding|phosphoprotein binding|,14,28,3400000000,18.3%
Q9CQW3,0.991064137,0.181083333,0.039343953,0.007833333,0.990981632,0.011790321,-0.7255,-0.441,1.698,0.208,0.327,0.02,Q9CQW3,Proz,Q9CQW3_Proz,Q9CQW3,Proz,1,41,9,9,Q9CQW3|Q8CI01,MOUSE,45615.9,33.8,170,170.1,162.39,162.39,,399,Vitamin K-dependent protein Z,extracellular region|extracellular exosome|,proteolysis|blood coagulation|,serine-type endopeptidase activity|calcium ion binding|,9,41,18800000000,33.8%
Q9D154,0.213452452,-0.582916667,13.99708782,1.239833333,0.039837421,2.627395847,-0.7885,-0.615,-2.205,-0.183,0.267,0.027,Q9D154,Serpinb1a,Q9D154_Serpinb1a,Q9D154,Serpinb1a,1,21,16,16,Q9D154|Q8VHP7|Q5SV42|Q9JK88|I7HJI5|Q9DAV6|Q9D6A7,MOUSE,42745.3,39.5,171,171.1,161.88,161.88,,379,Leukocyte elastase inhibitor A,extracellular space|cytoplasm|membrane|extracellular exosome|,negative regulation of endopeptidase activity|regulation of protein catabolic process|,serine-type endopeptidase inhibitor activity|,16,21,616000000,39.5%
P01837,0.31416078,-0.13275,10.25546536,0.5875,0.094287357,1.986111398,-0.1165,-0.688,-0.475,-0.249,0.407,0.325,P01837,NotFound,P01837_NotFound,P01837,,1,49,11,11,P01837|A0A075B5P2,MOUSE,11948.8,94.3,172,172.1,161.04,161.04,,106,Ig kappa chain C region,plasma membrane|,,antigen binding|,11,49,1.43E+11,94.3%
P03987,0.456433733,-0.254916667,6.325539552,0.781833333,0.233048357,1.328691695,0.3805,-0.497,-1.821,-0.095,0.551,-0.048,P03987,NotFound,P03987_NotFound,P03987,,1,49,11,11,A0A1Y7VJN6|P03987|P03987-2,MOUSE,44498.8,28.3,173,173.1,160.75,160.75,,398,Ig gamma-3 chain C region,extracellular region|plasma membrane|integral component of membrane|,,antigen binding|immunoglobulin receptor binding|,11,49,14600000000,28.3%
P18242,0.480243199,-0.12125,5.873774885,0.307833333,0.258596422,1.247968575,-0.1835,-0.051,-0.591,-0.072,0.148,0.022,P18242,Ctsd,P18242_Ctsd,P18242,Ctsd,1,24,11,11,P18242|F8WIR1,MOUSE,45409.4,27.8,174,174.1,159.83,159.83,,410,Cathepsin D,extracellular space|mitochondrion|lysosome|melanosome|membrane raft|extracellular exosome|extracellular matrix|,autophagosome assembly|proteolysis|autophagy|protein catabolic process|epithelial tube branching involved in lung morphogenesis|,aspartic-type endopeptidase activity|peptidase activity|peptide binding|,11,24,8950000000,27.8%
P52480,0.072965798,0.47425,24.08127752,-1.0185,0.003907259,-4.549476953,0.8665,1.019,1.065,0.137,-0.222,-0.02,P52480,Pkm,P52480_Pkm,P52480,Pkm,1,25,15,15,P52480|P52480-2|P53657|G3X925|E9Q509,MOUSE,58414.4,35.4,175,175.1,158.72,158.72,,531,Pyruvate kinase PKM,nucleus|cytoplasm|mitochondrion|plasma membrane|cilium|extracellular matrix|vesicle|myelin sheath|extracellular exosome|extracellular vesicle|,glycolytic process|programmed cell death|phosphorylation|,magnesium ion binding|pyruvate kinase activity|protein binding|ATP binding|MHC class II protein complex binding|potassium ion binding|poly(A) RNA binding|,16,25,253000000,35.4%
G5E8J0,0.742574146,-0.13025,2.48785748,0.1805,0.563915786,0.610561375,0.0355,-0.741,0.044,-0.14,0.009,0.011,G5E8J0,Notch2,G5E8J0_Notch2,G5E8J0,Notch2,1,23,14,14,G5E8J0|O35516|O35516-2,MOUSE,279492.6,6.3,176,176.1,156.79,156.79,,2473,Neurogenic locus notch homolog protein 2,nucleus|integral component of plasma membrane|cell surface|receptor complex|,pulmonary valve morphogenesis|cell cycle arrest|Notch signaling pathway|negative regulation of cell proliferation|cell growth|cell differentiation|positive regulation of Ras protein signal transduction|bone remodeling|regulation of developmental process|atrial septum morphogenesis|,calcium ion binding|,14,23,725000000,6.3%
Q8K0D2,0.425473432,-0.1509,6.960428159,0.61975,0.201352573,1.475264317,-1.0685,0.023,,0.347,-0.049,-0.007,Q8K0D2,Habp2,Q8K0D2_Habp2,Q8K0D2,Habp2,1,26,13,13,Q8K0D2|E9QM92|E9Q092|Q8K0D2-2|Q3V1J8|E9Q0C5,MOUSE,64409.4,22.5,177,177.1,156.68,156.68,,558,Hyaluronan-binding protein 2,extracellular region|,proteolysis|,serine-type endopeptidase activity|peptidase activity|,13,26,2000000000,22.5%
P98086,0.926381931,0.825416667,0.531301055,0.107833333,0.884850487,0.151209095,0.5695,0.279,1.466,0.376,2.357,-0.095,P98086,C1qa,P98086_C1qa,P98086,C1qa,1,48,10,10,P98086,MOUSE,26202.1,35.1,178,178.1,155.68,155.68,,245,Complement C1q subcomponent subunit A,collagen trimer|extracellular exosome|,"complement activation, classical pathway|innate immune response|",protein binding|,10,48,60700000000,35.1%
P47877,0.214239872,-0.35475,13.85792787,1.0475,0.041134594,2.603260109,-0.7315,-0.268,-1.636,0.442,0.085,-0.02,P47877,Igfbp2,P47877_Igfbp2,P47877,Igfbp2,1,22,11,11,P47877|D3YU40,MOUSE,33930.2,38.6,179,179.1,154.53,154.53,,305,Insulin-like growth factor-binding protein 2,extracellular region|extracellular space|apical plasma membrane|cytoplasmic vesicle|extracellular exosome|,regulation of cell growth|signal transduction|female pregnancy|aging|response to nutrient|response to mechanical stimulus|response to lithium ion|response to estradiol|response to retinoic acid|cellular response to hormone stimulus|positive regulation of activated T cell proliferation|response to drug|regulation of insulin-like growth factor receptor signaling pathway|response to glucocorticoid|,insulin-like growth factor binding|insulin-like growth factor I binding|insulin-like growth factor II binding|,11,22,4150000000,38.6%
Q80YC5,0.565879699,-0.02675,4.653551619,0.370833333,0.342487589,1.031780239,-0.7345,-0.334,0.432,0.404,0.076,-0.004,Q80YC5,F12,Q80YC5_F12,Q80YC5,F12,1,33,11,11,Q80YC5|E9Q698,MOUSE,67982.3,21.7,180,180.1,154,154,,597,Coagulation factor XII,extracellular space|extracellular exosome|,plasma kallikrein-kinin cascade|Factor XII activation|blood coagulation|positive regulation of plasminogen activation|protein processing|protein autoprocessing|regulation of blood coagulation|positive regulation of blood coagulation|zymogen activation|fibrinolysis|response to misfolded protein|positive regulation of fibrinolysis|,serine-type endopeptidase activity|peptidase activity|serine-type aminopeptidase activity|,11,33,8540000000,21.7%
P98063,0.331936472,-0.280416667,9.235735573,0.472166667,0.119241229,1.816636231,-0.6495,-0.769,-0.131,-0.106,-0.074,0.047,P98063,Bmp1,P98063_Bmp1,P98063,Bmp1,1,19,14,14,P98063|Q9WVM6|E9Q5B9|G3X9F5|Q62381|Q62381-2,MOUSE,113889.4,16.8,181,181.1,153.57,153.57,,991,Bone morphogenetic protein 1,proteinaceous extracellular matrix|extracellular space|Golgi apparatus|membrane-bounded vesicle|,ossification|proteolysis|cell differentiation|cartilage development|positive regulation of cartilage development|,metalloendopeptidase activity|cytokine activity|calcium ion binding|protein binding|growth factor activity|peptidase activity|zinc ion binding|,14,19,1290000000,16.8%
P52430,0.800204643,0.103583333,1.767380156,0.196833333,0.665674598,0.454564338,-0.8685,0.267,0.617,0.4,0.256,-0.05,P52430,Pon1,P52430_Pon1,P52430,Pon1,1,34,10,10,P52430|H3BLB8,MOUSE,39735.6,30.1,182,182.1,151.36,151.36,,355,Serum paraoxonase/arylesterase 1,extracellular space|high-density lipoprotein particle|spherical high-density lipoprotein particle|intracellular membrane-bounded organelle|extracellular exosome|blood microparticle|,blood circulation|cholesterol metabolic process|response to toxic substance|positive regulation of cholesterol efflux|dephosphorylation|aromatic compound catabolic process|response to nutrient levels|positive regulation of transporter activity|carboxylic acid catabolic process|organophosphate catabolic process|phosphatidylcholine metabolic process|positive regulation of binding|response to fatty acid|response to fluoride|,aryldialkylphosphatase activity|arylesterase activity|calcium ion binding|phospholipid binding|high-density lipoprotein particle binding|protein homodimerization activity|,10,34,8480000000,30.1%
Q91Y47,0.323693105,-0.20125,9.846489732,1.0125,0.103597918,1.92359337,-0.1545,-0.254,-1.714,-0.268,0.8,0.383,Q91Y47,F11,Q91Y47_F11,Q91Y47,F11,1,23,12,12,Q91Y47,MOUSE,71784.4,17.1,183,183.1,151.34,151.34,,624,Coagulation factor XI,extracellular space|extracellular exosome|,blood coagulation|regulation of blood coagulation|plasminogen activation|positive regulation of fibrinolysis|,serine-type endopeptidase activity|heparin binding|,12,23,829000000,17.1%
O55111,0.373407521,-0.927916667,8.383778905,1.9105,0.145084865,1.678677977,-0.5495,-0.496,-4.604,0.063,-0.029,0.048,O55111,Dsg2,O55111_Dsg2,O55111,Dsg2,1,14,11,11,O55111|Q811I1|Q8VCE3,MOUSE,123181.5,13.1,184,184.1,148.04,148.04,,1122,Desmoglein-2,plasma membrane|cell surface|intercalated disc|integral component of membrane|apical plasma membrane|lateral plasma membrane|desmosome|extracellular exosome|,desmosome organization|Purkinje myocyte development|cell adhesion|homophilic cell adhesion via plasma membrane adhesion molecules|response to progesterone|maternal process involved in female pregnancy|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|regulation of ventricular cardiac muscle cell action potential|,calcium ion binding|cell adhesion molecule binding|,11,14,229000000,13.1%
Q8C196,0.43481237,0.063916667,6.809897897,-1.967833333,0.208453989,-1.412087836,0.5465,4.165,-1.568,-0.868,-1.038,-0.854,Q8C196,Cps1,Q8C196_Cps1,Q8C196,Cps1,1,16,13,13,Q8C196,MOUSE,165813.2,9.5,185,185.1,147.89,147.89,,1500,"Carbamoyl-phosphate synthase [ammonia], mitochondrial",nucleolus|cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial nucleoid|protein complex|,urea cycle|glycogen catabolic process|'de novo' pyrimidine nucleobase biosynthetic process|proteolysis|arginine biosynthetic process|glutamine metabolic process|midgut development|response to toxic substance|response to zinc ion|response to amine|triglyceride catabolic process|response to food|response to lipopolysaccharide|response to drug|response to starvation|response to amino acid|cellular response to fibroblast growth factor stimulus|positive regulation of vasodilation|nitric oxide metabolic process|homocysteine metabolic process|anion homeostasis|response to growth hormone|hepatocyte differentiation|carbamoyl phosphate biosynthetic process|cellular response to cAMP|cellular response to glucagon stimulus|cellular response to oleic acid|response to dexamethasone|,carbamoyl-phosphate synthase (ammonia) activity|carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity|endopeptidase activity|calcium ion binding|protein binding|ATP binding|phospholipid binding|glutamate binding|protein complex binding|modified amino acid binding|,13,16,799000000,9.5%
P03953,0.434899442,-0.43325,6.785826326,0.9005,0.209612592,1.407962573,-0.5545,0.181,-2.277,-0.179,-0.009,0.239,P03953,Cfd,P03953_Cfd,P03953,Cfd,1,40,8,8,P03953|P03953-2,MOUSE,28569.8,35.9,186,186.1,144.85,144.85,,259,Complement factor D,extracellular space|extracellular exosome|,"proteolysis|complement activation, alternative pathway|",serine-type endopeptidase activity|,8,40,27600000000,35.9%
Q8CIT9,0.509872886,-0.418083333,5.476406823,0.914833333,0.283373554,1.180074318,0.0235,0.031,-2.681,-0.191,0.155,0.154,Q8CIT9,Sbsn,Q8CIT9_Sbsn,Q8CIT9,Sbsn,1,20,10,10,Q8CIT9|E9QPB2|S4R2I1|Q8CIT9-3|A0A0R4J2A5,MOUSE,72446.7,19.7,187,187.1,143.41,143.41,,700,Suprabasin,cytoplasm|extracellular exosome|,,,10,20,1550000000,19.7%
P12246,0.742574146,0.1911,2.519544396,0.303083333,0.559816327,0.625193928,0.0285,-0.01,,-0.144,1.141,-0.06,P12246,Apcs,P12246_Apcs,P12246,Apcs,1,29,10,10,P12246,MOUSE,26417.6,30.3,188,188.1,141.46,141.46,,224,Serum amyloid P-component,extracellular space|nucleus|protein complex|extracellular exosome|blood microparticle|extracellular matrix|,protein complex assembly|negative regulation by host of viral exo-alpha-sialidase activity|negative regulation by host of viral glycoprotein metabolic process|innate immune response|negative regulation of monocyte differentiation|negative regulation of viral entry into host cell|negative regulation of viral process|negative regulation of exo-alpha-sialidase activity|negative regulation of glycoprotein metabolic process|,complement component C1q binding|calcium ion binding|carbohydrate binding|virion binding|,10,29,7840000000,30.3%
Q9CWF2,0.622619577,0.38475,3.845811411,-0.370833333,0.412495162,-0.881570456,0.8145,1.061,-0.165,0.419,-0.301,0.48,Q9CWF2,Tubb2b,Q9CWF2_Tubb2b,Q9CWF2,Tubb2b,1,18,11,1,Q9CWF2|Q7TMM9|A0A1D5RM76,MOUSE,50408.6,28,189,189.1,141.21,16.49,,445,Tubulin beta-2B chain,nucleus|cytoplasm|microtubule|,neuron migration|microtubule-based process|metabolic process|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|,11,18,835000000,28.0%
P99024,0.214239872,0.5554,13.68949196,-1.505166667,0.042761291,-2.718699422,,2.105,0.812,0.302,-0.688,0.246,P99024,Tubb5,P99024_Tubb5,P99024,Tubb5,1,1,11,1,P99024,MOUSE,50126.4,28.1,189,189.2,135.22,10.5,,444,Tubulin beta-5 chain,nucleus|nuclear envelope lumen|cytosol|microtubule|cytoplasmic ribonucleoprotein granule|cell body|tubulin complex|extracellular exosome|,protein folding|microtubule-based process|cellular process|spindle assembly|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|protein domain specific binding|ubiquitin protein ligase binding|protein complex binding|GTPase activating protein binding|MHC class I protein binding|,1,1,12900000,3.3%
P68372,0.889361503,0.3185,0.917973263,-0.131333333,0.809473571,-0.257976063,,0.417,,0.337,-0.191,0.711,P68372,Tubb4b,P68372_Tubb4b,P68372,Tubb4b,1,1,10,1,P68372|Q9D6F9|Q922F4,MOUSE,50286.6,24.7,189,189.3,119.71,5.11,,445,Tubulin beta-4B chain,nucleus|cytoplasm|microtubule|myelin sheath|tubulin complex|extracellular exosome|extracellular vesicle|,microtubule-based process|metabolic process|protein polymerization|,double-stranded RNA binding|GTPase activity|structural constituent of cytoskeleton|GTP binding|,1,1,57000000,3.3%
A2AQ07,0.932038361,0.392083333,0.479592633,0.087166667,0.895448754,0.13718431,1.2145,0.735,-0.904,0.686,-0.265,0.886,A2AQ07,Tubb1,A2AQ07_Tubb1,A2AQ07,Tubb1,1,4,6,3,A2AQ07,MOUSE,51124.7,12.6,189,189.4,66.83,37.1,,451,Tubulin beta-1 chain,cytoplasm|microtubule|extracellular exosome|,microtubule-based process|metabolic process|spindle assembly|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|,3,4,161000000,8.4%
Q922D8,0.899330297,-0.14525,0.780574934,0.069833333,0.835492405,0.216898844,0.0175,0.22,-0.778,-0.153,-0.154,-0.024,Q922D8,Mthfd1,Q922D8_Mthfd1,Q922D8,Mthfd1,1,16,14,14,Q922D8|A0A1W2P733,MOUSE,101882.4,15.4,190,190.1,140.73,140.73,,935,"C-1-tetrahydrofolate synthase, cytoplasmic",mitochondrion|cytosol|membrane|extracellular exosome|,histidine biosynthetic process|neutrophil homeostasis|neural tube closure|purine nucleotide biosynthetic process|methionine metabolic process|one-carbon metabolic process|heart development|serine family amino acid metabolic process|serine family amino acid biosynthetic process|methionine biosynthetic process|10-formyltetrahydrofolate biosynthetic process|transsulfuration|tetrahydrofolate interconversion|oxidation-reduction process|somite development|,formate-tetrahydrofolate ligase activity|methenyltetrahydrofolate cyclohydrolase activity|methylenetetrahydrofolate dehydrogenase (NAD+) activity|methylenetetrahydrofolate dehydrogenase (NADP+) activity|ATP binding|,14,16,516000000,15.4%
Q62009,0.835045105,0.01025,1.498584988,-0.0925,0.708176484,-0.392634616,0.2135,-0.112,0.068,-0.269,0.089,0.072,Q62009,Postn,Q62009_Postn,Q62009,Postn,1,16,13,13,Q62009|Q62009-2|Q62009-3|Q62009-5|Q62009-4,MOUSE,93826.5,18.3,191,191.1,139.01,139.01,,838,Periostin,proteinaceous extracellular matrix|extracellular space|trans-Golgi network|extracellular matrix|,cell adhesion|regulation of Notch signaling pathway|tissue development|extracellular matrix organization|,heparin binding|cell adhesion molecule binding|,13,16,203000000,18.3%
P31532,0.604460486,0.162583333,4.167062261,0.290166667,0.383083789,0.940984215,-0.4175,0.177,0.293,0.532,0.445,-0.054,P31532,Saa4,P31532_Saa4,P31532,Saa4,1,28,10,10,P31532,MOUSE,15144.6,68.4,192,192.1,138.66,138.66,,130,Serum amyloid A-4 protein,extracellular space|high-density lipoprotein particle|,acute-phase response|positive chemotaxis|cell chemotaxis|,chemoattractant activity|,10,28,7160000000,68.4%
Q60994,0.167167113,-0.526083333,16.82876165,1.1955,0.020755052,3.131603547,-0.9155,-0.624,-1.832,-0.238,0.27,0.183,Q60994,Adipoq,Q60994_Adipoq,Q60994,Adipoq,1,55,8,8,Q60994,MOUSE,26922.6,27.1,193,193.1,137.85,137.85,,247,Adiponectin,collagen trimer|extracellular space|endoplasmic reticulum|cell surface|perinuclear region of cytoplasm|extracellular exosome|cell periphery|,"response to hypoxia|positive regulation of protein phosphorylation|glucose metabolic process|fatty acid beta-oxidation|response to nutrient|circadian rhythm|response to sucrose|response to glucose|positive regulation of signal transduction|negative regulation of platelet-derived growth factor receptor signaling pathway|positive regulation of protein kinase A signaling|negative regulation of macrophage derived foam cell differentiation|negative regulation of tumor necrosis factor-mediated signaling pathway|positive regulation of cholesterol efflux|regulation of glucose metabolic process|response to activity|negative regulation of smooth muscle cell migration|fatty acid oxidation|negative regulation of cell migration|negative regulation of granulocyte differentiation|negative regulation of protein autophosphorylation|positive regulation of cellular protein metabolic process|negative regulation of tumor necrosis factor production|positive regulation of interleukin-8 production|cellular response to insulin stimulus|positive regulation of myeloid cell apoptotic process|adiponectin-activated signaling pathway|negative regulation of heterotypic cell-cell adhesion|low-density lipoprotein particle clearance|response to tumor necrosis factor|cellular response to drug|glucose homeostasis|positive regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of MAP kinase activity|response to ethanol|negative regulation of fat cell differentiation|negative regulation of macrophage differentiation|negative regulation of low-density lipoprotein particle receptor biosynthetic process|negative regulation of gluconeogenesis|negative regulation of blood pressure|positive regulation of blood pressure|negative regulation of transcription, DNA-templated|positive regulation of fatty acid metabolic process|positive regulation of glucose import|negative regulation of hormone secretion|negative regulation of smooth muscle cell proliferation|negative regulation of inflammatory response|positive regulation of peptidyl-tyrosine phosphorylation|negative regulation of phagocytosis|negative regulation of synaptic transmission|brown fat cell differentiation|protein homooligomerization|response to glucocorticoid|membrane depolarization|membrane hyperpolarization|protein heterotrimerization|negative regulation of ERK1 and ERK2 cascade|response to linoleic acid|detection of oxidative stress|cellular response to cAMP|positive regulation of monocyte chemotactic protein-1 production|cellular response to epinephrine stimulus|protein localization to plasma membrane|negative regulation of intracellular protein transport|negative regulation of receptor binding|negative regulation of DNA biosynthetic process|positive regulation of glycogen (starch) synthase activity|positive regulation of metanephric glomerular visceral epithelial cell development|positive regulation of cAMP-dependent protein kinase activity|positive regulation of renal albumin absorption|negative regulation of platelet-derived growth factor receptor-alpha signaling pathway|negative regulation of metanephric mesenchymal cell migration|",receptor binding|hormone activity|protein binding|sialic acid binding|identical protein binding|protein homodimerization activity|,8,55,1.18E+11,27.1%
Q3TQC7,0.849755878,0.06125,1.331182766,0.0915,0.736006625,0.353236262,-0.2315,0.002,0.276,0.365,-0.093,0.049,Q3TQC7,Entpd5,Q3TQC7_Entpd5,Q3TQC7,Entpd5,1,20,10,10,Q3TQC7|Q9WUZ9,MOUSE,50293.2,25.8,194,194.1,136.5,136.5,,452,Ectonucleoside triphosphate diphosphohydrolase 5,extracellular exosome|,metabolic process|,hydrolase activity|,10,20,2380000000,25.8%
Q3SXB8-2,0.318473122,-0.37725,10.0355593,1.147166667,0.09918456,1.955218466,-0.2335,-0.381,-2.238,0.042,0.562,-0.015,Q3SXB8,Colec11,Q3SXB8-2_Colec11,Q3SXB8-2,Colec11,1,20,11,11,Q3SXB8-2|A0A1Y7VKG6|Q3SXB8|A0A0R4J0M6,MOUSE,29981.5,33,195,195.1,135.11,135.11,,272,Isoform 2 of Collectin-11,extracellular region|collagen trimer|,multicellular organismal development|developmental process|,mannose binding|,11,20,1150000000,33.0%
Q8BND5,0.432160496,-1.23725,6.858717063,2.753833333,0.206123873,1.420448509,-0.1545,-0.397,-7.291,0.082,0.337,0,Q8BND5,Qsox1,Q8BND5_Qsox1,Q8BND5,Qsox1,1,20,13,2,Q8BND5|Q8BND5-2,MOUSE,83582.5,18.1,196,196.1,134.94,29.07,,748,Sulfhydryl oxidase 1,extracellular space|endoplasmic reticulum|Golgi apparatus|integral component of Golgi membrane|intracellular membrane-bounded organelle|intercellular bridge|extracellular exosome|,protein folding|negative regulation of macroautophagy|cell redox homeostasis|oxidation-reduction process|,protein disulfide isomerase activity|flavin-linked sulfhydryl oxidase activity|,13,20,930000000,18.1%
Q8BND5-3,0.271520577,0.493583333,11.38629966,-0.7305,0.072672489,-2.176854238,1.3745,0.739,0.463,0.475,-0.17,0.08,Q8BND5,Qsox1,Q8BND5-3_Qsox1,Q8BND5-3,Qsox1,1,3,13,3,Q8BND5-3,MOUSE,64076.9,21.1,196,196.2,120.8,20.64,,748,Isoform 3 of Sulfhydryl oxidase 1,extracellular space|endoplasmic reticulum|Golgi apparatus|integral component of Golgi membrane|intracellular membrane-bounded organelle|intercellular bridge|extracellular exosome|,protein folding|negative regulation of macroautophagy|cell redox homeostasis|oxidation-reduction process|,protein disulfide isomerase activity|flavin-linked sulfhydryl oxidase activity|,3,3,39500000,3.8%
P04202,0.956042887,0.1753,0.271611675,-0.022416667,0.939374642,-0.079961367,0.1975,0.18,,0.133,0.412,-0.046,P04202,Tgfb1,P04202_Tgfb1,P04202,Tgfb1,1,18,13,13,P04202,MOUSE,44993.8,31.5,197,197.1,134.39,134.39,,390,Transforming growth factor beta-1,proteinaceous extracellular matrix|extracellular space|nucleus|cytoplasm|cell surface|secretory granule|axon|neuronal cell body|blood microparticle|microvillus|,"protein import into nucleus, translocation|negative regulation of transcription from RNA polymerase II promoter|MAPK cascade|skeletal system development|ureteric bud development|response to hypoxia|cell activation|epithelial to mesenchymal transition|negative regulation of protein phosphorylation|positive regulation of protein phosphorylation|regulation of sodium ion transport|chondrocyte differentiation|hematopoietic progenitor cell differentiation|CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment|adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains|tolerance induction to self antigen|protein phosphorylation|protein export from nucleus|ATP biosynthetic process|phosphate-containing compound metabolic process|cellular calcium ion homeostasis|defense response|inflammatory response|cell cycle arrest|mitotic cell cycle checkpoint|epidermal growth factor receptor signaling pathway|transforming growth factor beta receptor signaling pathway|common-partner SMAD protein phosphorylation|SMAD protein complex assembly|SMAD protein import into nucleus|Notch signaling pathway|negative regulation of neuroblast proliferation|salivary gland morphogenesis|endoderm development|skeletal muscle tissue development|female pregnancy|aging|negative regulation of DNA replication|cell proliferation|positive regulation of cell proliferation|negative regulation of cell proliferation|germ cell migration|response to radiation|response to wounding|response to glucose|defense response to fungus, incompatible interaction|organ morphogenesis|regulation of gene expression|positive regulation of gene expression|negative regulation of gene expression|positive regulation of epithelial to mesenchymal transition|positive regulation of fibroblast migration|positive regulation of peptidyl-threonine phosphorylation|positive regulation of pathway-restricted SMAD protein phosphorylation|negative regulation of macrophage cytokine production|oligodendrocyte development|cell growth|regulation of striated muscle tissue development|regulation of transforming growth factor beta receptor signaling pathway|evasion or tolerance of host defenses by virus|negative regulation of cell-cell adhesion|hyaluronan catabolic process|T cell differentiation|negative regulation of ossification|negative regulation of cell growth|positive regulation of cell migration|positive regulation of bone mineralization|mammary gland development|positive regulation of histone deacetylation|organ regeneration|positive regulation of protein complex assembly|positive regulation of exit from mitosis|lipopolysaccharide-mediated signaling pathway|positive regulation of cellular protein metabolic process|response to estradiol|response to progesterone|regulation of interleukin-23 production|negative regulation of interleukin-17 production|positive regulation of interleukin-17 production|receptor catabolic process|regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation|positive regulation of superoxide anion generation|mononuclear cell proliferation|positive regulation of collagen biosynthetic process|positive regulation of peptidyl-serine phosphorylation|response to vitamin D|response to laminar fluid shear stress|positive regulation of histone acetylation|positive regulation of protein dephosphorylation|wound healing|T cell activation|regulation of cell proliferation|negative regulation of T cell proliferation|regulation of protein import into nucleus|positive regulation of protein import into nucleus|positive regulation of odontogenesis|response to drug|myelination|regulation of apoptotic process|myeloid dendritic cell differentiation|T cell homeostasis|positive regulation of apoptotic process|positive regulation of MAP kinase activity|regulation of MAPK cascade|protein kinase B signaling|positive regulation of blood vessel endothelial cell migration|negative regulation of blood vessel endothelial cell migration|positive regulation of phosphatidylinositol 3-kinase activity|ossification involved in bone remodeling|regulatory T cell differentiation|cell-cell junction organization|negative regulation of fat cell differentiation|negative regulation of myoblast differentiation|negative regulation of cell cycle|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|negative regulation of mitotic cell cycle|positive regulation of transcription from RNA polymerase II promoter|positive regulation of fibroblast proliferation|positive regulation of isotype switching to IgA isotypes|cell development|lymph node development|digestive tract development|negative regulation of skeletal muscle tissue development|inner ear development|positive regulation of epithelial cell proliferation|negative regulation of epithelial cell proliferation|positive regulation of protein secretion|negative regulation of phagocytosis|negative regulation of T cell activation|positive regulation of chemotaxis|positive regulation of NF-kappaB transcription factor activity|regulation of binding|regulation of DNA binding|positive regulation of smooth muscle cell differentiation|negative regulation of release of sequestered calcium ion into cytosol|positive regulation of protein kinase B signaling|face morphogenesis|frontal suture morphogenesis|pathway-restricted SMAD protein phosphorylation|positive regulation of SMAD protein import into nucleus|SMAD protein signal transduction|mammary gland branching involved in thelarche|branch elongation involved in mammary gland duct branching|regulation of branching involved in mammary gland duct morphogenesis|negative regulation of gene silencing by miRNA|regulation of cartilage development|lens fiber cell differentiation|response to cholesterol|positive regulation of cell cycle arrest|cellular response to growth factor stimulus|cellular response to organic cyclic compound|cellular response to dexamethasone stimulus|cellular response to transforming growth factor beta stimulus|T-helper 17 cell lineage commitment|extracellular matrix assembly|positive regulation of branching involved in ureteric bud morphogenesis|extrinsic apoptotic signaling pathway|negative regulation of hyaluronan biosynthetic process|positive regulation of protein localization to nucleus|positive regulation of NAD+ ADP-ribosyltransferase activity|regulation of actin cytoskeleton reorganization|positive regulation of transcription regulatory region DNA binding|",glycoprotein binding|antigen binding|type II transforming growth factor beta receptor binding|cytokine activity|transforming growth factor beta receptor binding|protein binding|growth factor activity|enzyme binding|type I transforming growth factor beta receptor binding|type III transforming growth factor beta receptor binding|protein homodimerization activity|protein heterodimerization activity|protein N-terminus binding|,13,18,751000000,31.5%
Q8CJH3,0.742574146,0.173416667,2.487410791,-0.268166667,0.56397379,-0.61102898,-0.1985,-0.13,1.251,-0.035,0.151,0.002,Q8CJH3,Plxnb1,Q8CJH3_Plxnb1,Q8CJH3,Plxnb1,1,21,11,11,Q8CJH3,MOUSE,234738.4,5.9,198,198.1,133.08,133.08,,2119,Plexin-B1,semaphorin receptor complex|integral component of plasma membrane|,negative regulation of cell adhesion|regulation of cell shape|positive regulation of phosphatidylinositol 3-kinase signaling|negative regulation of osteoblast proliferation|positive regulation of GTPase activity|ossification involved in bone maturation|neuron projection morphogenesis|positive regulation of axonogenesis|regulation of cytoskeleton organization|semaphorin-plexin signaling pathway|semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis|,protein binding|semaphorin receptor activity|GTPase activating protein binding|,11,21,890000000,5.9%
G5E8Q8,0.365418926,-0.1377,8.533737916,0.46675,0.140160684,1.752528981,-0.2605,-0.575,,0.005,0.136,0.006,G5E8Q8,Adgrf5,G5E8Q8_Adgrf5,G5E8Q8,Adgrf5,1,18,10,10,G5E8Q8,MOUSE,151723.4,9.1,199,199.1,132.77,132.77,,1348,Adhesion G protein-coupled receptor F5,,,,10,18,3130000000,9.1%
P22629,0.023108713,0.798416667,34.36222726,-2.226166667,0.00036625,-7.197469362,2.4765,1.634,1.624,-0.323,-0.402,-0.219,P22629,NotFound,P22629_NotFound,P22629,,1,185,7,1,P22629,STRAV,18833.4,43.1,200,200.1,127.86,23.95,,183,Streptavidin,,,,7,185,5.28E+12,43.1%
Q53532,0.023108713,0.78575,32.68750825,-2.4895,0.000538579,-6.786675423,2.7735,1.68,1.638,-0.472,-0.368,-0.537,Q53532,NotFound,Q53532_NotFound,Q53532,,1,26,7,2,Q53532|Q53533,STRVL,18863.4,43.1,200,200.2,113.35,30.52,,183,Streptavidin-V1,,,,2,26,2.9E+11,20.2%
P01592,0.50176456,-0.46775,5.627414509,0.886833333,0.27368976,1.206768963,0.1005,-0.226,-2.608,-0.221,0.083,0.065,P01592,Jchain,P01592_Jchain,P01592,Jchain,1,36,10,10,P01592,MOUSE,18469.7,71.6,201,201.1,125.78,125.78,,159,Immunoglobulin J chain,extracellular space|extracellular exosome|monomeric IgA immunoglobulin complex|dimeric IgA immunoglobulin complex|secretory IgA immunoglobulin complex|secretory dimeric IgA immunoglobulin complex|pentameric IgM immunoglobulin complex|blood microparticle|,adaptive immune response|glomerular filtration|humoral immune response|antibacterial humoral response|positive regulation of protein oligomerization|innate immune response|positive regulation of respiratory burst|,antigen binding|IgA binding|protein homodimerization activity|single-stranded DNA binding|phosphatidylcholine binding|immunoglobulin receptor binding|peptidoglycan binding|,10,36,44700000000,71.6%
Q7TSK7,0.32515976,-0.0573,9.532860565,0.586583333,0.111356082,1.931598698,-0.2125,-0.606,,0.085,0.445,0.002,Q7TSK7,Adamtsl2,Q7TSK7_Adamtsl2,Q7TSK7,Adamtsl2,1,16,10,10,Q7TSK7,MOUSE,109068.3,11.8,202,202.1,125.15,125.15,,957,ADAMTS-like protein 2,extracellular region|proteinaceous extracellular matrix|,proteolysis|negative regulation of transforming growth factor beta receptor signaling pathway|,metalloendopeptidase activity|zinc ion binding|,10,16,647000000,11.8%
P51885,0.817095546,-0.02225,1.627644153,-0.088166667,0.687441244,-0.422442652,0.0415,-0.098,0.122,-0.108,-0.049,-0.042,P51885,Lum,P51885_Lum,P51885,Lum,1,15,10,10,P51885,MOUSE,38663.6,34.9,203,203.1,125.04,125.04,,338,Lumican,proteinaceous extracellular matrix|fibrillar collagen trimer|extracellular space|extracellular exosome|extracellular matrix|,visual perception|response to organic cyclic compound|collagen fibril organization|positive regulation of transforming growth factor beta1 production|positive regulation of transcription from RNA polymerase II promoter|cartilage development|response to growth factor|,collagen binding|,10,15,2010000000,34.9%
P11152,0.050383195,-0.5863,26.00369846,1.45325,0.002509748,5.60583392,-1.5345,-1.382,,-0.137,0.042,0.08,P11152,Lpl,P11152_Lpl,P11152,Lpl,1,18,9,9,P11152,MOUSE,53679,23.8,204,204.1,124.19,124.19,,474,Lipoprotein lipase,extracellular space|plasma membrane|cell surface|extracellular matrix|anchored component of membrane|very-low-density lipoprotein particle|chylomicron|extracellular exosome|,fatty acid biosynthetic process|response to cold|positive regulation of macrophage derived foam cell differentiation|positive regulation of cholesterol storage|positive regulation of sequestering of triglyceride|triglyceride biosynthetic process|triglyceride catabolic process|very-low-density lipoprotein particle remodeling|response to drug|triglyceride homeostasis|,lipoprotein lipase activity|triglyceride lipase activity|receptor binding|protein binding|heparin binding|triglyceride binding|apolipoprotein binding|,9,18,1770000000,23.8%
P70274,0.32515976,-0.06925,9.663130902,0.421833333,0.108065461,1.887677809,-0.1865,-0.458,-0.196,0.271,0.155,-0.001,P70274,Selenop,P70274_Selenop,P70274,Selenop,1,28,9,9,P70274,MOUSE,43595.1,20.7,205,205.1,123.69,123.69,,380,Selenoprotein P,extracellular region|extracellular space|extracellular exosome|,selenium compound metabolic process|brain development|locomotory behavior|post-embryonic development|sexual reproduction|growth|,selenium binding|,9,28,6450000000,20.7%
Q5MJS3,0.468728046,0.15025,6.149921012,-0.319166667,0.242665423,-1.295965882,0.4235,0.529,-0.023,0.066,-0.067,-0.027,Q5MJS3,Fam20c,Q5MJS3_Fam20c,Q5MJS3,Fam20c,1,16,10,10,Q5MJS3|Q8CID3,MOUSE,66392.3,17.2,206,206.1,121.58,121.58,,579,Extracellular serine/threonine protein kinase FAM20C,extracellular space|Golgi apparatus|extracellular exosome|,skeletal system development|protein phosphorylation|positive regulation of bone mineralization|biomineral tissue development|osteoclast maturation|regulation of fibroblast growth factor receptor signaling pathway|positive regulation of osteoblast differentiation|regulation of phosphorus metabolic process|enamel mineralization|odontoblast differentiation|dentinogenesis|,protein serine/threonine kinase activity|calcium ion binding|manganese ion binding|,10,16,858000000,17.2%
Q04857,0.84738773,-0.03725,1.375526997,0.0785,0.728529765,0.363756865,-0.1315,-0.068,-0.03,-0.179,0.086,0.099,Q04857,Col6a1,Q04857_Col6a1,Q04857,Col6a1,1,11,10,10,Q04857,MOUSE,109628.6,11.6,207,207.1,121.29,121.29,,1025,Collagen alpha-1(VI) chain,extracellular region|proteinaceous extracellular matrix|collagen trimer|lysosomal membrane|membrane|extracellular matrix|sarcolemma|protein complex|extracellular exosome|extracellular matrix|,osteoblast differentiation|cell adhesion|endodermal cell differentiation|protein heterotrimerization|cellular response to amino acid stimulus|,platelet-derived growth factor binding|,10,11,519000000,11.6%
Q71KU9,0.968031615,-0.007083333,0.168231128,0.014166667,0.962004021,0.049664322,0.3755,-0.148,-0.27,-0.265,0.248,0.017,Q71KU9,Fgl1,Q71KU9_Fgl1,Q71KU9,Fgl1,1,18,10,10,Q71KU9|A0A0R4J0E1|Q3SZZ7,MOUSE,36724.1,26.7,208,208.1,120.73,120.73,,314,Fibrinogen-like protein 1,extracellular exosome|,cholesterol metabolic process|regulation of glucose metabolic process|response to stilbenoid|adipose tissue development|,,10,18,667000000,26.7%
Q07113,0.477010276,0.102416667,6.019057145,-0.2815,0.250088825,-1.273265058,0.1295,0.15,0.45,-0.12,0.023,-0.018,Q07113,Igf2r,Q07113_Igf2r,Q07113,Igf2r,1,18,12,12,Q07113,MOUSE,280828.2,4.9,209,209.1,120.3,120.3,,2483,Cation-independent mannose-6-phosphate receptor,nucleus|nuclear envelope lumen|lysosomal membrane|endosome|early endosome|late endosome|trans-Golgi network|focal adhesion|cell surface|membrane|integral component of membrane|endocytic vesicle|trans-Golgi network transport vesicle|extracellular exosome|,transport|,glycoprotein binding|transporter activity|insulin-like growth factor binding|mannose binding|identical protein binding|phosphoprotein binding|,12,18,988000000,4.9%
A0A075B5R5,0.413719377,-0.0857,7.32915235,0.535083333,0.184962959,1.537123674,-0.8065,-0.007,,0.222,0.202,-0.039,A0A075B5R5,NotFound,A0A075B5R5_NotFound,A0A075B5R5,Ighv4-1,1,20,7,7,A0A075B5R5|P01807|P01808|P01812|P01806|P01809|P01810|A0A075B5Q2|A0A075B5P7|A0A0A6YWG4,MOUSE,13044.9,68.1,210,210.1,119.2,114.55,,116,Immunoglobulin heavy variable 4-1 (Fragment),,,,9,20,1800000000,68.1%
P18524,0.745307288,0.334875,2.367063492,0.371166667,0.579820613,0.603029394,0.0565,,,-0.263,0.923,0.623,P18524,NotFound,P18524_NotFound,P18524,,1,1,3,1,P18524,MOUSE,13036.9,23.9,210,210.2,21.29,4.98,,117,Ig heavy chain V region RF,,,antigen binding|,1,1,1340000,9.4%
P27656,0.394562768,-0.146416667,7.894409981,0.424833333,0.162389895,1.592753104,-0.1885,-0.111,-0.777,0.087,0.124,-0.013,P27656,Lipc,P27656_Lipc,P27656,Lipc,1,17,8,8,P27656|Q3TYU0,MOUSE,58072.5,17.8,211,211.1,118.07,118.07,,510,Hepatic triacylglycerol lipase,extracellular space|high-density lipoprotein particle|,fatty acid biosynthetic process|cholesterol metabolic process|triglyceride catabolic process|cholesterol transport|very-low-density lipoprotein particle remodeling|low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|cholesterol homeostasis|triglyceride homeostasis|,triglyceride lipase activity|protein binding|heparin binding|lipase activity|,8,17,740000000,17.8%
E9QN70,0.393807795,-0.0857,7.922353395,0.62175,0.161348399,1.645918978,-0.7555,-0.162,,-0.252,0.202,0.539,E9QN70,Lamb1,E9QN70_Lamb1,E9QN70,Lamb1,1,14,11,11,E9QN70|P02469,MOUSE,209741,5.7,212,212.1,117.7,117.7,,1834,Laminin subunit beta-1,proteinaceous extracellular matrix|basement membrane|basal lamina|laminin-1 complex|laminin-2 complex|extracellular space|extracellular matrix|laminin complex|laminin-8 complex|laminin-10 complex|extracellular exosome|basement membrane|,embryo implantation|cell migration|neuronal-glial interaction involved in cerebral cortex radial glia guided migration|positive regulation of cell migration|neuron projection development|substrate adhesion-dependent cell spreading|endodermal cell differentiation|odontogenesis|,integrin binding|extracellular matrix structural constituent|protein binding|enzyme binding|glycosphingolipid binding|,11,14,322000000,5.7%
P14106,0.644280913,0.7731,3.61640993,0.725583333,0.434869558,0.850063766,0.8195,-0.144,,0.69,2.527,-0.027,P14106,C1qb,P14106_C1qb,P14106,C1qb,1,40,8,8,P14106,MOUSE,26945.1,38.7,213,213.1,117.2,117.2,,253,Complement C1q subcomponent subunit B,collagen trimer|extracellular exosome|blood microparticle|,"complement activation, classical pathway|innate immune response|inner ear development|",protein homodimerization activity|,8,40,85800000000,38.7%
P11589,0.233962779,-0.64775,12.84984576,1.710833333,0.051881846,2.429857027,-0.9815,-0.475,-3.053,-0.029,0.66,-0.008,P11589,NotFound,P11589_NotFound,P11589,Mup2,1,21,9,9,P11589|Q4FZE8|A2BIN1|P04938|A2CEK7|P02762|P11588|A2CEL1|A2AKN8|Q58EV3|B5X0G2|A9C496|E9PVW0|A2CEL0|E9QA79|A9C497|A2AKN9|A9R9W0|A2CEK6|L7N222|A2BIN0|P11591|A2AV72|P04939|Q3KQQ2|Q80YX8|A2ANT6,MOUSE,20948.4,50.5,214,214.1,116.99,116.99,,180,Major urinary protein 2,extracellular space|nucleus|cytosol|,"energy reserve metabolic process|transport|insulin receptor signaling pathway|aerobic respiration|positive regulation of gene expression|negative regulation of lipid storage|positive regulation of glucose metabolic process|heat generation|glucose homeostasis|locomotor rhythm|negative regulation of gluconeogenesis|positive regulation of lipid metabolic process|negative regulation of transcription, DNA-templated|negative regulation of lipid biosynthetic process|positive regulation of protein kinase B signaling|negative regulation of insulin secretion involved in cellular response to glucose stimulus|mitochondrion morphogenesis|cellular response to lipid|",insulin-activated receptor activity|transporter activity|pheromone binding|small molecule binding|,9,21,1850000000,50.5%
P00698,0.023108713,0.701583333,32.73252577,-2.433166667,0.000533025,-6.781292534,2.5715,1.342,1.841,-0.644,-0.486,-0.415,P00698,NotFound,P00698_NotFound,P00698,LYZ,1,17,9,9,P00698,CHICK,16751.9,65.3,215,215.1,116.5,116.5,,147,Lysozyme C,,,,9,17,3020000000,65.3%
Q91VB8,0.669813064,0.013416667,3.318914074,0.3165,0.465702525,0.77969207,-0.9275,0.277,0.216,0.495,-0.119,0.139,Q91VB8,Hba-a1,Q91VB8_Hba-a1,Q91VB8,Hba-a1,1,47,7,7,Q91VB8|P01942|P01966,MOUSE,15169,63.3,216,216.1,115.82,115.82,,142,Alpha globin 1,hemoglobin complex|,oxygen transport|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,7,47,1.94E+11,63.3%
A0A075B5Y4,0.916739094,0.44125,0.640469118,-0.111166667,0.862885335,-0.180390258,-0.1005,-0.059,1.65,-0.062,1.208,0.011,A0A075B5Y4,NotFound,A0A075B5Y4_NotFound,A0A075B5Y4,Ighv1-81,1,20,8,4,A0A075B5Y4|A0A0A6YVW3|P06327|A0A075B5X2|A0A075B5W5|A0A0A6YXA5,MOUSE,13102.5,60.6,217,217.1,114.65,74.75,,117,Immunoglobulin heavy variable 1-81 (Fragment),,,,8,20,1170000000,60.6%
P06330,0.214239872,-0.34625,13.69363394,1.181833333,0.042720527,2.574830639,-0.5575,-0.457,-1.797,-0.259,0.602,0.391,P06330,NotFound,P06330_NotFound,P06330,,1,12,7,4,P06330|A0A075B5V0|A0A075B5V1|P01757|P01756|A0A075B5V6|A0A075B5V2|A0A075B5U6|A0A075B5V7|A0A075B5U5,MOUSE,13048.2,71.1,217,217.2,107.09,65.97,,118,Ig heavy chain V region AC38 205.12,,,antigen binding|,4,12,6280000000,44.9%
A0A075B5U4,0.537820564,0.1179,4.964711885,0.366083333,0.318807707,1.106890425,-0.3375,0.134,,0.522,0.336,-0.065,A0A075B5U4,NotFound,A0A075B5U4_NotFound,A0A075B5U4,Ighv1-18,1,6,5,2,A0A075B5U4,MOUSE,11351.7,50.9,217,217.3,72.77,39.51,,102,Immunoglobulin heavy variable V1-18,,,,2,6,283000000,34.3%
A0A075B5U7,0.43481237,0.0519,6.809529244,0.718583333,0.208471684,1.447969025,-0.4845,-0.274,,-0.188,1.178,0.028,A0A075B5U7,NotFound,A0A075B5U7_NotFound,A0A075B5U7,Ighv1-22,1,4,4,2,A0A075B5U7|P01758,MOUSE,13135.6,50.4,217,217.4,66.59,44.12,,117,Immunoglobulin heavy variable 1-22 (Fragment),,,,2,4,62700000,29.9%
A0A0B4J1J7,0.64802674,-0.0943,3.567261164,0.244083333,0.439818896,0.838935578,-0.2655,-0.216,,-0.287,0.236,0.061,A0A0B4J1J7,NotFound,A0A0B4J1J7_NotFound,A0A0B4J1J7,Ighv1-82,1,5,4,2,A0A0B4J1J7,MOUSE,10763.9,34.6,217,217.5,42.08,22.88,,98,Immunoglobulin heavy variable 1-82,,,,2,5,71300000,25.5%
A0A075B5Y3,0.604460486,-0.456583333,4.122166473,0.8485,0.38706451,0.933760903,0.8725,-0.719,-2.796,-0.33,0.284,-0.051,A0A075B5Y3,NotFound,A0A075B5Y3_NotFound,A0A075B5Y3,Ighv1-80,1,1,3,1,A0A075B5Y3,MOUSE,12877.4,24.7,217,217.6,41.33,22.13,,117,Immunoglobulin heavy variable 1-80 (Fragment),,,,1,1,21000000,17.0%
A0A0B4J1M0,,0.641666667,,,,,,,,0.211,1.634,0.08,A0A0B4J1M0,NotFound,A0A0B4J1M0_NotFound,A0A0B4J1M0,Ighv1-77,1,2,3,1,A0A0B4J1M0,MOUSE,10775.9,24.4,217,217.7,37.38,18.18,,98,Immunoglobulin heavy variable 1-77,,,,1,2,6370000,15.3%
A0A075B674,0.84738773,0.1267,1.370098981,-0.148416667,0.729440885,-0.366288302,-0.0595,0.491,,-0.376,0.582,-0.004,A0A075B674,NotFound,A0A075B674_NotFound,A0A075B674,Ighv1-78,1,2,3,1,A0A075B674,MOUSE,11161.3,25.5,217,217.8,31.86,12.66,,98,Immunoglobulin heavy variable 1-78,,,,1,2,89800000,16.3%
P01746,0.612149353,0.116416667,3.960475353,-0.500833333,0.401746836,-0.903320524,0.8275,1.134,-0.861,-0.193,-0.276,0.067,P01746,NotFound,P01746_NotFound,P01746,,1,4,2,1,P01746|P01747,MOUSE,15628.2,17.1,217,217.9,21.68,8.39,,140,Ig heavy chain V region 93G7,,,antigen binding|,1,4,189000000,7.1%
Q02105,0.416202343,0.437083333,7.241287183,0.963166667,0.188743186,1.485720953,0.4525,-0.089,-0.497,0.491,2.282,-0.017,Q02105,C1qc,Q02105_C1qc,Q02105,C1qc,1,36,8,8,Q02105,MOUSE,26390.5,35.3,218,218.1,114.02,114.02,,246,Complement C1q subcomponent subunit C,collagen trimer|extracellular space|membrane|extracellular exosome|blood microparticle|,"complement activation, classical pathway|negative regulation of granulocyte differentiation|innate immune response|negative regulation of macrophage differentiation|",tumor necrosis factor receptor binding|,8,36,83000000000,35.3%
O88968,0.512767633,-0.256916667,5.377390886,0.283166667,0.289908475,1.160704367,-0.3455,-0.157,-0.693,-0.226,-0.108,-0.012,O88968,Tcn2,O88968_Tcn2,O88968,Tcn2,1,23,9,9,O88968,MOUSE,48041.3,21.1,219,219.1,112.93,112.93,,430,Transcobalamin-2,extracellular space|extracellular exosome|,cobalt ion transport|cobalamin transport|,cobalamin binding|metal ion binding|,9,23,3920000000,21.1%
P02662,0.188763465,0.31375,15.19086305,-0.654833333,0.03026312,-2.823403393,0.5595,0.569,0.795,0.215,-0.18,-0.076,P02662,NotFound,P02662_NotFound,P02662,CSN1S1,1,17,7,7,P02662,BOVIN,24585.5,36.9,220,220.1,111.28,111.28,,214,"Alpha-S1-casein, Michrom mix 6",,,,7,17,1390000000,36.9%
Q8VCS0,0.886819929,0.145583333,0.983429036,-0.0685,0.797364868,-0.268438078,-0.1255,0.379,0.286,0.302,0.122,-0.09,Q8VCS0,Pglyrp2,Q8VCS0_Pglyrp2,Q8VCS0,Pglyrp2,1,15,7,7,Q8VCS0|Q8VCS0-2|Q8VCS0-3,MOUSE,58219.2,18.3,221,221.1,106.95,106.95,,530,N-acetylmuramoyl-L-alanine amidase,membrane|extracellular exosome|,pattern recognition receptor signaling pathway|peptidoglycan catabolic process|detection of bacterium|negative regulation of interferon-gamma production|negative regulation of natural killer cell differentiation involved in immune response|growth of symbiont in host|regulation of inflammatory response|defense response to Gram-positive bacterium|,zinc ion binding|N-acetylmuramoyl-L-alanine amidase activity|peptidoglycan receptor activity|peptidoglycan binding|,7,15,677000000,18.3%
O08689,0.817448119,0.010583333,1.610256528,0.1295,0.690199034,0.418454193,0.4735,-0.179,-0.457,0.013,0.238,-0.025,O08689,Mstn,O08689_Mstn,O08689,Mstn,1,17,10,10,O08689|A0A087WQL8|Q9Z1W4,MOUSE,43662.3,28.9,222,222.1,106.45,106.45,,376,Growth/differentiation factor 8,extracellular space|cytoplasm|,"positive regulation of defense response to virus by host|transforming growth factor beta receptor signaling pathway|response to heat|response to gravity|positive regulation of pathway-restricted SMAD protein phosphorylation|skeletal muscle atrophy|negative regulation of muscle hypertrophy|response to muscle activity|ovulation cycle process|response to testosterone|negative regulation of kinase activity|regulation of apoptotic process|skeletal muscle tissue regeneration|regulation of MAPK cascade|response to estrogen|response to ethanol|negative regulation of myoblast differentiation|positive regulation of transcription, DNA-templated|negative regulation of insulin receptor signaling pathway|muscle cell cellular homeostasis|cell development|negative regulation of skeletal muscle tissue growth|response to electrical stimulus|negative regulation of protein kinase B signaling|SMAD protein signal transduction|cellular response to dexamethasone stimulus|activation of mitophagy in response to mitochondrial depolarization|negative regulation of skeletal muscle satellite cell proliferation|negative regulation of satellite cell differentiation|negative regulation of myoblast proliferation|",receptor binding|cytokine activity|transforming growth factor beta receptor binding|protein binding|growth factor activity|heparin binding|identical protein binding|,10,17,838000000,28.9%
P55284,0.254188227,-0.1239,12.07609933,0.633083333,0.061999768,2.396116131,-0.4175,-0.59,,0.11,0.278,0,P55284,Cdh5,P55284_Cdh5,P55284,Cdh5,1,12,9,9,P55284,MOUSE,88186.6,12.5,223,223.1,106.11,106.11,,784,Cadherin-5,plasma membrane|cell-cell junction|adherens junction|bicellular tight junction|integral component of membrane|cell junction|cell periphery|,blood vessel maturation|homophilic cell adhesion via plasma membrane adhesion molecules|negative regulation of cell proliferation|single organismal cell-cell adhesion|regulation of establishment of cell polarity|,receptor binding|calcium ion binding|protein binding|beta-catenin binding|protein phosphatase binding|ion channel binding|,9,12,500000000,12.5%
B2RXS4,0.654257714,-0.105916667,3.499237616,0.3525,0.446762012,0.814937997,0.3705,-0.045,-1.172,0.013,0.22,-0.022,B2RXS4,Plxnb2,B2RXS4_Plxnb2,B2RXS4,Plxnb2,1,17,10,10,B2RXS4,MOUSE,209079.3,6.3,224,224.1,106.08,106.08,,1842,Plexin-B2,integral component of plasma membrane|cell surface|extracellular exosome|,neural tube closure|regulation of protein phosphorylation|neuroblast proliferation|brain development|regulation of cell shape|regulation of GTPase activity|positive regulation of axonogenesis|semaphorin-plexin signaling pathway|regulation of neuron migration|,protein binding|semaphorin receptor activity|,10,17,935000000,6.3%
E9QPK1,0.78213603,-0.045916667,1.892651735,0.181833333,0.646747601,0.482633751,0.5495,-0.262,-0.698,-0.202,0.257,0.08,E9QPK1,Cgref1,E9QPK1_Cgref1,E9QPK1,Cgref1,1,21,8,8,E9QPK1|Q8R1U2,MOUSE,35428.9,33.5,225,225.1,105.96,105.96,,325,Cell growth regulator with EF hand domain protein 1,,negative regulation of cell growth|,calcium ion binding|,8,21,24900000000,33.5%
Q9WUB3,0.918638583,-0.124083333,0.607572712,0.1175,0.86944623,0.171656544,0.9135,0.263,-1.725,0.02,-0.171,-0.045,Q9WUB3,Pygm,Q9WUB3_Pygm,Q9WUB3,Pygm,1,13,12,12,Q9WUB3|E9PUM3|Q8CI94|Q9ET01|Q3UEJ6,MOUSE,97741,16.5,226,226.1,105.52,105.52,,842,"Glycogen phosphorylase, muscle form",cytoplasm|sarcoplasmic reticulum|Z disc|extracellular exosome|,response to hypoxia|glycogen catabolic process|cellular calcium ion homeostasis|response to cAMP|,drug binding|glycogen phosphorylase activity|AMP binding|pyridoxal phosphate binding|carbohydrate binding|,12,13,376000000,16.5%
O09159,0.752963149,0.1663,2.172609484,0.175083333,0.606371878,0.549449945,-0.1505,0.273,,0.254,0.505,-0.05,O09159,Man2b1,O09159_Man2b1,O09159,Man2b1,1,14,12,12,O09159,MOUSE,115216.7,13.6,227,227.1,104.55,104.55,,1013,Lysosomal alpha-mannosidase,lysosome|extracellular exosome|,mannose metabolic process|cellular protein modification process|learning or memory|,alpha-mannosidase activity|mannose binding|zinc ion binding|,12,14,466000000,13.6%
Q91XL1,0.739889317,-0.089416667,2.603025291,0.140166667,0.549158198,0.634565327,-0.0605,-0.25,-0.168,-0.142,-0.088,0.172,Q91XL1,Lrg1,Q91XL1_Lrg1,Q91XL1,Lrg1,1,26,7,7,Q91XL1,MOUSE,37829.6,21.6,228,228.1,100.29,100.29,,342,Leucine-rich HEV glycoprotein,extracellular space|extracellular exosome|,positive regulation of endothelial cell proliferation|positive regulation of transforming growth factor beta receptor signaling pathway|positive regulation of angiogenesis|brown fat cell differentiation|,transforming growth factor beta receptor binding|,7,26,5480000000,21.6%
Q99P87,0.416202343,-0.302416667,7.2311816,0.596833333,0.189182883,1.484002001,-0.2295,-0.134,-1.439,0.011,-0.124,0.101,Q99P87,Retn,Q99P87_Retn,Q99P87,Retn,1,14,6,6,Q99P87,MOUSE,13119,55.2,229,229.1,99.37,99.37,,114,Resistin,extracellular region|extracellular space|extracellular exosome|,,hormone activity|,6,14,4150000000,55.2%
P39876,0.390133764,0.23475,8.040178053,-0.396833333,0.157029842,-1.617198591,0.3375,0.28,0.682,0.266,-0.12,-0.037,P39876,Timp3,P39876_Timp3,P39876,Timp3,1,15,9,9,P39876,MOUSE,24923.3,37.9,230,230.1,99.27,99.27,,211,Metalloproteinase inhibitor 3,proteinaceous extracellular matrix|basement membrane|extracellular space|nucleus|cytoplasm|extracellular exosome|extracellular matrix|,central nervous system development|aging|response to mechanical stimulus|response to hormone|negative regulation of endopeptidase activity|response to cytokine|tissue regeneration|response to estrogen|negative regulation of metalloenzyme activity|negative regulation of membrane protein ectodomain proteolysis|response to folic acid|cellular response to organic substance|,protease binding|metalloendopeptidase inhibitor activity|metal ion binding|,9,15,796000000,37.9%
P02663,0.663065362,0.25375,3.420076053,-0.546833333,0.454980093,-0.799516494,0.1295,-0.604,2.056,0.079,-0.097,-0.041,P02663,NotFound,P02663_NotFound,P02663,CSN1S2,1,21,8,8,P02663,BOVIN,26189.4,30.6,231,231.1,97.03,97.03,,222,Alpha-S2-casein,,,,8,21,2000000000,30.6%
Q07235,0.708127867,0.0837,2.940263763,0.239083333,0.508128581,0.712385706,-0.0385,-0.081,,0.62,-0.137,0.055,Q07235,Serpine2,Q07235_Serpine2,Q07235,Serpine2,1,13,8,8,Q07235,MOUSE,44263.6,22.1,232,232.1,96.89,96.89,,397,Glia-derived nexin,extracellular region|extracellular space|cytosol|extracellular matrix|platelet alpha granule|extrinsic component of external side of plasma membrane|neuromuscular junction|neuronal cell body|extracellular vesicle|,"embryo implantation|blood coagulation|negative regulation of cell proliferation|response to radiation|response to wounding|negative regulation of peptidase activity|negative regulation of platelet activation|negative regulation of plasminogen activation|negative regulation of sodium ion transport|negative regulation of endopeptidase activity|negative regulation of protein processing|positive regulation of neuron projection development|negative regulation of phosphatidylinositol 3-kinase signaling|cerebellar granular layer morphogenesis|negative regulation of blood coagulation|negative regulation of cell growth|secretion by cell|secretory granule organization|negative regulation of protein catabolic process|mating plug formation|negative regulation of proteolysis|negative regulation of smoothened signaling pathway|regulation of timing of cell differentiation|positive regulation of astrocyte differentiation|detection of mechanical stimulus involved in sensory perception|regulation of synaptic transmission, glutamatergic|long-term synaptic potentiation|innervation|seminal vesicle epithelium development|dense core granule biogenesis|negative regulation of platelet aggregation|",serine-type endopeptidase inhibitor activity|receptor binding|glycosaminoglycan binding|heparin binding|,8,13,216000000,22.1%
Q61406,0.415101064,-0.062583333,7.29800344,0.447166667,0.186294338,1.492281416,-0.0075,-0.114,-0.737,0.278,-0.134,0.339,Q61406,Cfhr1,Q61406_Cfhr1,Q61406,Cfhr1,1,19,7,7,Q61406,MOUSE,39640.4,26.5,233,233.1,95.78,95.78,,343,Complement factor H-related 1,extracellular exosome|blood microparticle|,,,7,19,2080000000,26.5%
Q01705,0.295068854,0.228916667,10.76857329,-0.531833333,0.083780447,-2.071469925,0.8175,0.256,0.411,-0.22,0.125,-0.016,Q01705,Notch1,Q01705_Notch1,Q01705,Notch1,1,12,9,9,Q01705|Q01705-3|Q01705-4|Q01705-2,MOUSE,284808.6,4.3,234,234.1,95.61,95.61,,2531,Neurogenic locus notch homolog protein 1,Golgi membrane|acrosomal vesicle|ruffle|MAML1-RBP-Jkappa- ICN1 complex|extracellular region|nucleus|nucleoplasm|cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|cytosol|cytoskeleton|plasma membrane|integral component of plasma membrane|cell surface|lamellipodium|cytoplasmic vesicle|receptor complex|cell periphery|,"negative regulation of transcription from RNA polymerase II promoter|in utero embryonic development|cell fate specification|epithelial to mesenchymal transition|liver development|heart looping|sprouting angiogenesis|osteoblast fate commitment|positive regulation of neuroblast proliferation|inflammatory response to antigenic stimulus|endocardium development|endocardium morphogenesis|atrioventricular node development|coronary vein morphogenesis|aortic valve morphogenesis|atrioventricular valve morphogenesis|pulmonary valve morphogenesis|mitral valve formation|epithelial to mesenchymal transition involved in endocardial cushion formation|endocardial cushion morphogenesis|cardiac chamber formation|cardiac ventricle morphogenesis|cardiac atrium morphogenesis|cardiac right atrium morphogenesis|cardiac left ventricle morphogenesis|cardiac right ventricle formation|ventricular trabecula myocardium morphogenesis|growth involved in heart morphogenesis|regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation|Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation|cell migration involved in endocardial cushion formation|pericardium morphogenesis|regulation of transcription from RNA polymerase II promoter|transcription from RNA polymerase II promoter|humoral immune response|Notch signaling pathway|positive regulation of transcription of Notch receptor target|spermatogenesis|determination of left/right symmetry|compartment pattern specification|axonogenesis|foregut morphogenesis|endoderm development|heart development|positive regulation of cell proliferation|negative regulation of cell proliferation|epidermis development|regulation of Notch signaling pathway|auditory receptor cell fate commitment|glial cell differentiation|regulation of gene expression|positive regulation of epithelial to mesenchymal transition|negative regulation of cell-substrate adhesion|negative regulation of myotube differentiation|mesenchymal cell development|regulation of somitogenesis|cell differentiation in spinal cord|neural tube development|cell differentiation|neuron differentiation|keratinocyte differentiation|negative regulation of ossification|lung development|embryonic limb morphogenesis|regulation of cell migration|positive regulation of cell migration|positive regulation of BMP signaling pathway|negative regulation of BMP signaling pathway|forebrain development|hair follicle morphogenesis|organ regeneration|response to corticosteroid|response to muramyl dipeptide|response to lipopolysaccharide|embryonic hindlimb morphogenesis|tube formation|skeletal muscle cell differentiation|cellular response to vascular endothelial growth factor stimulus|regulation of cell proliferation|tissue regeneration|positive regulation of apoptotic process|negative regulation of catalytic activity|cell fate commitment|negative regulation of cell differentiation|positive regulation of endothelial cell differentiation|regulation of auditory receptor cell differentiation|negative regulation of auditory receptor cell differentiation|positive regulation of keratinocyte differentiation|negative regulation of myoblast differentiation|negative regulation of neuron differentiation|negative regulation of osteoblast differentiation|positive regulation of Notch signaling pathway|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|negative regulation of calcium ion-dependent exocytosis|positive regulation of JAK-STAT cascade|negative regulation of photoreceptor cell differentiation|somatic stem cell division|neuron fate commitment|astrocyte differentiation|oligodendrocyte differentiation|positive regulation of astrocyte differentiation|negative regulation of oligodendrocyte differentiation|branching morphogenesis of an epithelial tube|regulation of epithelial cell proliferation|positive regulation of epithelial cell proliferation|regulation of neurogenesis|negative regulation of neurogenesis|cardiac muscle tissue morphogenesis|cardiac muscle cell proliferation|positive regulation of cardiac muscle cell proliferation|negative regulation of glial cell proliferation|cilium morphogenesis|cardiac epithelial to mesenchymal transition|cardiac septum morphogenesis|ventricular septum morphogenesis|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development|negative regulation of cell death|prostate gland epithelium morphogenesis|regulation of epithelial cell proliferation involved in prostate gland development|arterial endothelial cell differentiation|venous endothelial cell differentiation|cardiac vascular smooth muscle cell development|endocardial cell differentiation|vasculogenesis involved in coronary vascular morphogenesis|coronary artery morphogenesis|Notch signaling involved in heart development|regulation of cell adhesion involved in heart morphogenesis|heart trabecula morphogenesis|positive regulation of transcription from RNA polymerase II promoter in response to hypoxia|left/right axis specification|cellular response to follicle-stimulating hormone stimulus|distal tubule development|collecting duct development|glomerular mesangial cell development|interleukin-4 secretion|negative regulation of cell migration involved in sprouting angiogenesis|negative regulation of canonical Wnt signaling pathway|neuronal stem cell maintenance|positive regulation of ephrin receptor signaling pathway|regulation of extracellular matrix assembly|apoptotic process involved in embryonic digit morphogenesis|negative regulation of stem cell differentiation|negative regulation of anoikis|negative regulation of pro-B cell differentiation|negative regulation of endothelial cell chemotaxis|",core promoter binding|RNA polymerase II transcription factor binding transcription activator activity|chromatin binding|sequence-specific DNA binding transcription factor activity|enzyme inhibitor activity|receptor activity|Notch binding|calcium ion binding|protein binding|enzyme binding|chromatin DNA binding|sequence-specific DNA binding|protein heterodimerization activity|,9,12,407000000,4.3%
Q8C7G5,0.486898887,0.124416667,5.797870341,-0.354833333,0.263155812,-1.234710612,-0.1745,0.453,0.627,0.051,-0.162,-0.048,Q8C7G5,Apoa5,Q8C7G5_Apoa5,Q8C7G5,Apoa5,1,11,8,8,Q8C7G5|A0A1L1SQP3|A0A1L1SV61,MOUSE,41318.5,25,235,235.1,95.58,95.58,,368,Apolipoprotein A-V,extracellular region|extracellular space|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|blood microparticle|,triglyceride metabolic process|cholesterol biosynthetic process|lipid transport|response to hormone|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|positive regulation of very-low-density lipoprotein particle remodeling|triglyceride catabolic process|regulation of intestinal cholesterol absorption|organ regeneration|neuron projection regeneration|cholesterol efflux|phospholipid efflux|triglyceride-rich lipoprotein particle remodeling|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|lipoprotein metabolic process|tissue regeneration|cholesterol homeostasis|reverse cholesterol transport|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|positive regulation of lipid catabolic process|positive regulation of lipoprotein lipase activity|acylglycerol homeostasis|triglyceride homeostasis|,phospholipid binding|enzyme activator activity|heparin binding|lipid binding|cholesterol binding|cholesterol transporter activity|enzyme binding|phosphatidylcholine binding|lipase binding|low-density lipoprotein particle receptor binding|phosphatidylcholine-sterol O-acyltransferase activator activity|lipase activator activity|lipoprotein lipase activator activity|lipoprotein particle receptor binding|,8,11,309000000,25.0%
Q62356,0.906482719,-0.059583333,0.728741985,0.045833333,0.845523731,0.203440645,-0.2675,0.074,-0.054,-0.184,0.035,0.039,Q62356,Fstl1,Q62356_Fstl1,Q62356,Fstl1,1,9,7,7,Q62356,MOUSE,35694.4,27.4,236,236.1,93.34,93.34,,306,Follistatin-related protein 1,extracellular space|extracellular exosome|,response to starvation|,calcium ion binding|protein binding|heparin binding|,7,9,179000000,27.4%
P62827,0.425473432,0.386416667,6.979311071,-0.7275,0.200479003,-1.441069448,-0.1805,0.713,1.718,0.263,-0.189,-0.006,P62827,Ran,P62827_Ran,P62827,Ran,1,9,8,8,P62827|Q14AA6|Q61820,MOUSE,24593.8,33.3,237,237.1,91.77,91.77,,216,GTP-binding nuclear protein Ran,nucleus|nuclear envelope|nucleoplasm|nucleolus|cytoplasm|centriole|membrane|midbody|melanosome|RNA nuclear export complex|recycling endosome|extracellular exosome|chromatin|,"ribosomal subunit export from nucleus|ribosomal large subunit export from nucleus|ribosomal small subunit export from nucleus|protein import into nucleus, translocation|protein import into nucleus|protein export from nucleus|mitotic nuclear division|small GTPase mediated signal transduction|metabolic process|actin cytoskeleton organization|positive regulation of protein binding|cellular protein localization|cellular protein complex localization|cell division|protein localization to nucleolus|",GTPase activity|protein binding|GTP binding|GDP binding|poly(A) RNA binding|pre-miRNA binding|,8,9,4630000000,33.3%
Q8VC49,0.84738773,0.02425,1.35802262,-0.0805,0.731472053,-0.35961139,0.2765,-0.136,0.053,-0.004,-0.002,-0.042,Q8VC49,Ifi27l2b,Q8VC49_Ifi27l2b,Q8VC49,Ifi27l2b,1,11,6,6,Q8VC49,MOUSE,27886.1,26.1,238,238.1,91.53,91.53,,283,Interferon alpha-inducible protein 27-like protein 2B,integral component of membrane|,,,6,11,8510000000,26.1%
P43025,0.579776471,-0.1421,4.50210584,0.281916667,0.354641386,1.019880568,-0.5025,-0.12,,-0.146,0.034,0.024,P43025,NotFound,P43025_NotFound,P43025,Clec3b,1,13,6,6,P43025|Q8CFZ6,MOUSE,22656.5,28.7,239,239.1,91.52,91.52,,202,Tetranectin,granular component|proteinaceous extracellular matrix|extracellular space|cytoplasm|extracellular exosome|,skeletal system development|ossification|positive regulation of plasminogen activation|bone mineralization|,calcium ion binding|protein binding|heparin binding|carbohydrate binding|kringle domain binding|,6,13,320000000,28.7%
Q9ET66,0.425473432,-0.287916667,7.008814736,0.5265,0.19912167,1.445995144,-0.6025,0.113,-1.164,0.039,-0.074,-0.039,Q9ET66,Pi16,Q9ET66_Pi16,Q9ET66,Pi16,1,17,6,6,E9QNE5|Q9ET66|D3Z6T6|Q9ET66-2,MOUSE,53234.3,15.1,240,240.1,90.52,90.52,,489,Peptidase inhibitor 16,extracellular space|integral component of membrane|extracellular exosome|,negative regulation of peptidase activity|negative regulation of cell growth involved in cardiac muscle cell development|,peptidase inhibitor activity|,6,17,908000000,15.1%
Q8QZR4,0.611417348,-0.0103,3.999884184,0.329083333,0.398117787,0.923777616,-0.5745,0.159,,0.408,0.023,-0.067,Q8QZR4,Oaf,Q8QZR4_Oaf,Q8QZR4,Oaf,1,8,8,8,Q8QZR4,MOUSE,32151.3,26.2,241,241.1,90.03,90.03,,282,Out at first protein homolog,extracellular exosome|,,,8,8,613000000,26.2%
O88200,0.456433733,0.335083333,6.332195096,-0.7535,0.232691485,-1.329843589,0.0805,0.063,1.992,-0.185,0.074,-0.014,O88200,Clec11a,O88200_Clec11a,O88200,Clec11a,1,10,8,8,O88200,MOUSE,36793.1,24.3,242,242.1,86.94,86.94,,328,C-type lectin domain family 11 member A,extracellular region|extracellular space|cytoplasm|,positive regulation of cell proliferation|,growth factor activity|carbohydrate binding|,8,10,691000000,24.3%
A0A075B5S2,0.444023573,-0.10825,6.607124228,0.455833333,0.218417573,1.375365315,-0.5145,0.145,-0.639,-0.175,0.53,0.004,A0A075B5S2,NotFound,A0A075B5S2_NotFound,A0A075B5S2,Ighv7-1,1,17,7,7,A0A075B5S2|P01791|P01794|P01788|P01787|P01790|P01793|P01792|P01789,MOUSE,13815.5,56.1,243,243.1,86.57,86.57,,121,Immunoglobulin heavy variable 7-1 (Fragment),,,,8,17,1260000000,56.1%
P11627,0.315406172,-0.23625,10.15442674,0.483166667,0.096506669,1.969316776,-0.2995,-0.317,-0.817,-0.027,0.058,-0.015,P11627,NotFound,P11627_NotFound,P11627,L1cam,1,12,9,9,P11627|Q6PGJ3|A2AFG8|A2AFG7,MOUSE,141935.8,6.9,244,244.1,85.86,85.86,,1260,Neural cell adhesion molecule L1,plasma membrane|focal adhesion|external side of plasma membrane|cell surface|membrane|integral component of membrane|presynaptic membrane|terminal bouton|,homophilic cell adhesion via plasma membrane adhesion molecules|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|leukocyte cell-cell adhesion|cell surface receptor signaling pathway|axon guidance|positive regulation of cell-cell adhesion|neuron projection development|cell-cell adhesion mediated by integrin|homotypic cell-cell adhesion|positive regulation of calcium-mediated signaling|,integrin binding|protein binding|sialic acid binding|identical protein binding|protein self-association|,9,12,228000000,6.9%
O35664-3,0.390133764,-0.1501,8.00284407,0.60775,0.158385563,1.659281907,-0.9515,-0.078,,0.285,0.038,-0.044,O35664,Ifnar2,O35664-3_Ifnar2,O35664-3,Ifnar2,1,23,7,7,O35664-3|O35664|O35664-2|F6XX07,MOUSE,28268.1,19.3,245,245.1,85.84,85.84,,513,Isoform 3 of Interferon alpha/beta receptor 2,extracellular space|plasma membrane|integral component of plasma membrane|integral component of membrane|,regulation of transcription from RNA polymerase II promoter|cell proliferation|cytokine-mediated signaling pathway|response to interferon-alpha|type I interferon signaling pathway|,type I interferon receptor activity|protein kinase binding|type I interferon binding|,7,23,7720000000,19.3%
A0A140T8M2,0.399659508,0.1231,7.741086951,0.763083333,0.168225297,1.616067902,-0.7945,0.125,,0.975,0.37,-0.06,A0A140T8M2,NotFound,A0A140T8M2_NotFound,A0A140T8M2,Igkv12-44,1,21,5,3,A0A140T8M2,MOUSE,12728.1,43.4,246,246.1,83.99,43.97,,115,Immunoglobulin kappa variable 12-44 (Fragment),,,,5,21,6560000000,43.4%
P01636,0.64802674,0.0551,3.582059753,0.573083333,0.438322763,0.843252345,-1.2615,0.684,,0.818,0.172,-0.137,P01636,NotFound,P01636_NotFound,P01636,,1,1,3,1,P01636,MOUSE,12144.3,35.1,246,246.2,47.48,7.46,,108,Ig kappa chain V-V region MOPC 149,,,antigen binding|,1,1,7820000,9.2%
Q9Z0M6,0.372499343,-0.072083333,8.40829645,0.422833333,0.144268114,1.678779948,-0.4775,-0.145,-0.228,-0.001,0.451,-0.032,Q9Z0M6,Adgre5,Q9Z0M6_Adgre5,Q9Z0M6,Cd97,1,12,6,6,E9QJS7|Q9Z0M6|Q9Z0M6-3|E9QMJ5|Q9Z0M6-2|A0A0D9SEG8|Q9DC42,MOUSE,92922.2,7.9,247,247.1,83.7,83.7,,818,CD97 antigen,plasma membrane|focal adhesion|membrane|integral component of membrane|extracellular exosome|,cell adhesion|G-protein coupled receptor signaling pathway|positive regulation of synapse assembly|,transmembrane signaling receptor activity|G-protein coupled receptor activity|calcium ion binding|,6,12,170000000,7.9%
Q99K41,0.476454309,0.736916667,6.040575388,-0.8425,0.24885276,-1.27919793,2.3585,1.038,0.078,0.617,0.77,-0.44,Q99K41,Emilin1,Q99K41_Emilin1,Q99K41,Emilin1,1,8,7,7,Q99K41,MOUSE,108895,9.1,248,248.1,82.51,82.51,,1017,EMILIN-1,extracellular region|proteinaceous extracellular matrix|collagen trimer|extracellular matrix|extracellular exosome|extracellular matrix|,cell adhesion|positive regulation of cell-substrate adhesion|extracellular matrix organization|,protein binding|extracellular matrix constituent conferring elasticity|identical protein binding|,7,8,57600000,9.1%
A0A0B4J1H7,0.199303152,-0.079583333,14.59473302,1.0725,0.034715762,2.73166096,-0.7865,-0.22,-0.841,-0.256,0.717,0.909,A0A0B4J1H7,NotFound,A0A0B4J1H7_NotFound,A0A0B4J1H7,Igkv1-135,1,19,6,1,A0A0B4J1H7,MOUSE,13419.1,32.5,249,249.1,82.23,16.3,,120,Immunoglobulin kappa variable 1-135 (Fragment),,,,6,19,6150000000,32.5%
A0A0B4J1H8,0.960706745,0.278916667,0.23948222,0.048166667,0.946349981,0.070205762,1.4075,0.198,-0.841,-0.117,-0.201,1.227,A0A0B4J1H8,NotFound,A0A0B4J1H8_NotFound,A0A0B4J1H8,Igkv1-133,1,4,6,3,A0A0B4J1H8|A0A0B4J1H9,MOUSE,13351.1,32.5,249,249.2,72.78,29.92,,120,Immunoglobulin kappa variable 1-133 (Fragment),,,,3,4,30400000,21.6%
P01869,0.937564668,0.21775,0.434126103,0.0545,0.9048725,0.124740248,0.3055,-0.474,0.74,-0.045,-0.089,0.869,P01869,NotFound,P01869_NotFound,P01869,Ighg1,1,13,5,5,P01869|P01868,MOUSE,44070.3,20.8,250,250.1,81.62,81.62,,393,"Ig gamma-1 chain C region, membrane-bound form",plasma membrane|integral component of membrane|,,antigen binding|immunoglobulin receptor binding|,5,13,355000000,20.8%
P14847,0.654257714,0.0095,3.493943487,0.22875,0.447306955,0.824385153,-0.0205,-0.235,,0.323,0,-0.02,P14847,Crp,P14847_Crp,P14847,Crp,1,8,7,7,P14847,MOUSE,25530.6,35.1,251,251.1,81.42,81.42,,225,C-reactive protein,extracellular space|extracellular exosome|,acute-phase response|positive regulation of gene expression|negative regulation of macrophage derived foam cell differentiation|negative regulation of lipid storage|positive regulation of superoxide anion generation|negative regulation of vasodilation|regulation of interleukin-8 secretion|,complement component C1q binding|calcium ion binding|low-density lipoprotein particle binding|low-density lipoprotein particle receptor binding|,7,8,155000000,35.1%
A0A075B5R6,0.708680709,0.345916667,2.915863706,0.292166667,0.510991445,0.699297726,-0.4325,0.443,0.589,0.509,1.025,-0.058,A0A075B5R6,NotFound,A0A075B5R6_NotFound,A0A075B5R6,Ighv11-1,1,11,7,7,A0A075B5R6|A0A075B5R8,MOUSE,13378.9,51.2,252,252.1,81.35,81.35,,117,Immunoglobulin heavy variable 11-1 (Fragment),,,,7,11,623000000,51.2%
P01845,0.940910696,0.07925,0.377234849,0.0415,0.916804033,0.109016626,-0.3495,-0.173,0.698,-0.198,-0.045,0.543,P01845,NotFound,P01845_NotFound,P01845,Iglc3,1,12,5,2,P01845,MOUSE,11541.6,65.3,253,253.1,81.17,41.91,,104,Ig lambda-3 chain C region,plasma membrane|,,antigen binding|,5,12,4960000000,65.3%
P01844,0.32515976,-0.1387,9.70849109,0.67175,0.106942638,1.96320279,-0.7435,-0.34,,-0.28,0.292,0.378,P01844,NotFound,P01844_NotFound,P01844,Iglc2,1,8,5,2,P01844,MOUSE,11425.5,65.3,253,253.2,80.68,41.42,,104,Ig lambda-2 chain C region,plasma membrane|,,,2,8,1060000000,38.4%
P10493,0.156058059,0.257916667,17.38301491,-0.747833333,0.018268316,-3.215782342,0.5145,0.909,0.472,-0.171,-0.114,-0.063,P10493,Nid1,P10493_Nid1,P10493,Nid1,1,11,9,9,P10493,MOUSE,139387.9,8.3,254,254.1,81.02,81.02,,1245,Nidogen-1,extracellular region|proteinaceous extracellular matrix|basement membrane|basal lamina|extracellular matrix|extracellular exosome|cell periphery|extracellular matrix|,cell-matrix adhesion|positive regulation of cell-substrate adhesion|extracellular matrix organization|glomerular basement membrane development|,calcium ion binding|protein binding|collagen binding|laminin binding|laminin-1 binding|proteoglycan binding|extracellular matrix binding|,9,11,261000000,8.3%
P47878,0.574625459,-0.271083333,4.551346018,0.440833333,0.350643182,1.013365915,0.1495,-0.24,-1.384,-0.24,0.007,0.081,P47878,Igfbp3,P47878_Igfbp3,P47878,Igfbp3,1,12,7,7,P47878,MOUSE,32713.3,22.6,255,255.1,80.78,80.78,,292,Insulin-like growth factor-binding protein 3,extracellular space|nucleus|insulin-like growth factor ternary complex|extracellular exosome|,regulation of cell growth|osteoblast differentiation|negative regulation of protein phosphorylation|protein phosphorylation|negative regulation of cell proliferation|regulation of glucose metabolic process|negative regulation of smooth muscle cell migration|regulation of growth|positive regulation of apoptotic process|positive regulation of catalytic activity|positive regulation of MAPK cascade|positive regulation of insulin-like growth factor receptor signaling pathway|type B pancreatic cell proliferation|positive regulation of myoblast differentiation|negative regulation of smooth muscle cell proliferation|,fibronectin binding|insulin-like growth factor binding|protein tyrosine phosphatase activator activity|insulin-like growth factor I binding|insulin-like growth factor II binding|,7,12,1490000000,22.6%
Q8R357,0.44527584,-2.800583333,6.555743844,5.641833333,0.221016967,1.36843378,-0.7215,-0.522,-15.621,0.075,-0.021,0.007,Q8R357,Olfm1,Q8R357_Olfm1,Q8R357,Olfm1,1,8,6,6,Q8R357|O88998|G3X9Q7|O88998-3|A3KGE4|O88998-2|O88998-4,MOUSE,55769.1,13.6,256,256.1,79.67,79.67,,485,Noelin,extracellular space|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex|synaptic membrane|,atrioventricular valve formation|positive regulation of gene expression|negative regulation of gene expression|positive regulation of epithelial to mesenchymal transition|protein oligomerization|cardiac epithelial to mesenchymal transition|regulation of beta-amyloid formation|negative regulation of beta-amyloid formation|negative regulation of neuron migration|,beta-amyloid binding|protein binding|,6,8,347000000,13.6%
P05366,0.174726314,0.39325,16.04816249,-2.587166667,0.024841839,-2.989859474,3.3475,-0.163,1.876,-1.102,-0.793,-0.806,P05366,Saa1,P05366_Saa1,P05366,Saa1,1,17,6,5,P05366|P04918,MOUSE,13884.1,50,257,257.1,79.08,68.17,,122,Serum amyloid A-1 protein,extracellular space|cytosol|cytoplasmic microtubule|high-density lipoprotein particle|extracellular exosome|,acute-phase response|cholesterol metabolic process|positive chemotaxis|cell chemotaxis|,G-protein coupled receptor binding|protein binding|heparin binding|chemoattractant activity|,6,17,1320000000,50.0%
P05367,0.140795444,0.816083333,19.04868596,-3.346833333,0.012448912,-3.548479597,4.6105,1.98,0.878,-0.793,-1.173,-0.606,P05367,Saa2,P05367_Saa2,P05367,Saa2,1,7,5,4,P05367|A0A1B0GQV5,MOUSE,13736,36,257,257.2,54.06,43.15,,122,Serum amyloid A-2 protein,extracellular space|cytosol|cytoplasmic microtubule|high-density lipoprotein particle|extracellular exosome|,acute-phase response|response to stilbenoid|positive chemotaxis|cell chemotaxis|,G-protein coupled receptor binding|protein binding|chemoattractant activity|,4,7,347000000,27.8%
Q9CZT5,0.167167113,0.562083333,16.8083582,-1.202166667,0.020852791,-3.12786887,1.2405,0.451,1.798,0.096,-0.197,-0.016,Q9CZT5,Vasn,Q9CZT5_Vasn,Q9CZT5,Vasn,1,8,7,7,Q9CZT5,MOUSE,73401,12.3,258,258.1,78.48,78.48,,673,Vasorin,extracellular space|mitochondrion|lysosomal membrane|plasma membrane|cell surface|integral component of membrane|extracellular exosome|,negative regulation of epithelial to mesenchymal transition|negative regulation of transforming growth factor beta receptor signaling pathway|cellular response to hypoxia|cellular response to redox state|,protein binding|transforming growth factor beta binding|,7,8,163000000,12.3%
Q80VA0-2,0.331936472,-0.64325,9.220613291,1.4545,0.119657155,1.818914222,-0.6795,-0.203,-3.229,0.156,0.108,-0.012,Q80VA0,Galnt7,Q80VA0-2_Galnt7,Q80VA0-2,Galnt7,1,13,8,8,Q80VA0-2|Q80VA0|Q80VA0-3,MOUSE,76183.4,10.9,259,259.1,77.97,77.97,,657,Isoform 2 of N-acetylgalactosaminyltransferase 7,Golgi membrane|membrane|integral component of membrane|extracellular exosome|,protein O-linked glycosylation|,polypeptide N-acetylgalactosaminyltransferase activity|carbohydrate binding|metal ion binding|,8,13,399000000,10.9%
Q91ZA3,0.045653191,0.63425,27.26730464,-2.077166667,0.001876159,-5.33060156,2.3345,1.428,1.256,-0.019,-0.823,-0.371,Q91ZA3,Pcca,Q91ZA3_Pcca,Q91ZA3,Pcca,1,9,7,7,Q91ZA3,MOUSE,80547.9,11.4,260,260.1,77.09,77.09,,724,"Propionyl-CoA carboxylase alpha chain, mitochondrial",mitochondrion|mitochondrial matrix|,metabolic process|,biotin carboxylase activity|propionyl-CoA carboxylase activity|ATP binding|enzyme binding|metal ion binding|,7,9,61700000,11.4%
Q61171,0.886819929,0.29325,1.000698141,0.1135,0.794200554,0.272946214,-0.0185,0.887,-0.159,0.561,-0.241,0.73,Q61171,Prdx2,Q61171_Prdx2,Q61171,Prdx2,1,9,7,7,Q61171,MOUSE,21949.4,39.3,261,261.1,76.73,76.73,,198,Peroxiredoxin-2,mitochondrion|myelin sheath|extracellular exosome|,activation of MAPK activity|respiratory burst involved in inflammatory response|response to oxidative stress|regulation of hydrogen peroxide metabolic process|removal of superoxide radicals|positive regulation of blood coagulation|negative regulation of lipopolysaccharide-mediated signaling pathway|negative regulation of NF-kappaB transcription factor activity|response to lipopolysaccharide|cellular response to oxidative stress|T cell proliferation|hydrogen peroxide metabolic process|hydrogen peroxide catabolic process|regulation of apoptotic process|negative regulation of T cell differentiation|thymus development|homeostasis of number of cells|oxidation-reduction process|negative regulation of reactive oxygen species metabolic process|negative regulation of extrinsic apoptotic signaling pathway|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand|,peroxidase activity|protein binding|thioredoxin peroxidase activity|selenium binding|antioxidant activity|,7,9,725000000,39.3%
P01843,0.141445692,-0.3637,18.67635096,1.100916667,0.013563286,3.733418277,-0.9195,-1.129,,-0.218,0.272,0.176,P01843,NotFound,P01843_NotFound,P01843,,1,16,4,4,A0A0G2JE99|P01843,MOUSE,11745.8,64.7,262,262.1,76.27,76.27,,105,Ig lambda-1 chain C region,plasma membrane|,,antigen binding|,4,16,6880000000,64.7%
Q02788,0.679041452,0.064583333,3.200028278,-0.199833333,0.478626976,-0.755425128,0.2165,0.462,-0.185,-0.168,-0.081,0.143,Q02788,Col6a2,Q02788_Col6a2,Q02788,Col6a2,1,13,7,7,Q02788|D3Z7D5,MOUSE,111473.4,5.6,263,263.1,75.9,75.9,,1034,Collagen alpha-2(VI) chain,extracellular region|proteinaceous extracellular matrix|collagen trimer|extracellular space|extracellular matrix|sarcolemma|protein complex|extracellular exosome|extracellular vesicle|extracellular matrix|,cell adhesion|response to glucose|protein heterotrimerization|,,7,13,502000000,5.6%
P01631,0.14994666,-0.33725,18.20734348,1.037833333,0.015110041,3.368042408,-1.0325,-0.959,-0.577,-0.199,0.648,0.096,P01631,NotFound,P01631_NotFound,P01631,,1,23,5,5,P01631|A0A140T8M0|A0A0B4J1I0|A0A075B5K8|A0A140T8N1|A0A140T8M9|A0A075B5N0,MOUSE,12386.7,40.7,264,264.1,75.81,75.81,,113,Ig kappa chain V-II region 26-10,,,antigen binding|,5,23,32800000000,40.7%
E9QPU1,0.533851106,0.389916667,5.070065444,-0.4865,0.311166945,-1.107569189,1.3095,0.701,-0.111,-0.331,0.416,0.355,E9QPU1,Vwf,E9QPU1_Vwf,E9QPU1,Vwf,1,11,7,7,E9QPU1|Q8CIZ8,MOUSE,322558.9,2.4,265,265.1,74.77,74.77,,2813,von Willebrand factor,extracellular region|proteinaceous extracellular matrix|endoplasmic reticulum|external side of plasma membrane|extracellular matrix|Weibel-Palade body|extracellular exosome|,liver development|placenta development|cell adhesion|blood coagulation|hemostasis|platelet activation|cell-substrate adhesion|protein homooligomerization|platelet activation|,glycoprotein binding|protease binding|integrin binding|protein binding|collagen binding|immunoglobulin binding|identical protein binding|protein homodimerization activity|protein N-terminus binding|chaperone binding|,7,11,537000000,2.4%
Q91YW3,0.44527584,-0.1493,6.532655144,0.41325,0.222195104,1.393979704,-0.2865,-0.508,,-0.27,0.072,0.246,Q91YW3,Dnajc3,Q91YW3_Dnajc3,Q91YW3,Dnajc3,1,7,7,7,Q91YW3,MOUSE,57919.4,12.6,266,266.1,72.9,72.9,,504,DnaJ homolog subfamily C member 3,cytoplasm|endoplasmic reticulum lumen|smooth endoplasmic reticulum|cytosol|membrane|extracellular exosome|extracellular vesicle|endoplasmic reticulum Sec complex|,negative regulation of protein kinase activity|endoplasmic reticulum unfolded protein response|negative regulation of apoptotic process|proteolysis involved in cellular protein catabolic process|negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation|negative regulation of cyclin-dependent protein kinase activity|,protein binding|chaperone binding|misfolded protein binding|,7,7,176000000,12.6%
E9QP56,0.857108733,0.24175,1.272024496,0.145833333,0.746100877,0.339354775,0.3175,0.778,-0.589,0.662,0.404,-0.122,E9QP56,Apoc3,E9QP56_Apoc3,E9QP56,Apoc3,1,25,4,4,E9QP56|P33622|A0A0R4J1N3,MOUSE,15162.8,36.4,267,267.1,71.64,71.64,,137,Apolipoprotein C-III,extracellular region|,triglyceride metabolic process|triglyceride mobilization|lipid transport|cholesterol metabolic process|triglyceride catabolic process|lipoprotein metabolic process|,lipid binding|,4,25,15000000000,36.4%
P01645,0.32515976,-0.0929,9.536893133,0.795583333,0.111252733,1.940195927,-0.9535,-0.187,,-0.256,0.461,0.471,P01645,NotFound,P01645_NotFound,P01645,,1,15,6,5,P01645|P01644|P01646|P01647|A0A140T8M1|P01648|P01643|P01649|A0A075B5L0,MOUSE,12068.2,58.3,268,268.1,71.3,60.46,,108,Ig kappa chain V-V region HP 93G7,,,antigen binding|,7,15,2590000000,58.3%
P01670,0.293302242,0.335916667,10.81461215,-0.653166667,0.082896994,-2.0791365,1.2185,0.42,0.349,0.159,-0.173,0.042,P01670,NotFound,P01670_NotFound,P01670,,1,3,3,1,P01670,MOUSE,12153.4,25.2,268,268.2,33.31,18.59,,111,Ig kappa chain V-III region PC 6684,,,antigen binding|,1,3,170000000,15.3%
Q8BYB9,0.742574146,0.193416667,2.500996848,-0.478833333,0.562212264,-0.613877581,-0.8265,-0.056,2.181,-0.284,-0.113,0.259,Q8BYB9,Poglut1,Q8BYB9_Poglut1,Q8BYB9,Poglut1,1,7,6,6,Q8BYB9,MOUSE,46892.1,15.5,269,269.1,70.49,70.49,,392,Protein O-glucosyltransferase 1,endoplasmic reticulum lumen|extracellular exosome|,protein O-linked glycosylation|regulation of Notch signaling pathway|cardiovascular system development|,protein xylosyltransferase activity|UDP-glucosyltransferase activity|UDP-xylosyltransferase activity|glucosyltransferase activity|,6,7,512000000,15.5%
G3UX19,0.604460486,-0.242583333,4.130175603,0.491833333,0.386351355,0.935261977,0.2225,-0.034,-1.654,-0.027,-0.099,0.136,G3UX19,NotFound,G3UX19_NotFound,G3UX19,Atf6b,1,8,5,5,G3UX19|A0A0A0MQ69|O35451,MOUSE,77389.6,9.1,270,270.1,69.61,69.61,,709,Cyclic AMP-dependent transcription factor ATF-6 beta,intracellular|nucleus|endoplasmic reticulum membrane|protein-DNA complex|,endoplasmic reticulum unfolded protein response|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress|,sequence-specific DNA binding transcription factor activity|cAMP response element binding|sequence-specific DNA binding|transcription regulatory region DNA binding|,5,8,236000000,9.1%
Q9QUM0,0.515672747,-0.049416667,5.324251656,0.5495,0.293477516,1.153044319,0.2195,0.109,-1.301,0.478,-0.155,0.353,Q9QUM0,Itga2b,Q9QUM0_Itga2b,Q9QUM0,Itga2b,1,8,7,7,Q9QUM0,MOUSE,113760,8.2,271,271.1,69.19,69.19,,1033,Integrin alpha-IIb,focal adhesion|integrin complex|external side of plasma membrane|cell surface|extracellular exosome|blood microparticle|,positive regulation of leukocyte migration|cell-matrix adhesion|integrin-mediated signaling pathway|platelet aggregation|,identical protein binding|metal ion binding|extracellular matrix binding|fibrinogen binding|,7,8,141000000,8.2%
Q8CBR6,0.330192854,0.33825,9.387558897,-0.947166667,0.115144742,-1.846841766,1.3505,1.421,-0.336,-0.12,-0.124,-0.162,Q8CBR6,Tsku,Q8CBR6_Tsku,Q8CBR6,Tsku,1,7,4,4,Q8CBR6,MOUSE,38760.8,16.6,272,272.1,69.1,69.1,,354,Tsukushin,extracellular space|,regulation of gene expression|corpus callosum morphogenesis|lateral ventricle development|anterior commissure morphogenesis|negative regulation of Wnt signaling pathway|camera-type eye development|ciliary body morphogenesis|,protein binding|,4,7,90600000,16.6%
Q9R182,0.897099471,-0.060083333,0.838185829,0.1195,0.824482453,0.231860205,-0.5885,-0.781,1.01,-0.19,0.183,0.006,Q9R182,Angptl3,Q9R182_Angptl3,Q9R182,Angptl3,1,8,6,6,Q9R182,MOUSE,52770.3,15.3,273,273.1,68.38,68.38,,455,Angiopoietin-related protein 3,extracellular region|extracellular space|early endosome|Golgi apparatus|cell surface|,glycerol metabolic process|fatty acid metabolic process|triglyceride metabolic process|phospholipid metabolic process|cell-matrix adhesion|signal transduction|cholesterol metabolic process|phospholipid catabolic process|response to hormone|negative regulation of phospholipase activity|lipid storage|positive regulation of cell migration|cholesterol homeostasis|positive regulation of angiogenesis|positive regulation of lipid metabolic process|artery morphogenesis|positive regulation of lipid catabolic process|negative regulation of lipoprotein lipase activity|lipid homeostasis|acylglycerol homeostasis|phospholipid homeostasis|triglyceride homeostasis|,enzyme inhibitor activity|phospholipase inhibitor activity|integrin binding|growth factor activity|,6,8,643000000,15.3%
A0A075B5R2,0.886819929,0.1389,1.009207441,0.144416667,0.79264597,0.2776141,0.7775,-0.673,,0.299,-0.151,0.442,A0A075B5R2,NotFound,A0A075B5R2_NotFound,A0A075B5R2,Ighv7-3,1,14,4,4,A0A075B5R2|A0A075B5R3|P01786,MOUSE,13628.3,29.1,274,274.1,67.85,67.85,,120,Immunoglobulin heavy variable 7-3 (Fragment),,,,4,14,689000000,29.1%
Q8BI84,0.888540941,0.03125,0.941909867,0.078833333,0.805024343,0.258020755,-0.2265,-0.231,0.433,-0.179,-0.016,0.407,Q8BI84,Mia3,Q8BI84_Mia3,Q8BI84,Mia3,1,13,8,8,Q8BI84|Q8BI84-2|J3KMH5|Q8BI84-3,MOUSE,214298.7,5,275,275.1,67.49,67.49,,1930,Transport and Golgi organization protein 1 homolog,endoplasmic reticulum membrane|membrane|integral component of membrane|intracellular membrane-bounded organelle|,chondrocyte development|positive regulation of leukocyte migration|exocytosis|negative regulation of cell adhesion|protein transport|collagen fibril organization|negative regulation of cell migration|positive regulation of bone mineralization|wound healing|,,8,13,3080000000,5.0%
E9QPX1,0.509872886,0.187416667,5.446621039,-0.338166667,0.285323732,-1.172958529,0.7225,0.443,-0.096,0.174,-0.045,-0.074,E9QPX1,Col18a1,E9QPX1_Col18a1,E9QPX1,Col18a1,1,9,5,5,E9QPX1|P39061|P39061-1|P39061-2,MOUSE,183320.5,3.4,276,276.1,67.34,67.34,,1774,Collagen alpha-1(XVIII) chain,collagen trimer|basement membrane|extracellular space|extracellular matrix|extracellular exosome|extracellular matrix|,angiogenesis|endothelial cell morphogenesis|cell adhesion|positive regulation of cell proliferation|extracellular matrix organization|positive regulation of cell migration|positive regulation of endothelial cell apoptotic process|,structural molecule activity|identical protein binding|,5,9,1050000000,3.4%
Q9WUU7,0.232730937,-0.117916667,13.07412505,0.617833333,0.04927056,2.458550743,-0.3995,-0.172,-0.709,0.272,0.306,-0.005,Q9WUU7,Ctsz,Q9WUU7_Ctsz,Q9WUU7,Ctsz,1,14,6,6,Q9WUU7,MOUSE,34680.3,18.9,277,277.1,66.77,66.77,,306,Cathepsin Z,extracellular space|lysosome|endoplasmic reticulum|intracellular membrane-bounded organelle|extracellular exosome|,proteolysis involved in cellular protein catabolic process|epithelial tube branching involved in lung morphogenesis|,cysteine-type endopeptidase activity|,6,14,1180000000,18.9%
A0A075B5N4,0.605123924,0.1481,4.077038639,0.38975,0.391107493,0.940267697,0.0125,-0.184,,-0.017,0.959,-0.03,A0A075B5N4,NotFound,A0A075B5N4_NotFound,A0A075B5N4,Igkv8-27,1,16,5,2,A0A075B5N4|A0A140T8P7,MOUSE,11090.2,60,278,278.1,66.55,26.15,,100,Immunoglobulin kappa chain variable 8-27,,,,5,16,2760000000,60.0%
A0A140T8M4,0.390133764,-0.1151,8.002966617,0.723583333,0.158381094,1.663227882,-0.9555,-0.143,,-0.297,0.636,0.184,A0A140T8M4,NotFound,A0A140T8M4_NotFound,A0A140T8M4,Igkv8-19,1,1,4,1,A0A140T8M4,MOUSE,11230.2,42.5,278,278.2,64.78,21.85,,101,Immunoglobulin kappa variable 8-19,,,,1,1,4820000,14.8%
A0A140T8P5,0.723545917,0.1571,2.758721218,0.34975,0.529819426,0.675693655,0.3135,-0.419,,-0.183,1.091,-0.017,A0A140T8P5,NotFound,A0A140T8P5_NotFound,A0A140T8P5,Igkv8-24,1,5,4,2,A0A140T8P5,MOUSE,13434.9,35.5,278,278.3,56.26,32.68,,121,Immunoglobulin kappa chain variable 8-24 (Fragment),,,,2,5,302000000,17.3%
A0A140T8M3,0.679041452,0.0823,3.222977644,0.300916667,0.476104444,0.770989353,0.0235,-0.22,,-0.147,0.787,-0.032,A0A140T8M3,NotFound,A0A140T8M3_NotFound,A0A140T8M3,Igkv8-30,1,2,4,1,A0A140T8M3,MOUSE,13506,35.5,278,278.4,52.23,11.83,,121,Immunoglobulin kappa chain variable 8-30 (Fragment),,,,1,2,69000000,9.9%
A0A075B5N3,0.153374531,-0.0979,17.68197264,1.84725,0.017053076,3.545301677,-1.2145,-1.198,,-0.258,0.956,1.225,A0A075B5N3,NotFound,A0A075B5N3_NotFound,A0A075B5N3,Igkv8-28,1,2,4,2,A0A075B5N3,MOUSE,11017,50.4,278,278.5,48.96,22.85,,101,Immunoglobulin kappa variable 8-28,,,,2,2,145000000,31.6%
A0A140T8N5,0.26283168,-0.2061,11.67749937,0.70025,0.067959483,2.32211125,-0.5135,-0.739,,-0.241,0.288,0.175,A0A140T8N5,NotFound,A0A140T8N5_NotFound,A0A140T8N5,Igkv6-23,1,9,2,2,A0A140T8N5,MOUSE,12901.2,15.6,278,278.6,30.67,30.67,,115,Immunoglobulin kappa variable 6-23 (Fragment),,,,2,9,851000000,15.6%
Q8R0Z6,0.469723424,0.720083333,6.121248673,-1.0035,0.244272812,-1.293245222,0.9235,-0.11,2.852,-0.142,0.762,0.035,Q8R0Z6,Angptl6,Q8R0Z6_Angptl6,Q8R0Z6,Angptl6,1,8,6,6,Q8R0Z6,MOUSE,51493.9,15.7,279,279.1,66.53,66.53,,457,Angiopoietin-related protein 6,secretory granule|extracellular exosome|,angiogenesis|cell differentiation|,,6,8,298000000,15.7%
Q9JHI0,0.44527584,0.28975,6.512441133,-0.372833333,0.22323171,-1.358466146,0.3115,0.222,0.895,0.242,0.126,-0.058,Q9JHI0,Mmp19,Q9JHI0_Mmp19,Q9JHI0,Mmp19,1,5,5,5,Q9JHI0|Q3UW97,MOUSE,59349.2,14.2,280,280.1,66.27,66.27,,527,Matrix metalloproteinase-19,extracellular region|proteinaceous extracellular matrix|plasma membrane|anchored component of membrane|,angiogenesis|ovarian follicle development|ovulation from ovarian follicle|luteolysis|proteolysis|response to hormone|cell differentiation|collagen catabolic process|response to cAMP|,metalloendopeptidase activity|calcium ion binding|zinc ion binding|,5,5,25700000,14.2%
P70428,0.704033794,0.121583333,2.974541944,-0.173166667,0.504133788,-0.710434557,0.3865,0.348,-0.11,0.097,-0.072,0.08,P70428,Ext2,P70428_Ext2,P70428,Ext2,1,11,6,6,P70428|V9GX32|E9Q1M5,MOUSE,82804.6,9,281,281.1,66.25,66.25,,718,Exostosin-2,Golgi membrane|endoplasmic reticulum|endoplasmic reticulum membrane|Golgi apparatus|membrane|integral component of membrane|UDP-N-acetylglucosamine transferase complex|extracellular exosome|,"ossification|mesoderm formation|glycosaminoglycan biosynthetic process|protein glycosylation|heparan sulfate proteoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|cell differentiation|cellular polysaccharide biosynthetic process|","acetylglucosaminyltransferase activity|glucuronosyltransferase activity|transferase activity, transferring glycosyl groups|heparan sulfate N-acetylglucosaminyltransferase activity|protein homodimerization activity|metal ion binding|protein heterodimerization activity|glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity|acetylglucosaminyltransferase activity|",6,11,111000000,9.0%
Q08879-2,0.861013543,0.05425,1.232440289,-0.2125,0.752932374,-0.329825302,1.1885,0.574,-1.281,-0.037,-0.157,0.038,Q08879,Fbln1,Q08879-2_Fbln1,Q08879-2,Fbln1,1,11,7,7,Q08879-2|Q08879,MOUSE,79390.4,10.8,282,282.1,65.28,65.28,,705,Isoform C of Fibulin-1,proteinaceous extracellular matrix|basement membrane|extracellular space|extracellular exosome|elastic fiber|fibrinogen complex|extracellular matrix|,"negative regulation of protein phosphorylation|negative regulation of cell adhesion|embryo implantation|positive regulation of gene expression|positive regulation of peptidase activity|extracellular matrix organization|positive regulation of fibroblast proliferation|negative regulation of ERK1 and ERK2 cascade|blood coagulation, fibrin clot formation|negative regulation of substrate adhesion-dependent cell spreading|negative regulation of transformation of host cell by virus|positive regulation of substrate-dependent cell migration, cell attachment to substrate|negative regulation of cell motility|negative regulation of stem cell proliferation|negative regulation of transforming growth factor-beta secretion|",fibronectin binding|integrin binding|extracellular matrix structural constituent|calcium ion binding|protein binding|protein C-terminus binding|peptidase activator activity|protein complex binding|identical protein binding|fibrinogen binding|,7,11,230000000,10.8%
A0A075B5N7,0.232788104,-0.1929,12.97205514,0.698083333,0.050442254,2.564580909,-0.5195,-0.704,,-0.063,0.04,0.282,A0A075B5N7,NotFound,A0A075B5N7_NotFound,A0A075B5N7,Igkv6-13,1,15,5,3,A0A075B5N7|A0A140T8P1,MOUSE,10554.5,56.8,283,283.1,64.38,39.33,,95,Immunoglobulin kappa variable 6-13,,,,5,15,2140000000,56.8%
A0A140T8Q3,0.935838029,0.2085,0.447738952,-0.06125,0.902040641,-0.12959557,-0.0685,0.559,,-0.17,-0.178,0.9,A0A140T8Q3,NotFound,A0A140T8Q3_NotFound,A0A140T8Q3,Igkv6-17,1,3,4,1,A0A140T8Q3|P01633,MOUSE,12874.2,40,283,283.2,61.85,13.82,,115,Immunoglobulin kappa variable 6-17 (Fragment),,,,1,3,421000000,7.8%
A0A140T8M5,0.214239872,-0.1345,13.7451188,1.140416667,0.042217073,2.729590019,-0.9125,-0.725,,-0.232,0.916,0.281,A0A140T8M5,NotFound,A0A140T8M5_NotFound,A0A140T8M5,Igkv6-15,1,10,4,3,A0A140T8M5,MOUSE,12871.1,40,283,283.3,52.1,38.25,,115,Immunoglobulin kappa variable 6-15 (Fragment),,,,3,10,2370000000,32.1%
A0A140T8N7,0.377571059,0.0945,8.282215045,0.542916667,0.148517796,1.707564779,-0.1045,-0.358,,0.333,0.624,-0.022,A0A140T8N7,NotFound,A0A140T8N7_NotFound,A0A140T8N7,Igkv6-25,1,3,3,1,A0A140T8N7,MOUSE,12853.2,33.9,283,283.4,53.65,16.82,,115,Immunoglobulin kappa chain variable 6-25 (Fragment),,,,1,3,140000000,7.8%
Q769J6,0.175974166,0.553416667,15.78452696,-1.208833333,0.026396558,-2.942495951,0.7665,0.687,2.02,-0.158,0.076,-0.071,Q769J6,Adamts13,Q769J6_Adamts13,Q769J6,Adamts13,1,8,6,6,Q769J6|A2ALB3,MOUSE,160032.5,6.3,284,284.1,63.23,63.23,,1426,A disintegrin and metalloproteinase with thrombospondin motifs 13,proteinaceous extracellular matrix|extracellular space|,proteolysis|blood coagulation|response to toxic substance|response to interferon-gamma|response to tumor necrosis factor|peptide catabolic process|response to interleukin-4|,endopeptidase activity|metalloendopeptidase activity|zinc ion binding|,6,8,66100000,6.3%
Q02596,0.372499343,-0.151416667,8.417661527,0.4375,0.143957351,1.680344092,-0.1715,-0.219,-0.72,0.117,-0.126,0.211,Q02596,Glycam1,Q02596_Glycam1,Q02596,Glycam1,1,4,4,4,Q02596,MOUSE,16208.6,29.1,285,285.1,62.95,62.95,,151,Glycosylation-dependent cell adhesion molecule 1,extracellular region|plasma membrane|,cell adhesion|,sulfate binding|cell adhesion molecule binding|,4,4,308000000,29.1%
P09813,0.509872886,0.022583333,5.454431658,0.626166667,0.28481105,1.176178891,0.4695,0.041,-1.382,0.629,0.465,-0.087,P09813,Apoa2,P09813_Apoa2,P09813,Apoa2,1,18,4,4,P09813,MOUSE,11366,43.1,286,286.1,62.35,62.35,,102,Apolipoprotein A-II,extracellular region|extracellular space|cytosol|very-low-density lipoprotein particle|high-density lipoprotein particle|spherical high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|,acute inflammatory response|negative regulation of cytokine secretion involved in immune response|protein folding|fatty acid metabolic process|phosphatidylcholine biosynthetic process|lipid transport|cholesterol metabolic process|phospholipid catabolic process|response to glucose|positive regulation of cholesterol esterification|negative regulation of very-low-density lipoprotein particle remodeling|beta-glucoside transport|protein oxidation|peptidyl-methionine modification|regulation of intestinal cholesterol absorption|organ regeneration|regulation of protein stability|negative regulation of cholesterol transport|cholesterol efflux|phospholipid efflux|triglyceride-rich lipoprotein particle remodeling|low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|high-density lipoprotein particle clearance|lipoprotein metabolic process|response to drug|cholesterol homeostasis|positive regulation of catalytic activity|response to estrogen|reverse cholesterol transport|positive regulation of interleukin-8 biosynthetic process|diacylglycerol catabolic process|negative regulation of lipid catabolic process|positive regulation of lipid catabolic process|response to glucocorticoid|negative regulation of lipase activity|negative regulation of cholesterol import|negative regulation of cholesterol transporter activity|,lipid transporter activity|phospholipid binding|high-density lipoprotein particle binding|lipid binding|cholesterol binding|phosphatidylcholine binding|apolipoprotein receptor binding|protein homodimerization activity|protein heterodimerization activity|lipase inhibitor activity|phosphatidylcholine-sterol O-acyltransferase activator activity|high-density lipoprotein particle receptor binding|cholesterol transporter activity|,4,18,42300000000,43.1%
Q9R100,0.534055254,-0.166083333,5.029239602,0.630166667,0.314105861,1.10022574,0.2495,0.07,-1.763,0.108,-0.02,0.359,Q9R100,Cdh17,Q9R100_Cdh17,Q9R100,Cdh17,1,7,5,5,Q9R100|A2AKS7,MOUSE,92100.1,8.3,287,287.1,62.33,62.33,,827,Cadherin-17,plasma membrane|integral component of plasma membrane|basolateral plasma membrane|,oligopeptide transport|homophilic cell adhesion via plasma membrane adhesion molecules|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|oligopeptide transmembrane transport|,proton-dependent oligopeptide secondary active transmembrane transporter activity|calcium ion binding|protein binding|,5,7,261000000,8.3%
Q8BLY1,0.36057292,0.43925,8.634225991,-0.941833333,0.136954845,-1.720708487,0.1995,0.389,2.142,0.013,-0.11,0.002,Q8BLY1,Smoc1,Q8BLY1_Smoc1,Q8BLY1,Smoc1,1,11,5,5,A0A0R4J1E4|Q8BLY1|E9QKW2|Q8BLY1-2|D3Z3A3,MOUSE,52330.4,12.5,288,288.1,60.53,60.53,,463,SPARC-related modular calcium-binding protein 1,basement membrane|,eye development|signal transduction|positive regulation of cell-substrate adhesion|cell differentiation|extracellular matrix organization|regulation of osteoblast differentiation|limb development|,calcium ion binding|extracellular matrix binding|,5,11,2550000000,12.5%
P01887,0.191512401,-0.2043,15.05247349,0.872416667,0.031242994,2.969353626,-0.9585,-0.497,,0.12,0.308,0.006,P01887,B2m,P01887_B2m,P01887,B2m,1,23,4,4,P01887,MOUSE,13892.8,22.6,289,289.1,59.98,59.98,,119,Beta-2-microglobulin,extracellular space|cytoplasm|Golgi apparatus|plasma membrane|focal adhesion|external side of plasma membrane|membrane|phagocytic vesicle membrane|MHC class I protein complex|extracellular exosome|,"positive regulation of T cell mediated cytotoxicity|response to molecule of bacterial origin|antigen processing and presentation of peptide antigen via MHC class I|antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent|cellular defense response|T cell differentiation in thymus|protein refolding|response to drug|response to cadmium ion|iron ion homeostasis|negative regulation of receptor binding|",glycoprotein binding|protein binding|identical protein binding|,4,23,29900000000,22.6%
O35887,0.468728046,-0.1885,6.147012744,0.455416667,0.242827979,1.324193304,-0.8335,-0.09,,-0.179,0.188,-0.028,O35887,Calu,O35887_Calu,O35887,Calu,1,5,5,5,O35887|Q6XLQ8|G3V004|G3UWR0|G3UWV3,MOUSE,37177.2,17.4,290,290.1,59.97,59.97,,315,Calumenin,extracellular region|endoplasmic reticulum|endoplasmic reticulum lumen|membrane|sarcoplasmic reticulum lumen|melanosome|,peripheral nervous system axon regeneration|response to organic cyclic compound|negative regulation of catalytic activity|,enzyme inhibitor activity|calcium ion binding|enzyme binding|,5,5,425000000,17.4%
Q3U367,0.331936472,0.0825,9.212408523,-0.565416667,0.119883427,-1.874049684,0.1355,0.708,,-0.147,-0.235,-0.049,Q3U367,Aldh9a1,Q3U367_Aldh9a1,Q3U367,Aldh9a1,1,6,5,5,Q3U367|Q9JLJ2,MOUSE,56856.5,9.8,291,291.1,59.43,59.43,,518,4-trimethylaminobutyraldehyde dehydrogenase,mitochondrion|cytosol|extracellular exosome|,cellular aldehyde metabolic process|carnitine metabolic process|neurotransmitter biosynthetic process|oxidation-reduction process|,"aldehyde dehydrogenase (NAD) activity|oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor|aminobutyraldehyde dehydrogenase activity|4-trimethylammoniobutyraldehyde dehydrogenase activity|",5,6,571000000,9.8%
A0A075B5M7,0.742574146,0.6023,2.472406636,0.498416667,0.565925595,0.615127194,0.2905,0.316,,0.098,2.33,-0.023,A0A075B5M7,NotFound,A0A075B5M7_NotFound,A0A075B5M7,Igkv5-39,1,18,4,4,A0A075B5M7|A0A0B4J1J1|A0A0B4J1J2,MOUSE,10459.3,52.6,292,292.1,59.41,59.41,,95,Immunoglobulin kappa variable 5-39,,,,4,18,5220000000,52.6%
A0A075B5K0,0.533851106,0.328916667,5.066681651,-0.3045,0.311409484,-1.105336583,0.2715,0.333,0.839,0.092,0.457,-0.019,A0A075B5K0,NotFound,A0A075B5K0_NotFound,A0A075B5K0,Igkv14-126,1,18,4,2,A0A075B5K0|P01637,MOUSE,13228.7,41.8,293,293.1,59.14,35.94,,117,Immunoglobulin kappa variable 14-126 (Fragment),,,,5,18,9940000000,41.8%
A0A140T8P9,0.392487589,0.1523,7.950157729,0.99175,0.160318716,1.653718446,-0.4345,-0.451,,-0.179,1.61,0.216,A0A140T8P9,NotFound,A0A140T8P9_NotFound,A0A140T8P9,Igkv14-111,1,3,4,1,A0A140T8P9,MOUSE,13403.1,40.1,293,293.2,54.26,21.51,,117,Immunoglobulin kappa variable 14-111 (Fragment),,,,1,3,111000000,15.3%
Q9Z1T2,0.420535932,-0.673916667,7.150646169,1.973166667,0.192723815,1.470293368,0.2645,-0.43,-4.816,-0.189,0.686,0.441,Q9Z1T2,Thbs4,Q9Z1T2_Thbs4,Q9Z1T2,Thbs4,1,4,4,3,Q9Z1T2,MOUSE,109046.1,6,294,294.1,57.77,42.08,,963,Thrombospondin-4,basement membrane|extracellular space|endoplasmic reticulum|sarcoplasmic reticulum|extracellular matrix|extracellular exosome|,positive regulation of endothelial cell proliferation|response to unfolded protein|negative regulation of angiogenesis|regulation of tissue remodeling|response to endoplasmic reticulum stress|behavioral response to pain|tissue remodeling|positive regulation of peptidyl-tyrosine phosphorylation|myoblast migration|positive regulation of cell division|endothelial cell-cell adhesion|positive regulation of neutrophil chemotaxis|,integrin binding|calcium ion binding|protein binding|growth factor activity|heparin binding|,4,4,855000000,6.0%
Q9R0G6,0.579776471,-0.0729,4.494898557,0.255583333,0.355230416,1.018513554,-0.2705,-0.182,,0.009,0.105,-0.026,Q9R0G6,Comp,Q9R0G6_Comp,Q9R0G6,Comp,1,3,4,3,Q9R0G6,MOUSE,84965.2,6.3,294,294.2,52.71,37.02,,755,Cartilage oligomeric matrix protein,proteinaceous extracellular matrix|extracellular space|extracellular exosome|extracellular matrix|,growth plate cartilage development|apoptotic process|cell adhesion|extracellular matrix organization|negative regulation of apoptotic process|limb development|,protease binding|extracellular matrix structural constituent|calcium ion binding|protein binding|collagen binding|heparin binding|heparan sulfate proteoglycan binding|,3,3,20700000,5.0%
Q61982,0.555101425,0.204916667,4.779539948,-0.507166667,0.332694794,-1.055056125,1.1595,0.796,-0.58,-0.139,-0.028,0.021,Q61982,Notch3,Q61982_Notch3,Q61982,Notch3,1,8,5,5,Q61982,MOUSE,257423.3,2.4,295,295.1,57.74,57.74,,2318,Neurogenic locus notch homolog protein 3,nucleoplasm|cytoplasm|plasma membrane|integral component of plasma membrane|actin cytoskeleton|receptor complex|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|Notch signaling pathway|forebrain development|negative regulation of cell differentiation|negative regulation of neuron differentiation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of smooth muscle cell proliferation|neuron fate commitment|artery morphogenesis|glomerular capillary formation|",calcium ion binding|protein binding|enzyme binding|,5,8,89200000,2.4%
O88325,0.716811684,-0.35925,2.821546032,0.563833333,0.522210256,0.680132033,0.3555,0.314,-2.593,-0.184,-0.024,-0.024,O88325,Naglu,O88325_Naglu,O88325,Naglu,1,5,5,5,O88325,MOUSE,83165.4,9.7,296,296.1,57.18,57.18,,739,Alpha-N-acetylglucosaminidase,extracellular exosome|,lysosome organization|cerebellar Purkinje cell layer development|middle ear morphogenesis|locomotor rhythm|retinal rod cell development|inner ear receptor cell development|,,5,5,23000000,9.7%
O08538,0.888540941,0.107583333,0.941995896,-0.209833333,0.805008397,-0.258225237,1.7515,0.398,-1.512,0.142,0.143,-0.277,O08538,Angpt1,O08538_Angpt1,O08538,Angpt1,1,6,6,6,O08538,MOUSE,58088.5,12.6,297,297.1,57.14,57.14,,498,Angiopoietin-1,extracellular space|plasma membrane|microvillus|membrane raft|extracellular exosome|,angiogenesis|patterning of blood vessels|vasculogenesis|in utero embryonic development|negative regulation of protein phosphorylation|sprouting angiogenesis|positive regulation of receptor internalization|negative regulation of cytokine secretion involved in immune response|endocardium morphogenesis|negative regulation of cell adhesion|transmembrane receptor protein tyrosine kinase signaling pathway|activation of transmembrane receptor protein tyrosine kinase activity|endoderm development|positive regulation of endothelial cell migration|positive regulation of phosphatidylinositol 3-kinase signaling|regulation of satellite cell proliferation|hemopoiesis|heparin biosynthetic process|positive regulation of vascular endothelial growth factor receptor signaling pathway|positive regulation of protein ubiquitination|cell-substrate adhesion|regulation of tumor necrosis factor production|positive regulation of peptidyl-serine phosphorylation|protein localization to cell surface|negative regulation of protein import into nucleus|negative regulation of apoptotic process|negative regulation of vascular permeability|regulation of I-kappaB kinase/NF-kappaB signaling|regulation of protein binding|negative regulation of neuron apoptotic process|positive regulation of blood vessel endothelial cell migration|positive regulation of cell adhesion|Tie signaling pathway|positive regulation of peptidyl-tyrosine phosphorylation|positive chemotaxis|positive regulation of protein kinase B signaling|cardiac muscle tissue morphogenesis|vasculogenesis involved in coronary vascular morphogenesis|positive regulation of ERK1 and ERK2 cascade|glomerulus vasculature development|negative regulation of endothelial cell apoptotic process|regulation of macrophage migration inhibitory factor signaling pathway|,receptor binding|vascular endothelial growth factor receptor binding|receptor tyrosine kinase binding|,6,6,146000000,12.6%
D3Z4E2,0.30087555,-0.0787,10.66493165,0.630083333,0.085803862,2.136334895,-0.6715,-0.242,,0.312,0.238,-0.03,D3Z4E2,NotFound,D3Z4E2_NotFound,D3Z4E2,Nrn1,1,11,4,4,D3Z4E2|A0A286YD56|Q8CFV4,MOUSE,17406.3,20.8,298,298.1,56.69,56.69,,158,Neuritin,alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex|,axonogenesis|,,4,11,1590000000,20.8%
P34928,0.32515976,0.1395,9.655935029,0.740416667,0.108244664,1.957685092,-0.5065,-0.103,,0.873,0.467,-0.033,P34928,Apoc1,P34928_Apoc1,P34928,Apoc1,1,17,5,5,P34928,MOUSE,9696.2,32.9,299,299.1,56.17,56.17,,88,Apolipoprotein C-I,endoplasmic reticulum|very-low-density lipoprotein particle|high-density lipoprotein particle|extracellular exosome|,triglyceride metabolic process|cholesterol metabolic process|negative regulation of phosphatidylcholine catabolic process|negative regulation of very-low-density lipoprotein particle clearance|negative regulation of cholesterol transport|cholesterol efflux|phospholipid efflux|plasma lipoprotein particle remodeling|chylomicron remnant clearance|very-low-density lipoprotein particle clearance|lipoprotein metabolic process|negative regulation of fatty acid biosynthetic process|negative regulation of receptor-mediated endocytosis|negative regulation of lipoprotein lipase activity|,phospholipase inhibitor activity|fatty acid binding|,5,17,11400000000,32.9%
O09043,0.865833869,0.163083333,1.160226262,-0.1315,0.765556721,-0.312304501,0.0365,-0.414,1.064,-0.007,0.319,-0.02,O09043,Napsa,O09043_Napsa,O09043,Napsa,1,8,3,3,O09043,MOUSE,45942.9,10,300,300.1,55.47,55.47,,419,Napsin-A,extracellular space|lysosome|extracellular exosome|alveolar lamellar body|,protein catabolic process|membrane protein proteolysis|surfactant homeostasis|,endopeptidase activity|aspartic-type endopeptidase activity|protein binding|peptidase activity|,3,8,229000000,10.0%
P62983,0.094463849,0.340416667,21.81261882,-2.2575,0.006587765,-4.101139727,1.6335,2.444,0.33,-0.767,-0.969,-0.629,P62983,Rps27a,P62983_Rps27a,P62983,Rps27a,1,10,6,6,P62983|P0CG50|P0CG49|P62984|A0A0A6YW67|E9QNP0|D3YYZ2,MOUSE,18292.9,32.6,301,301.1,54.91,54.91,,156,Ubiquitin-40S ribosomal protein S27a,nucleoplasm|nucleolus|cytoplasm|cytosol|small ribosomal subunit|membrane|cytosolic small ribosomal subunit|myelin sheath|extracellular exosome|,translation|circadian rhythm|,structural constituent of ribosome|poly(A) RNA binding|metal ion binding|,6,10,87800000,32.6%
Q9EQ21,0.708127867,0.00175,2.934280465,0.291833333,0.508829115,0.703023651,0.1535,0.394,-0.98,0.393,0.097,-0.047,Q9EQ21,Hamp,Q9EQ21_Hamp,Q9EQ21,Hamp,1,13,3,2,Q9EQ21,MOUSE,9865.4,45.7,302,302.1,54.27,42.54,,83,Hepcidin,extracellular region|extracellular space|nucleus|,negative regulation of transcription from RNA polymerase II promoter|myeloid cell homeostasis|cellular iron ion homeostasis|JAK-STAT cascade|cellular response to extracellular stimulus|membrane protein proteolysis|negative regulation of iron ion transmembrane transport|defense response to bacterium|positive regulation of macrophage activation|negative regulation of bone resorption|positive regulation of transcription from RNA polymerase II promoter|negative regulation of inflammatory response|defense response to fungus|iron ion homeostasis|cellular response to iron ion|positive regulation of cellular protein catabolic process|,hormone activity|copper ion binding|,3,13,505000000,45.7%
Q80T19,0.742574146,0.2323,2.529393962,0.222583333,0.558548132,0.626514933,0.2695,-0.072,,0.762,0.247,-0.045,Q80T19,Hamp2,Q80T19_Hamp2,Q80T19,Hamp2,1,4,3,2,Q5M9M1|Q80T19,MOUSE,9923.4,46.9,302,302.2,41.37,29.64,,83,Hepcidin-2,extracellular region|cell|,cellular iron ion homeostasis|killing of cells of other organism|defense response to bacterium|defense response to fungus|,hormone activity|,2,4,57500000,30.1%
P97464,0.809866332,-0.0769,1.689329273,0.13975,0.677746171,0.440869412,0.1795,-0.501,,0.026,-0.083,-0.006,P97464,Ext1,P97464_Ext1,P97464,Ext1,1,7,6,6,P97464,MOUSE,87047.9,6.7,303,303.1,53.83,53.83,,746,Exostosin-1,Golgi membrane|endoplasmic reticulum|Golgi apparatus|integral component of endoplasmic reticulum membrane|,"ossification|glycosaminoglycan biosynthetic process|protein glycosylation|gastrulation|axon guidance|brain development|endoderm development|mesoderm development|heparan sulfate proteoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|olfactory bulb development|cellular polysaccharide biosynthetic process|embryonic skeletal joint development|","acetylglucosaminyltransferase activity|glucuronosyltransferase activity|transferase activity, transferring glycosyl groups|protein homodimerization activity|metal ion binding|protein heterodimerization activity|glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity|",6,7,91000000,6.7%
Q6P069,0.40834567,-0.1293,7.45666819,0.47825,0.179611103,1.559957956,-0.4355,-0.397,,-0.136,-0.103,0.425,Q6P069,Sri,Q6P069_Sri,Q6P069,Sri,1,6,5,5,Q6P069|Q6P069-2,MOUSE,21912.2,28.7,304,304.1,52.92,52.92,,198,Sorcin,intracellular|nucleoplasm|cytoplasm|mitochondrion|endoplasmic reticulum membrane|smooth endoplasmic reticulum|cytosol|plasma membrane|membrane|Z disc|T-tubule|vesicle|sarcoplasmic reticulum membrane|axon terminus|dendritic spine neck|extracellular exosome|chromaffin granule membrane|,proteolysis|calcium ion transport|heart development|negative regulation of heart rate|positive regulation of insulin secretion involved in cellular response to glucose stimulus|cytoplasmic sequestering of transcription factor|positive regulation of release of sequestered calcium ion into cytosol|regulation of calcium ion transport|negative regulation of ryanodine-sensitive calcium-release channel activity|regulation of cardiac muscle cell contraction|regulation of relaxation of muscle|regulation of high voltage-gated calcium channel activity|regulation of cell communication by electrical coupling involved in cardiac conduction|negative regulation of transcription regulatory region DNA binding|,protease binding|calcium-dependent cysteine-type endopeptidase activity|calcium ion binding|protein binding|protein heterodimerization activity|repressing transcription factor binding|,5,6,409000000,28.7%
E9Q0F0,0.323693105,0.288416667,9.862866188,-1.970166667,0.103208004,-1.92633231,3.4185,1.137,-0.735,-1.014,-0.313,-0.763,E9Q0F0,Krt78,E9Q0F0_Krt78,E9Q0F0,Krt78,1,18,3,3,E9Q0F0,MOUSE,114088.5,1.9,305,305.1,52.67,52.67,,1068,Keratin 78,extracellular space|keratin filament|extracellular exosome|,,structural molecule activity|,3,18,24200000000,1.9%
A0A140T8P6,0.641826969,-0.519083333,3.642209442,0.852833333,0.432293849,0.842595158,0.1265,0.386,-3.349,-0.12,-0.166,0.008,A0A140T8P6,NotFound,A0A140T8P6_NotFound,A0A140T8P6,Igkv12-46,1,14,3,3,A0A140T8P6,MOUSE,12733.1,40.8,306,306.1,52.03,52.03,,115,Immunoglobulin kappa variable 12-46 (Fragment),,,,3,14,1070000000,40.8%
A0A0A6YYE7,0.752055167,0.324583333,2.189061314,0.494833333,0.604079181,0.547565704,1.3445,0.713,-1.826,-0.179,1.394,0.501,A0A0A6YYE7,NotFound,A0A0A6YYE7_NotFound,A0A0A6YYE7,Igkv4-57,1,5,3,2,A0A0A6YYE7|A0A0B4J1I4|A0A0B4J1I3|A0A0A6YYE5|A0A075B5L8|A0A075B5M4,MOUSE,12803.3,39.3,307,307.1,52.02,31.14,,117,Immunoglobulin kappa variable 4-57 (Fragment),,,,3,5,430000000,39.3%
A0A0B4J1I9,0.740451784,0.1249,2.592444306,0.368583333,0.550497777,0.640686572,0.4785,-0.671,,-0.18,1.06,-0.063,A0A0B4J1I9,NotFound,A0A0B4J1I9_NotFound,A0A0B4J1I9,Igkv4-55,1,3,2,1,A0A0B4J1I9|P04945,MOUSE,12850.3,27.3,307,307.2,37.9,17.02,,117,Immunoglobulin kappa variable 4-55 (Fragment),,,,1,3,105000000,13.6%
P01639,0.520433101,0.2277,5.24553627,0.531583333,0.298845261,1.161658942,-0.1475,-0.035,,0.145,1.199,-0.023,P01639,NotFound,P01639_NotFound,P01639,Gm5571,1,5,3,3,P01639|A0A140T8N0,MOUSE,14482,28.4,308,308.1,51.78,51.78,,130,Ig kappa chain V-V region MOPC 41,,,antigen binding|,3,5,223000000,28.4%
P26618,0.745307288,0.1453,2.336317825,-0.202416667,0.583939989,-0.58508122,0.6765,-0.143,,0.151,0.075,-0.033,P26618,Pdgfra,P26618_Pdgfra,P26618,Pdgfra,1,7,6,6,P26618|P26618-2|A0A0J9YV87,MOUSE,123651.1,6.4,309,309.1,51.27,51.27,,1089,Platelet-derived growth factor receptor alpha,nucleus|cytoplasm|cytosol|integral component of plasma membrane|microvillus|external side of plasma membrane|cell surface|membrane|intrinsic component of plasma membrane|protein complex|,luteinization|in utero embryonic development|hematopoietic progenitor cell differentiation|positive regulation of cytosolic calcium ion concentration|estrogen metabolic process|positive regulation of cell proliferation|female gonad development|anatomical structure morphogenesis|organ morphogenesis|response to inorganic substance|negative regulation of platelet activation|positive regulation of phospholipase C activity|cell migration|peptidyl-tyrosine phosphorylation|signal transduction involved in regulation of gene expression|extracellular matrix organization|lung development|adrenal gland development|positive regulation of cell migration|male genitalia development|response to estradiol|Leydig cell differentiation|response to cytokine|cellular response to reactive oxygen species|platelet-derived growth factor receptor-alpha signaling pathway|positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway|wound healing|gliogenesis|odontogenesis of dentin-containing tooth|positive regulation of phosphatidylinositol 3-kinase activity|positive regulation of DNA replication|protein autophosphorylation|platelet-derived growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|positive regulation of fibroblast proliferation|embryonic digestive tract morphogenesis|embryonic cranial skeleton morphogenesis|skeletal system morphogenesis|inner ear development|regulation of chemotaxis|cardiac myofibril assembly|response to hyperoxia|palate development|face morphogenesis|cell chemotaxis|retina vasculature development in camera-type eye|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|cellular response to amino acid stimulus|metanephric glomerular capillary formation|regulation of mesenchymal stem cell differentiation|,protein kinase activity|transmembrane receptor protein tyrosine kinase activity|platelet-derived growth factor alpha-receptor activity|vascular endothelial growth factor-activated receptor activity|platelet-derived growth factor receptor binding|ATP binding|protein complex binding|vascular endothelial growth factor binding|protein homodimerization activity|phosphatidylinositol 3-kinase binding|platelet-derived growth factor binding|,6,7,85700000,6.4%
Q61646,0.983016154,-0.617416667,0.090649035,-0.045166667,0.979343616,-0.027008592,3.1905,-1.309,-3.666,-0.372,-0.695,-0.853,Q61646,Hp,Q61646_Hp,Q61646,Hp,1,6,4,4,Q61646,MOUSE,39265.1,10,310,310.1,51.27,51.27,,347,Haptoglobin,extracellular space|endoplasmic reticulum|Golgi apparatus|haptoglobin-hemoglobin complex|extracellular exosome|blood microparticle|,response to hypoxia|liver development|immune system process|acute-phase response|Notch signaling pathway|spermatogenesis|response to heat|response to X-ray|response to lead ion|positive regulation of cell death|organ regeneration|response to magnesium ion|response to lipopolysaccharide|response to cobalamin|response to L-ascorbic acid|response to drug|response to hydrogen peroxide|defense response to bacterium|negative regulation of oxidoreductase activity|response to glucocorticoid|response to electrical stimulus|response to growth hormone|negative regulation of hydrogen peroxide catabolic process|,antioxidant activity|hemoglobin binding|protein homodimerization activity|,4,6,144000000,10.0%
A0A140T8N3,0.719190794,-0.119416667,2.799738096,0.3435,0.52483911,0.675680171,0.7215,-1.165,-0.43,-0.239,0.241,0.155,A0A140T8N3,NotFound,A0A140T8N3_NotFound,A0A140T8N3,Igkv13-84,1,7,4,4,A0A140T8N3|A0A075B666,MOUSE,12788.3,37.3,311,311.1,51.01,51.01,,115,Immunoglobulin kappa chain variable 13-84 (Fragment),,,,4,7,852000000,37.3%
Q8BM72,0.752055167,0.35025,2.207614554,-0.307833333,0.601504034,-0.551565087,-0.3615,0.165,1.709,0.402,0.214,-0.027,Q8BM72,Hspa13,Q8BM72_Hspa13,Q8BM72,Hspa13,1,6,5,5,Q8BM72|D3Z0Y0|Q8BM72-2,MOUSE,51765.4,10.8,312,312.1,50.57,50.57,,471,Heat shock 70 kDa protein 13,endoplasmic reticulum|extracellular exosome|,,ATP binding|,5,6,68400000,10.8%
O54819,0.214239872,-0.3779,13.83230557,1.11975,0.041377995,2.746690109,-1.5415,-0.558,,-0.17,0.363,0.017,O54819,Tfpi,O54819_Tfpi,O54819,Tfpi,1,6,4,4,O54819|A2ARA0|O54819-2|A2ARA3|Q8BSB7,MOUSE,36070.2,16.3,313,313.1,50.35,50.35,,306,Tissue factor pathway inhibitor,extracellular space|cell surface|,blood coagulation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,4,6,203000000,16.3%
Q8CAR0,0.534055254,-0.1555,5.013510118,0.29125,0.315245567,1.115991091,-0.4545,-0.206,,-0.129,-0.015,0.027,Q8CAR0,Igf1,Q8CAR0_Igf1,Q8CAR0,Igf1,1,8,4,4,Q8CAR0|Q4VJB9|P05017-2|P05017|E9PU89|E9Q138,MOUSE,18872.4,25.4,314,314.1,50.21,50.21,,165,Insulin-like growth factor I,extracellular space|intracellular|insulin-like growth factor ternary complex|,"cell activation|regulation of protein phosphorylation|blood vessel remodeling|nervous system development|cell proliferation|positive regulation of cell proliferation|negative regulation of cell proliferation|response to heat|glial cell differentiation|regulation of gene expression|positive regulation of glycoprotein biosynthetic process|positive regulation of cardiac muscle hypertrophy|phosphatidylinositol 3-kinase signaling|positive regulation of phosphatidylinositol 3-kinase signaling|skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration|muscle hypertrophy|myotube cell development|positive regulation of smooth muscle cell migration|positive regulation of cerebellar granule cell precursor proliferation|water homeostasis|proteoglycan biosynthetic process|lung development|positive regulation of cell migration|mammary gland development|exocrine pancreas development|regulation of establishment or maintenance of cell polarity|positive regulation of protein import into nucleus, translocation|negative regulation of smooth muscle cell apoptotic process|multicellular organism growth|bone mineralization involved in bone maturation|regulation of multicellular organism growth|positive regulation of activated T cell proliferation|positive regulation of tyrosine phosphorylation of Stat5 protein|negative regulation of apoptotic process|positive regulation of DNA binding|positive regulation of MAPK cascade|protein kinase B signaling|positive regulation of insulin-like growth factor receptor signaling pathway|myoblast differentiation|positive regulation of osteoblast differentiation|positive regulation of glycogen biosynthetic process|positive regulation of DNA replication|positive regulation of glycolytic process|positive regulation of mitotic nuclear division|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of glucose import|positive regulation of Ras protein signal transduction|insulin-like growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|positive regulation of fibroblast proliferation|lung alveolus development|cell development|positive regulation of smooth muscle cell proliferation|branching morphogenesis of an epithelial tube|inner ear development|chondroitin sulfate proteoglycan biosynthetic process|positive regulation of epithelial cell proliferation|positive regulation of protein secretion|positive regulation of peptidyl-tyrosine phosphorylation|protein stabilization|regulation of protein metabolic process|myoblast proliferation|positive regulation of protein kinase B signaling|negative regulation of oocyte development|lung vasculature development|lung lobe morphogenesis|Type I pneumocyte differentiation|Type II pneumocyte differentiation|prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis|prostate gland growth|prostate gland epithelium morphogenesis|prostate gland stromal morphogenesis|negative regulation of androgen receptor signaling pathway|ERK1 and ERK2 cascade|negative regulation of ERK1 and ERK2 cascade|positive regulation of calcineurin-NFAT signaling cascade|extrinsic apoptotic signaling pathway in absence of ligand|positive regulation of trophectodermal cell proliferation|positive regulation of myoblast proliferation|negative regulation of extrinsic apoptotic signaling pathway|",insulin receptor binding|insulin-like growth factor receptor binding|integrin binding|hormone activity|protein binding|growth factor activity|,4,8,509000000,25.4%
Q62178,0.418338077,0.114916667,7.188131273,0.486166667,0.191067523,1.47444888,-0.6245,0.211,0.029,0.47,0.625,-0.021,Q62178,Sema4a,Q62178_Sema4a,Q62178,Sema4a,1,4,4,4,Q62178|D3YWV5,MOUSE,84389.1,5.9,315,315.1,49.74,49.74,,760,Semaphorin-4A,plasma membrane|integral component of membrane|,angiogenesis|T cell differentiation involved in immune response|axonogenesis|regulation of cell shape|regulation of endothelial cell migration|negative regulation of angiogenesis|T-helper 1 cell differentiation|semaphorin-plexin signaling pathway|,,4,4,43300000,5.9%
Q04592,0.038106411,0.671583333,28.4659624,-1.529833333,0.001423652,-5.571801908,1.2205,1.218,1.871,0.006,-0.231,-0.055,Q04592,Pcsk5,Q04592_Pcsk5,Q04592,Pcsk5,1,7,7,7,Q04592|Q04592-2,MOUSE,220321.6,3.9,316,316.1,49.41,49.41,,1877,Proprotein convertase subtilisin/kexin type 5,extracellular space|endoplasmic reticulum lumen|Golgi apparatus|integral component of membrane|secretory granule|,kidney development|renin secretion into blood stream|signal peptide processing|heart development|embryo implantation|anterior/posterior pattern specification|protein processing|peptide hormone processing|viral life cycle|respiratory tube development|limb morphogenesis|cytokine biosynthetic process|peptide biosynthetic process|embryonic digestive tract development|embryonic skeletal system development|,endopeptidase activity|serine-type endopeptidase activity|peptidase activity|peptide binding|,7,7,593000000,3.9%
A0A087WPN7,0.84738773,0.25325,1.356982762,-0.181166667,0.731647215,-0.359635126,0.0485,-0.368,1.351,-0.258,0.483,0.263,A0A087WPN7,NotFound,A0A087WPN7_NotFound,A0A087WPN7,Ighv13-2,1,7,4,4,A0A087WPN7,MOUSE,11456.7,44,317,317.1,49.3,49.3,,100,Immunoglobulin heavy variable 13-2,,,,4,7,316000000,44.0%
A0A1Y7VJX7,0.846221454,0.229583333,1.390122918,0.204833333,0.726085407,0.367483883,1.1615,-0.093,-0.687,0.261,-0.186,0.921,A0A1Y7VJX7,NotFound,A0A1Y7VJX7_NotFound,A0A1Y7VJX7,Ighe,1,6,4,4,A0A1Y7VJX7|P06336,MOUSE,55752.3,13.7,318,318.1,49.02,49.02,,486,Immunoglobulin heavy constant epsilon (Fragment),,,,4,6,85300000,13.7%
Q9Z1R3,0.917908932,0.0771,0.616741733,0.046416667,0.867612552,0.175461173,-0.0115,0.11,,0.096,0.25,-0.059,Q9Z1R3,Apom,Q9Z1R3_Apom,Q9Z1R3,Apom,1,9,4,4,Q9Z1R3,MOUSE,21615.3,16.3,319,319.1,48.7,48.7,,190,Apolipoprotein M,extracellular region|very-low-density lipoprotein particle|low-density lipoprotein particle|high-density lipoprotein particle|discoidal high-density lipoprotein particle|spherical high-density lipoprotein particle|extracellular exosome|,response to glucose|cholesterol efflux|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|high-density lipoprotein particle clearance|negative regulation of plasma lipoprotein particle oxidation|lipoprotein metabolic process|reverse cholesterol transport|,lipid transporter activity|phospholipid binding|antioxidant activity|,4,9,348000000,16.3%
Q09200,0.161969809,0.612583333,17.040554,-1.407833333,0.019767175,-3.170467973,1.2085,0.54,2.201,-0.108,-0.086,-0.08,Q09200,B4galnt1,Q09200_B4galnt1,Q09200,B4galnt1,1,8,5,5,Q09200|A0A1W2P6F0,MOUSE,59610.2,8.6,320,320.1,48.7,48.7,,533,"Beta-1,4 N-acetylgalactosaminyltransferase 1",plasma membrane|integral component of Golgi membrane|,ganglioside biosynthetic process|protein glycosylation|glycosphingolipid metabolic process|spermatogenesis|lipid storage|lipid glycosylation|,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity|,5,8,76600000,8.6%
O35622,0.509872886,-0.157416667,5.482176871,0.254166667,0.282997314,1.179241061,-0.2185,-0.17,-0.465,0.013,-0.069,-0.035,O35622,Fgf15,O35622_Fgf15,O35622,Fgf15,1,5,4,4,O35622,MOUSE,25520.6,19.7,321,321.1,48.18,48.18,,218,Fibroblast growth factor 15,extracellular region|,neural crest cell migration|positive regulation of protein phosphorylation|heart development|positive regulation of cell proliferation|fibroblast growth factor receptor signaling pathway|negative regulation of gene expression|positive regulation of glucose import|positive regulation of JNK cascade|positive regulation of ERK1 and ERK2 cascade|negative regulation of bile acid biosynthetic process|,fibroblast growth factor receptor binding|growth factor activity|,4,5,52300000,19.7%
P10126,0.188763465,0.1211,15.14854251,-1.69525,0.030559465,-3.009683403,0.3045,1.972,,-0.776,-0.614,-0.281,P10126,Eef1a1,P10126_Eef1a1,P10126,Eef1a1,1,7,4,4,P10126|P62631,MOUSE,50455.3,8.4,322,322.1,47.83,47.83,,462,Elongation factor 1-alpha 1,extracellular space|nucleus|nucleolus|cytoplasm|cytosol|plasma membrane|membrane|cortical actin cytoskeleton|ruffle membrane|myelin sheath|extracellular exosome|,translational elongation|cellular response to epidermal growth factor stimulus|,tRNA binding|translation elongation factor activity|GTPase activity|protein binding|GTP binding|protein kinase binding|poly(A) RNA binding|,4,7,375000000,8.4%
P01675,0.233962779,-0.219916667,12.86304274,1.095833333,0.051724431,2.432112026,-0.4915,-0.253,-1.559,-0.232,0.683,0.533,P01675,NotFound,P01675_NotFound,P01675,,1,7,4,4,P01675|P01676|P01677|P01678|P01679|A0A075B5L5,MOUSE,11741,36.4,323,323.1,47.55,47.55,,107,Ig kappa chain V-VI region XRPC 44,,,antigen binding|,4,7,1940000000,36.4%
P16056,0.84738773,-0.066583333,1.352739038,0.189166667,0.732362496,0.358627579,0.1515,0.666,-1.301,0.173,-0.016,-0.073,P16056,NotFound,P16056_NotFound,P16056,Met,1,6,5,5,P16056|F8VQL0,MOUSE,155885.1,5.6,324,324.1,46.7,46.7,,1379,Hepatocyte growth factor receptor,basal plasma membrane|cell surface|membrane|integral component of membrane|,activation of MAPK activity|endothelial cell morphogenesis|liver development|placenta development|synaptic transmission|brain development|muscle organ development|skeletal muscle tissue development|positive regulation of glucose transport|muscle cell migration|myotube differentiation|peptidyl-tyrosine phosphorylation|adult behavior|glucose homeostasis|positive regulation of transcription from RNA polymerase II promoter|protein autophosphorylation|hepatocyte growth factor receptor signaling pathway|branching morphogenesis of an epithelial tube|regulation of synaptic transmission|positive chemotaxis|myoblast proliferation|regulation of excitatory postsynaptic membrane potential|regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling|semaphorin-plexin signaling pathway|negative regulation of hydrogen peroxide-mediated programmed cell death|positive regulation of endothelial cell chemotaxis|,protein kinase activity|hepatocyte growth factor-activated receptor activity|protein binding|ATP binding|protein phosphatase binding|,5,6,89300000,5.6%
P01728,0.14994666,-0.3959,17.94284733,1.623083333,0.016058881,3.602950111,-1.8535,-0.886,,-0.228,0.617,0.371,P01728,NotFound,P01728_NotFound,P01728,,1,10,3,2,P01728|A0A075B664|P01729|P01726,MOUSE,12392.7,41.8,325,325.1,46.68,34.36,,117,Ig lambda-2 chain V region,,,antigen binding|,4,10,13000000000,41.8%
P01723,0.890329957,0.0495,0.884438133,0.119333333,0.815748317,0.249166927,,-0.04,,-0.283,0.512,0.009,P01723,NotFound,P01723_NotFound,P01723,,1,3,3,1,P01727|A0A075B663|P01723,MOUSE,12335.6,41.8,325,325.2,44.07,25.25,,117,Ig lambda-1 chain V region,plasma membrane|,,antigen binding|,1,3,256000000,28.2%
A0A075B6D5,0.651504812,0.5535,3.528105914,0.55625,0.443802157,0.832527908,0.5255,-0.086,,-0.322,1.7,0.95,A0A075B6D5,NotFound,A0A075B6D5_NotFound,A0A075B6D5,Igkv19-93,1,7,5,5,A0A075B6D5,MOUSE,12905.5,42.1,326,326.1,46.34,46.34,,114,Immunoglobulin kappa chain variable 19-93,,,,5,7,369000000,42.1%
Q8CF98,0.864716947,0.121583333,1.180219999,-0.139166667,0.762040407,-0.317173318,-0.0445,-0.477,1.095,-0.046,0.208,-0.006,Q8CF98,Colec10,Q8CF98_Colec10,Q8CF98,Colec10,1,10,4,4,Q8CF98,MOUSE,30922.6,15.1,327,327.1,46.2,46.2,,277,Collectin-10,extracellular region|collagen trimer|nucleus|cytoplasm|cytosol|,defense response|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|embryo development|,mannose binding|,4,10,285000000,15.1%
P09803,0.597174093,-0.1089,4.253232085,0.43975,0.375557805,0.97426579,0.2705,-1.016,,0.071,-0.042,0.172,P09803,Cdh1,P09803_Cdh1,P09803,Cdh1,1,4,4,4,A0A0R4IZW5|P09803,MOUSE,98767.5,5.3,328,328.1,45.05,45.05,,884,Cadherin-1,cytoplasm|endosome|trans-Golgi network|plasma membrane|cell-cell junction|adherens junction|cell-cell adherens junction|focal adhesion|cytoplasmic side of plasma membrane|cell surface|actin cytoskeleton|integral component of membrane|aggresome|basolateral plasma membrane|lateral plasma membrane|catenin complex|flotillin complex|lamellipodium|cell junction|axon|node of Ranvier|lateral loop|Schmidt-Lanterman incisure|apical junction complex|axon terminus|apical part of cell|perinuclear region of cytoplasm|extracellular exosome|cell periphery|catenin complex|cortical actin cytoskeleton|,"in utero embryonic development|trophectodermal cell differentiation|epithelial cell morphogenesis|homophilic cell adhesion via plasma membrane adhesion molecules|embryo implantation|sensory perception of sound|single organismal cell-cell adhesion|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|protein metabolic process|negative regulation of cell-cell adhesion|regulation of protein localization|regulation of water loss via skin|adherens junction organization|uterine epithelium development|positive regulation of transcription factor import into nucleus|regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of transcription, DNA-templated|decidualization|negative regulation of epithelial cell proliferation|protein homooligomerization|intestinal epithelial cell development|salivary gland cavitation|regulation of branching involved in salivary gland morphogenesis|bicellular tight junction assembly|cellular response to amino acid stimulus|cellular response to lithium ion|cellular response to indole-3-methanol|protein localization to plasma membrane|establishment of protein localization to plasma membrane|negative regulation of canonical Wnt signaling pathway|cochlea development|regulation of protein localization to cell surface|regulation of neuron migration|",glycoprotein binding|calcium ion binding|protein binding|beta-catenin binding|protein phosphatase binding|protein domain specific binding|ankyrin binding|GTPase activating protein binding|gamma-catenin binding|cell adhesion molecule binding|,4,4,30500000,5.3%
P01655,0.425473432,0.436916667,6.945505805,-0.451166667,0.20204561,-1.432477815,1.2185,0.42,0.349,0.144,0.41,0.08,P01655,NotFound,P01655_NotFound,P01655,,1,6,3,1,P01655|P01654|P01656|A0A075B5P0|P01659|P01667|P01672|P01669|P01671|P01673,MOUSE,12168.4,51.7,329,329.1,44.96,12.77,,112,Ig kappa chain V-III region PC 7132,,,antigen binding|,4,6,234000000,51.7%
P01660,0.597174093,0.2483,4.26969813,0.467583333,0.374136593,0.977430139,0.2615,-0.326,,-0.298,0.899,0.705,P01660,NotFound,P01660_NotFound,P01660,,1,2,3,1,P01660|A0A140T8M6,MOUSE,12213.3,31.5,329,329.2,39.91,14.79,,111,Ig kappa chain V-III region PC 3741/TEPC 111,,,antigen binding|,1,2,53600000,9.9%
P03977,0.758326556,0.640875,2.105003481,0.547166667,0.615885036,0.544286816,0.2305,,,-0.274,1.992,0.615,P03977,NotFound,P03977_NotFound,P03977,,1,1,3,1,P03977,MOUSE,12156.3,39.6,329,329.3,38.55,6.36,,111,Ig kappa chain V-III region 50S10.1,,,antigen binding|,1,1,1760000000,9.9%
A0A075B5N9,0.214239872,-0.1355,13.91425077,0.86625,0.040604571,2.745335759,-0.4495,-0.861,,0.451,-0.084,0.266,A0A075B5N9,NotFound,A0A075B5N9_NotFound,A0A075B5N9,Igkv3-7,1,1,2,1,A0A075B5N9|P01674,MOUSE,10969.9,29.2,329,329.4,34.71,16.12,,99,Immunoglobulin kappa variable 3-7,,,,1,1,44800000,12.1%
P01657,0.233962779,-0.3633,12.77894584,1.357416667,0.052735785,2.542502583,-1.8655,-0.49,,-0.271,0.602,0.208,P01657,NotFound,P01657_NotFound,P01657,,1,1,2,1,P01657,MOUSE,12063.3,23.4,329,329.5,31.66,13.07,,111,Ig kappa chain V-III region PC 2413,,,antigen binding|,1,1,39800000,8.1%
P01665,0.32515976,0.216416667,9.567206044,-0.7035,0.110478914,-1.876887107,0.3765,1.165,0.163,-0.468,-0.263,0.325,P01665,NotFound,P01665_NotFound,P01665,,1,2,2,1,P01665|P01664|P01666|P01668|A0A140T8Q0|A0A140T8Q4,MOUSE,12116.1,29.7,329,329.6,28.88,10.29,,111,Ig kappa chain V-III region PC 7043,,,antigen binding|,1,2,113000000,14.4%
A0A0A6YWI9,0.616649209,-0.1441,3.907600427,0.24275,0.40666796,0.905734294,-0.4265,-0.153,,-0.183,-0.002,0.044,A0A0A6YWI9,NotFound,A0A0A6YWI9_NotFound,A0A0A6YWI9,Ighv1-11,1,8,4,4,A0A0A6YWI9,MOUSE,13035.6,40.1,330,330.1,44.37,44.37,,117,Immunoglobulin heavy variable V1-11 (Fragment),,,,4,8,13600000000,40.1%
P07356,0.415101064,-0.003416667,7.266550738,-1.885833333,0.187648426,-1.490017115,3.3005,1.405,-1.887,-1.114,-0.848,-0.877,P07356,Anxa2,P07356_Anxa2,P07356,Anxa2,1,4,3,3,P07356,MOUSE,38960.8,10.6,331,331.1,44.01,44.01,,339,Annexin A2,ruffle|basement membrane|extracellular space|nucleus|cytoplasm|lysosomal membrane|endosome|early endosome|lipid particle|cytosol|plasma membrane|cell cortex|cell surface|membrane|basolateral plasma membrane|extrinsic component of plasma membrane|midbody|late endosome membrane|vesicle|myelin sheath adaxonal region|sarcolemma|melanosome|Schmidt-Lanterman incisure|macropinosome|perinuclear region of cytoplasm|extracellular exosome|PCSK9-AnxA2 complex|membrane raft|,angiogenesis|membrane raft assembly|positive regulation of protein phosphorylation|negative regulation of receptor internalization|membrane budding|body fluid secretion|collagen fibril organization|positive regulation of vesicle fusion|negative regulation of low-density lipoprotein particle receptor catabolic process|osteoclast development|fibrinolysis|negative regulation of catalytic activity|positive regulation of fibroblast proliferation|positive regulation of binding|protein heterotetramerization|protein targeting to plasma membrane|negative regulation of receptor binding|positive regulation of receptor activity|,"calcium ion binding|protein binding|calcium-dependent phospholipid binding|phosphatidylinositol-4,5-bisphosphate binding|cytoskeletal protein binding|Rab GTPase binding|phospholipase A2 inhibitor activity|S100 protein binding|poly(A) RNA binding|calcium-dependent protein binding|receptor activator activity|",3,4,111000000,10.6%
Q6T5E4,0.528184073,-0.387916667,5.14477291,0.943833333,0.305860017,1.120978035,0.2895,-0.045,-2.824,0.307,0.03,-0.085,Q6T5E4,Gcnt2,Q6T5E4_Gcnt2,Q6T5E4,Gcnt2,1,4,4,4,Q6T5E4,MOUSE,46854.9,10.9,332,332.1,43.51,43.51,,401,"Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme",membrane|,protein glycosylation|transforming growth factor beta receptor signaling pathway|posttranscriptional regulation of gene expression|positive regulation of epithelial to mesenchymal transition|negative regulation of cell-substrate adhesion|positive regulation of cell migration|positive regulation of heterotypic cell-cell adhesion|maintenance of lens transparency|positive regulation of protein kinase B signaling|positive regulation of ERK1 and ERK2 cascade|,"N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity|acetylglucosaminyltransferase activity|",4,4,70000000,10.9%
Q9Z0L8,0.708680709,0.0267,2.916832063,-0.185083333,0.510877521,-0.707555121,0.0355,0.24,,0.066,-0.157,-0.051,Q9Z0L8,Ggh,Q9Z0L8_Ggh,Q9Z0L8,Ggh,1,6,3,3,Q9Z0L8|Q9Z0L8-2,MOUSE,35697.1,12.3,333,333.1,43.4,43.4,,317,Gamma-glutamyl hydrolase,extracellular space|nucleus|lysosome|cytosol|melanosome|extracellular exosome|,proteolysis|glutamine metabolic process|response to zinc ion|response to insulin|response to drug|response to ethanol|,gamma-glutamyl-peptidase activity|,3,6,536000000,12.3%
Q9EQI5,0.469723424,0.2223,6.116970457,0.51675,0.244513563,1.321373182,0.0485,-0.224,,0.891,-0.114,0.51,Q9EQI5,Ppbp,Q9EQI5_Ppbp,Q9EQI5,Ppbp,1,9,3,3,Q9EQI5,MOUSE,12593.7,20.3,334,334.1,42.98,42.98,,113,"Chemokine (C-X-C motif) ligand 7, isoform CRA_b",extracellular space|cell|,leukocyte migration involved in inflammatory response|positive regulation of leukocyte chemotaxis|inflammatory response|immune response|G-protein coupled receptor signaling pathway|neutrophil chemotaxis|response to lipopolysaccharide|regulation of cell proliferation|neutrophil degranulation|chemokine-mediated signaling pathway|,chemokine activity|CXCR chemokine receptor binding|,3,9,7890000000,20.3%
Q3UFC6,0.732280772,-0.006416667,2.655209488,0.410166667,0.542599078,0.645975317,0.4185,0.478,-1.531,-0.032,-0.199,0.827,Q3UFC6,Dsg3,Q3UFC6_Dsg3,Q3UFC6,Dsg3,1,6,4,4,Q3UFC6|O35902|O35902-2,MOUSE,109212.9,4.8,335,335.1,42.79,42.79,,993,Desmoglein-3,plasma membrane|integral component of membrane|extracellular exosome|,homophilic cell adhesion via plasma membrane adhesion molecules|,calcium ion binding|,4,6,201000000,4.8%
A0A0B4J1N0,0.742574146,0.7927,2.543415677,-0.33425,0.556747701,-0.630277072,1.0705,0.916,,0.568,1.505,-0.096,A0A0B4J1N0,NotFound,A0A0B4J1N0_NotFound,A0A0B4J1N0,Ighv1-76,1,9,4,4,A0A0B4J1N0|A0A075B5Y2|A0A075B5Y5,MOUSE,10993.2,48.9,336,336.1,42.41,42.41,,98,Immunoglobulin heavy variable 1-76,,,,5,9,2190000000,48.9%
A0A0A6YXQ0,0.611417348,-0.147916667,3.990495988,0.201166667,0.398979334,0.90788657,-0.4125,-0.134,-0.199,-0.199,0.018,0.039,A0A0A6YXQ0,NotFound,A0A0A6YXQ0_NotFound,A0A0A6YXQ0,Ighv8-8,1,10,4,4,A0A0A6YXQ0,MOUSE,13299,26,337,337.1,41.57,41.57,,119,Immunoglobulin heavy variable 8-8 (Fragment),,,,4,10,1510000000,26.0%
G5E8D6,0.046051981,0.486083333,26.97399189,-1.090833333,0.002007247,-5.208155524,1.0455,0.931,1.118,-0.134,-0.067,0.023,G5E8D6,Efemp2,G5E8D6_Efemp2,G5E8D6,Efemp2,1,8,4,4,G5E8D6|Q9WVJ9|E9Q3N9,MOUSE,53745,8.6,338,338.1,41.31,41.31,,462,EGF-containing fibulin-like extracellular matrix protein 2,proteinaceous extracellular matrix|extracellular exosome|extracellular vesicle|,,calcium ion binding|,4,8,1490000000,8.6%
Q9EPS3,0.330192854,0.25025,9.369735007,-0.4345,0.115618279,-1.838915987,0.5755,0.242,0.585,0.125,-0.169,0.143,Q9EPS3,Glce,Q9EPS3_Glce,Q9EPS3,Glce,1,5,4,4,Q9EPS3,MOUSE,70429.9,7.7,339,339.1,40.96,40.96,,618,D-glucuronyl C5-epimerase,Golgi membrane|Golgi apparatus|integral component of membrane|,heparan sulfate proteoglycan biosynthetic process|heparin biosynthetic process|,"racemase and epimerase activity, acting on carbohydrates and derivatives|heparosan-N-sulfate-glucuronate 5-epimerase activity|UDP-glucuronate 5'-epimerase activity|",4,5,27300000,7.7%
P02666,0.40834567,0.131916667,7.47830559,-1.4685,0.178718471,-1.525964923,0.2925,-0.759,3.065,-0.557,-0.489,-0.761,P02666,NotFound,P02666_NotFound,P02666,CSN2,1,7,3,3,P02666,BOVIN,25163.9,14.7,340,340.1,40.96,40.96,,224,Beta-casein,,,,3,7,684000000,14.7%
F8VQD7,0.74463639,0.0271,2.438961731,0.151416667,0.570300598,0.607158504,-0.0745,-0.053,,0.093,0.149,0.021,F8VQD7,Ptprg,F8VQD7_Ptprg,F8VQD7,Ptprg,1,6,5,5,F8VQD7|Q05909|D6RD11,MOUSE,162430.7,4.7,341,341.1,40.01,40.01,,1442,Receptor-type tyrosine-protein phosphatase gamma,extracellular exosome|,negative regulation of epithelial cell migration|peptidyl-tyrosine dephosphorylation|toxin transport|,protein tyrosine phosphatase activity|identical protein binding|,5,6,274000000,4.7%
Q05144,0.756361919,0.0371,2.137411932,-0.166083333,0.611306209,-0.541718519,0.4475,-0.174,,-0.084,-0.028,0.024,Q05144,Rac2,Q05144_Rac2,Q05144,Rac2,1,4,4,4,Q05144|Q3TLP8|P63001|P60764,MOUSE,21839.8,23.9,342,342.1,39.72,39.72,,192,Ras-related C3 botulinum toxin substrate 2,nuclear envelope|cytoplasm|cytosol|focal adhesion|membrane|lamellipodium|extracellular exosome|actin filament|,chemotaxis|actin filament organization|G-protein coupled receptor signaling pathway|small GTPase mediated signal transduction|positive regulation of cell proliferation|positive regulation of lamellipodium assembly|regulation of cell-substrate adhesion|cell projection assembly|actin cytoskeleton organization|regulation of T cell proliferation|regulation of mast cell degranulation|bone resorption|regulation of protein kinase activity|regulation of respiratory burst|regulation of mast cell chemotaxis|lymphocyte aggregation|positive regulation of neutrophil chemotaxis|regulation of neutrophil migration|positive regulation of protein targeting to mitochondrion|,GTPase activity|GTP binding|protein kinase regulator activity|,4,4,21500000,23.9%
P35454,0.611417348,0.16275,4.014778403,-0.374833333,0.396754773,-0.913573125,1.2075,-0.208,0.051,0.021,-0.087,-0.008,P35454,Oxt,P35454_Oxt,P35454,Oxt,1,4,3,3,P35454|P35455,MOUSE,13934.7,36.8,343,343.1,39.71,39.71,,125,Oxytocin-neurophysin 1,extracellular region|extracellular space|cytoplasm|cytosol|secretory granule|terminal bouton|,response to amphetamine|regulation of heart rate|maternal aggressive behavior|positive regulation of cytosolic calcium ion concentration|heart development|female pregnancy|memory|grooming behavior|response to mechanical stimulus|response to sucrose|positive regulation of norepinephrine secretion|response to activity|sleep|response to food|positive regulation of prostaglandin secretion|response to estradiol|response to retinoic acid|response to progesterone|response to prostaglandin E|social behavior|negative regulation of urine volume|positive regulation of renal sodium excretion|response to cocaine|hyperosmotic salinity response|maternal behavior|sperm ejaculation|eating behavior|drinking behavior|response to external biotic stimulus|response to peptide hormone|response to ether|negative regulation of blood pressure|positive regulation of blood pressure|positive regulation of ossification|positive regulation of female receptivity|positive regulation of synaptic transmission|response to glucocorticoid|response to cAMP|response to electrical stimulus|regulation of sensory perception of pain|positive regulation of synapse assembly|male mating behavior|positive regulation of penile erection|positive regulation of hindgut contraction|negative regulation of gastric acid secretion|positive regulation of uterine smooth muscle contraction|,neurohypophyseal hormone activity|oxytocin receptor binding|,3,4,13800000,36.8%
O08807,0.109460228,0.3945,20.80129361,-2.432916667,0.008315161,-4.270010211,1.0075,2.701,,-0.371,-0.859,-0.506,O08807,Prdx4,O08807_Prdx4,O08807,Prdx4,1,4,3,1,O08807,MOUSE,31280.1,13.8,344,344.1,39.54,16.93,,274,Peroxiredoxin-4,extracellular space|nucleus|cytoplasm|mitochondrion|endoplasmic reticulum|smooth endoplasmic reticulum|cytosol|extracellular exosome|,spermatogenesis|male gonad development|4-hydroxyproline metabolic process|protein maturation by protein folding|extracellular matrix organization|cell redox homeostasis|oxidation-reduction process|reactive oxygen species metabolic process|negative regulation of male germ cell proliferation|,peroxidase activity|protein homodimerization activity|peroxiredoxin activity|,3,4,1490000000,13.8%
P35700,0.045581473,0.3787,27.40777215,-2.842583333,0.001816447,-6.121041867,1.5105,2.658,,-0.658,-1.16,-0.457,P35700,Prdx1,P35700_Prdx1,P35700,Prdx1,1,1,3,1,P35700,MOUSE,22404.3,14.5,344,344.2,38.77,16.16,,199,Peroxiredoxin-1,extracellular space|nucleus|cytoplasm|mitochondrion|melanosome|myelin sheath|extracellular exosome|,response to reactive oxygen species|retina homeostasis|response to oxidative stress|cell proliferation|removal of superoxide radicals|regulation of stress-activated MAPK cascade|erythrocyte homeostasis|natural killer cell mediated cytotoxicity|regulation of NF-kappaB import into nucleus|hydrogen peroxide catabolic process|oxidation-reduction process|,peroxidase activity|protein binding|thioredoxin peroxidase activity|identical protein binding|poly(A) RNA binding|,1,1,3400000,5.0%
Q6S5C2-2,0.353357975,0.295916667,8.806892779,-0.655166667,0.131616616,-1.749650577,0.6105,-0.032,1.292,0.063,-0.12,-0.038,Q6S5C2,Gnptg,Q6S5C2-2_Gnptg,Q6S5C2-2,Gnptg,1,6,3,3,Q6S5C2-2|A0A140T8R4|Q6S5C2|A0A0R4J0H5,MOUSE,35349.5,13,345,345.1,39.5,39.5,,307,Isoform 2 of N-acetylglucosamine-1-phosphotransferase subunit gamma,Golgi apparatus|extracellular exosome|,carbohydrate phosphorylation|,protein homodimerization activity|,3,6,478000000,13.0%
Q9Z2L6,0.32515976,-0.34625,9.805536336,0.9285,0.104579453,1.916744148,-0.2015,-0.365,-1.865,0.294,0.054,0.006,Q9Z2L6,Minpp1,Q9Z2L6_Minpp1,Q9Z2L6,Minpp1,1,5,3,3,Q9Z2L6,MOUSE,55164,7.9,346,346.1,39.24,39.24,,481,Multiple inositol polyphosphate phosphatase 1,endoplasmic reticulum lumen|plasma membrane|extracellular exosome|,dephosphorylation|,acid phosphatase activity|bisphosphoglycerate 3-phosphatase activity|inositol hexakisphosphate 2-phosphatase activity|,3,5,22000000,7.9%
A0A0B4J1J6,0.176827041,-0.2749,15.70807035,0.91225,0.026865379,3.101515211,-0.7515,-0.893,,-0.201,0.328,0.143,A0A0B4J1J6,NotFound,A0A0B4J1J6_NotFound,A0A0B4J1J6,Ighv10-1,1,8,4,4,A0A0B4J1J6,MOUSE,13720.5,35.2,347,347.1,38.95,38.95,,119,Immunoglobulin heavy variable 10-1 (Fragment),,,,4,8,499000000,35.2%
A0A075B5M3,0.398617191,-0.502416667,7.772205152,1.774166667,0.167024233,1.575691879,-0.0815,-0.137,-3.95,-0.099,1.21,0.043,A0A075B5M3,NotFound,A0A075B5M3_NotFound,A0A075B5M3,Igkv4-58,1,8,3,2,A0A075B5M3|P01680|A0A075B5L2,MOUSE,10407.3,40.2,348,348.1,38.91,23.55,,97,Immunoglobulin kappa variable 4-58,,,,3,8,1550000000,40.2%
A0A075B5M2,0.246154564,0.4277,12.32474285,-0.70175,0.05854984,-2.442561984,0.7005,0.997,,0.028,0.387,0.026,A0A075B5M2,NotFound,A0A075B5M2_NotFound,A0A075B5M2,Igkv4-61,1,3,2,1,A0A075B5M2|J3QNZ9|L7N239,MOUSE,10267.2,29.7,348,348.2,35.96,20.6,,94,Immunoglobulin kappa chain variable 4-61,,,,1,3,45700000,18.0%
A0A075B677,0.408004807,-0.0909,7.524710219,0.720583333,0.17681902,1.577087644,-1.1545,0.108,,0.318,0.312,-0.038,A0A075B677,NotFound,A0A075B677_NotFound,A0A075B677,Igkv4-53,1,6,2,2,A0A075B677,MOUSE,10480.4,40.2,349,349.1,38.37,38.37,,97,Immunoglobulin kappa variable 4-53,,,,2,6,188000000,40.2%
P01751,0.266764579,-0.1463,11.56368087,0.944083333,0.069764087,2.312787117,-0.3165,-1.109,,-0.228,0.492,0.43,P01751,NotFound,P01751_NotFound,P01751,Ighv1-72,1,6,3,3,P01751|P01754|P01753,MOUSE,15590.3,14.3,350,350.1,38.31,38.31,,139,Ig heavy chain V region B1-8/186-2,,,,3,6,2130000000,14.3%
P10854,0.03692053,1.076083333,29.06083858,-4.160166667,0.001241413,-5.783371182,1.9205,4.746,2.802,-1.128,-1.059,-0.825,P10854,Hist1h2bm,P10854_Hist1h2bm,P10854,Hist1h2bm,1,8,5,5,P10854|Q64478|Q64525|Q6ZWY9|Q8CGP2-2|Q8CBB6|P70696|Q8CGP2|Q64475|P10853|Q8CGP1|Q9D2U9|Q64524|Q8CGP0,MOUSE,13935.9,31.7,351,351.1,37.77,37.77,,126,Histone H2B type 1-M,nuclear nucleosome|nucleus|nucleoplasm|extracellular exosome|,nucleosome assembly|,DNA binding|protein heterodimerization activity|,5,8,406000000,31.7%
P01634,0.394562768,-0.0377,7.860693247,0.590916667,0.163655526,1.633604297,-0.1885,-0.596,,-0.063,-0.013,0.672,P01634,NotFound,P01634_NotFound,P01634,,1,7,4,4,P01634|A0A140T8P2|A0A075B5N2|A0A075B5N1|P01632,MOUSE,15072.8,22.7,352,352.1,37.3,37.3,,136,Ig kappa chain V-V region MOPC 21,,,antigen binding|,4,7,1060000000,22.7%
Q8VI78,0.418338077,0.648916667,7.185220851,-1.311833333,0.191195609,-1.476180737,0.3155,0.199,3.4,0.001,-0.165,0.143,Q8VI78,Pla1a,Q8VI78_Pla1a,Q8VI78,Pla1a,1,5,4,4,Q8VI78,MOUSE,50838.6,11.4,353,353.1,37.23,37.23,,456,Phospholipase A1 member A,acrosomal membrane|extracellular exosome|,lipid catabolic process|,phosphatidylcholine 1-acylhydrolase activity|,4,5,76700000,11.4%
Q9D1Q6,0.604460486,-0.69025,4.147502638,1.305833333,0.384813001,0.93850729,0.3285,0.329,-4.687,-0.049,0.024,-0.087,Q9D1Q6,Erp44,Q9D1Q6_Erp44,Q9D1Q6,Erp44,1,5,3,3,Q9D1Q6,MOUSE,47251.5,7.1,354,354.1,37.16,37.16,,406,Endoplasmic reticulum resident protein 44,endoplasmic reticulum lumen|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|cell surface|extracellular exosome|,protein folding|response to unfolded protein|glycoprotein metabolic process|response to endoplasmic reticulum stress|cell redox homeostasis|,protein disulfide isomerase activity|protein binding|,3,5,107000000,7.1%
P16014,0.878945326,0.112416667,1.065738307,-0.270833333,0.782395185,-0.28910447,1.4175,1.284,-1.958,0.14,-0.29,0.081,P16014,Chgb,P16014_Chgb,P16014,Chgb,1,7,5,5,P16014,MOUSE,78081.7,6.9,355,355.1,37.05,37.05,,677,Secretogranin-1,extracellular region|secretory granule|,,protein binding|,5,7,53400000,6.9%
Q60805,0.421131351,-0.41975,7.120962481,1.0035,0.194045579,1.465236251,-0.2925,0.02,-2.492,0.014,0.269,-0.037,Q60805,Mertk,Q60805_Mertk,Q60805,Mertk,1,4,4,4,Q60805,MOUSE,111239.5,3.3,356,356.1,36.83,36.83,,994,Tyrosine-protein kinase Mer,photoreceptor outer segment|extracellular space|cytoplasm|integral component of membrane|rhabdomere|,natural killer cell differentiation|phagocytosis|spermatogenesis|peptidyl-tyrosine phosphorylation|platelet activation|secretion by cell|substrate adhesion-dependent cell spreading|apoptotic cell clearance|protein kinase B signaling|positive regulation of phagocytosis|negative regulation of lymphocyte activation|retina development in camera-type eye|vagina development|negative regulation of leukocyte apoptotic process|,transmembrane receptor protein tyrosine kinase activity|ATP binding|,4,4,82800000,3.3%
Q91W90,0.879859764,0.0155,1.053890652,0.164583333,0.784532492,0.288836845,0.7985,-0.965,,0.023,0.135,0.086,Q91W90,Txndc5,Q91W90_Txndc5,Q91W90,Txndc5,1,2,2,2,Q91W90|E9PXX7|A0A0R4J1Y7,MOUSE,47099.3,6.2,357,357.1,35.79,35.79,,417,Thioredoxin domain-containing protein 5,endoplasmic reticulum lumen|extracellular exosome|,protein folding|response to endoplasmic reticulum stress|apoptotic cell clearance|cell redox homeostasis|,protein disulfide isomerase activity|,2,2,552000000,6.2%
A0A075B697,0.424326234,-0.0033,7.064727227,0.584916667,0.196574544,1.493144717,-0.4565,-0.252,,-0.14,0.821,0.011,A0A075B697,NotFound,A0A075B697_NotFound,A0A075B697,Ighv2-9-1,1,12,3,1,A0A075B697|P01820|P01819|A0A075B5Q1|P01821|A0A075B6A7|A0A075B696|A0A075B5Q7,MOUSE,12709.4,22.4,358,358.1,35.78,17.8,,116,Immunoglobulin heavy variable 2-9-1 (Fragment),,,,4,12,5440000000,22.4%
A0A075B5Q5,0.679041452,-0.0091,3.20197747,-0.34475,0.478412208,-0.766990407,-0.4055,0.801,,-0.416,-0.058,0.033,A0A075B5Q5,NotFound,A0A075B5Q5_NotFound,A0A075B5Q5,Ighv2-9,1,1,3,1,A0A075B5Q5,MOUSE,12705.5,26.7,358,358.2,28.74,10.76,,116,Immunoglobulin heavy variable 2-9 (Fragment),,,,1,1,12200000,13.7%
A0A075B5P8,0.758633627,-0.01375,2.091057075,0.199,0.617865993,0.540073407,,-0.163,,0.142,-0.13,0.096,A0A075B5P8,NotFound,A0A075B5P8_NotFound,A0A075B5P8,Ighv2-2,1,1,3,1,A0A075B5P8,MOUSE,12806.4,26.7,358,358.3,28.38,10.2,,116,Immunoglobulin heavy variable 2-2 (Fragment),,,,1,1,23000000,13.7%
A0A075B680,0.742574146,0.34325,2.519288816,-0.397833333,0.559849273,-0.61770745,-0.4055,0.124,1.908,-0.287,0.589,0.131,A0A075B680,NotFound,A0A075B680_NotFound,A0A075B680,Ighv1-62-2,1,5,3,3,A0A075B680|A0A0G2JFL3|A0A075B5V8,MOUSE,11338.5,40,359,359.1,35.28,35.28,,100,Immunoglobulin heavy variable 1-62-2,,,,3,5,839000000,40.0%
A0A075B5W3,0.214239872,-0.1385,13.72912736,0.98875,0.04237281,2.713840135,-0.4995,-0.964,,-0.199,0.562,0.408,A0A075B5W3,NotFound,A0A075B5W3_NotFound,A0A075B5W3,Ighv1-53,1,6,2,2,A0A075B5W3,MOUSE,12962.4,27.3,360,360.1,35.22,35.22,,117,Immunoglobulin heavy variable 1-53 (Fragment),,,,2,6,2150000000,27.3%
P12382,0.616649209,0.0021,3.904014966,-0.244416667,0.407003837,-0.905036579,-0.0195,0.317,,-0.165,-0.128,0.006,P12382,Pfkl,P12382_Pfkl,P12382,Pfkl,1,6,3,2,P12382|Q9WUA3-2,MOUSE,86157.1,5.3,361,361.1,35.21,23.89,,780,"ATP-dependent 6-phosphofructokinase, liver type",cytosol|6-phosphofructokinase complex|membrane|extracellular exosome|,"fructose 6-phosphate metabolic process|glycolytic process|response to glucose|fructose 1,6-bisphosphate metabolic process|negative regulation of insulin secretion|carbohydrate phosphorylation|protein oligomerization|protein homotetramerization|",6-phosphofructokinase activity|ATP binding|kinase binding|identical protein binding|metal ion binding|fructose binding|fructose-6-phosphate binding|6-phosphofructokinase activity|,3,6,140000000,5.3%
P47857-3,0.284060945,0.0603,11.04951043,-1.334083333,0.078532416,-2.217194501,-0.0565,1.778,,-0.366,-0.728,-0.326,P47857,Pfkm,P47857-3_Pfkm,P47857-3,Pfkm,1,2,3,2,P47857-3|P47857-2|P47857,MOUSE,103523.5,3.6,361,361.2,26.23,14.91,,780,"Isoform 3 of ATP-dependent 6-phosphofructokinase, muscle type",cytosol|6-phosphofructokinase complex|apical plasma membrane|extracellular exosome|sperm principal piece|,fructose 6-phosphate metabolic process|glycolytic process|positive regulation of insulin secretion|glucose homeostasis|muscle cell cellular homeostasis|carbohydrate phosphorylation|protein oligomerization|glycolytic process through fructose-6-phosphate|,6-phosphofructokinase activity|protein binding|ATP binding|protein C-terminus binding|phosphofructokinase activity|kinase binding|identical protein binding|protein homodimerization activity|metal ion binding|fructose binding|,2,2,3900000,2.6%
Q8C605,0.44527584,-0.14275,6.536270023,0.507,0.222010236,1.445382767,,-0.523,,0.027,-0.065,-0.01,Q8C605,Pfkp,Q8C605_Pfkp,Q8C605,Pfkp,1,1,2,1,Q8C605|Q9WUA3,MOUSE,86686.7,2.6,361,361.3,17.93,6.61,,784,ATP-dependent 6-phosphofructokinase,nucleus|cytosol|6-phosphofructokinase complex|membrane|extracellular exosome|,fructose 6-phosphate metabolic process|glycolytic process|carbohydrate phosphorylation|activation of mitophagy in response to mitochondrial depolarization|,6-phosphofructokinase activity|ATP binding|protein complex binding|metal ion binding|,1,1,2660000,1.5%
Q8K2I4,0.742574146,-0.15975,2.523307438,0.254166667,0.559331472,0.618548017,0.4725,-0.299,-1.034,0.028,-0.119,-0.007,Q8K2I4,Manba,Q8K2I4_Manba,Q8K2I4,Manba,1,3,3,3,A0A0R4J092|Q8K2I4|D6RGR1,MOUSE,101513.6,4.3,362,362.1,34.92,34.92,,879,Beta-mannosidase,lysosome|intracellular membrane-bounded organelle|,carbohydrate metabolic process|glycoprotein catabolic process|mannan catabolic process|,beta-mannosidase activity|,3,3,18400000,4.3%
P10107,0.518066528,0.73375,5.2757218,-0.7915,0.296775346,-1.144393793,1.3835,1.798,0.207,0.066,-0.624,1.572,P10107,Anxa1,P10107_Anxa1,P10107,Anxa1,1,4,4,4,P10107,MOUSE,39018.9,12.7,363,363.1,34.86,34.86,,346,Annexin A1,cornified envelope|extracellular space|nucleus|cytoplasm|endosome|cytosol|plasma membrane|focal adhesion|cilium|cell surface|basolateral plasma membrane|mitochondrial membrane|vesicle|sarcolemma|mast cell granule|protein complex|extracellular exosome|,DNA strand renaturation|neutrophil homeostasis|signal transduction|cell surface receptor signaling pathway|response to X-ray|myoblast migration involved in skeletal muscle regeneration|peptide cross-linking|insulin secretion|keratinocyte differentiation|prostate gland development|endocrine pancreas development|positive regulation of vesicle fusion|positive regulation of prostaglandin biosynthetic process|response to estradiol|DNA duplex unwinding|positive regulation of neutrophil apoptotic process|DNA rewinding|gliogenesis|regulation of cell proliferation|response to drug|response to peptide hormone|estrous cycle|alpha-beta T cell differentiation|arachidonic acid secretion|cellular response to hydrogen peroxide|hepatocyte differentiation|prolactin secretion|response to interleukin-1|cellular response to glucocorticoid stimulus|neutrophil clearance|positive regulation of G1/S transition of mitotic cell cycle|negative regulation of phospholipase A2 activity|negative regulation of interleukin-8 secretion|,"single-stranded DNA binding|single-stranded RNA binding|helicase activity|structural molecule activity|calcium ion binding|protein binding|calcium-dependent phospholipid binding|phospholipase A2 inhibitor activity|protein binding, bridging|double-stranded DNA-dependent ATPase activity|annealing helicase activity|protein homodimerization activity|calcium-dependent protein binding|",4,4,40600000,12.7%
P09542,0.254188227,0.5497,11.96364056,-3.675083333,0.063626194,-2.387766999,0.1505,5.359,,-0.839,-0.967,-0.955,P09542,Myl3,P09542_Myl3,P09542,Myl3,1,4,4,4,P09542|A0A0G2JDM3,MOUSE,22535.3,20,364,364.1,33.67,33.67,,204,Myosin light chain 3,myosin complex|A band|I band|,regulation of the force of heart contraction|regulation of striated muscle contraction|skeletal muscle tissue development|metabolic process|ventricular cardiac muscle tissue morphogenesis|cardiac muscle contraction|,motor activity|actin monomer binding|calcium ion binding|,4,4,418000000,20.0%
Q80W65,0.742574146,-0.09675,2.513841137,-0.567166667,0.560551974,-0.616567495,0.0045,2.12,-1.564,0.051,-0.704,-0.488,Q80W65,Pcsk9,Q80W65_Pcsk9,Q80W65,Pcsk9,1,4,3,3,Q80W65,MOUSE,76419.3,5.4,365,365.1,32.73,32.73,,694,Proprotein convertase subtilisin/kexin type 9,extracellular region|extracellular space|cytoplasm|lysosome|early endosome|late endosome|endoplasmic reticulum|endoplasmic reticulum lumen|rough endoplasmic reticulum|Golgi apparatus|plasma membrane|cell surface|ER to Golgi transport vesicle|perinuclear region of cytoplasm|PCSK9-LDLR complex|PCSK9-AnxA2 complex|,kidney development|liver development|negative regulation of receptor recycling|positive regulation of receptor internalization|triglyceride metabolic process|phospholipid metabolic process|apoptotic process|lysosomal transport|cholesterol metabolic process|cellular response to starvation|regulation of receptor activity|negative regulation of low-density lipoprotein particle clearance|protein autoprocessing|neurogenesis|neuron differentiation|low-density lipoprotein receptor particle metabolic process|low-density lipoprotein particle receptor catabolic process|regulation of low-density lipoprotein particle receptor catabolic process|positive regulation of low-density lipoprotein particle receptor catabolic process|cellular response to insulin stimulus|lipoprotein metabolic process|cholesterol homeostasis|regulation of neuron apoptotic process|positive regulation of neuron apoptotic process|negative regulation of receptor activity|negative regulation of sodium ion transmembrane transporter activity|,serine-type endopeptidase activity|sodium channel inhibitor activity|low-density lipoprotein particle binding|receptor inhibitor activity|apolipoprotein binding|very-low-density lipoprotein particle binding|apolipoprotein receptor binding|protein self-association|poly(A) RNA binding|low-density lipoprotein particle receptor binding|very-low-density lipoprotein particle receptor binding|,3,4,101000000,5.4%
Q9CYA0,0.174726314,-0.4063,15.8713566,0.824083333,0.025874046,3.134813467,-0.9955,-0.806,,-0.208,-0.066,0.044,Q9CYA0,Creld2,Q9CYA0_Creld2,Q9CYA0,Creld2,1,3,2,2,Q9CYA0,MOUSE,40386.9,9.7,366,366.1,32.65,32.65,,350,Cysteine-rich with EGF-like domain protein 2,extracellular space|endoplasmic reticulum|Golgi apparatus|,,calcium ion binding|,2,3,20600000,9.7%
O08742,0.410280507,0.165416667,7.401846633,-0.746166667,0.181892728,-1.512997522,0.4945,1.481,-0.36,-0.242,-0.42,0.039,O08742,NotFound,O08742_NotFound,O08742,Gp5,1,4,3,3,O08742,MOUSE,63980.2,5.2,367,367.1,32.51,32.51,,567,Platelet glycoprotein V,integral component of membrane|,cell adhesion|blood coagulation|,,3,4,321000000,5.2%
Q62351,0.32515976,0.166083333,9.540413344,-0.6235,0.111162592,-1.868803256,0.2185,1.113,0.102,-0.236,-0.18,-0.021,Q62351,Tfrc,Q62351_Tfrc,Q62351,Tfrc,1,4,4,4,Q62351|Q8C872,MOUSE,86129.2,5.3,368,368.1,32.18,32.18,,763,Transferrin receptor protein 1,extracellular region|extracellular space|mitochondrion|endosome|plasma membrane|coated pit|external side of plasma membrane|cell surface|membrane|integral component of membrane|cytoplasmic membrane-bounded vesicle|melanosome|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|recycling endosome|recycling endosome membrane|extracellular exosome|blood microparticle|extracellular vesicle|HFE-transferrin receptor complex|,response to hypoxia|cellular iron ion homeostasis|receptor-mediated endocytosis|acute-phase response|aging|response to nutrient|response to manganese ion|osteoclast differentiation|cellular response to extracellular stimulus|response to retinoic acid|transferrin transport|iron ion transmembrane transport|cellular response to drug|positive regulation of bone resorption|response to copper ion|cellular response to iron ion|iron ion import|,glycoprotein binding|double-stranded RNA binding|transferrin receptor activity|iron ion transmembrane transporter activity|protein binding|Hsp70 protein binding|transferrin transmembrane transporter activity|identical protein binding|poly(A) RNA binding|chaperone binding|,4,4,121000000,5.3%
A0A0B4J1I1,0.153374531,-0.324083333,17.70684109,1.040833333,0.016955707,3.275261852,-1.1015,-0.28,-1.152,0.082,0.104,0.403,A0A0B4J1I1,NotFound,A0A0B4J1I1_NotFound,A0A0B4J1I1,Igkv16-104,1,4,2,2,A0A0B4J1I1,MOUSE,13045.5,23.2,369,369.1,32.13,32.13,,116,Immunoglobulin kappa variable 16-104 (Fragment),,,,2,4,284000000,23.2%
A0A075B5R4,0.223059057,0.677583333,13.30986402,-1.535166667,0.046667399,-2.508687284,0.4365,1.152,2.747,-0.181,-0.323,0.234,A0A075B5R4,NotFound,A0A075B5R4_NotFound,A0A075B5R4,Ighv14-1,1,4,2,2,A0A075B5R4|A0A075B5R9|A0A075B5R7|A0A075B5S3,MOUSE,13162.6,19.6,370,370.1,31.83,31.83,,117,Immunoglobulin heavy variable 14-1 (Fragment),,,,2,4,149000000,19.6%
Q6GSS7,0.14994666,0.643916667,18.05372031,-3.091166667,0.015654095,-3.358954179,2.0815,4.079,0.408,-0.696,-1.408,-0.601,Q6GSS7,Hist2h2aa1,Q6GSS7_Hist2h2aa1,Q6GSS7,Hist2h2aa1,1,6,5,3,Q6GSS7|Q64523|Q8R1M2|A0A0N4SV66|P27661|Q8CGP5|Q8CGP7|C0HKE6|Q8BFU2|Q8CGP4|Q8CGP6|Q64522,MOUSE,14095.2,25.3,371,371.1,31.76,17.12,,130,Histone H2A type 2-A,nucleosome|nucleus|extracellular exosome|,nucleosome assembly|,DNA binding|protein heterodimerization activity|,5,6,123000000,25.3%
P0C0S6,0.748259409,-0.52525,2.251625003,0.695166667,0.595439306,0.561023097,0.5595,0.657,-3.835,-0.391,-0.069,-0.073,P0C0S6,H2afz,P0C0S6_H2afz,P0C0S6,H2afz,1,1,3,1,P0C0S6|Q3THW5|Q3UA95|G3UWL7,MOUSE,13552.5,17.1,371,371.2,19.58,4.94,,128,Histone H2A.Z,nucleosome|nucleus|nuclear euchromatin|nuclear heterochromatin|extracellular exosome|Barr body|,multicellular organismal development|positive regulation of transcription from RNA polymerase II promoter|cellular response to estradiol stimulus|,RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II core promoter sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|chromatin DNA binding|nucleosomal DNA binding|protein heterodimerization activity|,1,1,73100000,11.7%
P27046,0.48709819,0.523916667,5.776125399,-1.479833333,0.264476726,-1.232937102,-1.2455,1.344,3.693,0.142,-0.396,-0.394,P27046,Man2a1,P27046_Man2a1,P27046,Man2a1,1,2,2,2,P27046,MOUSE,132370.8,2.2,372,372.1,31.51,31.51,,1150,Alpha-mannosidase 2,Golgi membrane|Golgi apparatus|cis-Golgi network|membrane|integral component of membrane|extracellular exosome|,in utero embryonic development|liver development|mannose metabolic process|N-glycan processing|mitochondrion organization|vacuole organization|respiratory gaseous exchange|lung alveolus development|positive regulation of neurogenesis|retina morphogenesis in camera-type eye|,"mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity|zinc ion binding|mannosidase activity|hydrolase activity, hydrolyzing N-glycosyl compounds|carbohydrate binding|",2,2,9350000,2.2%
A0A075B5T7,0.940910696,0.45625,0.386417855,-0.077166667,0.914867531,-0.111566332,-0.4055,-0.018,1.908,-0.245,1.028,0.47,A0A075B5T7,NotFound,A0A075B5T7_NotFound,A0A075B5T7,Ighv1-7,1,4,2,2,A0A075B5T7|A0A075B5T4,MOUSE,13273.8,23.9,373,373.1,31.48,31.48,,117,Immunoglobulin heavy variable V1-7 (Fragment),,,,2,4,799000000,23.9%
Q8VCN3,0.606593787,0.2491,4.05814244,-0.43025,0.392812913,-0.936606,-0.1185,1.133,,0.343,-0.101,-0.011,Q8VCN3,Ugt2b37,Q8VCN3_Ugt2b37,Q8VCN3,Ugt2b37,1,3,3,3,Q8VCN3|Q91WH2|Q8K169|P17717|Q8BJL9|Q8R084|Q3UEP4|K9J7B2|Q64435|E9PXN7|P70691|D3Z748|Q63886|B2RT14|Q62452|Q6ZQM8|D3YZE6,MOUSE,61328.4,6.6,374,374.1,30.92,30.92,,530,UDP-glucuronosyltransferase,mitochondrial inner membrane|endoplasmic reticulum|intracellular membrane-bounded organelle|,flavonoid biosynthetic process|cellular response to hormone stimulus|flavonoid glucuronidation|,glucuronosyltransferase activity|,3,3,61900000,6.6%
P17742,0.699470325,-0.20125,3.017201054,-1.5075,0.499206113,-0.719734713,1.1165,4.62,-4.079,-0.917,-1.242,-0.706,P17742,Ppia,P17742_Ppia,P17742,Ppia,1,4,4,4,P17742|A0A1L1SST0|F8VPN3,MOUSE,18142.2,17.6,375,375.1,30.78,30.78,,164,Peptidyl-prolyl cis-trans isomerase A,extracellular space|nucleus|cytosol|focal adhesion|membrane|myelin sheath|extracellular exosome|,protein peptidyl-prolyl isomerization|protein folding|neuron differentiation|lipid particle organization|regulation of viral genome replication|positive regulation of viral genome replication|positive regulation of protein secretion|,peptidyl-prolyl cis-trans isomerase activity|peptide binding|poly(A) RNA binding|,4,4,41400000,17.6%
P15116,0.194244025,-0.38675,14.95793946,0.868166667,0.031930525,2.782658053,-0.4895,-0.572,-1.401,0.01,0.052,0.08,P15116,Cdh2,P15116_Cdh2,P15116,Cdh2,1,5,3,3,P15116|D3YYT0,MOUSE,100251,4.6,376,376.1,30.14,30.14,,906,Cadherin-2,cell-cell junction|adherens junction|cell-cell adherens junction|fascia adherens|focal adhesion|intercalated disc|membrane|integral component of membrane|basolateral plasma membrane|apical plasma membrane|catenin complex|lamellipodium|plasma membrane raft|synapse|extracellular exosome|cortical actin cytoskeleton|,cell adhesion|homophilic cell adhesion via plasma membrane adhesion molecules|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|glial cell differentiation|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|cell migration|regulation of myelination|regulation of Rho protein signal transduction|positive regulation of MAPK cascade|cell-cell adhesion mediated by cadherin|blood vessel morphogenesis|regulation of axonogenesis|striated muscle cell differentiation|protein heterooligomerization|establishment of protein localization to plasma membrane|negative regulation of canonical Wnt signaling pathway|neuroligin clustering involved in postsynaptic membrane assembly|neuronal stem cell maintenance|regulation of postsynaptic density protein 95 clustering|positive regulation of synaptic vesicle clustering|,calcium ion binding|protein binding|beta-catenin binding|enzyme binding|protein kinase binding|protein phosphatase binding|protein complex binding|alpha-catenin binding|gamma-catenin binding|nitric-oxide synthase binding|,3,5,17400000,4.6%
A0A0B4J1H6,0.174726314,-0.2035,16.05575354,1.427083333,0.024798456,3.196709527,-1.3415,-0.778,,-0.24,0.908,0.434,A0A0B4J1H6,NotFound,A0A0B4J1H6_NotFound,A0A0B4J1H6,Igkv2-137,1,5,2,2,A0A0B4J1H6|P01630,MOUSE,13302,20,377,377.1,29.72,29.72,,120,Immunoglobulin kappa chain variable 2-137 (Fragment),,,,2,5,2600000000,20.0%
P10404,0.745307288,-0.1179,2.340147782,0.16225,0.583425251,0.585908541,-0.0315,-0.399,,-0.189,0.014,0.016,P10404,NotFound,P10404_NotFound,P10404,,1,3,2,2,P10404,MOUSE,70752.6,4,378,378.1,29.47,29.47,,641,MLV-related proviral Env polyprotein,plasma membrane|integral component of membrane|viral capsid|viral envelope|virion membrane|,viral life cycle|,metal ion binding|,2,3,65300000,4.0%
A0A075B5R0,0.728945731,0.079083333,2.692474235,-0.226833333,0.53796321,-0.653372059,0.6975,0.214,-0.334,-0.276,-0.136,0.309,A0A075B5R0,NotFound,A0A075B5R0_NotFound,A0A075B5R0,Ighv5-16,1,4,2,2,A0A075B5R0,MOUSE,13388.1,23.2,379,379.1,29.37,29.37,,116,Immunoglobulin heavy variable 5-16,,,,2,4,88700000,23.2%
E9QNX4,0.174726314,-0.3483,16.04397334,0.916583333,0.024865813,3.170185337,-1.1565,-0.64,,-0.007,0.065,-0.003,E9QNX4,Alpk1,E9QNX4_Alpk1,E9QNX4,Alpk1,1,6,3,3,E9QNX4|Q9CXB8,MOUSE,137413.2,2.1,380,380.1,29.21,29.21,,1231,Alpha-protein kinase 1,,positive regulation of defense response to virus by host|protein phosphorylation|activation of mitophagy in response to mitochondrial depolarization|,protein serine/threonine kinase activity|ATP binding|,3,6,559000000,2.1%
P02668,0.900484269,0.07625,0.769188129,-0.133833333,0.837685865,-0.214091646,-0.2125,-0.871,1.513,0.218,-0.014,-0.176,P02668,NotFound,P02668_NotFound,P02668,CSN3,1,3,2,2,P02668,BOVIN,21383.1,14.7,381,381.1,28.9,28.9,,190,Kappa-casein,,,,2,3,74100000,14.7%
Q9EPL0,0.841448046,-0.090083333,1.432102334,0.1635,0.719100791,0.377377359,0.0475,0.488,-1.051,0.055,-0.2,0.12,Q9EPL0,Xylt2,Q9EPL0_Xylt2,Q9EPL0,Xylt2,1,3,3,3,Q9EPL0|F2Z436,MOUSE,97608.3,4.1,382,382.1,28.85,28.85,,865,Xylosyltransferase 2,Golgi membrane|endoplasmic reticulum membrane|integral component of membrane|,glycosaminoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process|proteoglycan biosynthetic process|chondroitin sulfate biosynthetic process|heparin biosynthetic process|,acetylglucosaminyltransferase activity|protein xylosyltransferase activity|,3,3,13600000,4.1%
Q59IW6,0.219826621,0.16325,13.42527173,-0.599833333,0.04544361,-2.518306596,0.7285,0.464,0.197,-0.157,-0.171,-0.082,Q59IW6,Abi3bp,Q59IW6_Abi3bp,Q59IW6,Abi3bp,1,4,3,3,Q59IW6|Q59IW5|Q59IW9|E9Q8E3,MOUSE,130163.5,2,383,383.1,28.44,28.44,,1179,"ABI gene family, member 3 (NESH)-binding protein",proteinaceous extracellular matrix|interstitial matrix|extracellular space|,positive regulation of cell-substrate adhesion|extracellular matrix organization|,collagen binding|glycosaminoglycan binding|heparin binding|,3,4,67200000,2.0%
P17182,0.401922334,0.024083333,7.678190265,-1.706166667,0.170679347,-1.559804143,1.7205,2.585,-1.674,-0.769,-1.077,-0.641,P17182,Eno1,P17182_Eno1,P17182,Eno1,1,6,4,4,P17182,MOUSE,47482.3,6.9,384,384.1,28.29,28.29,,434,Alpha-enolase,phosphopyruvate hydratase complex|plasma membrane|myelin sheath|,glycolytic process|,magnesium ion binding|phosphopyruvate hydratase activity|,4,6,17800000000,6.9%
P47880,0.302686697,-0.1647,10.55048585,0.757583333,0.088095031,2.116254885,-0.2375,-1.001,,0.103,-0.079,0.391,P47880,Igfbp6,P47880_Igfbp6,P47880,Igfbp6,1,4,3,3,P47880,MOUSE,26259,11.7,385,385.1,28.29,28.29,,238,Insulin-like growth factor-binding protein 6,extracellular space|Golgi apparatus|extracellular exosome|,regulation of cell growth|regulation of insulin-like growth factor receptor signaling pathway|,insulin-like growth factor I binding|insulin-like growth factor II binding|,3,4,113000000,11.7%
Q9CQ45,0.745307288,0.0961,2.326217056,0.151416667,0.58529969,0.582897979,-0.0045,0.015,,0.249,0.227,-0.006,Q9CQ45,Nenf,Q9CQ45_Nenf,Q9CQ45,Nenf,1,3,3,3,Q9CQ45,MOUSE,18904.1,17.5,386,386.1,27.96,27.96,,171,Neudesin,extracellular space|nucleus|nucleoplasm|endomembrane system|membrane|,negative regulation of appetite|positive regulation of MAPK cascade|,growth factor activity|heme binding|metal ion binding|,3,3,32100000,17.5%
P18528,0.917908932,0.2911,0.618378668,-0.071916667,0.867285595,-0.176072792,0.6235,0.045,,0.034,0.817,-0.064,P18528,NotFound,P18528_NotFound,P18528,,1,4,2,2,P18528,MOUSE,11121.3,24.4,387,387.1,27.92,27.92,,98,Ig heavy chain V region 6.96,,,antigen binding|,2,4,134000000,24.4%
A2ASS6,0.402949774,-1.06325,7.641705092,2.093833333,0.172119268,1.553633722,-0.5485,-0.446,-5.336,-0.237,-0.033,0.221,A2ASS6,NotFound,A2ASS6_NotFound,A2ASS6,Ttn,1,12,5,5,A2ASS6|E9Q8K5|E9Q8N1|A2ASS6-2,MOUSE,3935740.7,0.1,388,388.1,27.84,27.84,,35213,Titin,nucleus|cytoplasm|,somitogenesis|protein phosphorylation|heart development|regulation of relaxation of cardiac muscle|,protein serine/threonine kinase activity|protein binding|calmodulin binding|ATP binding|ankyrin binding|metal ion binding|,5,12,81000000000,0.1%
P97333,0.279012296,0.716083333,11.16669522,-1.986166667,0.076441725,-2.144824645,0.2225,1.059,3.846,-0.288,-0.412,-0.131,P97333,Nrp1,P97333_Nrp1,P97333,Nrp1,1,5,4,4,P97333,MOUSE,104253.4,5.6,389,389.1,27.62,27.62,,923,Neuropilin-1,extracellular space|early endosome|cytosol|neurofilament|plasma membrane|focal adhesion|integral component of membrane|axon|sorting endosome|,angiogenesis|patterning of blood vessels|neuron migration|sprouting angiogenesis|cell migration involved in sprouting angiogenesis|axon guidance|axonal fasciculation|heart development|motor neuron axon guidance|dendrite development|cell migration|facial nerve structural organization|trigeminal nerve morphogenesis|trigeminal nerve structural organization|vestibulocochlear nerve structural organization|nerve development|branchiomotor neuron axon guidance|gonadotrophin-releasing hormone neuronal migration to the hypothalamus|negative regulation of axon extension|retinal ganglion cell axon guidance|cellular response to hepatocyte growth factor stimulus|endothelial cell chemotaxis|cellular response to vascular endothelial growth factor stimulus|ventral trunk neural crest cell migration|VEGF-activated neuropilin signaling pathway|otic placode formation|negative regulation of neuron apoptotic process|platelet-derived growth factor receptor signaling pathway|vascular endothelial growth factor receptor signaling pathway|hepatocyte growth factor receptor signaling pathway|sympathetic nervous system development|neuron development|regulation of axon extension involved in axon guidance|positive regulation of axon extension involved in axon guidance|negative regulation of axon extension involved in axon guidance|artery morphogenesis|axon extension involved in axon guidance|positive regulation of peptidyl-tyrosine phosphorylation|positive chemotaxis|axonogenesis involved in innervation|dichotomous subdivision of terminal units involved in salivary gland branching|angiogenesis involved in coronary vascular morphogenesis|cell migration involved in coronary vasculogenesis|coronary artery morphogenesis|retina vasculature morphogenesis in camera-type eye|renal artery morphogenesis|sympathetic ganglion development|trigeminal ganglion development|ganglion morphogenesis|positive regulation of ERK1 and ERK2 cascade|semaphorin-plexin signaling pathway|commissural neuron axon guidance|regulation of retinal ganglion cell axon guidance|sensory neuron axon guidance|sympathetic neuron projection extension|sympathetic neuron projection guidance|neural crest cell migration involved in autonomic nervous system development|toxin transport|semaphorin-plexin signaling pathway involved in neuron projection guidance|semaphorin-plexin signaling pathway involved in axon guidance|positive regulation of retinal ganglion cell axon guidance|VEGF-activated neuropilin signaling pathway involved in axon guidance|protein localization to early endosome|facioacoustic ganglion development|negative regulation of extrinsic apoptotic signaling pathway|,vascular endothelial growth factor-activated receptor activity|protein binding|heparin binding|semaphorin receptor activity|growth factor binding|vascular endothelial growth factor binding|metal ion binding|,4,5,17000000,5.6%
Q922Q9,0.424326234,0.36575,7.074137659,-0.968166667,0.196149061,-1.457253902,1.8165,1.389,-0.656,-0.002,-0.326,-0.027,Q922Q9,Chid1,Q922Q9_Chid1,Q922Q9,Chid1,1,4,4,4,A0A0R4J242|Q922Q9|A0A0R4J058|Q922Q9-2|A0A1B0GSH5,MOUSE,45075.9,8.3,390,390.1,27.55,27.55,,393,Chitinase domain-containing protein 1,extracellular region|extracellular space|nucleus|lysosome|late endosome|trans-Golgi network|membrane|extracellular exosome|,carbohydrate metabolic process|chitin catabolic process|innate immune response|negative regulation of cytokine production involved in inflammatory response|,chitinase activity|chitin binding|oligosaccharide binding|,4,4,206000000,8.3%
Q923X1,0.398617191,0.497416667,7.781204823,-0.6435,0.166678475,-1.577211855,0.4045,0.38,1.673,0.279,0.035,0.213,Q923X1,Adgrl4,Q923X1_Adgrl4,Q923X1,Adgrl4,1,2,2,2,Q923X1,MOUSE,84526.8,4.6,391,391.1,27.52,27.52,,739,Adhesion G protein-coupled receptor L4,plasma membrane|integral component of membrane|,G-protein coupled receptor signaling pathway|,G-protein coupled receptor activity|calcium ion binding|,2,2,21000000,4.6%
Q9Z126,0.351568198,0.320083333,8.913105944,-0.528833333,0.128436779,-1.762953174,0.7235,0.135,0.895,0.315,-0.188,0.04,Q9Z126,Pf4,Q9Z126_Pf4,Q9Z126,Pf4,1,6,3,3,Q9Z126|A0A0J9YTR7,MOUSE,11471.5,25.7,392,392.1,27.38,27.38,,105,Platelet factor 4,extracellular space|platelet alpha granule|protein complex|,positive regulation of leukocyte chemotaxis|protein complex assembly|inflammatory response|immune response|G-protein coupled receptor signaling pathway|positive regulation of gene expression|positive regulation of macrophage derived foam cell differentiation|negative regulation of angiogenesis|cytokine-mediated signaling pathway|platelet activation|leukocyte chemotaxis|positive regulation of cAMP metabolic process|response to lipopolysaccharide|positive regulation of tumor necrosis factor production|regulation of cell proliferation|positive regulation of cAMP-mediated signaling|negative regulation of MHC class II biosynthetic process|positive regulation of macrophage differentiation|negative regulation of megakaryocyte differentiation|negative regulation of cytolysis|positive regulation of transcription from RNA polymerase II promoter|chemokine-mediated signaling pathway|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand|,chemokine activity|heparin binding|CXCR chemokine receptor binding|CXCR3 chemokine receptor binding|,3,6,86900000,25.7%
P24270,0.535473385,0.040583333,4.992840464,-0.7605,0.316749511,-1.093668906,0.2695,1.878,-0.885,-0.245,-0.568,-0.206,P24270,Cat,P24270_Cat,P24270,Cat,1,4,3,3,P24270|A2AL20,MOUSE,60079.5,5.1,393,393.1,27.11,27.11,,527,Catalase,extracellular space|mitochondrion|mitochondrial intermembrane space|lysosome|peroxisome|peroxisomal membrane|endoplasmic reticulum|Golgi apparatus|cytosol|plasma membrane|focal adhesion|membrane|intracellular membrane-bounded organelle|extracellular exosome|,response to reactive oxygen species|osteoblast differentiation|ureteric bud development|response to hypoxia|triglyceride metabolic process|response to oxidative stress|aging|cholesterol metabolic process|aerobic respiration|response to toxic substance|response to light intensity|UV protection|response to ozone|response to lead ion|positive regulation of phosphatidylinositol 3-kinase signaling|response to activity|response to inactivity|hemoglobin metabolic process|negative regulation of NF-kappaB transcription factor activity|response to estradiol|response to insulin|response to vitamin A|response to vitamin E|response to L-ascorbic acid|response to drug|hydrogen peroxide catabolic process|negative regulation of apoptotic process|response to ethanol|response to cadmium ion|positive regulation of NF-kappaB transcription factor activity|protein tetramerization|protein homotetramerization|positive regulation of cell division|response to hyperoxia|response to fatty acid|cellular response to growth factor stimulus|response to phenylpropanoid|,"aminoacylase activity|catalase activity|receptor binding|antioxidant activity|oxidoreductase activity, acting on peroxide as acceptor|enzyme binding|heme binding|protein homodimerization activity|metal ion binding|NADP binding|",3,4,61800000,5.1%
A0A0B4J1I8,0.302686697,-0.13325,10.58127422,1.2225,0.087472709,2.046578351,-0.1265,-0.225,-1.882,-0.28,0.888,0.826,A0A0B4J1I8,NotFound,A0A0B4J1I8_NotFound,A0A0B4J1I8,Igkv4-59,1,10,3,3,A0A0B4J1I8|P04944|P04940|P04941|P04942|P04943|A0A0B4J1I5|P70670|Q9JKC6|A0N8I8,MOUSE,12784.1,17.9,394,394.1,27.03,27.03,,117,Immunoglobulin kappa variable 4-59 (Fragment),,,,3,10,2950000000,17.9%
Q0VBK2,0.174726314,0.35025,16.17708316,-1.923166667,0.024115245,-3.013111913,2.5985,1.29,0.047,-0.602,-0.637,-0.595,Q0VBK2,Krt80,Q0VBK2_Krt80,Q0VBK2,Krt80,1,2,2,2,Q0VBK2,MOUSE,51173.1,5,395,395.1,26.99,26.99,,452,"Keratin, type II cytoskeletal 80",cytoplasm|intermediate filament|keratin filament|,,structural molecule activity|,2,2,49000000,5.0%
Q61268,0.271520577,0.0275,11.41578084,0.687083333,0.072180837,2.273804462,-0.2905,-0.479,,0.404,0.525,-0.022,Q61268,Apoc4,Q61268_Apoc4,Q61268,Apoc4,1,6,2,2,Q61268,MOUSE,14459.4,16.1,396,396.1,26.89,26.89,,124,Apolipoprotein C-IV,very-low-density lipoprotein particle|high-density lipoprotein particle|,lipid transport|positive regulation of sequestering of triglyceride|triglyceride homeostasis|,,2,6,1320000000,16.1%
D3Z450,0.362472178,-0.610916667,8.597194409,1.417833333,0.13812763,1.714497862,-0.5755,-0.151,-3.233,-0.108,0.372,0.03,D3Z450,Serpina3i,D3Z450_Serpina3i,D3Z450,Serpina3i,1,24,3,3,D3Z450,MOUSE,45964.2,6.3,397,397.1,26.64,26.64,,408,"Serine (or cysteine) peptidase inhibitor, clade A, member 3I",extracellular space|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,3,24,3.63E+11,6.3%
Q9D0F3,0.437741736,-0.728916667,6.723933114,1.537833333,0.212621261,1.397346912,-0.2245,-0.145,-4.124,0.01,0.148,-0.038,Q9D0F3,Lman1,Q9D0F3_Lman1,Q9D0F3,Lman1,1,3,3,3,Q9D0F3,MOUSE,58073,5.2,398,398.1,26.64,26.64,,517,Protein ERGIC-53,Golgi membrane|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|membrane|integral component of membrane|sarcomere|ER to Golgi transport vesicle|endoplasmic reticulum-Golgi intermediate compartment membrane|host cell perinuclear region of cytoplasm|extracellular exosome|,ER to Golgi vesicle-mediated transport|endoplasmic reticulum organization|Golgi organization|positive regulation of organelle organization|protein transport|,carbohydrate binding|metal ion binding|,3,3,63800000,5.2%
A0A075B5Q6,0.400461196,0.1419,7.719554075,0.714416667,0.169061451,1.612189609,-0.4395,-0.134,,-0.263,0.923,0.623,A0A075B5Q6,NotFound,A0A075B5Q6_NotFound,A0A075B5Q6,Ighv5-9-1,1,6,3,3,A0A075B5Q6|P18526|A0A075B5Q0,MOUSE,13238,28.4,399,399.1,26.42,26.42,,116,Immunoglobulin heavy variable 5-9-1,,,,4,6,288000000,28.4%
Q64339,0.783716231,0.0449,1.870824751,-0.138083333,0.650006239,-0.482286541,0.2575,-0.002,,-0.139,-0.131,0.239,Q64339,Isg15,Q64339_Isg15,Q64339,Isg15,1,2,2,2,Q64339,MOUSE,18068.5,16.7,400,400.1,26.38,26.38,,161,Ubiquitin-like protein ISG15,extracellular region|cytoplasm|,modification-dependent protein catabolic process|negative regulation of protein ubiquitination|ISG15-protein conjugation|regulation of interferon-gamma production|response to type I interferon|defense response to bacterium|negative regulation of viral genome replication|positive regulation of erythrocyte differentiation|defense response to virus|,protein binding|protein tag|,2,2,2280000,16.7%
A0A075B5K2,0.899330297,0.1673,0.810819819,0.115916667,0.829694131,0.226864776,0.6965,-0.501,,-0.103,0.772,-0.028,A0A075B5K2,NotFound,A0A075B5K2_NotFound,A0A075B5K2,Igkv9-124,1,4,2,2,A0A075B5K2,MOUSE,10533.4,32.6,401,401.1,26.33,26.33,,95,Immunoglobulin kappa chain variable 9-124,,,,2,4,154000000,32.6%
F8WID5,0.047034419,0.83675,26.52516166,-3.438166667,0.002225788,-5.150851641,1.6965,3.912,2.059,-0.855,-1.516,-0.276,F8WID5,NotFound,F8WID5_NotFound,F8WID5,Tpm1,1,4,2,2,F8WID5|E9Q454|E9Q450|Q8BP43|E9Q448|P58771-2|Q8BSH3|P58771|B7ZNL3|E9Q452|E9Q455|G5E8R2|E9Q456|G5E8R1|E9Q453|G5E8R0|E9Q5J9|P21107|A0A0R4J1P2|P21107-2|D3Z2H9|D3Z6I8|E9Q7Q3|A2AIM4|P58774-2|P58774|S4R2U0,MOUSE,37469.2,5.5,402,402.1,26.26,26.26,,326,Tropomyosin alpha-1 chain,cytoplasm|muscle thin filament tropomyosin|myofibril|filamentous actin|,in utero embryonic development|,structural constituent of cytoskeleton|,3,4,70700000,5.5%
P70194,0.861013543,-0.0229,1.221329037,-0.09275,0.754861188,-0.329911655,0.0125,0.053,,-0.284,0.181,-0.077,P70194,Clec4f,P70194_Clec4f,P70194,Clec4f,1,2,2,2,P70194|A0A0R4IZZ5,MOUSE,61667,3.6,403,403.1,26.05,26.05,,548,C-type lectin domain family 4 member F,plasma membrane|integral component of membrane|,endocytosis|NK T cell activation|,galactose binding|glycolipid binding|,2,2,172000000,3.6%
P00974,0.001379044,0.86825,54.64107566,-6.077166667,3.43473E-06,-16.68908778,4.5755,3.44,3.705,-2.314,-2.31,-1.887,P00974,NotFound,P00974_NotFound,P00974,,1,5,2,2,P00974,BOVIN,11359,19,404,404.1,25.88,25.88,,100,Pancreatic trypsin inhibitor,,,,2,5,413000000,19.0%
Q61592,0.779458336,0.0123,1.920646497,-0.12825,0.642592053,-0.493515733,0.2265,-0.048,,0.003,-0.068,-0.052,Q61592,Gas6,Q61592_Gas6,Q61592,Gas6,1,3,3,3,Q61592,MOUSE,76548.1,5,405,405.1,25.84,25.84,,674,Growth arrest-specific protein 6,extracellular space|cytoplasm|extracellular exosome|,"neuron migration|positive regulation of protein phosphorylation|positive regulation of cytokine-mediated signaling pathway|positive regulation of glomerular filtration|protein phosphorylation|phagocytosis|signal transduction|enzyme linked receptor protein signaling pathway|blood coagulation|cellular response to starvation|positive regulation of gene expression|negative regulation of tumor necrosis factor-mediated signaling pathway|macrophage cytokine production|peptidyl-serine phosphorylation|fusion of virus membrane with host plasma membrane|viral genome replication|organ regeneration|cell-substrate adhesion|positive regulation of TOR signaling|activation of protein kinase B activity|negative regulation of interferon-gamma production|negative regulation of interleukin-6 production|negative regulation of tumor necrosis factor production|positive regulation of natural killer cell differentiation|positive regulation of peptidyl-serine phosphorylation|negative regulation of protein import into nucleus, translocation|cellular response to interferon-alpha|cellular response to drug|B cell chemotaxis|regulation of growth|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|apoptotic cell clearance|negative regulation of sequence-specific DNA binding transcription factor activity|protein kinase B signaling|positive regulation of protein kinase activity|negative regulation of transcription, DNA-templated|viral entry into host cell|receptor-mediated virion attachment to host cell|positive regulation of protein export from nucleus|positive regulation of fibroblast proliferation|negative regulation of interleukin-1 secretion|positive regulation of phagocytosis|positive regulation of protein kinase B signaling|positive regulation of protein tyrosine kinase activity|negative regulation of biomineral tissue development|positive regulation of ERK1 and ERK2 cascade|calcium ion transmembrane transport|cellular response to vitamin K|cellular response to glucose stimulus|cellular response to growth factor stimulus|protein targeting to plasma membrane|extracellular matrix assembly|dendritic cell differentiation|hematopoietic stem cell migration to bone marrow|negative regulation of oligodendrocyte apoptotic process|negative regulation of interleukin-6 secretion|negative regulation of fibroblast apoptotic process|negative regulation of endothelial cell apoptotic process|positive regulation of dendritic cell chemotaxis|negative regulation of renal albumin absorption|negative regulation of dendritic cell apoptotic process|","phosphatidylserine binding|receptor binding|voltage-gated calcium channel activity|calcium ion binding|protein tyrosine kinase activator activity|receptor tyrosine kinase binding|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|receptor agonist activity|binding, bridging|",3,3,72100000,5.0%
P08003,0.759970158,-0.0063,2.068849503,-0.370916667,0.621033532,-0.527231763,1.3435,-0.911,,-0.247,-0.047,-0.17,P08003,Pdia4,P08003_Pdia4,P08003,Pdia4,1,3,3,3,A0A0R4J0Z1|P08003,MOUSE,72323.4,4.8,406,406.1,25.77,25.77,,638,Protein disulfide-isomerase A4,endoplasmic reticulum|endoplasmic reticulum lumen|cell surface|endoplasmic reticulum chaperone complex|melanosome|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|chaperone-mediated protein folding|,protein disulfide isomerase activity|poly(A) RNA binding|,3,3,233000000,4.8%
P01662,0.745307288,-0.185916667,2.325530383,0.317833333,0.585392241,0.576815692,0.5125,-0.009,-1.538,-0.219,-0.009,0.147,P01662,NotFound,P01662_NotFound,P01662,,1,2,2,2,P01662|P01663,MOUSE,12155.2,21.6,407,407.1,24.96,24.96,,111,Ig kappa chain V-III region ABPC 22/PC 9245,,,antigen binding|,2,2,40900000,21.6%
H7BWY6,0.956356881,-0.047583333,0.264684671,0.073833333,0.940874142,0.077387345,1.1695,0.908,-2.331,0.241,-0.19,-0.083,H7BWY6,Rbp4,H7BWY6_Rbp4,H7BWY6,Rbp4,1,4,3,3,H7BWY6|Q00724,MOUSE,28746.7,12.2,408,408.1,24.92,24.92,,245,Retinol-binding protein 4,extracellular space|protein complex|extracellular exosome|,maintenance of gastrointestinal epithelium|positive regulation of insulin secretion|response to retinoic acid|retinol transport|retinol metabolic process|glucose homeostasis|response to ethanol|,retinol binding|retinol transporter activity|protein heterodimerization activity|,3,4,539000000,12.2%
P01724,0.152136082,-0.3955,17.82964066,1.08375,0.016482988,3.547100514,-1.2375,-0.854,,-0.233,0.098,0.249,P01724,NotFound,P01724_NotFound,P01724,,1,2,2,2,P01724,MOUSE,13593.1,31,409,409.1,24.8,24.8,,129,Ig lambda-1 chain V regions MOPC 104E/RPC20/J558/S104,,,antigen binding|,2,2,2390000000,31.0%
O35490,0.024258763,0.6539,31.97627592,-4.213083333,0.000634413,-7.732764833,2.8775,3.486,,-0.158,-1.653,-1.283,O35490,Bhmt,O35490_Bhmt,O35490,Bhmt,1,2,2,2,O35490,MOUSE,45476.1,5.8,410,410.1,24.78,24.78,,407,Betaine--homocysteine S-methyltransferase 1,cytoplasm|,amino-acid betaine catabolic process|methionine biosynthetic process|methylation|,zinc ion binding|S-adenosylmethionine-homocysteine S-methyltransferase activity|betaine-homocysteine S-methyltransferase activity|,2,2,815000000,5.8%
P35822,0.322583882,-0.2101,9.942451363,0.496083333,0.101333925,2.005383483,-0.4735,-0.542,,-0.021,-0.005,-0.009,P35822,Ptprk,P35822_Ptprk,P35822,Ptprk,1,3,3,3,A0A1W2P7Y1|P35822|B2RRF0,MOUSE,166179.6,1.8,411,411.1,24.67,24.67,,1457,Receptor-type tyrosine-protein phosphatase kappa,photoreceptor outer segment|cell-cell junction|cell surface|integral component of membrane|axon|dendrite|leading edge membrane|neuronal cell body|,"protein dephosphorylation|cell adhesion|signal transduction|transforming growth factor beta receptor signaling pathway|negative regulation of cell proliferation|negative regulation of keratinocyte proliferation|cell migration|negative regulation of cell migration|protein localization to cell surface|cellular response to reactive oxygen species|cellular response to UV|peptidyl-tyrosine dephosphorylation|negative regulation of cell cycle|negative regulation of transcription, DNA-templated|focal adhesion assembly|",protein tyrosine phosphatase activity|beta-catenin binding|protein kinase binding|gamma-catenin binding|,3,3,129000000,1.8%
A0A075B5N6,0.20304305,-0.1265,14.39911363,1.077083333,0.036315216,2.849160187,-0.7315,-0.814,,-0.248,0.706,0.455,A0A075B5N6,NotFound,A0A075B5N6_NotFound,A0A075B5N6,Igkv8-16,1,5,2,2,A0A075B5N6|A0A0G2JGT0,MOUSE,13623.3,15.8,412,412.1,24.62,24.62,,120,Immunoglobulin kappa variable 8-16,,,,2,5,1150000000,15.8%
P08032,0.277799132,0.34775,11.22528167,-2.0915,0.075417448,-2.154675568,1.0695,-0.393,3.504,-0.407,-1.078,-0.609,P08032,Spta1,P08032_Spta1,P08032,Spta1,1,3,3,3,P08032,MOUSE,281001,1.5,413,413.1,24.51,24.51,,2415,"Spectrin alpha chain, erythrocytic 1",spectrin|spectrin-associated cytoskeleton|membrane|cortical cytoskeleton|cuticular plate|,porphyrin-containing compound biosynthetic process|plasma membrane organization|regulation of cell shape|actin cytoskeleton organization|hemopoiesis|positive regulation of protein binding|positive regulation of T cell proliferation|actin filament capping|,actin binding|calcium ion binding|protein heterodimerization activity|,3,3,98300000,1.5%
P02468,0.940910696,-0.06875,0.371232956,0.072833333,0.91807192,0.107347704,0.7585,0.582,-1.656,0.024,-0.281,0.16,P02468,NotFound,P02468_NotFound,P02468,Lamc1,1,2,2,2,P02468|F8VQJ3,MOUSE,182943.8,1.9,414,414.1,24.37,24.37,,1607,Laminin subunit gamma-1,extracellular region|basement membrane|basal lamina|extracellular matrix|laminin-10 complex|extracellular exosome|basement membrane|extracellular matrix|,protein complex assembly|cell adhesion|cell migration|extracellular matrix disassembly|neuron projection development|hemidesmosome assembly|substrate adhesion-dependent cell spreading|,extracellular matrix structural constituent|protein binding|glycosphingolipid binding|,2,2,42100000,1.9%
Q91V80,0.534055254,-0.0779,5.039590757,0.278083333,0.313358099,1.120849455,-0.1995,-0.29,,0.052,0.021,0.027,Q91V80,Apof,Q91V80_Apof,Q91V80,Apof,1,2,1,1,A0A0R4J0M4|Q91V80,MOUSE,34701.1,6,415,415.1,24.35,24.35,,315,Apolipoprotein F,low-density lipoprotein particle|high-density lipoprotein particle|,triglyceride metabolic process|cholesterol metabolic process|cholesterol efflux|,,1,2,100000000,6.0%
A0A075B5X7,0.637910794,0.0031,3.732283857,0.643916667,0.42342024,0.872949619,-1.4365,0.67,,0.135,-0.228,0.875,A0A075B5X7,NotFound,A0A075B5X7_NotFound,A0A075B5X7,Ighv1-69,1,1,1,1,A0A075B5X7|A0A075B5W1,MOUSE,13062.5,21.5,416,416.1,23.77,23.77,,116,Immunoglobulin heavy variable 1-69,,,,1,1,18700000,21.5%
P60335,0.200683013,0.359583333,14.49916588,-0.851833333,0.035488154,-2.702871351,0.6405,1.21,0.506,-0.38,-0.135,0.316,P60335,Pcbp1,P60335_Pcbp1,P60335,Pcbp1,1,2,2,2,P60335,MOUSE,38010.7,6.1,417,417.1,23.68,23.68,,356,Poly(rC)-binding protein 1,nucleoplasm|cytoplasm|membrane|ribonucleoprotein complex|intracellular membrane-bounded organelle|extracellular exosome|,mRNA processing|positive regulation of translation|,single-stranded DNA binding|RNA binding|protein binding|translation activator activity|poly(A) RNA binding|,2,2,144000000,6.1%
P13609,0.991064137,0.1637,0.038982391,0.004916667,0.991064137,0.011782363,0.7065,-0.385,,0.369,-0.033,0.161,P13609,Srgn,P13609_Srgn,P13609,Srgn,1,2,2,2,P13609,MOUSE,16825.2,19.7,418,418.1,22.81,22.81,,152,Serglycin,Golgi membrane|extracellular space|Golgi apparatus|secretory granule|zymogen granule|mast cell granule|,granzyme-mediated apoptotic signaling pathway|protein processing|negative regulation of bone mineralization|biomineral tissue development|mast cell secretory granule organization|T cell secretory granule organization|maintenance of protease location in mast cell secretory granule|maintenance of granzyme B location in T cell secretory granule|negative regulation of cytokine secretion|,protein binding|collagen binding|,2,2,29700000,19.7%
A0A087WRT4,0.157989283,0.57075,17.28142931,-1.240166667,0.018700666,-3.214889163,0.5795,1.207,1.786,0.21,-0.444,0.086,A0A087WRT4,Fat1,A0A087WRT4_Fat1,A0A087WRT4,Fat1,1,3,3,3,A0A1L1SQU7|A0A087WRT4|F2Z4A3,MOUSE,511001.9,0.5,419,419.1,22.45,22.45,,4602,FAT atypical cadherin 1,nucleus|plasma membrane|cell-cell junction|focal adhesion|lamellipodium|cell junction|filopodium|perinuclear region of cytoplasm|extracellular exosome|,actin filament organization|homophilic cell adhesion via plasma membrane adhesion molecules|establishment or maintenance of cell polarity|single organismal cell-cell adhesion|,calcium ion binding|protein binding|,3,3,265000000,0.5%
Q9ES89,0.183725972,0.341083333,15.43634978,-0.894166667,0.028599933,-2.866527141,0.2765,1.236,0.852,0.027,-0.266,-0.079,Q9ES89,Extl2,Q9ES89_Extl2,Q9ES89,Extl2,1,5,2,2,Q9ES89|Q3TSR0,MOUSE,37618.1,4.2,420,420.1,22.33,22.33,,330,Exostosin-like 2,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|extracellular exosome|,glycosaminoglycan biosynthetic process|N-acetylglucosamine metabolic process|heparan sulfate proteoglycan biosynthetic process|UDP-N-acetylgalactosamine metabolic process|,"glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|alpha-1,4-N-acetylgalactosaminyltransferase activity|metal ion binding|",2,5,232000000,4.2%
E9Q401,0.141445692,-0.5641,18.77152278,1.439416667,0.013269291,3.773500091,-1.9045,-0.951,,-0.169,0.055,0.149,E9Q401,Ryr2,E9Q401_Ryr2,E9Q401,Ryr2,1,7,3,3,E9Q401|F6U7V1,MOUSE,570001.1,0.6,421,421.1,22.25,22.25,,4966,Ryanodine receptor 2,smooth endoplasmic reticulum|membrane|integral component of membrane|sarcoplasmic reticulum|sarcomere|Z disc|sarcoplasmic reticulum membrane|calcium channel complex|protein complex|extracellular exosome|,response to hypoxia|regulation of heart rate|embryonic heart tube morphogenesis|left ventricular cardiac muscle tissue morphogenesis|cardiac muscle hypertrophy|detection of calcium ion|calcium ion transport|cellular calcium ion homeostasis|positive regulation of heart rate|regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion|regulation of cardiac muscle contraction by calcium ion signaling|release of sequestered calcium ion into cytosol by sarcoplasmic reticulum|response to muscle activity|calcium-mediated signaling|BMP signaling pathway|response to caffeine|calcium-mediated signaling using intracellular calcium source|response to muscle stretch|release of sequestered calcium ion into cytosol|positive regulation of sequestering of calcium ion|response to redox state|regulation of cardiac muscle contraction|cardiac muscle contraction|canonical Wnt signaling pathway|cytosolic calcium ion transport|calcium ion transport into cytosol|calcium ion transmembrane transport|cellular response to caffeine|cellular response to epinephrine stimulus|establishment of protein localization to endoplasmic reticulum|ventricular cardiac muscle cell action potential|Purkinje myocyte to ventricular cardiac muscle cell signaling|type B pancreatic cell apoptotic process|positive regulation of the force of heart contraction|regulation of AV node cell action potential|regulation of SA node cell action potential|regulation of atrial cardiac muscle cell action potential|regulation of ventricular cardiac muscle cell action potential|positive regulation of calcium-transporting ATPase activity|,intracellular ligand-gated calcium channel activity|ryanodine-sensitive calcium-release channel activity|calcium channel activity|calcium ion binding|protein binding|calmodulin binding|calcium-release channel activity|enzyme binding|protein kinase binding|protein kinase A catalytic subunit binding|protein kinase A regulatory subunit binding|identical protein binding|protein self-association|suramin binding|calcium-induced calcium release activity|organic cyclic compound binding|,3,7,20000000000,0.6%
F6R7E8,0.023108713,0.74175,34.21868986,-2.4615,0.000378557,-7.197644309,2.5305,1.367,2.02,-0.545,-0.496,-0.426,F6R7E8,Gm2663,F6R7E8_Gm2663,F6R7E8,Gm2663,1,4,3,3,F6R7E8|Q9CPN7,MOUSE,27260.6,16.1,422,422.1,22.16,22.16,,247,Predicted gene 2663,extracellular space|,proteolysis|,serine-type endopeptidase activity|,3,4,1230000000,16.1%
E9Q5D9,0.580131828,-0.1197,4.474619037,0.420916667,0.356893055,1.016636853,0.1825,-0.927,,-0.014,-0.06,0.22,E9Q5D9,Igfbp7,E9Q5D9_Igfbp7,E9Q5D9,Igfbp7,1,3,3,3,E9Q5D9|F8WH23|Q61581,MOUSE,33887.1,9.2,423,423.1,22.12,22.12,,313,Insulin-like growth factor-binding protein 7,extracellular space|extracellular matrix|extracellular exosome|,regulation of cell growth|cell adhesion|,insulin-like growth factor binding|,3,3,124000000,9.2%
Q9DAU1,0.778765645,0.1025,1.931073014,0.19625,0.641051172,0.49640811,0.4745,-0.505,,0.18,0.396,-0.033,Q9DAU1,Cnpy3,Q9DAU1_Cnpy3,Q9DAU1,Cnpy3,1,3,2,2,Q9DAU1,MOUSE,30936.7,6.5,424,424.1,22.03,22.03,,276,Protein canopy homolog 3,endoplasmic reticulum|,innate immune response|,receptor binding|,2,3,38200000,6.5%
P55104,0.331936472,0.685083333,9.197675827,-1.402166667,0.120290801,-1.815076397,-0.3655,1.863,2.661,-0.037,-0.078,0.067,P55104,Inhbc,P55104_Inhbc,P55104,Inhbc,1,4,3,3,P55104,MOUSE,40085.3,7.6,425,425.1,21.91,21.91,,352,Inhibin beta C chain,extracellular space|extracellular exosome|,positive regulation of pathway-restricted SMAD protein phosphorylation|regulation of apoptotic process|regulation of MAPK cascade|cell development|SMAD protein signal transduction|,cytokine activity|transforming growth factor beta receptor binding|hormone activity|growth factor activity|,3,4,34300000,7.6%
Q9Z0J1,0.600490317,0.1061,4.212015772,-0.276083333,0.379138967,-0.964548222,0.4985,0.045,,-0.079,0.121,-0.055,Q9Z0J1,Reck,Q9Z0J1_Reck,Q9Z0J1,Reck,1,3,2,2,Q9Z0J1,MOUSE,111101,2.1,426,426.1,21.86,21.86,,971,Reversion-inducing cysteine-rich protein with Kazal motifs,plasma membrane|anchored component of membrane|,blood vessel maturation|embryo implantation|negative regulation of endopeptidase activity|extracellular matrix organization|embryonic forelimb morphogenesis|positive regulation of Notch signaling pathway|,endopeptidase inhibitor activity|serine-type endopeptidase inhibitor activity|,2,3,198000000,2.1%
Q91Y97,0.31416078,0.2127,10.28461929,-2.812583333,0.093656532,-2.076437537,-0.3815,4.182,,-0.804,-1.015,-0.918,Q91Y97,Aldob,Q91Y97_Aldob,Q91Y97,Aldob,1,3,3,3,Q91Y97,MOUSE,39962.7,7.9,427,427.1,21.7,21.7,,364,Fructose-bisphosphate aldolase B,nucleus|lysosome|microtubule organizing center|cytosol|plasma membrane|rough endoplasmic reticulum membrane|smooth endoplasmic reticulum membrane|centriolar satellite|perinuclear region of cytoplasm|extracellular exosome|,"liver development|fructose metabolic process|glycolytic process|NADH oxidation|response to fructose|response to zinc ion|fructose 1,6-bisphosphate metabolic process|cellular response to extracellular stimulus|positive regulation of ATPase activity|cellular response to insulin stimulus|response to drug|response to starvation|response to amino acid|response to copper ion|response to glucocorticoid|response to cAMP|vacuolar proton-transporting V-type ATPase complex assembly|response to interleukin-6|",fructose-bisphosphate aldolase activity|cytoskeletal protein binding|phosphatidylcholine binding|identical protein binding|ATPase binding|fructose-1-phosphate aldolase activity|fructose binding|,3,3,74200000,7.9%
A0A075B5Y1,0.32515976,-0.0577,9.695761861,0.670083333,0.107256548,1.960910549,-0.6295,-0.29,,-0.22,0.426,0.425,A0A075B5Y1,NotFound,A0A075B5Y1_NotFound,A0A075B5Y1,Ighv1-74,1,5,2,2,A0A075B5Y1|P01750,MOUSE,13070.6,16.3,428,428.1,21.6,21.6,,116,Immunoglobulin heavy variable V1-74,,,,2,5,2140000000,16.3%
Q9DC11,0.716811684,0.28625,2.82329056,-0.481833333,0.52200053,-0.680487825,-0.1365,-0.447,2.165,0.146,-0.027,0.017,Q9DC11,Plxdc2,Q9DC11_Plxdc2,Q9DC11,Plxdc2,1,5,2,2,Q9DC11|B1AY85|B1AY86,MOUSE,60185.7,2.8,429,429.1,21.45,21.45,,530,Plexin domain-containing protein 2,plasma membrane|integral component of membrane|extracellular exosome|,,,2,5,80600000,2.8%
Q9CQV8,0.036439399,0.526083333,29.28170998,-2.4695,0.001179856,-5.841009184,1.3365,2.536,1.41,-0.852,-1.024,-0.25,Q9CQV8,Ywhab,Q9CQV8_Ywhab,Q9CQV8,Ywhab,1,3,2,2,Q9CQV8|P68254|P68254-2|Q9CQV8-2|P63101,MOUSE,28200,6.9,430,430.1,21.45,21.45,,246,14-3-3 protein beta/alpha,nucleus|cytoplasm|cytosol|focal adhesion|membrane|transcriptional repressor complex|cytoplasmic vesicle membrane|melanosome|perinuclear region of cytoplasm|extracellular exosome|,"protein targeting|negative regulation of protein dephosphorylation|positive regulation of catalytic activity|negative regulation of transcription, DNA-templated|cytoplasmic sequestering of protein|protein heterooligomerization|",transcription corepressor activity|protein binding|protein C-terminus binding|enzyme binding|protein domain specific binding|protein complex binding|histone deacetylase binding|phosphoserine binding|phosphoprotein binding|,2,3,12400000,6.9%
Q9WTL4,0.114297048,0.727583333,20.54288841,-4.1485,0.008824928,-3.842175144,4.5815,3.355,0.469,-1.754,-1.776,-0.51,Q9WTL4,Insrr,Q9WTL4_Insrr,Q9WTL4,Insrr,1,5,2,2,Q9WTL4,MOUSE,147382.5,1.3,431,431.1,21.23,21.23,,1300,Insulin receptor-related protein,integral component of plasma membrane|receptor complex|,transmembrane receptor protein tyrosine kinase signaling pathway|peptidyl-tyrosine phosphorylation|male sex determination|actin cytoskeleton reorganization|protein autophosphorylation|cellular response to alkaline pH|,transmembrane receptor protein tyrosine kinase activity|ATP binding|phosphatidylinositol 3-kinase binding|insulin receptor substrate binding|,2,5,1450000000,1.3%
P13707,0.425473432,0.483916667,7.023949118,-0.907833333,0.198428975,-1.448691253,1.0485,1.884,-0.119,0.86,-0.571,-0.199,P13707,Gpd1,P13707_Gpd1,P13707,Gpd1,1,3,2,2,P13707|E0CXN5,MOUSE,38199.6,6,432,432.1,21.13,21.13,,349,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",mitochondrion|cytosol|glycerol-3-phosphate dehydrogenase complex|extracellular exosome|,glycerol-3-phosphate metabolic process|gluconeogenesis|NADH oxidation|glycerophosphate shuttle|positive regulation of glycolytic process|glycerol-3-phosphate catabolic process|glycerolipid metabolic process|cellular response to cAMP|cellular response to tumor necrosis factor|,glycerol-3-phosphate dehydrogenase [NAD+] activity|glycerol-3-phosphate dehydrogenase activity|protein homodimerization activity|NAD binding|,2,3,17400000,6.0%
P01642,0.899330297,0.1135,0.820660967,-0.147916667,0.827816166,-0.229419299,1.1325,-0.728,,-0.362,0.033,0.492,P01642,NotFound,P01642_NotFound,P01642,Gm10881,1,3,2,2,P01642,MOUSE,12729,15.6,433,433.1,20.89,20.89,,115,Ig kappa chain V-V region L7 (Fragment),,,,2,3,154000000,15.6%
P19639,0.081099342,0.711916667,23.32940385,-3.257166667,0.00464579,-4.422926853,1.2355,4.021,1.765,-0.807,-1.139,-0.804,P19639,Gstm3,P19639_Gstm3,P19639,Gstm3,1,2,2,2,G5E8M7|P19639|P15626|Q80W21|O35660|D3YVP5|D3YX76|D3YVP6,MOUSE,25929.4,8.7,434,434.1,20.81,20.81,,218,Glutathione S-transferase Mu 3,cytoplasm|,metabolic process|cellular response to drug|cellular response to organic cyclic compound|,glutathione transferase activity|protein homodimerization activity|,2,2,72800000,8.7%
Q9CZB2,0.745307288,0.2383,2.306186194,-0.209916667,0.58800549,-0.578753775,0.6535,0.075,,-0.022,-0.082,0.567,Q9CZB2,Pmel,Q9CZB2_Pmel,Q9CZB2,Pmel,1,2,2,2,Q9CZB2|Q60696,MOUSE,66927.6,4.1,435,435.1,20.78,20.78,,626,Melanocyte protein PMEL,endoplasmic reticulum membrane|Golgi apparatus|multivesicular body membrane|melanosome|,melanosome organization|melanin biosynthetic process|,,2,2,74500000,4.1%
Q80T14,0.586005351,0.0285,4.394882022,-0.25125,0.363506179,-0.999503831,0.2335,0.125,,-0.141,-0.011,-0.064,Q80T14,Fras1,Q80T14_Fras1,Q80T14,Fras1,1,2,2,2,Q80T14,MOUSE,453771.9,0.7,436,436.1,20.68,20.68,,4010,Extracellular matrix protein FRAS1,basement membrane|plasma membrane|integral component of membrane|sublamina densa|,morphogenesis of an epithelium|metanephros morphogenesis|cell communication|protein transport|embryonic limb morphogenesis|skin development|palate development|,metal ion binding|,2,2,15500000,0.7%
P97927,0.142953995,0.4975,18.57424645,-1.264583333,0.013885942,-3.710673378,0.9295,1.583,,-0.159,0.272,-0.138,P97927,Lama4,P97927_Lama4,P97927,Lama4,1,2,2,2,P97927,MOUSE,204497.2,0.8,437,437.1,20.59,20.59,,1816,Laminin subunit alpha-4,extracellular region|basement membrane|basal lamina|extracellular exosome|,blood vessel development|cell adhesion|regulation of cell adhesion|regulation of cell migration|regulation of embryonic development|brown fat cell differentiation|,receptor binding|,2,2,7840000,0.8%
A0A075B5Q3,0.728945731,0.093416667,2.69414129,0.363166667,0.537756751,0.654011897,-0.8675,-0.414,1.017,-0.267,0.597,0.495,A0A075B5Q3,NotFound,A0A075B5Q3_NotFound,A0A075B5Q3,Ighv2-5,1,5,2,2,A0A075B5Q3,MOUSE,12727.5,16.5,438,438.1,20.52,20.52,,115,Immunoglobulin heavy variable 2-5,,,,2,5,1570000000,16.5%
Q8K1I3,0.023108713,0.998416667,34.92964125,-2.608833333,0.000321393,-7.435226183,2.1185,2.486,2.304,0.07,-0.975,-0.013,Q8K1I3,Spp2,Q8K1I3_Spp2,Q8K1I3,Spp2,1,3,2,2,Q8K1I3,MOUSE,23421,8.3,439,439.1,20.39,20.39,,203,Secreted phosphoprotein 24,extracellular exosome|,bone remodeling|,,2,3,40900000,8.3%
D3YYQ8,0.115419649,-0.3843,20.23134641,1.214083333,0.009481245,4.089767866,-1.1595,-1.066,,-0.219,0.314,0.209,D3YYQ8,Dnah10,D3YYQ8_Dnah10,D3YYQ8,Dnah10,1,10,3,3,D3YYQ8|F7ABZ6,MOUSE,532755.8,0.7,440,440.1,20.37,20.37,,4591,"Dynein, axonemal, heavy chain 10",inner dynein arm|,cilium movement|metabolic process|,microtubule motor activity|ATP binding|ATPase activity|,3,10,2310000000,0.7%
D3YZ61,0.157989283,0.5449,17.21759667,-1.056416667,0.018977558,-3.415560689,1.3745,0.983,,0.401,0.072,-0.106,D3YZ61,C1qtnf3,D3YZ61_C1qtnf3,D3YZ61,C1qtnf3,1,3,2,2,D3YZ61|Q9ES30,MOUSE,35268.9,5.9,441,441.1,20.25,20.25,,319,Complement C1q tumor necrosis factor-related protein 3,extracellular region|collagen trimer|extracellular space|cell|membrane|extracellular exosome|,negative regulation of gene expression|cellular triglyceride homeostasis|negative regulation of NF-kappaB import into nucleus|glucose homeostasis|negative regulation of gluconeogenesis|positive regulation of cytokine secretion|negative regulation of inflammatory response|protein oligomerization|positive regulation of protein kinase B signaling|positive regulation of adiponectin secretion|protein trimerization|positive regulation of ERK1 and ERK2 cascade|negative regulation of monocyte chemotactic protein-1 production|negative regulation of interleukin-6 secretion|,identical protein binding|,2,3,44100000,5.9%
Q63836,0.023108713,0.545916667,33.26562041,-1.793166667,0.000471453,-6.870056174,1.7585,1.377,1.192,-0.41,-0.516,-0.126,Q63836,Selenbp2,Q63836_Selenbp2,Q63836,Selenbp2,1,2,2,2,Q63836|P17563|D6RHN2|A0A0R4J135|G3UYY2,MOUSE,53179.6,5.9,442,442.1,20.25,20.25,,472,Selenium-binding protein 2,extracellular space|nucleolus|cytosol|membrane|extracellular exosome|,protein transport|,selenium binding|,2,2,10100000,5.9%
E9Q8Y0,0.1956928,0.6501,14.76420131,-4.01275,0.03338719,-2.931913633,0.7515,5.364,,-0.929,-1.074,-0.862,E9Q8Y0,NotFound,E9Q8Y0_NotFound,E9Q8Y0,Myl2,1,3,2,2,E9Q8Y0|P51667,MOUSE,19865,12.5,443,443.1,20.25,20.25,,176,"Myosin regulatory light chain 2, ventricular/cardiac muscle isoform",cytoskeleton|myofibril|actin cytoskeleton|,heart morphogenesis|heart development|post-embryonic development|negative regulation of cell growth|muscle cell fate specification|muscle fiber development|cardiac myofibril assembly|ventricular cardiac muscle tissue morphogenesis|heart contraction|cardiac muscle contraction|,actin monomer binding|calcium ion binding|,2,3,7910000,12.5%
Q9EPK6,0.745094346,-0.21075,2.422191135,0.266833333,0.572507112,0.597305836,0.5545,-0.49,-1.097,-0.078,-0.184,0.03,Q9EPK6,Sil1,Q9EPK6_Sil1,Q9EPK6,Sil1,1,2,2,2,Q9EPK6,MOUSE,52771.3,5.5,444,444.1,20.24,20.24,,465,Nucleotide exchange factor SIL1,extracellular space|endoplasmic reticulum|endoplasmic reticulum lumen|,protein transport|,,2,2,5310000,5.5%
Q8CG85,0.517051837,0.3099,5.30315982,-0.426416667,0.294906278,-1.170414548,0.9785,0.153,,-0.035,0.076,0.377,Q8CG85,Mamdc2,Q8CG85_Mamdc2,Q8CG85,Mamdc2,1,2,2,2,A0A0R4J0J7|Q8CG85,MOUSE,78406.9,3.2,445,445.1,20.16,20.16,,686,MAM domain-containing protein 2,proteinaceous extracellular matrix|interstitial matrix|endoplasmic reticulum|membrane|,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|,glycosaminoglycan binding|,2,2,17000000,3.2%
O88569,0.32515976,0.080916667,9.650071885,-1.085166667,0.108390897,-1.890745026,0.8795,1.574,-0.583,-0.337,-0.768,-0.28,O88569,Hnrnpa2b1,O88569_Hnrnpa2b1,O88569,Hnrnpa2b1,1,2,2,2,O88569|Q5EBP8|O88569-2|P49312|O88569-3|P49312-2,MOUSE,37459.1,5,446,446.1,20.04,20.04,,353,Heterogeneous nuclear ribonucleoproteins A2/B1,nucleus|nucleoplasm|spliceosomal complex|cytoplasm|membrane|ribonucleoprotein complex|catalytic step 2 spliceosome|,"negative regulation of transcription from RNA polymerase II promoter|mRNA processing|RNA splicing|negative regulation of mRNA splicing, via spliceosome|RNA transport|",nucleotide binding|RNA binding|single-stranded telomeric DNA binding|poly(A) RNA binding|pre-mRNA intronic binding|,2,2,9900000,5.0%
A0A075B5V5,0.846217076,0.2753,1.396453223,0.13175,0.725027831,0.372222951,0.1005,0.292,,0.34,0.751,-0.107,A0A075B5V5,NotFound,A0A075B5V5_NotFound,A0A075B5V5,Ighv1-39,1,2,2,2,A0A075B5V5,MOUSE,13044.4,29.9,447,447.1,20.01,20.01,,117,Immunoglobulin heavy variable 1-39 (Fragment),,,,2,2,267000000,29.9%
P52431,,0.267,,,,,,,,-0.179,0.525,0.455,P52431,Pold1,P52431_Pold1,P52431,Pold1,1,3,2,2,P52431|D6RFB8,MOUSE,125271.5,2.1,448,448.1,19.84,19.84,,1105,DNA polymerase delta catalytic subunit,nucleotide-excision repair complex|nucleus|nucleoplasm|cytoplasm|membrane|aggresome|delta DNA polymerase complex|,"DNA synthesis involved in DNA repair|DNA replication|DNA-dependent DNA replication|base-excision repair, gap-filling|nucleotide-excision repair, DNA gap filling|cellular response to UV|DNA replication proofreading|fatty acid homeostasis|nucleic acid phosphodiester bond hydrolysis|","nucleotide binding|DNA binding|chromatin binding|damaged DNA binding|DNA-directed DNA polymerase activity|3'-5'-exodeoxyribonuclease activity|3'-5' exonuclease activity|metal ion binding|4 iron, 4 sulfur cluster binding|",2,3,276000000,2.1%
A0A075B5W6,,0.433,,,,,,,,-0.179,1.122,0.356,A0A075B5W6,NotFound,A0A075B5W6_NotFound,A0A075B5W6,Ighv1-55,1,1,1,1,A0A075B5W6,MOUSE,12858.3,21.3,449,449.1,19.35,19.35,,117,Immunoglobulin heavy variable 1-55 (Fragment),,,,1,1,1740000,21.3%
Q8BYC6,0.140805649,-0.407416667,18.92772605,0.864166667,0.012800514,3.503480283,-1.0215,-0.542,-0.955,-0.132,0.177,0.029,Q8BYC6,Taok3,Q8BYC6_Taok3,Q8BYC6,Taok3,1,15,3,3,Q8BYC6|Q3V3K3,MOUSE,105790.3,4,450,450.1,19.29,19.29,,898,Serine/threonine-protein kinase TAO3,nucleus|cytoplasm|,MAPK cascade|activation of MAPKK activity|DNA repair|protein phosphorylation|cellular response to DNA damage stimulus|mitotic G2 DNA damage checkpoint|regulation of mitotic cell cycle|signal transduction by protein phosphorylation|stress-activated protein kinase signaling cascade|positive regulation of stress-activated MAPK cascade|regulation of apoptotic process|positive regulation of JUN kinase activity|negative regulation of JNK cascade|positive regulation of JNK cascade|protein autophosphorylation|,protein serine/threonine kinase activity|MAP kinase kinase kinase activity|ATP binding|transferase activity|,3,15,28600000000,4.0%
A0A075B5L7,0.216362079,-0.0049,13.54690551,1.283083333,0.044188519,2.690852748,-0.8905,-0.659,,-0.246,0.652,1.119,A0A075B5L7,NotFound,A0A075B5L7_NotFound,A0A075B5L7,Igkv4-80,1,4,2,2,A0A075B5L7,MOUSE,12676,18.9,451,451.1,19.03,19.03,,116,Immunoglobulin kappa variable 4-80 (Fragment),,,,2,4,511000000,18.9%
P15535,0.921042192,0.0093,0.577602018,0.045916667,0.875467036,0.16493382,0.0905,-0.127,,-0.122,-0.044,0.249,P15535,B4galt1,P15535_B4galt1,P15535,B4galt1,1,2,2,2,P15535|P15535-2|B1AXY5,MOUSE,44809.7,7,452,452.1,19.03,19.03,,399,"Beta-1,4-galactosyltransferase 1",Golgi trans cisterna|extracellular space|Golgi apparatus|plasma membrane|external side of plasma membrane|cell surface|membrane|integral component of membrane|basolateral plasma membrane|desmosome|glycocalyx|filopodium|brush border membrane|Golgi cisterna membrane|extracellular exosome|,epithelial cell development|acute inflammatory response|lactose biosynthetic process|galactose metabolic process|protein glycosylation|protein N-linked glycosylation|cell adhesion|binding of sperm to zona pellucida|penetration of zona pellucida|negative regulation of cell proliferation|glycoprotein biosynthetic process|oligosaccharide biosynthetic process|extracellular matrix organization|mammary gland development|wound healing|regulation of cell proliferation|positive regulation of apoptotic process|development of secondary sexual characteristics|branching morphogenesis of an epithelial tube|leukocyte migration|regulation of cellular component movement|regulation of acrosome reaction|positive regulation of epithelial cell proliferation involved in wound healing|angiogenesis involved in wound healing|positive regulation of apoptotic process involved in mammary gland involution|,"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity|N-acetyllactosamine synthase activity|lactose synthase activity|protein binding|cytoskeletal protein binding|galactosyltransferase activity|protein kinase binding|manganese ion binding|UDP-galactosyltransferase activity|protein homodimerization activity|alpha-tubulin binding|beta-tubulin binding|",2,2,19200000,7.0%
P56480,0.258721385,0.4733,11.8438718,-2.074916667,0.065405282,-2.365253812,0.2825,3.154,,-0.17,-0.467,-0.433,P56480,Atp5b,P56480_Atp5b,P56480,Atp5b,1,2,2,2,P56480,MOUSE,56299.5,5.6,453,453.1,18.87,18.87,,529,"ATP synthase subunit beta, mitochondrial","nucleus|mitochondrion|mitochondrial inner membrane|mitochondrial proton-transporting ATP synthase complex|plasma membrane|cell surface|membrane|mitochondrial membrane|mitochondrial nucleoid|myelin sheath|proton-transporting ATP synthase complex, catalytic core F(1)|extracellular exosome|",angiogenesis|osteoblast differentiation|lipid metabolic process|ATP biosynthetic process|negative regulation of cell adhesion involved in substrate-bound cell migration|ATP synthesis coupled proton transport|ATP hydrolysis coupled proton transport|proton transport|regulation of intracellular pH|,"ATP binding|MHC class I protein binding|proton-transporting ATP synthase activity, rotational mechanism|proton-transporting ATPase activity, rotational mechanism|ATPase activity|",2,2,3710000,5.6%
Q3U515,0.046051981,1.188083333,27.04034981,-2.334833333,0.00197681,-5.275175733,1.7295,2.136,3.201,-0.351,0.097,0.316,Q3U515,Vwce,Q3U515_Vwce,Q3U515,Vwce,1,2,2,2,Q3U515,MOUSE,103029.8,2.9,454,454.1,18.81,18.81,,929,von Willebrand factor C and EGF domain-containing protein,extracellular region|,positive regulation of cell proliferation|regulation of signal transduction|,calcium ion binding|,2,2,6430000,2.9%
F6VAN0,0.31416078,-0.1633,10.26778751,0.539083333,0.094020217,2.064211027,-0.3595,-0.614,,0.02,0.141,-0.004,F6VAN0,Atf6,F6VAN0_Atf6,F6VAN0,Atf6,1,5,2,2,F6VAN0,MOUSE,73149.6,3,455,455.1,18.58,18.58,,656,Cyclic AMP-dependent transcription factor ATF-6 alpha,nucleus|endoplasmic reticulum|Golgi apparatus|membrane|integral component of endoplasmic reticulum membrane|,"transcription, DNA-templated|endoplasmic reticulum unfolded protein response|positive regulation of transcription from RNA polymerase II promoter|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress|",RNA polymerase II regulatory region sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity|protein binding|cAMP response element binding|protein heterodimerization activity|,2,5,300000000,3.0%
P97821,0.40834567,-0.3715,7.457348435,0.819583333,0.179582973,1.564947392,-0.0895,-1.637,,-0.255,0.044,0.08,P97821,Ctsc,P97821_Ctsc,P97821,Ctsc,1,1,1,1,P97821,MOUSE,53174.2,2.5,456,456.1,18.55,18.55,,462,Dipeptidyl peptidase 1,extracellular space|lysosome|endoplasmic reticulum|Golgi apparatus|membrane|extracellular exosome|,T cell mediated cytotoxicity|proteolysis|apoptotic process|activation of cysteine-type endopeptidase activity involved in apoptotic process|aging|response to organic substance|proteolysis involved in cellular protein catabolic process|positive regulation of proteolysis involved in cellular protein catabolic process|positive regulation of apoptotic signaling pathway|,cysteine-type endopeptidase activity|serine-type endopeptidase activity|cysteine-type peptidase activity|cysteine-type endopeptidase activator activity involved in apoptotic process|peptidase activator activity involved in apoptotic process|phosphatase binding|chloride ion binding|identical protein binding|protein self-association|chaperone binding|,1,1,3870000,2.5%
A0A075B5K6,0.477721552,0.4233,5.930834185,0.570083333,0.255221103,1.288076172,-0.0305,0.193,,0.88,1.129,-0.055,A0A075B5K6,NotFound,A0A075B5K6_NotFound,A0A075B5K6,Igkv2-109,1,5,1,1,A0A075B5K6|P03976,MOUSE,13170.8,10.8,457,457.1,18.38,18.38,,120,Immunoglobulin kappa variable 2-109 (Fragment),,,,1,5,488000000,10.8%
A0A075B5L4,0.708905418,0.038416667,2.899511175,0.3565,0.512919113,0.695984968,0.5025,0.268,-1.19,0.005,-0.013,0.658,A0A075B5L4,NotFound,A0A075B5L4_NotFound,A0A075B5L4,Igkv12-89,1,6,2,2,A0A075B5L4,MOUSE,12138.5,24.3,458,458.1,18.19,18.19,,111,Immunoglobulin kappa chain variable 12-89,,,,2,6,2330000000,24.3%
A0A1W2P6U8,0.861013543,0.0475,1.230155098,-0.118,0.75332866,-0.336658544,,0.136,,0.063,-0.023,0.014,A0A1W2P6U8,LOC102635990,A0A1W2P6U8_LOC102635990,A0A1W2P6U8,4932415D10Rik,1,4,3,3,A0A1W2P6U8,MOUSE,557033.8,0.4,459,459.1,18.14,18.14,,4986,RIKEN cDNA 4932415D10 gene,,,,3,4,1290000000,0.4%
Q9R1P4,0.425473432,-0.0887,6.93779736,0.375083333,0.202404547,1.466922636,-0.2225,-0.405,,0.074,0.128,-0.018,Q9R1P4,Psma1,Q9R1P4_Psma1,Q9R1P4,Psma1,1,6,2,2,Q9R1P4|A0A1B0GS70,MOUSE,29831.3,5.7,460,460.1,17.88,17.88,,263,Proteasome subunit alpha type-1,"proteasome complex|nucleus|nucleoplasm|cytoplasm|centrosome|cytosol|proteasome core complex|proteasome core complex, alpha-subunit complex|extracellular exosome|",immune system process|negative regulation of inflammatory response to antigenic stimulus|proteasomal ubiquitin-independent protein catabolic process|proteasome-mediated ubiquitin-dependent protein catabolic process|,lipopolysaccharide binding|endopeptidase activity|threonine-type endopeptidase activity|protein binding|,2,6,1790000000,5.7%
Q9WU60,0.940910696,-0.095916667,0.366550768,0.071166667,0.91906224,0.106044388,0.6225,0.669,-1.686,-0.147,-0.023,-0.011,Q9WU60,Atrn,Q9WU60_Atrn,Q9WU60,Atrn,1,4,2,2,Q9WU60,MOUSE,163133.2,1.4,461,461.1,17.68,17.68,,1428,Attractin,extracellular space|cytoplasm|plasma membrane|integral component of membrane|extracellular exosome|,inflammatory response|response to oxidative stress|cerebellum development|regulation of multicellular organism growth|myelination|pigmentation|,receptor activity|protein binding|carbohydrate binding|,2,4,24700000,1.4%
Q2XU92,0.081099342,-0.4923,23.52083115,1.824916667,0.004445462,4.93227746,-1.9535,-1.221,,0.222,-0.061,0.552,Q2XU92,Acsbg2,Q2XU92_Acsbg2,Q2XU92,Acsbg2,1,7,2,2,Q2XU92,MOUSE,75116.7,2.5,462,462.1,17.65,17.65,,667,Long-chain-fatty-acid--CoA ligase ACSBG2,cytoplasm|mitochondrion|cytosol|membrane|,long-chain fatty acid metabolic process|fatty acid metabolic process|fatty acid beta-oxidation|multicellular organismal development|spermatogenesis|cell differentiation|,long-chain fatty acid-CoA ligase activity|ATP binding|acyl-CoA hydrolase activity|,2,7,10500000000,2.5%
O89023,0.801687588,0.2645,1.746355829,0.17625,0.668904961,0.454382779,0.4055,-0.088,,0.774,-0.136,0.367,O89023,Tpp1,O89023_Tpp1,O89023,Tpp1,1,3,2,2,O89023,MOUSE,61797.5,3.5,463,463.1,17.64,17.64,,562,Tripeptidyl-peptidase 1,mitochondrion|lysosome|melanosome|extracellular exosome|,proteolysis|lysosome organization|nervous system development|central nervous system development|epithelial cell differentiation|peptide catabolic process|bone resorption|neuromuscular process controlling balance|,endopeptidase activity|serine-type endopeptidase activity|protein binding|peptidase activity|serine-type peptidase activity|tripeptidyl-peptidase activity|metal ion binding|,2,3,39200000,3.5%
Q8BKH7,0.508548478,0.306083333,5.519794601,-1.2635,0.280556632,-1.187757332,3.2205,0.749,-1.156,-0.471,-0.231,-0.275,Q8BKH7,Mapkap1,Q8BKH7_Mapkap1,Q8BKH7,Mapkap1,1,4,2,2,Q8BKH7|Q8BKH7-2|Q8BKH7-3,MOUSE,59521.1,3.4,464,464.1,17.62,17.62,,522,Target of rapamycin complex 2 subunit MAPKAP1,nucleus|nucleoplasm|cytoplasm|Golgi apparatus|plasma membrane|cytoplasmic membrane-bounded vesicle|,substantia nigra development|negative regulation of Ras protein signal transduction|,"protein binding|phosphatidylinositol-4,5-bisphosphate binding|phosphatidylinositol-3,4,5-trisphosphate binding|Ras GTPase binding|protein kinase binding|phosphatidylinositol-3,4-bisphosphate binding|phosphatidic acid binding|phosphatidylinositol-3,5-bisphosphate binding|",2,4,6260000000,3.4%
P07743,0.20304305,-0.1093,14.38764925,0.761583333,0.036411207,2.837710054,-0.6595,-0.473,,0.089,0.377,0.12,P07743,Bpifa2,P07743_Bpifa2,P07743,Bpifa2,1,2,1,1,P07743,MOUSE,24923.6,6.8,465,465.1,17.57,17.57,,235,BPI fold-containing family A member 2,extracellular region|secretory granule|extracellular exosome|,defense response to bacterium|,lipopolysaccharide binding|,1,2,12000000,6.8%
A0A075B5P9,0.864716947,0.0563,1.171953397,0.13925,0.763492298,0.31814649,-0.5435,0.489,,-0.124,0.515,-0.055,A0A075B5P9,NotFound,A0A075B5P9_NotFound,A0A075B5P9,Ighv5-4,1,3,2,2,A0A075B5P9,MOUSE,13135.8,14.5,466,466.1,17.47,17.47,,117,Immunoglobulin heavy variable 5-4 (Fragment),,,,2,3,65700000,14.5%
E9Q3P4,0.449815931,0.5913,6.452993477,-1.98075,0.226308389,-1.383314975,3.7875,-0.228,,-0.762,1.338,-1.179,E9Q3P4,Cenpf,E9Q3P4_Cenpf,E9Q3P4,Cenpf,1,7,2,2,E9Q3P4,MOUSE,345546.7,0.9,467,467.1,17.42,17.42,,2997,Centromere protein F,"chromosome, centromeric region|spindle pole|condensed chromosome outer kinetochore|nucleus|nuclear envelope|nucleoplasm|cytoplasm|spindle|nuclear matrix|midbody|pronucleus|kinetochore|","mitotic cell cycle|chromosome segregation|regulation of G2/M transition of mitotic cell cycle|protein transport|regulation of striated muscle tissue development|negative regulation of transcription, DNA-templated|metaphase plate congression|",protein C-terminus binding|transcription factor binding|protein homodimerization activity|dynein binding|,2,7,3440000000,0.9%
Q3UHI0-2,0.048957957,-0.647583333,26.23827655,1.403833333,0.002377784,5.035049233,-1.3655,-1.035,-1.648,-0.225,0.315,0.073,Q3UHI0,Ccser2,Q3UHI0-2_Ccser2,Q3UHI0-2,Ccser2,1,6,2,2,Q3UHI0-2|Q3UHI0,MOUSE,115944.3,1.9,468,468.1,17.36,17.36,,833,Isoform 2 of Serine-rich coiled-coil domain-containing protein 2,microtubule cytoskeleton|,,microtubule binding|,2,6,1E+12,1.9%
Q9JHJ8-2,0.572204891,0.1863,4.587441575,-0.274083333,0.347740955,-1.03603809,0.4225,0.279,,0.217,0.094,-0.081,Q9JHJ8,Icosl,Q9JHJ8-2_Icosl,Q9JHJ8-2,Icoslg,1,3,3,3,Q9JHJ8-2|A0A1W2P6Q2|Q9JHJ8,MOUSE,39426.3,11.8,469,469.1,17.23,17.23,,322,Isoform 2 of ICOS ligand,integral component of plasma membrane|external side of plasma membrane|integral component of membrane|extracellular exosome|,signal transduction|positive regulation of activated T cell proliferation|T cell activation|isotype switching|positive regulation of interleukin-4 biosynthetic process|,receptor binding|protein binding|,3,3,126000000,11.8%
A0A075B5R1,0.745307288,0.0417,2.276513867,0.197416667,0.592036678,0.572126182,-0.4445,0.291,,0.057,0.343,-0.038,A0A075B5R1,NotFound,A0A075B5R1_NotFound,A0A075B5R1,Ighv5-17,1,2,1,1,A0A075B5R1,MOUSE,13075.8,16.2,470,470.1,17.1,17.1,,117,Immunoglobulin heavy variable 5-17 (Fragment),,,,1,2,10200000,16.2%
O35452,0.083117329,0.455416667,22.94827888,-1.2095,0.005071917,-4.306616578,0.9095,1.505,0.766,0.002,-0.266,-0.184,O35452,NotFound,O35452_NotFound,O35452,Tnxb,1,5,2,2,O35452|E9Q2T3,MOUSE,442488.3,0.4,471,471.1,17.03,17.03,,4006,Tenascin X,extracellular region|proteinaceous extracellular matrix|extracellular space|intracellular|extracellular exosome|fibrillar collagen trimer|extracellular matrix|,lipid metabolic process|fatty acid metabolic process|triglyceride metabolic process|cell-matrix adhesion|single organismal cell-cell adhesion|extracellular matrix organization|collagen fibril organization|collagen metabolic process|extracellular fibril organization|regulation of JUN kinase activity|elastic fiber assembly|phospholipid metabolic process|positive regulation of cell adhesion|,collagen binding|heparin binding|,2,5,39100000,0.4%
Q7TNB8,0.172893577,0.69475,16.41630821,-2.092833333,0.022822813,-3.056421645,2.7985,0.196,2.229,-0.52,-0.182,-0.353,Q7TNB8,Sbno2,Q7TNB8_Sbno2,Q7TNB8,Sbno2,1,3,3,3,Q7TNB8|Q7TNB8-2,MOUSE,150546.2,3.1,472,472.1,16.97,16.97,,1349,Protein strawberry notch homolog 2,,"macrophage activation involved in immune response|transcription, DNA-templated|bone mineralization|osteoclast differentiation|negative regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|regulation of inflammatory response|bone trabecula morphogenesis|multinuclear osteoclast differentiation|osteoclast fusion|",protein binding|,3,3,15300000000,3.1%
Q9Z222,0.32515976,-0.1141,9.538363694,0.491916667,0.111215068,1.93258824,-0.4645,-0.354,,0.147,0.127,-0.026,Q9Z222,B3gnt2,Q9Z222_B3gnt2,Q9Z222,B3GNT2,1,2,2,2,Q9Z222|P59997|F6YRW4|P59997-2|A0A087WP68|P59997-3|Q3U4H6-2|Q3U4H6|G3UWI7,MOUSE,46281.5,3.2,473,473.1,16.72,16.72,,397,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2",Golgi membrane|integral component of membrane|extracellular exosome|,protein glycosylation|axon guidance|sensory perception of smell|poly-N-acetyllactosamine biosynthetic process|,"galactosyltransferase activity|N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity|",2,2,63300000,3.2%
Q00612,0.153374531,0.99275,17.60848587,-1.522833333,0.017344086,-3.275587944,1.5375,1.334,2.391,0.542,-0.553,0.705,Q00612,G6pdx,Q00612_G6pdx,Q00612,G6pdx,1,3,3,3,Q00612|P97324|G3UWD6,MOUSE,59717.9,4.8,474,474.1,16.49,16.49,,515,Glucose-6-phosphate 1-dehydrogenase X,cytoplasm|centrosome|microtubule organizing center|cytosol|cytoplasmic side of plasma membrane|membrane|intracellular membrane-bounded organelle|extracellular exosome|,"cytokine production|angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure|vasodilation by angiotensin involved in regulation of systemic arterial blood pressure|glucose metabolic process|pentose-phosphate shunt|cholesterol biosynthetic process|NADP metabolic process|NADPH regeneration|NADP biosynthetic process|glutathione metabolic process|response to oxidative stress|pentose-phosphate shunt, oxidative branch|negative regulation of protein glutathionylation|pentose biosynthetic process|interleukin-10 production|interleukin-12 production|cellular response to oxidative stress|regulation of multicellular organism growth|erythrocyte maturation|ribose phosphate biosynthetic process|erythrocyte development|glucose 6-phosphate metabolic process|oxidation-reduction process|",glucose-6-phosphate dehydrogenase activity|glucose binding|identical protein binding|protein homodimerization activity|NADP binding|,3,3,44800000,4.8%
A6H584,0.421131351,-0.4038,7.125021348,1.1545,0.193864311,1.504999654,,0.148,-2.341,0.081,-0.034,0.127,A6H584,Col6a5,A6H584_Col6a5,A6H584,Col6a5,1,2,2,2,A0A140T8W1|A6H584|A0A140T8T7|E9Q6A6|Q8C6K9|Q8C6K9-2,MOUSE,291566.4,1.1,475,475.1,16.44,16.44,,2640,Collagen alpha-5(VI) chain,extracellular region|proteinaceous extracellular matrix|collagen trimer|,cell adhesion|,,2,2,6250000,1.1%
A0A075B5X8,0.679041452,-0.1499,3.203851257,0.251416667,0.478205839,0.766196454,0.0105,-0.612,,-0.276,-0.007,0.135,A0A075B5X8,NotFound,A0A075B5X8_NotFound,A0A075B5X8,Ighv8-12,1,5,2,2,A0A075B5X8|A0A075B693,MOUSE,11636.9,11.4,476,476.1,16.38,16.38,,105,Immunoglobulin heavy variable V8-12,,,,2,5,1470000000,11.4%
Q9CPN9,0.125102481,0.458583333,19.68600534,-0.899833333,0.010749777,-3.648599563,1.1545,0.946,0.625,0.171,-0.092,-0.053,Q9CPN9,2210010C04Rik,Q9CPN9_2210010C04Rik,Q9CPN9,2210010C04Rik,1,5,1,1,Q9CPN9,MOUSE,27106.2,4.8,477,477.1,16.12,16.12,,247,RIKEN cDNA 2210010C04 gene,extracellular space|,proteolysis|,serine-type endopeptidase activity|,1,5,867000000,4.8%
Q91WR8,0.437741736,-0.0451,6.730560994,0.364416667,0.212297021,1.429651956,-0.2785,-0.249,,0.106,-0.013,0.209,Q91WR8,Gpx6,Q91WR8_Gpx6,Q91WR8,Gpx6,1,3,1,1,Q91WR8,MOUSE,25188.2,7.6,478,478.1,16.05,16.05,,221,Glutathione peroxidase 6,extracellular region|,response to oxidative stress|oxidation-reduction process|,glutathione peroxidase activity|,1,3,12600000,7.6%
A0A075B5S9,0.968031615,0.4423,0.183462655,0.03425,0.958636001,0.054571485,0.9735,-0.13,,0.066,1.403,-0.101,A0A075B5S9,NotFound,A0A075B5S9_NotFound,A0A075B5S9,Ighv9-4,1,2,2,2,A0A075B5S9,MOUSE,11048.3,19.3,479,479.1,15.83,15.83,,98,Immunoglobulin heavy variable 9-4,,,,2,2,48200000,19.3%
A2AQH1,0.247098196,0.699583333,12.28544743,-1.0505,0.059082009,-2.333745386,1.1435,0.485,2.046,0.421,-0.2,0.302,A2AQH1,Cerkl,A2AQH1_Cerkl,A2AQH1,Cerkl,1,3,3,3,A2AQH1,MOUSE,59694.4,5.5,480,480.1,15.76,15.76,,525,Ceramide kinase-like,nucleolus|cytoplasm|endoplasmic reticulum|Golgi apparatus|,phosphorylation|negative regulation of apoptotic process|,kinase activity|,3,3,219000000,5.5%
Q9DBH5,0.925968725,0.1411,0.538904572,0.045583333,0.883302669,0.154453432,0.3145,-0.087,,0.374,0.115,-0.011,Q9DBH5,Lman2,Q9DBH5_Lman2,Q9DBH5,Lman2,1,2,1,1,Q9DBH5,MOUSE,40771.4,3.6,481,481.1,15.65,15.65,,358,Vesicular integral-membrane protein VIP36,Golgi membrane|extracellular space|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|integral component of plasma membrane|cell surface|extracellular exosome|,"retrograde vesicle-mediated transport, Golgi to ER|protein transport|positive regulation of phagocytosis|",glycoprotein binding|mannose binding|carbohydrate binding|heat shock protein binding|metal ion binding|,1,2,6690000,3.6%
Q9QUK9,0.015825163,0.830916667,38.64812071,-2.999166667,0.000136517,-8.670568038,2.9255,1.814,2.252,-0.896,-0.614,-0.496,Q9QUK9,Try5,Q9QUK9_Try5,Q9QUK9,Try5,1,3,2,2,Q9QUK9|Q9R0T7|Q792Z0|Q9Z1R9|Q792Y8|Q792Y9,MOUSE,26961,12.1,482,482.1,15.64,15.64,,246,MCG15083,extracellular space|extracellular exosome|,proteolysis|digestion|,serine-type endopeptidase activity|calcium ion binding|serine-type peptidase activity|,2,3,176000000,12.1%
P12804,0.168588473,-0.3725,16.65050443,0.914583333,0.021624673,3.295907989,-1.0465,-0.796,,-0.134,-0.087,0.201,P12804,Fgl2,P12804_Fgl2,P12804,Fgl2,1,1,1,1,P12804,MOUSE,49634.7,2.3,483,483.1,15.42,15.42,,432,Fibroleukin,extracellular exosome|,cytolysis|,,1,1,12000000,2.3%
Q61627,0.213452452,-0.3101,13.99400301,1.02275,0.039865728,2.766545973,-1.3555,-0.492,,0.114,-0.111,0.294,Q61627,Grid1,Q61627_Grid1,Q61627,Grid1,1,3,2,2,Q61627,MOUSE,113178,2.7,484,484.1,15.39,15.39,,1009,"Glutamate receptor ionotropic, delta-1",plasma membrane|ionotropic glutamate receptor complex|cell junction|dendrite|postsynaptic membrane|extracellular exosome|,"ion transmembrane transport|social behavior|ionotropic glutamate receptor signaling pathway|synaptic transmission, glutamatergic|",ionotropic glutamate receptor activity|extracellular-glutamate-gated ion channel activity|,2,3,1430000000,2.7%
Q792Z1,0.012995616,0.886916667,41.82470504,-3.1465,6.56946E-05,-9.808612919,2.9555,2.406,2.019,-0.896,-0.743,-0.42,Q792Z1,Try10,Q792Z1_Try10,Q792Z1,Try10,1,4,1,1,Q792Z1,MOUSE,26905,4,485,485.1,15.38,15.38,,246,MCG140784,extracellular space|extracellular exosome|blood microparticle|,proteolysis|digestion|,serine-type endopeptidase activity|,1,4,289000000,4.0%
P49452,0.33188014,-0.0309,9.319478454,0.515583333,0.116963985,1.893262916,-0.1875,-0.493,,0.204,0.288,0.034,P49452,Cenpc1,P49452_Cenpc1,P49452,Cenpc,1,2,2,2,P49452,MOUSE,102722.5,2.4,486,486.1,15.3,15.3,,906,Centromere protein C,"kinetochore|condensed chromosome kinetochore|condensed nuclear chromosome, centromeric region|nucleus|nucleoplasm|pericentric heterochromatin|cytoplasm|",mitotic cell cycle|chromosome segregation|mitotic nuclear division|cell division|kinetochore assembly|,protein binding|centromeric DNA binding|,2,2,2730000000,2.4%
F8VQ75,0.890329957,-0.0011,0.900523117,-0.07975,0.812732615,-0.249749965,0.3875,-0.294,,-0.126,-0.014,0.041,F8VQ75,Kif13a,F8VQ75_Kif13a,F8VQ75,Kif13a,1,3,3,3,F8VQ75|Q9EQW7,MOUSE,197294.8,2.1,487,487.1,15.15,15.15,,1749,Kinesin-like protein KIF13A,centrosome|kinesin complex|microtubule|endosome membrane|midbody|,cytokinesis|intracellular protein transport|microtubule-based movement|metabolic process|endosome to lysosome transport|melanosome organization|cargo loading into vesicle|,microtubule motor activity|ATP binding|microtubule binding|ATPase activity|,3,3,99800000,2.1%
A0A075B5K3,0.641826969,-0.1445,3.685669324,0.36875,0.427989454,0.863759601,-0.9005,0.169,,-0.307,0.094,0.222,A0A075B5K3,NotFound,A0A075B5K3_NotFound,A0A075B5K3,Igkv17-121,1,2,1,1,A0A075B5K3|A0A075B5J9,MOUSE,12863.4,13.7,488,488.1,15.02,15.02,,116,Immunoglobulin kappa variable 17-121,,,,1,2,118000000,13.7%
P54818,0.465934828,0.175916667,6.214931546,-0.313166667,0.239059962,-1.30721458,0.2835,0.446,0.268,0.261,-0.251,0.048,P54818,Galc,P54818_Galc,P54818,Galc,1,3,2,2,P54818,MOUSE,77483.2,5.1,489,489.1,15,15,,684,Galactocerebrosidase,mitochondrion|lysosome|extracellular exosome|,carbohydrate metabolic process|galactosylceramide catabolic process|,galactosylceramidase activity|,2,3,53900000,5.1%
Q3UGX2,0.05707638,0.82125,25.35475267,-3.419166667,0.002914236,-4.875866132,1.7265,1.745,4.121,-0.917,-1.197,-0.551,Q3UGX2,Sptb,Q3UGX2_Sptb,Q3UGX2,Sptb,1,2,2,2,Q3UGX2|E9Q397|P15508,MOUSE,268999.3,0.9,490,490.1,14.95,14.95,,2329,Spectrin beta chain,cytoplasm|plasma membrane|spectrin|cell surface|spectrin-associated cytoskeleton|membrane|cortical cytoskeleton|protein complex|,porphyrin-containing compound biosynthetic process|plasma membrane organization|hemopoiesis|,actin binding|structural constituent of cytoskeleton|phospholipid binding|ankyrin binding|protein heterodimerization activity|actin filament binding|,2,2,23100000,0.9%
G3X9D6,0.861718736,0.055916667,1.211608926,0.3675,0.756552564,0.324789353,1.3795,0.965,-2.728,0.085,-0.281,0.915,G3X9D6,Apon,G3X9D6_Apon,G3X9D6,Apon,1,1,1,1,G3X9D6,MOUSE,28249.3,7.1,491,491.1,14.92,14.92,,251,Apolipoprotein N,extracellular space|cytoplasm|,,,1,1,123000000,7.1%
P01725,0.115419649,-0.4713,20.32412793,1.377416667,0.009280838,4.111645694,-1.3755,-1.22,,-0.234,-0.036,0.509,P01725,NotFound,P01725_NotFound,P01725,,1,2,2,2,P01725,MOUSE,11767.9,26.3,492,492.1,14.83,14.83,,110,Ig lambda-1 chain V region S178,,,antigen binding|,2,2,2370000000,26.3%
P16460,0.14994666,0.580416667,18.1765675,-2.766166667,0.015217498,-3.382109446,0.4915,3.722,1.677,-0.463,-1.14,-0.805,P16460,Ass1,P16460_Ass1,P16460,Ass1,1,2,2,2,P16460,MOUSE,46868.9,4.8,493,493.1,14.82,14.82,,412,Argininosuccinate synthase,cytoplasm|mitochondrion|myelin sheath|extracellular exosome|,urea cycle|citrulline metabolic process|argininosuccinate metabolic process|arginine biosynthetic process|aspartate metabolic process|positive regulation of nitric oxide biosynthetic process|cellular response to laminar fluid shear stress|negative regulation of leukocyte cell-cell adhesion|,argininosuccinate synthase activity|ATP binding|amino acid binding|identical protein binding|poly(A) RNA binding|,2,2,6590000,4.8%
Q8BGS1-3,0.493198233,0.0961,5.712125963,0.420583333,0.268403023,1.244945596,-0.4445,0.132,,0.345,0.492,-0.044,Q8BGS1,Epb41l5,Q8BGS1-3_Epb41l5,Q8BGS1-3,Epb41l5,1,5,2,2,Q8BGS1-3|Q8BGS1|Q8BGS1-2,MOUSE,83272.7,2.8,494,494.1,14.8,14.8,,731,Isoform 3 of Band 4.1-like protein 5,nucleus|cytoplasm|cytoskeleton|plasma membrane|focal adhesion|extrinsic component of membrane|cell leading edge|ruffle membrane|,"cell morphogenesis involved in differentiation|in utero embryonic development|somitogenesis|epithelial to mesenchymal transition|neural plate morphogenesis|positive regulation of cell-matrix adhesion|epithelial cell morphogenesis|apical constriction|substrate-dependent cell migration, cell attachment to substrate|ectoderm development|endoderm development|mesoderm development|mesoderm migration involved in gastrulation|unidimensional cell growth|posttranscriptional regulation of gene expression|positive regulation of epithelial cell migration|positive regulation of epithelial to mesenchymal transition|negative regulation of cell-cell adhesion|actin cytoskeleton organization|actomyosin structure organization|negative regulation of protein binding|positive regulation of protein binding|somite rostral/caudal axis specification|axial mesoderm development|axial mesoderm morphogenesis|paraxial mesoderm development|embryonic foregut morphogenesis|positive regulation of focal adhesion assembly|regulation of establishment of protein localization|left/right axis specification|cellular response to transforming growth factor beta stimulus|",protein binding|cytoskeletal protein binding|protein domain specific binding|,2,5,6100000000,2.8%
Q8C2E4,0.968031615,-0.003083333,0.170543134,-0.0245,0.961492025,-0.0503676,0.6815,0.39,-1.044,0.105,-0.171,0.02,Q8C2E4,Ptcd1,Q8C2E4_Ptcd1,Q8C2E4,Ptcd1,1,3,3,3,Q8C2E4,MOUSE,78334.7,6,495,495.1,14.75,14.75,,695,"Pentatricopeptide repeat-containing protein 1, mitochondrial",mitochondrial matrix|,tRNA 3'-end processing|,,3,3,105000000,6.0%
Q9CSN1,0.087827031,-0.288083333,22.2430243,1.0035,0.005966197,4.159372665,-0.5755,-0.782,-1.012,0.305,0.328,0.008,Q9CSN1,Snw1,Q9CSN1_Snw1,Q9CSN1,Snw1,1,8,2,2,Q9CSN1|A0A0B4J1E2,MOUSE,61531.4,2.6,496,496.1,14.69,14.69,,536,SNW domain-containing protein 1,nucleus|nucleoplasm|spliceosomal complex|nuclear matrix|catalytic step 2 spliceosome|positive transcription elongation factor complex b|SMAD3-SMAD4 protein complex|,"negative regulation of transcription from RNA polymerase II promoter|mRNA splicing, via spliceosome|transcription, DNA-templated|positive regulation of transforming growth factor beta receptor signaling pathway|skeletal muscle cell differentiation|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator|positive regulation by host of viral transcription|negative regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of mRNA splicing, via spliceosome|retinoic acid receptor signaling pathway|regulation of retinoic acid receptor signaling pathway|positive regulation of neurogenesis|positive regulation of histone H3-K4 methylation|regulation of vitamin D receptor signaling pathway|positive regulation of vitamin D receptor signaling pathway|cellular response to retinoic acid|",transcription coactivator activity|transcription corepressor activity|Notch binding|protein binding|nuclear hormone receptor binding|vitamin D receptor binding|retinoic acid receptor binding|poly(A) RNA binding|SMAD binding|,2,8,1.71E+11,2.6%
E9Q1W3,0.440311255,0.0983,6.654595367,0.51425,0.216043131,1.416977355,-0.1215,-0.299,,0.82,0.118,-0.026,E9Q1W3,Neb,E9Q1W3_Neb,E9Q1W3,Neb,1,6,2,2,E9Q1W3|A2AQA9|B2RUJ5|B2RUJ5-3,MOUSE,831956.2,0.2,497,497.1,14.58,14.58,,7152,Nebulin,striated muscle thin filament|Z disc|protein complex|contractile fiber|extracellular exosome|,regulation of actin filament length|sarcomere organization|,actin binding|protein binding|,2,6,10100000000,0.2%
Q6P5E4,0.604460486,0.0525,4.110336751,-0.294583333,0.38812027,-0.94499393,0.5585,-0.1,,-0.091,-0.063,-0.042,Q6P5E4,Uggt1,Q6P5E4_Uggt1,Q6P5E4,Uggt1,1,1,1,1,Q6P5E4,MOUSE,177115,0.8,498,498.1,14.53,14.53,,1551,UDP-glucose:glycoprotein glucosyltransferase 1,endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum-Golgi intermediate compartment|extracellular exosome|,protein glycosylation|UDP-glucosylation|,UDP-glucose:glycoprotein glucosyltransferase activity|protein binding|unfolded protein binding|,1,1,1840000,0.8%
Q9WV54,0.242548931,0.21025,12.41162579,-1.441833333,0.057390158,-2.355178961,1.3795,1.844,-0.43,-0.718,-0.499,-0.315,Q9WV54,Asah1,Q9WV54_Asah1,Q9WV54,Asah1,1,1,1,1,Q9WV54,MOUSE,45068.1,2,499,499.1,14.51,14.51,,394,Acid ceramidase,lysosome|extracellular exosome|,lipid metabolic process|,ceramidase activity|,1,1,22200000,2.0%
H3BKH6,0.389385938,0.732083333,8.064794095,-0.7155,0.156142307,-1.625034339,1.8085,0.693,0.768,0.534,-0.231,0.82,H3BKH6,Esd,H3BKH6_Esd,H3BKH6,Esd,1,3,2,2,H3BKH6|Q9R0P3|H3BJL6|H3BLJ9,MOUSE,33399.4,8.4,500,500.1,14.48,14.48,,295,S-formylglutathione hydrolase,nucleoplasm|cytoplasm|Golgi apparatus|plasma membrane|extracellular exosome|,formaldehyde catabolic process|,"hydrolase activity, acting on ester bonds|S-formylglutathione hydrolase activity|",2,3,19500000,8.4%
A0A075B5M1,0.456433733,-0.697083333,6.358459494,2.1555,0.231288506,1.334387511,-0.1775,0.432,-5.579,1.116,0.136,-0.11,A0A075B5M1,NotFound,A0A075B5M1_NotFound,A0A075B5M1,Igkv4-63,1,4,2,2,A0A075B5M1|Q569Z6,MOUSE,10271.2,14.7,502,502.1,14.38,14.38,,95,Immunoglobulin kappa variable 4-63,,,,2,4,180000000,14.7%
F6ZDS4,0.115419649,-0.3503,20.22891859,1.22325,0.009486547,4.089196352,-0.8555,-1.313,,0.058,0.349,0.01,F6ZDS4,Tpr,F6ZDS4_Tpr,F6ZDS4,Tpr,1,2,2,2,F6ZDS4|Q7M739|Q8BQ30-2|Q8BQ30,MOUSE,274384.7,0.6,503,503.1,14.35,14.35,,2431,Nucleoprotein TPR,kinetochore|nucleus|nuclear envelope|nuclear pore|cytoplasm|cytoplasmic dynein complex|extrinsic component of membrane|nuclear membrane|nuclear periphery|nuclear inclusion body|nuclear pore nuclear basket|mitotic spindle|kinetochore|,negative regulation of transcription from RNA polymerase II promoter|MAPK import into nucleus|RNA import into nucleus|RNA export from nucleus|nuclear pore organization|mitotic nuclear division|mitotic spindle assembly checkpoint|regulation of mitotic sister chromatid separation|positive regulation of heterochromatin assembly|mRNA export from nucleus in response to heat stress|cellular response to heat|cellular response to interferon-alpha|positive regulation of protein import into nucleus|negative regulation of translational initiation|positive regulation of protein export from nucleus|negative regulation of RNA export from nucleus|cell division|response to epidermal growth factor|positive regulation of mitotic cell cycle spindle assembly checkpoint|positive regulation of intracellular protein transport|regulation of mitotic spindle assembly|protein import into nucleus|protein export from nucleus|nuclear pore organization|regulation of protein stability|regulation of protein import into nucleus|nuclear matrix organization|nuclear pore complex assembly|,chromatin binding|mRNA binding|nucleocytoplasmic transporter activity|protein binding|tubulin binding|heat shock protein binding|protein homodimerization activity|poly(A) RNA binding|mitogen-activated protein kinase binding|dynein complex binding|transporter activity|protein anchor|,2,2,379000000,0.6%
A0A075B5J6,0.358774153,-0.2433,8.670208137,0.662416667,0.135824835,1.779239675,-1.0935,-0.188,,-0.112,0.211,-0.034,A0A075B5J6,NotFound,A0A075B5J6_NotFound,A0A075B5J6,Gm20730,1,1,1,1,A0A075B5J6|P01629,MOUSE,13242.9,10.9,504,504.1,14.25,14.25,,119,"Predicted gene, 20730",,,,1,1,7980000,10.9%
E9Q3M9,0.116696197,0.0859,20.05149931,-2.690583333,0.009882119,-4.088393891,0.6555,2.745,,-1.06,-1.019,-0.892,E9Q3M9,2010300C02Rik,E9Q3M9_2010300C02Rik,E9Q3M9,2010300C02Rik,1,3,2,2,E9Q3M9|Q3TYL0,MOUSE,126478.6,1.1,505,505.1,14.1,14.1,,1175,RIKEN cDNA 2010300C02 gene,,,,2,3,591000000,1.1%
P10166,0.242548931,-0.1691,12.48419531,0.661916667,0.056439151,2.472467395,-0.7095,-0.423,,0.011,0.22,0.056,P10166,Mycl,P10166_Mycl,P10166,Mycl,1,6,2,2,P10166,MOUSE,41361,2.9,506,506.1,14.1,14.1,,368,Protein L-Myc,nucleus|,"regulation of transcription, DNA-templated|",DNA binding|sequence-specific DNA binding transcription factor activity|protein binding|protein dimerization activity|,2,6,5510000000,2.9%
P61027,0.012995616,0.949916667,41.73356835,-2.799833333,6.70877E-05,-9.759440104,2.6615,1.916,2.472,-0.49,-0.621,-0.239,P61027,Rab10,P61027_Rab10,P61027,Rab10,1,1,1,1,P61027,MOUSE,22768.7,6,507,507.1,14.06,14.06,,200,Ras-related protein Rab-10,endosome|endoplasmic reticulum membrane|Golgi apparatus|trans-Golgi network|focal adhesion|endosome membrane|phagocytic vesicle membrane|insulin-responsive compartment|perinuclear region of cytoplasm|recycling endosome|recycling endosome membrane|extracellular exosome|endoplasmic reticulum tubular network|primary cilium|exocyst|plasma membrane|,intracellular protein transport|Golgi to plasma membrane transport|vesicle docking involved in exocytosis|axonogenesis|protein secretion|vesicle-mediated transport|endosomal transport|regulation of exocytosis|antigen processing and presentation|polarized epithelial cell differentiation|Rab protein signal transduction|cellular response to insulin stimulus|Golgi to plasma membrane protein transport|establishment of neuroblast polarity|basolateral protein localization|cellular response to antibiotic|endoplasmic reticulum tubular network organization|protein localization to plasma membrane|establishment of protein localization to membrane|establishment of protein localization to endoplasmic reticulum membrane|,GTPase activity|protein binding|GTP binding|GDP binding|myosin V binding|,1,1,33500000,6.0%
Q0KL02-4,0.899330297,0.5913,0.780812491,-0.137416667,0.835446706,-0.21905065,0.6885,0.659,,1.657,-0.226,0.178,Q0KL02,Trio,Q0KL02-4_Trio,Q0KL02-4,Trio,1,4,2,2,Q0KL02-4|Q0KL02|Q0KL02-3|Q0KL02-2|G5E825|Q9CWR0|A0A0R4J211|Q9CWR0-2|A0A1Y7VNM7|A0A1W2P6R9,MOUSE,351137,0.7,508,508.1,14.05,14.05,,3102,Isoform 4 of Triple functional domain protein,cytoplasm|,protein phosphorylation|regulation of Rho protein signal transduction|positive regulation of GTPase activity|,protein serine/threonine kinase activity|Rho guanyl-nucleotide exchange factor activity|ATP binding|enzyme binding|,2,4,57600000000,0.7%
F8VQL9,0.174726314,-0.3097,15.88802222,1.577583333,0.025774947,3.161751138,-1.9755,-0.537,,0.236,0.552,0.176,F8VQL9,Ncor2,F8VQL9_Ncor2,F8VQL9,Ncor2,1,2,2,2,F8VQL9|E9Q701|Q9WU42|E9PY55|E9Q9V3|Q9WU42-2,MOUSE,274089,1.1,509,509.1,14,14,,2507,Nuclear receptor corepressor 2,histone deacetylase complex|nucleus|nucleoplasm|membrane|nuclear matrix|nuclear body|transcriptional repressor complex|,"negative regulation of transcription from RNA polymerase II promoter|in utero embryonic development|heart morphogenesis|telencephalon development|cell proliferation in forebrain|forebrain development|glucose homeostasis|negative regulation of fat cell differentiation|negative regulation of transcription, DNA-templated|white fat cell differentiation|Type I pneumocyte differentiation|regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter|positive regulation of protein deacetylation|",DNA binding|chromatin binding|transcription corepressor activity|Notch binding|protein binding|histone deacetylase binding|sequence-specific DNA binding|protein N-terminus binding|,2,2,11700000000,1.1%
A0A1Y7VLS3,0.105031831,-0.4521,21.05243358,1.446916667,0.007847957,4.285920393,-1.7115,-0.929,,0.186,0.157,0.037,A0A1Y7VLS3,Togaram1,A0A1Y7VLS3_Togaram1,A0A1Y7VLS3,Togaram1,1,2,2,2,A0A1Y7VLS3|Q6A070|Q6A070-2,MOUSE,201882.1,0.9,510,510.1,13.98,13.98,,1826,TOG array regulator of axonemal microtubules protein 1,,,,2,2,957000000,0.9%
A4Q9F4,0.862182784,0.1237,1.203114977,0.089083333,0.75803368,0.325457528,0.1705,-0.03,,0.255,0.271,-0.048,A4Q9F4,Ttll11,A4Q9F4_Ttll11,A4Q9F4,Ttll11,1,3,2,2,A4Q9F4|A4Q9F4-2|A4Q9F4-3,MOUSE,83044.2,3.9,511,511.1,13.97,13.97,,727,Tubulin polyglutamylase TTLL11,cytoplasm|cytoskeleton|cilium|,protein polyglutamylation|microtubule severing|,ligase activity|,2,3,135000000,3.9%
Q7TQ48,0.728945731,-0.163583333,2.682339035,0.3605,0.53922013,0.651578359,0.1555,0.335,-1.522,-0.311,-0.045,0.406,Q7TQ48,Srl,Q7TQ48_Srl,Q7TQ48,Srl,1,3,2,2,Q7TQ48,MOUSE,99581.6,1.9,512,512.1,13.92,13.92,,910,Sarcalumenin,sarcoplasmic reticulum lumen|,,GTP binding|,2,3,15700000,1.9%
A2AQB2,0.921042192,0.261083333,0.579139756,0.051833333,0.875157108,0.163955169,0.3725,-0.02,0.353,0.82,0.092,-0.051,A2AQB2,NotFound,A2AQB2_NotFound,A2AQB2,Neb,1,6,2,2,A2AQB2,MOUSE,354700.3,0.4,513,513.1,13.88,13.88,,3044,Nebulin,striated muscle thin filament|Z disc|protein complex|contractile fiber|extracellular exosome|,regulation of actin filament length|sarcomere organization|,actin binding|protein binding|,2,6,10000000000,0.4%
P10639,0.184225648,0.441083333,15.38994908,-1.716833333,0.028907138,-2.87206119,1.2175,2.435,0.246,-0.254,-0.928,-0.07,P10639,Txn1,P10639_Txn1,P10639,Txn,1,2,2,2,P10639,MOUSE,12017.6,19,514,514.1,13.85,13.85,,105,Thioredoxin,nucleus|cytoplasm|mitochondrion|cytosol|extracellular exosome|,"sulfate assimilation|negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|protein folding|glycerol ether metabolic process|response to radiation|positive regulation of peptidyl-serine phosphorylation|regulation of protein import into nucleus, translocation|cellular response to oxidative stress|positive regulation of DNA binding|cell redox homeostasis|negative regulation of protein export from nucleus|oxidation-reduction process|negative regulation of hydrogen peroxide-induced cell death|","protein binding|protein disulfide oxidoreductase activity|peptide disulfide oxidoreductase activity|oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor|poly(A) RNA binding|",2,2,12300000,19.0%
P29416,0.266764579,-0.206,11.5689253,0.862666667,0.069679892,2.461868326,,-0.853,,0.052,-0.032,0.009,P29416,Hexa,P29416_Hexa,P29416,Hexa,1,1,1,1,P29416,MOUSE,61182.5,2,515,515.1,13.83,13.83,,528,Beta-hexosaminidase subunit alpha,lysosome|membrane|extracellular exosome|,skeletal system development|carbohydrate metabolic process|ganglioside catabolic process|lysosome organization|sensory perception of sound|locomotory behavior|adult walking behavior|lipid storage|sexual reproduction|glycosaminoglycan metabolic process|myelination|cell morphogenesis involved in neuron differentiation|neuromuscular process controlling posture|neuromuscular process controlling balance|SMAD protein signal transduction|,beta-N-acetylhexosaminidase activity|protein heterodimerization activity|,1,1,5130000,2.0%
Q8R116,0.188763465,0.435583333,15.15758076,-0.9665,0.030495933,-2.823650914,0.5365,1.411,0.809,0.36,-0.392,-0.111,Q8R116,Notum,Q8R116_Notum,Q8R116,Notum,1,3,1,1,Q8R116|Q8R116-2,MOUSE,57496.3,1.3,516,516.1,13.83,13.83,,503,Palmitoleoyl-protein carboxylesterase NOTUM,extracellular region|,Wnt signaling pathway|negative regulation of Wnt signaling pathway|protein depalmitoleylation|GPI anchor release|,palmitoleyl hydrolase activity|,1,3,11300000,1.3%
Q6JHY2,0.174726314,0.8297,15.90138152,-1.63425,0.025695783,-3.164529002,2.1575,1.463,,-0.58,0.801,0.307,Q6JHY2,Smgc,Q6JHY2_Smgc,Q6JHY2,Muc19,1,1,1,1,Q6JHY2|Q6JHY2-2|Q6JHY2-5|Q6JHY2-3,MOUSE,74495.3,2.5,517,517.1,13.8,13.8,,733,Submandibular gland protein C,extracellular region|,,,1,1,2090000,2.5%
A0A0B4J1J5,0.353357975,-0.34725,8.793793927,0.7685,0.132014188,1.747455834,-1.2565,-1.13,0.192,-0.151,0.24,0.022,A0A0B4J1J5,NotFound,A0A0B4J1J5_NotFound,A0A0B4J1J5,Ighv9-3,1,4,2,2,A0A0B4J1J5,MOUSE,13109.7,17,518,518.1,13.74,13.74,,117,Immunoglobulin heavy variable V9-3 (Fragment),,,,2,4,275000000,17.0%
Q8BMJ2,0.012995616,0.837416667,40.91948683,-3.9735,8.09192E-05,-9.602130164,3.1785,2.109,3.185,-1.025,-1.646,-0.777,Q8BMJ2,Lars,Q8BMJ2_Lars,Q8BMJ2,Lars,1,3,2,2,Q8BMJ2,MOUSE,135445.1,1.3,519,519.1,13.69,13.69,,1178,"Leucine--tRNA ligase, cytoplasmic",nucleus|cytoplasm|cytosol|,leucyl-tRNA aminoacylation|regulation of translational fidelity|methionyl-tRNA aminoacylation|,aminoacyl-tRNA editing activity|leucine-tRNA ligase activity|ATP binding|methionine-tRNA ligase activity|,2,3,3090000000,1.3%
Q9ESG6,0.476454309,0.490416667,6.034449957,-0.652166667,0.249203997,-1.278130137,0.0245,0.571,1.854,0.435,-0.174,0.232,Q9ESG6,P2ry14,Q9ESG6_P2ry14,Q9ESG6,P2ry14,1,4,2,2,A0A0G2JEW9|Q9ESG6,MOUSE,39259.9,6.5,520,520.1,13.42,13.42,,338,P2Y purinoceptor 14,integral component of plasma membrane|,G-protein coupled receptor signaling pathway|G-protein coupled purinergic nucleotide receptor signaling pathway|,G-protein coupled purinergic nucleotide receptor activity|,2,4,17300000000,6.5%
A0A075B5T9,0.560948789,-0.0627,4.70946969,0.398416667,0.338106119,1.06003904,-0.6195,0.016,,-0.312,0.424,0.178,A0A075B5T9,NotFound,A0A075B5T9_NotFound,A0A075B5T9,Ighv1-9,1,1,1,1,A0A075B5T9,MOUSE,13045.5,21.5,521,521.1,13.4,13.4,,116,Immunoglobulin heavy variable V1-9,,,,1,1,37800000,21.5%
Q3U2I3,0.921042192,-0.082416667,0.567745848,-0.089833333,0.877456136,-0.16101448,0.3205,0.817,-1.25,-0.334,-0.108,0.06,Q3U2I3,Fam160a2,Q3U2I3_Fam160a2,Q3U2I3,Fam160a2,1,2,2,2,A0A1C7CYU5|Q3U2I3|Q3U2I3-2|F8WHJ1|Q3U2I3-3,MOUSE,107509.4,1.7,522,522.1,13.24,13.24,,975,FTS and Hook-interacting protein,FHF complex|,endosome organization|lysosome organization|endosome to lysosome transport|protein transport|early endosome to late endosome transport|,,2,2,242000000,1.7%
P86793,0.508444437,0.0141,5.530497757,-0.33775,0.279866054,-1.21163727,0.1355,0.298,,-0.298,-0.176,0.111,P86793,Ccl21c,P86793_Ccl21c,P86793,Ccl21c,1,1,1,1,P86793|P84444,MOUSE,14983.2,7.5,523,523.1,13.24,13.24,,133,C-C motif chemokine 21c,extracellular space|,inflammatory response|immune response|cell chemotaxis|,chemokine activity|CCR7 chemokine receptor binding|,1,1,1630000,7.5%
E9PZ36,0.5707655,0.47425,4.607288697,-0.919833333,0.346155415,-1.023624759,0.8245,-0.828,2.806,-0.219,-0.085,0.347,E9PZ36,Pkhd1,E9PZ36_Pkhd1,E9PZ36,Pkhd1,1,3,2,2,E9PZ36,MOUSE,450351.1,0.7,524,524.1,13.16,13.16,,4059,Polycystic kidney and hepatic disease 1,cytoplasm|centrosome|apical plasma membrane|ciliary basal body|perinuclear region of cytoplasm|extracellular exosome|primary cilium|mitotic spindle|,kidney development|cellular calcium ion homeostasis|positive regulation of cell proliferation|regulation of centrosome duplication|regulation of TOR signaling|negative regulation of NF-kappaB transcription factor activity|cilium assembly|negative regulation of apoptotic process|negative regulation of protein kinase B signaling|regulation of ERK1 and ERK2 cascade|,protein binding|,2,3,278000000,0.7%
Q9ESK3,0.916310019,0.3171,0.664552693,0.083916667,0.858113493,0.188409834,0.0275,0.506,,1.026,0.114,-0.088,Q9ESK3,Capn10,Q9ESK3_Capn10,Q9ESK3,Capn10,1,3,2,2,Q9ESK3|D6RGR0|Q9CPY2,MOUSE,76078.2,4.9,525,525.1,13.08,13.08,,666,Calpain-10,cell|cytoplasm|mitochondrion|cytosol|,proteolysis|actin cytoskeleton reorganization|positive regulation of insulin secretion|positive regulation of intracellular transport|cellular response to insulin stimulus|positive regulation of glucose import|type B pancreatic cell apoptotic process|positive regulation of type B pancreatic cell apoptotic process|,calcium-dependent cysteine-type endopeptidase activity|,2,3,182000000,4.9%
Q80UM7,0.274215486,0.243416667,11.30163834,-1.2255,0.074103064,-2.167520406,1.2855,1.626,-0.343,-0.523,-0.632,0.047,Q80UM7,Mogs,Q80UM7_Mogs,Q80UM7,Mogs,1,2,2,2,Q80UM7,MOUSE,92000.8,1.7,526,526.1,13.05,13.05,,834,Mannosyl-oligosaccharide glucosidase,endoplasmic reticulum membrane|membrane|integral component of membrane|extracellular exosome|,protein N-linked glycosylation|oligosaccharide metabolic process|,mannosyl-oligosaccharide glucosidase activity|,2,2,778000000,1.7%
P10648,0.087827031,1.0816,22.20724655,-3.934833333,0.00601555,-4.624567182,,4.546,2.339,0.472,-1.171,-0.778,P10648,Gsta2,P10648_Gsta2,P10648,Gsta2,1,2,1,1,P13745|Q6P8Q0|P10648|P30115,MOUSE,25655.6,4.9,527,527.1,13.04,13.04,,222,Glutathione S-transferase A2,extracellular exosome|,glutathione metabolic process|response to stilbenoid|,glutathione transferase activity|,1,2,68000000,4.9%
A11112,0.666753363,0.3157,3.380251988,-0.313416667,0.45917137,-0.802692872,0.8935,0.114,,0.4,-0.214,0.385,A11112,NotFound,A11112_NotFound,A11112,,1,2,2,2,A11112,MOUSE,26302.5,9.4,528,528.1,13.02,13.02,,,mKate2,,,,2,2,9990000,9.4%
Q9R0P5,0.167167113,0.6871,16.72964532,-2.203583333,0.021234179,-3.338986127,1.3675,2.651,,0.194,-1.151,0.374,Q9R0P5,Dstn,Q9R0P5_Dstn,Q9R0P5,Dstn,1,1,1,1,Q9R0P5,MOUSE,18863.6,7.8,529,529.1,13.01,13.01,,165,Destrin,cytoplasm|cortical actin cytoskeleton|extracellular exosome|,actin filament depolymerization|positive regulation of actin filament depolymerization|actin filament severing|,actin binding|,1,1,9280000,7.8%
P97873,0.867937645,0.2519,1.143574192,-0.098083333,0.768497715,-0.310819226,0.4705,0.151,,0.288,0.469,-0.119,P97873,Loxl1,P97873_Loxl1,P97873,Loxl1,1,2,2,2,P97873|A0A0R4J0Q4,MOUSE,67189.7,3.4,530,530.1,12.98,12.98,,607,Lysyl oxidase homolog 1,proteinaceous extracellular matrix|extracellular space|extracellular matrix|,oxidation-reduction process|,"copper ion binding|protein binding|oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor|",2,2,156000000,3.4%
E9PUR0,0.001379044,0.957916667,54.9990075,-4.351166667,3.163E-06,-16.53078044,3.2205,3.068,3.112,-1.097,-1.613,-0.943,E9PUR0,Ankhd1,E9PUR0_Ankhd1,E9PUR0,Ankhd1,1,2,2,2,E9PUR0|E9Q1M6|A0A0A6YX17|Q9CWU0|E1BKR4|Q5RJG1|Q9ET22,MOUSE,271726.3,0.5,531,531.1,12.98,12.98,,2548,Ankyrin repeat and KH domain-containing 1,,,poly(A) RNA binding|,2,2,97000000,0.5%
Q8VHI3,0.114958133,0.79725,20.44835293,-1.6265,0.009019131,-3.823250772,1.1605,1.245,2.426,0.221,-0.425,0.156,Q8VHI3,Pofut2,Q8VHI3_Pofut2,Q8VHI3,Pofut2,1,2,2,2,Q8VHI3,MOUSE,49770.7,3.9,532,532.1,12.97,12.97,,429,GDP-fucose protein O-fucosyltransferase 2,endoplasmic reticulum|Golgi apparatus|,mesoderm formation|fucose metabolic process|regulation of gene expression|regulation of epithelial to mesenchymal transition|fucosylation|protein O-linked fucosylation|regulation of secretion|,fucosyltransferase activity|peptide-O-fucosyltransferase activity|,2,2,38100000,3.9%
P00342,0.604460486,0.0125,4.098570863,-0.677083333,0.38917319,-0.944436453,-0.7235,1.561,,-0.082,-0.44,-0.253,P00342,Ldhc,P00342_Ldhc,P00342,Ldhc,1,3,2,2,P00342|A0A1B0GRE9|A0A1B0GSR2|A0A1B0GSX0|P06151|A0A1B0GSR9|A0A1B0GQX5,MOUSE,36253.5,6.3,533,533.1,12.95,12.95,,332,L-lactate dehydrogenase C chain,nucleus|cytoplasm|cilium|motile cilium|extracellular exosome|,carbohydrate metabolic process|pyruvate metabolic process|ATP biosynthetic process|lactate biosynthetic process from pyruvate|lactate oxidation|sperm motility|,L-lactate dehydrogenase activity|protein binding|,2,3,132000000,6.3%
F1MB32,0.534055254,0.40175,5.044618344,-0.652166667,0.312995552,-1.102993285,-0.0805,0.254,2.01,0.072,-0.257,0.412,F1MB32,NotFound,F1MB32_NotFound,F1MB32,A2ML1,1,2,2,2,F1MB32,BOVIN,157039.4,1.8,534,534.1,12.95,12.95,,1396,Uncharacterized protein,,,,2,2,749000000,1.8%
E9QAX2,0.174726314,-0.5855,15.95520371,1.912916667,0.025379299,3.175731816,-2.6645,-0.802,,0.213,0.32,0.006,E9QAX2,Myo18a,E9QAX2_Myo18a,E9QAX2,Myo18a,1,4,2,2,E9QAX2|Q9JMH9-6|Q9JMH9|B2RRE2|K3W4L0|Q9JMH9-1|Q9JMH9-4|A0A1C7ZN10|Q9JMH9-2|Q9JMH9-7|Q9JMH9-5|E9Q405|E9QA74,MOUSE,237125.2,1.5,535,535.1,12.74,12.74,,2083,Unconventional myosin-XVIIIa,Golgi membrane|trans-Golgi network|cytoskeleton|membrane|myosin complex|actomyosin|,Golgi organization|metabolic process|cell migration|actomyosin structure organization|negative regulation of apoptotic process|Golgi vesicle budding|positive regulation of protein secretion|Golgi ribbon formation|asymmetric Golgi ribbon formation|,motor activity|ATP binding|ADP binding|poly(A) RNA binding|actin filament binding|,2,4,7130000000,1.5%
Q9DBN5,0.921042192,0.0347,0.572608627,-0.050083333,0.876474201,-0.163585524,-0.2285,0.358,,0,0.134,-0.09,Q9DBN5,Lonp2,Q9DBN5_Lonp2,Q9DBN5,Lonp2,1,3,2,2,Q9DBN5|Q9DBN5-3|Q8BK80,MOUSE,95038.2,3.5,536,536.1,12.71,12.71,,852,"Lon protease homolog 2, peroxisomal",nucleus|cytoplasm|peroxisome|peroxisomal matrix|membrane|,misfolded or incompletely synthesized protein catabolic process|protein targeting to peroxisome|response to organic cyclic compound|protein processing|protein import into peroxisome matrix|regulation of fatty acid beta-oxidation|,protease binding|ATP-dependent peptidase activity|serine-type endopeptidase activity|receptor binding|protein binding|ATP binding|peptidase activity|enzyme binding|,2,3,1830000000,3.5%
Q9CR42,0.477125007,-0.3907,6.007709149,0.855083333,0.250743154,1.30214742,-1.9475,0.14,,-0.104,0.023,-0.065,Q9CR42,Ankrd1,Q9CR42_Ankrd1,Q9CR42,Ankrd1,1,3,2,2,Q9CR42,MOUSE,36345.4,5.6,537,537.1,12.7,12.7,,319,Ankyrin repeat domain-containing protein 1,nucleus|transcription factor complex|nucleolus|cytoplasm|cytosol|myofibril|sarcomere|I band|,"negative regulation of transcription from RNA polymerase II promoter|regulation of transcription from RNA polymerase II promoter|positive regulation of neuron projection development|cellular response to drug|skeletal muscle cell differentiation|response to muscle stretch|positive regulation of apoptotic process|positive regulation of DNA damage response, signal transduction by p53 class mediator|positive regulation of transcription from RNA polymerase II promoter|positive regulation of protein secretion|cardiac muscle tissue morphogenesis|cellular response to lipopolysaccharide|cellular response to mechanical stimulus|cellular response to interleukin-1|cellular response to tumor necrosis factor|cellular response to organic cyclic compound|cellular response to hypoxia|cellular response to transforming growth factor beta stimulus|negative regulation of DNA biosynthetic process|",RNA polymerase II transcription factor binding|RNA polymerase II transcription coactivator activity|p53 binding|DNA binding|transcription corepressor activity|protein binding|titin binding|histone deacetylase binding|R-SMAD binding|,2,3,1270000000,5.6%
Q8BYY9,0.699470325,-0.846083333,3.010343587,1.426166667,0.499994977,0.718356688,0.8425,0.836,-6.356,-0.153,-0.083,-0.163,Q8BYY9,Serpina3b,Q8BYY9_Serpina3b,Q8BYY9,Serpina3b,1,1,1,1,Q8BYY9,MOUSE,47642.2,2.6,538,538.1,12.69,12.69,,420,Serine protease inhibitor A3B,extracellular space|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,1,1,6810000,2.6%
Q61884,0.105031831,0.32125,21.16341935,-1.0765,0.007649941,-3.939474394,0.8415,1.246,0.491,-0.128,-0.331,-0.192,Q61884,Mns1,Q61884_Mns1,Q61884,Mns1,1,5,2,2,Q61884,MOUSE,60291.8,2.8,539,539.1,12.66,12.66,,491,Meiosis-specific nuclear structural protein 1,nuclear envelope|intermediate filament|axoneme|sperm flagellum|,spermatogenesis|cilium organization|positive regulation of cilium assembly|meiotic cell cycle|left/right axis specification|,identical protein binding|,2,5,223000000,2.8%
Q5S006,0.32515976,-0.0763,9.669213549,0.699916667,0.107914212,1.956751816,-0.9015,-0.091,,0.265,0.358,-0.012,Q5S006,Lrrk2,Q5S006_Lrrk2,Q5S006,Lrrk2,1,4,2,2,Q5S006|V9GX76|V9GXM4|E9Q174|Q64331|E9PVU0|E9Q3L1|E9Q175,MOUSE,288720.5,0.4,540,540.1,12.63,12.63,,2527,Leucine-rich repeat serine/threonine-protein kinase 2,extracellular space|cytoplasm|mitochondrion|mitochondrial outer membrane|mitochondrial inner membrane|mitochondrial matrix|lysosome|endosome|endoplasmic reticulum|Golgi apparatus|trans-Golgi network|cytosol|plasma membrane|synaptic vesicle|inclusion body|cell junction|axon|dendrite|ribonucleoprotein complex|synaptic vesicle membrane|cytoplasmic vesicle|mitochondrial membrane|cytoplasmic side of mitochondrial outer membrane|dendrite cytoplasm|neuron projection|neuronal cell body|terminal bouton|perikaryon|membrane raft|synapse|extracellular exosome|,"MAPK cascade|activation of MAPKK activity|activation of MAPK activity|negative regulation of protein phosphorylation|positive regulation of protein phosphorylation|protein phosphorylation|endocytosis|autophagy|response to oxidative stress|mitochondrion organization|Golgi organization|lysosome organization|small GTPase mediated signal transduction|neuromuscular junction development|determination of adult lifespan|positive regulation of autophagy|regulation of protein kinase A signaling|negative regulation of protein processing|regulation of neuron maturation|peptidyl-serine phosphorylation|peptidyl-threonine phosphorylation|calcium-mediated signaling|olfactory bulb development|tangential migration from the subventricular zone to the olfactory bulb|positive regulation of protein ubiquitination|negative regulation of protein binding|positive regulation of protein binding|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|negative regulation of GTPase activity|cellular response to oxidative stress|cellular protein localization|intracellular signal transduction|regulation of kidney size|exploration behavior|locomotory exploration behavior|synaptic vesicle recycling|regulation of locomotion|regulation of membrane potential|positive regulation of programmed cell death|positive regulation of GTPase activity|GTP metabolic process|protein autophosphorylation|intracellular distribution of mitochondria|neuron projection morphogenesis|mitochondrion localization|regulation of mitochondrial depolarization|regulation of synaptic transmission, glutamatergic|regulation of excitatory postsynaptic membrane potential|regulation of dopamine receptor signaling pathway|positive regulation of dopamine receptor signaling pathway|regulation of dendritic spine morphogenesis|neuron death|cellular response to manganese ion|reactive oxygen species metabolic process|regulation of neuron death|negative regulation of neuron death|negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway|positive regulation of protein autoubiquitination|regulation of neuroblast proliferation|regulation of synaptic vesicle transport|negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation|negative regulation of hydrogen peroxide-induced cell death|negative regulation of protein targeting to mitochondrion|cellular response to dopamine|regulation of branching morphogenesis of a nerve|regulation of synaptic vesicle exocytosis|negative regulation of peroxidase activity|",SNARE binding|glycoprotein binding|actin binding|GTPase activity|protein kinase activity|protein serine/threonine kinase activity|MAP kinase kinase activity|GTPase activator activity|protein binding|ATP binding|GTP binding|tubulin binding|kinase activity|Rho GTPase binding|syntaxin-1 binding|clathrin binding|GTP-dependent protein kinase activity|peroxidase inhibitor activity|identical protein binding|protein homodimerization activity|ion channel binding|protein kinase A binding|,2,4,999000000,0.4%
Q8VCC9,0.745307288,0.133625,2.282450538,0.278833333,0.591227935,0.583938721,-0.0755,,,-0.255,0.479,0.386,Q8VCC9,Spon1,Q8VCC9_Spon1,Q8VCC9,Spon1,1,1,1,1,Q8VCC9,MOUSE,93444.1,1.3,541,541.1,12.6,12.6,,807,Spondin-1,proteinaceous extracellular matrix|extracellular space|extracellular matrix|,cell adhesion|,,1,1,9600000,1.3%
Q3U492,0.477427431,0.213083333,5.962175411,-0.6035,0.253385909,-1.265518096,1.2915,0.741,-0.488,-0.119,-0.115,-0.032,Q3U492,Kcp,Q3U492_Kcp,Q3U492,Kcp,1,2,1,1,Q3U492|Q3U492-2|E9QNB3,MOUSE,178777.4,0.7,542,542.1,12.57,12.57,,1550,Kielin/chordin-like protein,extracellular space|,hematopoietic progenitor cell differentiation|positive regulation of BMP signaling pathway|,protein binding|,1,2,4270000,0.7%
P01627,0.534055254,0.0053,5.021557535,0.537583333,0.314661962,1.11988091,-0.9695,0.335,,0.313,0.442,-0.094,P01627,NotFound,P01627_NotFound,P01627,Gm5153,1,2,1,1,P01627|A0A075B5K5|P01628,MOUSE,13451,13.3,543,543.1,12.56,12.56,,120,Ig kappa chain V-II region VKappa167,,,,1,2,31900000,13.3%
K7N784,0.157989283,0.330416667,17.19316183,-0.834833333,0.019084633,-3.181105141,0.5295,0.556,1.158,-0.063,-0.073,-0.125,K7N784,NotFound,K7N784_NotFound,K7N784,Vmn2r4,1,2,2,2,K7N784|E9Q277|E9PYL5|H3BK29|E9PZ74|L7N478,MOUSE,104813.9,4.3,544,544.1,12.51,12.51,,913,"Vomeronasal 2, receptor 4",plasma membrane|integral component of membrane|,G-protein coupled receptor signaling pathway|,G-protein coupled receptor activity|,2,2,111000000,4.3%
Q62266,0.022480999,0.7729,35.52899934,-4.083083333,0.000279963,-9.228391064,3.2815,3.164,,-1.264,-1.184,-0.133,Q62266,Sprr1a,Q62266_Sprr1a,Q62266,Sprr1a,1,1,1,1,Q62266,MOUSE,16620.8,5.5,545,545.1,12.5,12.5,,144,Cornifin-A,cornified envelope|cytoplasm|cell periphery|,peptide cross-linking|keratinocyte differentiation|keratinization|,"structural molecule activity|protein binding, bridging|",1,1,23300000,5.5%
A0A0A6YW72,0.477427431,-0.1425,5.978800209,0.437083333,0.252417801,1.293617947,-0.0945,-0.715,,-0.257,0.206,0.148,A0A0A6YW72,NotFound,A0A0A6YW72_NotFound,A0A0A6YW72,Dchs2,1,3,2,2,A0A0A6YW72,MOUSE,367194.3,0.7,546,546.1,12.43,12.43,,3346,Dachsous cadherin-related 2,plasma membrane|integral component of membrane|,homophilic cell adhesion via plasma membrane adhesion molecules|,calcium ion binding|,2,3,1980000000,0.7%
E9Q328,0.172893577,0.70325,16.4262304,-1.979833333,0.02277073,-3.058222603,2.8015,1.887,0.391,-0.347,-0.7,0.187,E9Q328,5430401F13Rik,E9Q328_5430401F13Rik,E9Q328,5430401F13Rik,1,1,1,1,E9Q328|F6URP1,MOUSE,18977.3,6.8,547,547.1,12.39,12.39,,175,RIKEN cDNA 5430401F13 gene,,,,1,1,48900000,6.8%
Q9QYX7,0.546365857,-0.0729,4.887136145,0.98975,0.324553566,1.094677289,-1.9755,0.642,,1.141,-0.204,0.032,Q9QYX7,Pclo,Q9QYX7_Pclo,Q9QYX7,Pclo,1,2,2,2,Q9QYX7|Q9QYX7-2,MOUSE,552707.3,0.6,548,548.1,12.36,12.36,,5068,Protein piccolo,intracellular|postsynaptic density|cell junction|synapse|presynaptic active zone|extracellular exosome|,cytoskeleton organization|synapse assembly|synaptic vesicle targeting|regulation of exocytosis|cAMP-mediated signaling|insulin secretion|,calcium ion binding|protein binding|profilin binding|calcium-dependent phospholipid binding|,2,2,11700000000,0.6%
Q8K426,0.58697158,0.394416667,4.371284668,-0.566833333,0.365486663,-0.980167941,1.6625,-0.204,0.575,-0.244,-0.288,0.865,Q8K426,Retnlg,Q8K426_Retnlg,Q8K426,Retnlg,1,2,1,1,Q8K426,MOUSE,13276.1,10.2,550,550.1,12.31,12.31,,117,Resistin-like gamma,extracellular space|,myeloid dendritic cell chemotaxis|,hormone activity|,1,2,23500000,10.2%
Q9WUF3,0.279012296,0.05925,11.17517833,1.033666667,0.076292556,2.377927187,,-0.716,,0.637,0.314,0.002,Q9WUF3,Casp8ap2,Q9WUF3_Casp8ap2,Q9WUF3,Casp8ap2,1,2,2,2,Q9WUF3|E9Q368|Q3V2J0|Q9R0K4|B1AX75,MOUSE,221996.7,0.7,551,551.1,12.3,12.3,,1962,CASP8-associated protein 2,nucleus|cytoplasm|mitochondrion|PML body|,"transcription, DNA-templated|regulation of transcription, DNA-templated|activation of cysteine-type endopeptidase activity involved in apoptotic process|cell cycle|extrinsic apoptotic signaling pathway via death domain receptors|Fas signaling pathway|negative regulation of nucleic acid-templated transcription|",protease binding|DNA binding|transcription corepressor activity|protein binding|cysteine-type endopeptidase activator activity involved in apoptotic process|SUMO polymer binding|identical protein binding|,2,2,764000000,0.7%
Q60963,0.382558739,0.137416667,8.155123853,-0.526833333,0.152928213,-1.636741677,0.7955,0.61,-0.203,-0.105,-0.172,-0.101,Q60963,Pla2g7,Q60963_Pla2g7,Q60963,Pla2g7,1,2,1,1,Q60963,MOUSE,49599.7,2.7,552,552.1,12.27,12.27,,440,Platelet-activating factor acetylhydrolase,cytoplasm|low-density lipoprotein particle|,inflammatory response|lipid catabolic process|low-density lipoprotein particle remodeling|lipid oxidation|plasma lipoprotein particle oxidation|positive regulation of monocyte chemotaxis|,1-alkyl-2-acetylglycerophosphocholine esterase activity|phospholipid binding|calcium-independent phospholipase A2 activity|,1,2,15800000,2.7%
A0A140LIJ4,0.921042192,0.23275,0.577753131,-0.068166667,0.875436575,-0.163695639,-0.4265,0.761,0.466,0.552,-0.321,0.365,A0A140LIJ4,NotFound,A0A140LIJ4_NotFound,A0A140LIJ4,Dnah14,1,3,2,2,A0A140LIJ4,MOUSE,521611.8,0.6,553,553.1,12.21,12.21,,4489,"Dynein, axonemal, heavy chain 14",,,,2,3,170000000,0.6%
Q8R5K4,0.817448119,0.40025,1.612204157,0.277666667,0.689889578,0.430019101,,0.192,,1.232,0.097,0.08,Q8R5K4,Nol6,Q8R5K4_Nol6,Q8R5K4,Nol6,1,6,2,2,Q8R5K4|Q8R5K4-2|Q810B6,MOUSE,130081.4,1.1,554,554.1,11.99,11.99,,1152,Nucleolar protein 6,condensed nuclear chromosome|nucleus|nucleolus|mitochondrion|small-subunit processome|CURI complex|UTP-C complex|,rRNA processing|tRNA export from nucleus|,poly(A) RNA binding|,2,6,1090000000,1.1%
B2RQC6,0.315406172,1.0167,10.13011155,-2.752583333,0.097048504,-2.048187287,0.4535,4.883,,0.334,-0.605,0.018,B2RQC6,Cad,B2RQC6_Cad,B2RQC6,Cad,1,2,2,2,B2RQC6|G3UWN2|E9QAI5|B2RQC6-2,MOUSE,245801.4,0.7,555,555.1,11.93,11.93,,2225,CAD protein,nucleus|nucleoplasm|cytoplasm|cytosol|plasma membrane|membrane|nuclear matrix|neuronal cell body|terminal bouton|protein complex|extracellular exosome|,urea cycle|liver development|'de novo' pyrimidine nucleobase biosynthetic process|UTP biosynthetic process|arginine biosynthetic process|glutamine metabolic process|heart development|female pregnancy|lactation|response to amine|drug metabolic process|peptidyl-threonine phosphorylation|response to caffeine|organ regeneration|response to testosterone|cellular response to drug|'de novo' UMP biosynthetic process|protein autophosphorylation|response to cortisol|cellular response to epidermal growth factor stimulus|,UTP binding|aspartate carbamoyltransferase activity|carbamoyl-phosphate synthase (ammonia) activity|carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity|dihydroorotase activity|protein kinase activity|ATP binding|zinc ion binding|amino acid binding|enzyme binding|identical protein binding|,2,2,348000000,0.7%
E9Q043,0.045581473,-0.4275,27.50662143,1.967083333,0.00177557,6.060132776,-1.7975,-1.418,,0.654,0.392,0.032,E9Q043,Fndc1,E9Q043_Fndc1,E9Q043,Fndc1,1,2,1,1,E9Q043,MOUSE,189544.2,0.4,556,556.1,11.86,11.86,,1732,Fibronectin type III domain-containing 1,nucleoplasm|cytoplasm|plasma membrane|cell-cell junction|mitochondrial membrane|,positive regulation of protein phosphorylation|positive regulation of cardiac muscle cell apoptotic process|regulation of protein transport|cellular response to hypoxia|,,1,2,24400000,0.4%
O09010,,0.188666667,,,,,,,,-0.179,0.386,0.359,O09010,Lfng,O09010_Lfng,O09010,Lfng,1,2,2,2,O09010,MOUSE,42464.9,5.8,557,557.1,11.86,11.86,,378,"Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe",Golgi membrane|integral component of Golgi membrane|extracellular vesicle|,ovarian follicle development|somitogenesis|female meiotic division|compartment pattern specification|metabolic process|regulation of Notch signaling pathway|regulation of somitogenesis|positive regulation of protein binding|positive regulation of Notch signaling pathway|,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity|metal ion binding|,2,2,1.05E+11,5.8%
P24369,0.97243717,-0.435916667,0.14307215,-0.0655,0.96759315,-0.042381345,0.7305,2.098,-4.038,-0.353,-0.462,-0.591,P24369,Ppib,P24369_Ppib,P24369,Ppib,1,1,1,1,P24369,MOUSE,23713,6,558,558.1,11.84,11.84,,216,Peptidyl-prolyl cis-trans isomerase B,nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|focal adhesion|membrane|macromolecular complex|endoplasmic reticulum chaperone complex|melanosome|perinuclear region of cytoplasm|extracellular exosome|,protein peptidyl-prolyl isomerization|positive regulation of multicellular organism growth|positive regulation by host of viral process|positive regulation by host of viral genome replication|protein stabilization|bone development|chaperone-mediated protein folding|,peptidyl-prolyl cis-trans isomerase activity|protein complex binding|peptide binding|poly(A) RNA binding|RNA polymerase binding|collagen binding|,1,1,913000,6.0%
P16015,0.194871331,0.1455,14.81428685,-2.63125,0.03300436,-2.942000934,0.2715,3.177,,-0.741,-0.776,-1.204,P16015,Car3,P16015_Car3,P16015,Ca3,1,1,1,1,P16015,MOUSE,29651,4.6,559,559.1,11.81,11.81,,260,Carbonic anhydrase 3,cytosol|,one-carbon metabolic process|response to oxidative stress|dephosphorylation|response to ethanol|,carbonate dehydratase activity|zinc ion binding|nickel cation binding|phosphatase activity|,1,1,24900000,4.6%
P21550,0.407329798,0.03275,7.575942191,-1.688833333,0.174745412,-1.542504858,1.7205,2.585,-1.674,-0.765,-1.077,-0.593,P21550,Eno3,P21550_Eno3,P21550,Eno3,1,4,2,2,P21550,MOUSE,47366.4,2.9,560,560.1,11.79,11.79,,434,Beta-enolase,phosphopyruvate hydratase complex|extracellular space|cytoplasm|plasma membrane|extracellular exosome|,glycolytic process|aging|response to drug|skeletal muscle tissue regeneration|,magnesium ion binding|phosphopyruvate hydratase activity|protein homodimerization activity|protein heterodimerization activity|,2,4,17700000000,2.9%
K3W4R5,0.512767633,-0.2339,5.381269187,0.42975,0.289649699,1.184853476,-0.9505,-0.033,,-0.081,-0.092,-0.013,K3W4R5,Ckap5,K3W4R5_Ckap5,K3W4R5,Ckap5,1,2,2,2,K3W4R5|A2AGT5|A0A0R4J0K2|A2AGT5-3|Z4YL78|A2AGT5-2,MOUSE,227286.2,0.7,561,561.1,11.78,11.78,,2032,Cytoskeleton-associated protein 5,spindle pole|cytoplasm|centrosome|membrane|protein complex|gamma-tubulin complex|microtubule plus-end|,spindle organization|establishment or maintenance of microtubule cytoskeleton polarity|centrosome organization|,microtubule binding|ribonucleoprotein complex binding|,2,2,274000000,0.7%
Q8VCY6,0.565879699,0.9357,4.661276547,-0.995916667,0.341878937,-1.052086427,2.9435,0.123,,0.718,1.115,-0.221,Q8VCY6,Utp6,Q8VCY6_Utp6,Q8VCY6,Utp6,1,2,2,2,Q8VCY6|Q6I6G8|Q9JLV2|Q9JLV2-2|A0A0R4J0M8|Q8CDV6|Q8CDV6-2|Q9DAQ9|Q9DAQ9-2|A0A1L1SQQ1,MOUSE,70941.6,2.1,562,562.1,11.78,11.78,,597,U3 small nucleolar RNA-associated protein 6 homolog,nucleolus|small-subunit processome|Pwp2p-containing subcomplex of 90S preribosome|,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|",snoRNA binding|,2,2,76400000,2.1%
Q64323,0.141445692,-0.5927,18.70870244,1.845083333,0.013462625,3.775151782,-0.9965,-2.403,,0.038,0.358,0.04,Q64323,Piga,Q64323_Piga,Q64323,Piga,1,1,1,1,Q64323|A0A140LI97,MOUSE,55095.4,1.4,563,563.1,11.77,11.77,,485,N-acetylglucosaminyl-phosphatidylinositol biosynthetic protein,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex|endoplasmic reticulum membrane|membrane|integral component of membrane|,GPI anchor biosynthetic process|,"transferase activity, transferring glycosyl groups|",1,1,154000000,1.4%
O89001,0.322583882,-0.0091,9.929523608,1.191916667,0.101636017,2.011591862,-1.3685,-0.08,,1.181,-0.137,0.359,O89001,Cpd,O89001_Cpd,O89001,Cpd,1,6,2,2,O89001,MOUSE,153429.8,1,564,564.1,11.77,11.77,,1377,Carboxypeptidase D,membrane|integral component of membrane|extracellular exosome|,proteolysis|,metallocarboxypeptidase activity|serine-type carboxypeptidase activity|zinc ion binding|,2,6,6510000000,1.0%
O54988,0.047034419,-0.4485,26.61064302,1.549583333,0.002182407,5.785972425,-1.3095,-1.447,,0.138,0.353,0.023,O54988,Slk,O54988_Slk,O54988,Slk,1,7,2,2,O54988|O54988-2,MOUSE,142138.8,1.3,565,565.1,11.67,11.67,,1233,STE20-like serine/threonine-protein kinase,cytoplasm|extracellular exosome|,apoptotic process|regulation of mitotic cell cycle|signal transduction by protein phosphorylation|stress-activated protein kinase signaling cascade|activation of protein kinase activity|regulation of apoptotic process|protein autophosphorylation|,protein serine/threonine kinase activity|ATP binding|identical protein binding|protein homodimerization activity|,2,7,388000000,1.3%
A2AFQ0,0.524335469,-0.0151,5.185883279,-0.745583333,0.302978403,-1.150557273,-0.5975,1.462,,-0.322,-0.303,-0.315,A2AFQ0,Huwe1,A2AFQ0_Huwe1,A2AFQ0,Huwe1,1,2,2,2,A2AFQ0|Q7TMY8|Q7TMY8-3|Q7TMY8-4|Q7TMY8-2|Q8K482|Q8BLW8,MOUSE,486619.9,0.2,566,566.1,11.67,11.67,,4378,E3 ubiquitin-protein ligase HUWE1,nucleoplasm|cytoplasm|membrane|extracellular exosome|,protein polyubiquitination|base-excision repair|protein monoubiquitination|histone ubiquitination|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of protein targeting to mitochondrion|,ubiquitin-protein transferase activity|ligase activity|poly(A) RNA binding|,2,2,49700000,0.2%
Q80TF3,0.745189602,1.7745,2.41460284,-1.485416667,0.573508311,-0.602728582,1.0595,4.272,,5.637,-0.605,-1.491,Q80TF3,Pcdh19,Q80TF3_Pcdh19,Q80TF3,Pcdh19,1,2,2,2,Q80TF3|E9Q5E1,MOUSE,127231.1,1.5,567,567.1,11.66,11.66,,1145,Protocadherin-19,plasma membrane|integral component of membrane|,homophilic cell adhesion via plasma membrane adhesion molecules|brain development|,calcium ion binding|,2,2,20600000000,1.5%
A0A075B5L3,0.023108713,0.74875,32.40429139,-1.9135,0.000574872,-6.621397009,1.4145,1.914,1.788,-0.158,-0.585,0.119,A0A075B5L3,NotFound,A0A075B5L3_NotFound,A0A075B5L3,Igkv4-90,1,1,1,1,A0A075B5L3,MOUSE,12723.1,13.6,568,568.1,11.65,11.65,,117,Immunoglobulin kappa chain variable 4-90 (Fragment),,,,1,1,3050000,13.6%
P09411,0.641826969,-0.190083333,3.641003184,0.3915,0.432413935,0.842362835,-0.1215,0.334,-1.37,0.065,-0.056,0.008,P09411,Pgk1,P09411_Pgk1,P09411,Pgk1,1,3,2,2,P09411,MOUSE,44949.1,4.3,569,569.1,11.62,11.62,,417,Phosphoglycerate kinase 1,cytoplasm|,glycolytic process|phosphorylation|,phosphoglycerate kinase activity|ATP binding|,2,3,205000000,4.3%
E9PUU4,0.293302242,-0.0025,10.81374305,0.81875,0.082913585,2.168431113,-0.1605,-0.827,,0.726,0.241,0.008,E9PUU4,Gemin5,E9PUU4_Gemin5,E9PUU4,Gemin5,1,5,2,2,E9PUU4|Q8BX17|A2AFQ9,MOUSE,169370,1.3,570,570.1,11.56,11.56,,1503,Gem-associated protein 5,nucleus|nucleoplasm|cytoplasm|cytosol|membrane|nuclear body|SMN complex|SMN-Sm protein complex|,spliceosomal snRNP assembly|,snRNA binding|poly(A) RNA binding|,2,5,3090000000,1.3%
Q8BLR5,0.940910696,0.8867,0.362815968,-0.123416667,0.919852945,-0.105912582,0.1815,1.74,,2.871,-0.507,0.148,Q8BLR5,Psd4,Q8BLR5_Psd4,Q8BLR5,Psd4,1,2,1,1,Q8BLR5,MOUSE,113986.3,0.7,571,571.1,11.54,11.54,,1005,PH and SEC7 domain-containing protein 4,plasma membrane|membrane|cell junction|trans-Golgi network|,neuron differentiation|regulation of ARF protein signal transduction|positive regulation of GTPase activity|vesicle-mediated transport|,ARF guanyl-nucleotide exchange factor activity|lipid binding|,1,2,109000000,0.7%
P27106,0.26283168,-0.1321,11.669745,0.636083333,0.068080933,2.32067684,-0.5455,-0.482,,0.183,-0.106,0.29,P27106,NotFound,P27106_NotFound,P27106,Amh,1,4,1,1,P27106|Q5EC55,MOUSE,60405,1,572,572.1,11.49,11.49,,555,Muellerian-inhibiting factor,extracellular region|,gonadal mesoderm development|cell differentiation|,growth factor activity|,1,4,406000000,1.0%
Q8BYH8,0.425473432,-0.3033,6.966621205,0.729916667,0.201065649,1.476383809,-0.0355,-1.447,,-0.258,0.079,0.145,Q8BYH8,Chd9,Q8BYH8_Chd9,Q8BYH8,Chd9,1,2,2,2,Q8BYH8|Q8BYH8-2|A0A1B0GR76,MOUSE,326022.2,0.8,573,573.1,11.48,11.48,,2885,Chromodomain-helicase-DNA-binding protein 9,nucleus|cytoplasm|plasma membrane|,"transcription, DNA-templated|regulation of transcription, DNA-templated|chromatin modification|",DNA binding|helicase activity|ATP binding|,2,2,58600000,0.8%
Q03717,0.586005351,0.688583333,4.398518974,-0.8225,0.363201892,-0.985207054,-0.5575,1.184,2.673,0.446,-0.33,0.716,Q03717,Kcnb1,Q03717_Kcnb1,Q03717,Kcnb1,1,3,2,2,Q03717,MOUSE,96445.6,2.2,574,574.1,11.39,11.39,,857,Potassium voltage-gated channel subfamily B member 1,intracellular|plasma membrane|voltage-gated potassium channel complex|integral component of membrane|lateral plasma membrane|cell junction|axon|dendrite|dendrite membrane|neuronal cell body membrane|sarcolemma|perikaryon|postsynaptic membrane|,action potential|potassium ion transport|vesicle docking involved in exocytosis|glutamate receptor signaling pathway|positive regulation of norepinephrine secretion|cellular response to nutrient levels|positive regulation of catecholamine secretion|regulation of ion transmembrane transport|glucose homeostasis|positive regulation of calcium ion-dependent exocytosis|negative regulation of insulin secretion|protein homooligomerization|cellular response to glucose stimulus|potassium ion transmembrane transport|protein targeting to plasma membrane|positive regulation of protein targeting to membrane|regulation of action potential|positive regulation of long term synaptic depression|regulation of motor neuron apoptotic process|,voltage-gated potassium channel activity|delayed rectifier potassium channel activity|protein binding|outward rectifier potassium channel activity|ubiquitin-like protein binding|ion channel binding|protein heterodimerization activity|protein N-terminus binding|,2,3,56500000,2.2%
Q3TQQ9-2,0.415101064,0.18225,7.287287004,-0.6985,0.186754596,-1.493542176,1.4155,0.5,-0.321,-0.393,-0.021,-0.087,Q3TQQ9,BC055324,Q3TQQ9-2_BC055324,Q3TQQ9-2,,1,5,1,1,Q3TQQ9-2|Q3TQQ9|Q3TQQ9-3,MOUSE,105599.9,1.5,575,575.1,11.33,11.33,,903,Isoform 2 of Uncharacterized protein C1orf112 homolog,,,,1,5,188000000,1.5%
Q8CB77,0.353902242,-0.0717,8.743896023,0.593416667,0.1335397,1.790120389,-0.7905,-0.065,,0.041,0.29,0.166,Q8CB77,Eloa,Q8CB77_Eloa,Q8CB77,Eloa,1,2,2,2,Q8CB77,MOUSE,87502.1,3.6,576,576.1,11.33,11.33,,773,Elongin-A,extracellular space|nucleus|cytoplasm|integral component of membrane|elongin complex|,regulation of transcription from RNA polymerase II promoter|transcription elongation from RNA polymerase II promoter|protein ubiquitination involved in ubiquitin-dependent protein catabolic process|,DNA binding|ubiquitin-protein transferase activity|,2,2,217000000,3.6%
A7DTG3,0.654719332,0.1261,3.482976915,-0.326916667,0.448437898,-0.823480514,0.8295,-0.185,,-0.183,0.177,-0.008,A7DTG3,Sertad4,A7DTG3_Sertad4,A7DTG3,Sertad4,1,4,1,1,A7DTG3,MOUSE,41836.9,1.8,577,577.1,11.31,11.31,,377,SERTA domain-containing protein 4,nucleus|,,,1,4,177000000,1.8%
E9PZ26,0.230583402,-0.0491,13.14000798,0.79275,0.048528761,2.596516769,-0.2135,-0.836,,0.284,0.251,0.269,E9PZ26,Brd1,E9PZ26_Brd1,E9PZ26,Brd1,1,2,2,2,E9PZ26|G5E8P1|E9Q412,MOUSE,135652.4,1.2,578,578.1,11.3,11.3,,1189,Bromodomain-containing 1,nucleus|nucleoplasm|dendrite|perikaryon|MOZ/MORF histone acetyltransferase complex|,response to immobilization stress|histone H3 acetylation|response to electrical stimulus|,zinc ion binding|histone binding|,2,2,788000000,1.2%
P97366,0.755781438,0.2927,2.147443178,-0.20175,0.609895856,-0.544145297,0.8345,-0.007,,0.456,0.181,-0.001,P97366,NotFound,P97366_NotFound,P97366,Evi5,1,2,2,2,P97366|F8VPT6,MOUSE,93682.9,3.4,579,579.1,11.24,11.24,,809,Ecotropic viral integration site 5 protein,nucleus|Golgi apparatus|microtubule organizing center|spindle|cytosol|intracellular membrane-bounded organelle|,"cell cycle|retrograde transport, endosome to Golgi|positive regulation of GTPase activity|cell division|",GTPase activator activity|Rab GTPase binding|,2,2,354000000,3.4%
P62242,0.026097217,0.852916667,31.45698665,-2.841833333,0.000714992,-6.432210257,1.5145,2.347,2.96,-1.026,-0.418,-0.26,P62242,Rps8,P62242_Rps8,P62242,Rps8,1,1,1,1,P62242,MOUSE,24490,4.3,580,580.1,11.22,11.22,,208,40S ribosomal protein S8,nucleus|cytoplasm|focal adhesion|membrane|cytosolic small ribosomal subunit|ribonucleoprotein complex|extracellular exosome|,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|translation|",structural constituent of ribosome|poly(A) RNA binding|,1,1,2470000000,4.3%
Q6A037,0.861013543,0.0325,1.223353509,0.090416667,0.75450939,0.330406046,-0.1815,0.138,,0.218,-0.008,-0.004,Q6A037,N4bp1,Q6A037_N4bp1,Q6A037,N4bp1,1,6,2,2,Q6A037,MOUSE,99886.7,3.1,581,581.1,11.18,11.18,,893,NEDD4-binding protein 1,nucleus|nucleolus|PML body|,negative regulation of protein ubiquitination|negative regulation of proteasomal ubiquitin-dependent protein catabolic process|cellular response to UV|,protein binding|,2,6,1240000000,3.1%
E9PX59,0.219826621,-0.1263,13.44815435,1.202416667,0.045204801,2.671624251,-0.3165,-1.379,,0.271,0.763,0.03,E9PX59,Samd9l,E9PX59_Samd9l,E9PX59,Samd9l,1,3,2,2,E9PX59|Q69Z37,MOUSE,184076.8,1,582,582.1,11.15,11.15,,1579,Sterile alpha motif domain-containing protein 9-like,early endosome|,hematopoietic progenitor cell differentiation|stem cell division|endosomal vesicle fusion|common myeloid progenitor cell proliferation|regulation of protein catabolic process|spleen development|,,2,3,395000000,1.0%
Q69ZS0,0.14994666,-0.1371,18.09090273,0.973583333,0.015520644,3.604040718,-0.7845,-0.658,,0.047,0.385,0.325,Q69ZS0,Pdzrn3,Q69ZS0_Pdzrn3,Q69ZS0,Pdzrn3,1,2,2,2,Q69ZS0|Q69ZS0-3|Q69ZS0-2,MOUSE,120996.6,1.6,583,583.1,11.12,11.12,,1063,E3 ubiquitin-protein ligase PDZRN3,neuromuscular junction|,neuromuscular junction development|protein ubiquitination|,ubiquitin-protein transferase activity|protein binding|zinc ion binding|ligase activity|ubiquitin protein ligase activity|,2,2,889000000,1.6%
Q3TPE1,0.033048775,0.6159,30.23832348,-1.773083333,0.000946603,-6.961412504,1.7685,1.591,,-0.128,-0.017,-0.135,Q3TPE1,NotFound,Q3TPE1_NotFound,Q3TPE1,Vwf,1,2,2,2,Q3TPE1|Q3TD35|Q8CIZ8-2,MOUSE,46792.8,3.7,584,584.1,11.11,11.11,,405,von Willebrand factor,extracellular region|proteinaceous extracellular matrix|endoplasmic reticulum|external side of plasma membrane|extracellular matrix|Weibel-Palade body|extracellular exosome|,liver development|placenta development|cell adhesion|blood coagulation|hemostasis|platelet activation|cell-substrate adhesion|protein homooligomerization|platelet activation|,glycoprotein binding|protease binding|integrin binding|protein binding|collagen binding|immunoglobulin binding|identical protein binding|protein homodimerization activity|protein N-terminus binding|chaperone binding|,2,2,116000000,3.7%
Q9JK39-2,0.669813064,0.0451,3.33063188,-0.201083333,0.464447695,-0.79175258,0.1725,0.159,,-0.119,0.083,-0.07,Q9JK39,Btnl10,Q9JK39-2_Btnl10,Q9JK39-2,Btnl10,1,2,1,1,Q9JK39-2|Q9JK39|A0A0R4J1C6,MOUSE,54778.1,1.4,585,585.1,11.03,11.03,,275,Isoform 2 of Butyrophilin-like protein 10,integral component of membrane|,,,1,2,9720000,1.4%
P54822,0.768775298,0.3079,1.993721897,-0.170583333,0.631870108,-0.509882124,0.4425,0.378,,0.325,-0.186,0.58,P54822,Adsl,P54822_Adsl,P54822,Adsl,1,1,1,1,P54822|E9Q242,MOUSE,55607,2.2,586,586.1,11.02,11.02,,484,Adenylosuccinate lyase,mitochondrion|cytosol|,response to hypoxia|AMP biosynthetic process|'de novo' IMP biosynthetic process|response to nutrient|aerobic respiration|response to muscle activity|response to starvation|'de novo' AMP biosynthetic process|protein tetramerization|,"N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity|(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity|",1,1,28900000,2.2%
A2AFG3,0.116696197,-0.2219,20.0890879,1.121416667,0.009796957,4.056362426,-0.9855,-0.804,,0.383,0.291,0.006,A2AFG3,Pdzd4,A2AFG3_Pdzd4,A2AFG3,Pdzd4,1,3,2,2,A2AFG3,MOUSE,74414.1,2.4,587,587.1,10.97,10.97,,657,PDZ domain-containing protein 4,,protein ubiquitination|,ubiquitin protein ligase activity|,2,3,889000000,2.4%
Q62056,0.374970761,-0.3659,8.351738035,0.638916667,0.146159213,1.721953224,-1.2045,-0.294,,-0.285,-0.044,-0.002,Q62056,Psg17,Q62056_Psg17,Q62056,Psg17,1,1,1,1,Q62056,MOUSE,53425.2,4,588,588.1,10.95,10.95,,475,MCG130054,,immune response|female pregnancy|,protein binding|heparan sulfate proteoglycan binding|,1,1,227000000,4.0%
Q8BXX9,0.745307288,-0.059916667,2.314611807,-0.1335,0.586865824,-0.573978722,0.2395,-0.201,-0.018,-0.244,-0.11,-0.026,Q8BXX9,Ccdc169,Q8BXX9_Ccdc169,Q8BXX9,Ccdc169,1,4,1,1,Q8BXX9|D3YWT6|Q8BXX9-2|E9Q3J3,MOUSE,24753.8,4.6,589,589.1,10.92,10.92,,214,Coiled-coil domain-containing protein 169,,,,1,4,99200000,4.6%
Q8VCQ6,0.087827031,-0.28475,22.29433287,2.005666667,0.005896125,5.355941015,,-1.789,,0.376,0.231,0.043,Q8VCQ6,Sgms1,Q8VCQ6_Sgms1,Q8VCQ6,Sgms1,1,1,1,1,Q8VCQ6|E3W996|Q8VCQ6-3|Q8VCQ6-2,MOUSE,49829.3,2.1,590,590.1,10.92,10.92,,419,Phosphatidylcholine:ceramide cholinephosphotransferase 1,Golgi trans cisterna|nucleus|endoplasmic reticulum|plasma membrane|membrane|integral component of Golgi membrane|,sphingomyelin biosynthetic process|apoptotic process|cell growth|phosphorylation|negative regulation of extrinsic apoptotic signaling pathway|,kinase activity|sphingomyelin synthase activity|ceramide cholinephosphotransferase activity|,1,1,31400000,2.1%
P07214,0.831452937,-0.0003,1.524750118,-0.107583333,0.703922729,-0.40257328,0.0205,0.108,,-0.131,-0.155,0.156,P07214,Sparc,P07214_Sparc,P07214,Sparc,1,1,1,1,A0A1L1SSH9|P07214|Q5NCU4,MOUSE,35305.2,3.3,591,591.1,10.9,10.9,,302,SPARC,proteinaceous extracellular matrix|basement membrane|extracellular space|cell surface|nuclear matrix|platelet alpha granule|platelet alpha granule membrane|,negative regulation of endothelial cell proliferation|signal transduction|heart development|response to gravity|response to lead ion|positive regulation of endothelial cell migration|negative regulation of angiogenesis|regulation of cell morphogenesis|lung development|response to lipopolysaccharide|response to L-ascorbic acid|response to cytokine|wound healing|regulation of cell proliferation|response to peptide hormone|response to ethanol|response to cadmium ion|inner ear development|response to glucocorticoid|response to cAMP|response to calcium ion|bone development|cellular response to growth factor stimulus|,calcium ion binding|collagen binding|extracellular matrix binding|,1,1,6280000,3.3%
P50544,0.690196463,-0.244583333,3.106305494,0.765166667,0.489068229,0.737576924,0.3625,0.764,-3.008,0.759,-0.248,-0.097,P50544,Acadvl,P50544_Acadvl,P50544,Acadvl,1,3,2,2,P50544|B1AR28,MOUSE,71273.6,4.2,592,592.1,10.89,10.89,,656,"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial",nucleus|nucleolus|cytoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial nucleoid|,temperature homeostasis|epithelial cell differentiation|fatty acid beta-oxidation using acyl-CoA dehydrogenase|negative regulation of fatty acid biosynthetic process|negative regulation of fatty acid oxidation|regulation of cholesterol metabolic process|,acyl-CoA dehydrogenase activity|flavin adenine dinucleotide binding|,2,3,102000000,4.2%
P08228,0.087644071,0.405583333,22.48901811,-2.303166667,0.005637651,-4.242897202,1.0215,2.76,0.89,-0.717,-0.96,-0.561,P08228,Sod1,P08228_Sod1,P08228,Sod1,1,2,2,2,P08228,MOUSE,16113.6,13.6,593,593.1,10.87,10.87,,154,Superoxide dismutase [Cu-Zn],extracellular space|nucleus|nucleoplasm|cytoplasm|mitochondrion|mitochondrial intermembrane space|lysosome|peroxisome|cytosol|extracellular matrix|dense core granule|cytoplasmic vesicle|dendrite cytoplasm|neuronal cell body|myelin sheath|protein complex|extracellular exosome|plasma membrane|,activation of MAPK activity|response to reactive oxygen species|response to superoxide|ovarian follicle development|positive regulation of cytokine production|retina homeostasis|response to amphetamine|myeloid cell homeostasis|glutathione metabolic process|superoxide metabolic process|cellular iron ion homeostasis|response to oxidative stress|spermatogenesis|embryo implantation|aging|cell aging|sensory perception of sound|locomotory behavior|anterograde axon cargo transport|retrograde axon cargo transport|regulation of blood pressure|response to heat|response to organic substance|transmission of nerve impulse|removal of superoxide radicals|response to nutrient levels|peripheral nervous system myelin maintenance|positive regulation of superoxide anion generation|response to carbon monoxide|cellular response to potassium ion|regulation of multicellular organism growth|response to drug|response to hydrogen peroxide|superoxide anion generation|negative regulation of apoptotic process|positive regulation of catalytic activity|regulation of GTPase activity|negative regulation of neuron apoptotic process|response to ethanol|negative regulation of cholesterol biosynthetic process|regulation of protein kinase activity|response to antibiotic|response to copper ion|muscle cell cellular homeostasis|response to axon injury|hydrogen peroxide biosynthetic process|regulation of mitochondrial membrane potential|oxidation-reduction process|heart contraction|neurofilament cytoskeleton organization|relaxation of vascular smooth muscle|auditory receptor cell stereocilium organization|cellular response to cadmium ion|cellular response to ATP|reactive oxygen species metabolic process|response to antipsychotic drug|positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|,superoxide dismutase activity|copper ion binding|protein binding|zinc ion binding|protein phosphatase 2B binding|identical protein binding|Rac GTPase binding|chaperone binding|,2,2,13900000,13.6%
Q8VGD7,0.32515976,0.262916667,9.599745985,-2.633166667,0.109654233,-1.882328898,3.9325,2.46,-1.654,-1.117,-1.33,-0.714,Q8VGD7,Olfr1395,Q8VGD7_Olfr1395,Q8VGD7,Olfr1395,1,3,1,1,Q8VGD7|Q8VFM4|Q9EPF5|Q8VFM5|Q9EPF6|Q7TRN3|K7N641,MOUSE,36080.7,2.2,594,594.1,10.85,10.85,,317,Olfactory receptor 1395,plasma membrane|integral component of membrane|,G-protein coupled receptor signaling pathway|sensory perception of smell|detection of chemical stimulus involved in sensory perception of smell|,G-protein coupled receptor activity|olfactory receptor activity|,1,3,993000000,2.2%
S4R1G0,0.318405724,-0.0845,10.05535332,0.54875,0.098733531,2.025774516,-0.3455,-0.482,,-0.06,0.3,0.165,S4R1G0,NotFound,S4R1G0_NotFound,S4R1G0,Dnase2a,1,2,2,2,S4R1G0,MOUSE,16303.3,13.4,595,595.1,10.83,10.83,,149,Deoxyribonuclease II alpha,lysosome|extracellular exosome|,"DNA catabolic process, endonucleolytic|DNA catabolic process|apoptotic DNA fragmentation|erythrocyte differentiation|",deoxyribonuclease II activity|,2,2,81600000,13.4%
Q80W93,0.548180695,0.0367,4.863639118,0.289916667,0.326314286,1.08799636,-0.0695,-0.205,,0.259,0.232,-0.033,Q80W93,Hydin,Q80W93_Hydin,Q80W93,Hydin,1,2,2,2,Q80W93|Q80W93-2,MOUSE,587046.8,0.3,596,596.1,10.78,10.78,,5154,Hydrocephalus-inducing protein,axonemal central pair projection|,epithelial cell development|cilium movement|multicellular organismal development|ventricular system development|axoneme assembly|trachea development|,,2,2,4010000000,0.3%
Q3U129,0.886819929,-0.0011,0.988928615,-0.131416667,0.796355784,-0.272496479,-0.5785,0.734,,-0.273,-0.152,0.264,Q3U129,B3gntl1,Q3U129_B3gntl1,Q3U129,B3gntl1,1,2,2,2,Q3U129|Q3U129-2,MOUSE,41042.7,7.8,597,597.1,10.78,10.78,,357,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1",,metabolic process|,"transferase activity, transferring glycosyl groups|",2,2,27000000,7.8%
A0A0B4J1K5,0.505391749,-0.106,5.566488086,0.477333333,0.277556365,1.256139929,,-0.464,,-0.079,-0.107,0.226,A0A0B4J1K5,NotFound,A0A0B4J1K5_NotFound,A0A0B4J1K5,Iglv3,1,1,1,1,A0A0B4J1K5,MOUSE,13587,8.1,598,598.1,10.77,10.77,,122,Immunoglobulin lambda variable 3 (Fragment),,,,1,1,9210000,8.1%
Q9JL04,0.155936024,-0.3279,17.4328614,1.538083333,0.018059838,3.490715636,-0.8215,-1.68,,-0.215,0.692,0.385,Q9JL04,Fmn2,Q9JL04_Fmn2,Q9JL04,Fmn2,1,3,1,1,Q9JL04,MOUSE,168696,0.5,599,599.1,10.73,10.73,,1578,Formin-2,nucleolus|endoplasmic reticulum|endoplasmic reticulum membrane|spindle|cytosol|actin filament|plasma membrane|microvillus|cell cortex|cytoplasmic vesicle membrane|actin cytoskeleton|,cellular response to DNA damage stimulus|multicellular organismal development|protein transport|vesicle-mediated transport|meiotic chromosome movement towards spindle pole|polar body extrusion after meiotic divisions|negative regulation of protein catabolic process|negative regulation of apoptotic process|actin nucleation|intracellular transport|oogenesis|actin filament bundle assembly|establishment of meiotic spindle localization|homologous chromosome movement towards spindle pole involved in homologous chromosome segregation|formin-nucleated actin cable assembly|cellular response to hypoxia|,actin binding|microtubule binding|,1,3,84100000,0.5%
Q9R0N0,0.353357975,0.3577,8.816910462,-1.445916667,0.131313372,-1.809918591,0.0605,2.39,,0.018,-0.89,0.21,Q9R0N0,Galk1,Q9R0N0_Galk1,Q9R0N0,Galk1,1,1,1,1,Q9R0N0,MOUSE,42693.8,2.2,600,600.1,10.7,10.7,,392,Galactokinase,cytoplasm|membrane|extracellular exosome|,galactose metabolic process|galactitol metabolic process|carbohydrate phosphorylation|,galactokinase activity|protein binding|ATP binding|galactose binding|,1,1,9090000,2.2%
Q8R422,0.679171764,-0.129916667,3.191528641,0.781833333,0.479564621,0.754534202,-1.7645,-1.703,1.905,-0.202,0.499,0.486,Q8R422,Cd109,Q8R422_Cd109,Q8R422,Cd109,1,5,1,1,Q8R422,MOUSE,162454.4,0.4,601,601.1,10.68,10.68,,1442,CD109 antigen,extracellular space|plasma membrane|cell surface|anchored component of membrane|,negative regulation of protein phosphorylation|hair follicle development|negative regulation of keratinocyte proliferation|negative regulation of endopeptidase activity|negative regulation of transforming growth factor beta receptor signaling pathway|regulation of keratinocyte differentiation|negative regulation of wound healing|osteoclast fusion|,serine-type endopeptidase inhibitor activity|transforming growth factor beta binding|,1,5,23300000000,0.4%
Q8R1L8,0.331936472,0.2037,9.204281536,-0.530083333,0.120107975,-1.872591902,0.4135,0.63,,-0.013,-0.221,0.209,Q8R1L8,Angptl8,Q8R1L8_Angptl8,Q8R1L8,Angptl8,1,1,1,1,Q8R1L8,MOUSE,22119.7,8,602,602.1,10.67,10.67,,198,Angiopoietin-like protein 8,extracellular region|,glucose metabolic process|positive regulation of protein processing|regulation of lipid metabolic process|cellular lipid metabolic process|type B pancreatic cell proliferation|fat cell differentiation|cell maturation|regulation of lipoprotein metabolic process|negative regulation of lipoprotein lipase activity|triglyceride homeostasis|glucose metabolic process|type B pancreatic cell proliferation|,hormone activity|,1,1,22500000,8.0%
Q922W6,0.752055167,0.2969,2.18975953,0.174416667,0.603982071,0.553207823,0.0045,0.38,,0.639,0.073,0.388,Q922W6,Mmp3,Q922W6_Mmp3,Q922W6,Mmp3,1,2,2,2,Q922W6|P28862,MOUSE,54388.8,3.3,603,603.1,10.65,10.65,,479,Matrix metalloproteinase,extracellular matrix|,proteolysis|negative regulation of hydrogen peroxide metabolic process|regulation of cell migration|positive regulation of protein oligomerization|cellular response to amino acid stimulus|,endopeptidase activity|metalloendopeptidase activity|calcium ion binding|zinc ion binding|,2,2,2640000000,3.3%
P15105,0.017752896,1.038083333,37.01203833,-3.356166667,0.000198974,-8.161472326,2.5185,2.706,2.924,-0.294,-1.479,-0.147,P15105,Glul,P15105_Glul,P15105,Glul,1,1,1,1,P15105,MOUSE,42860.6,2.1,604,604.1,10.63,10.63,,373,Glutamine synthetase,nucleus|cytoplasm|mitochondrion|rough endoplasmic reticulum|perikaryon|myelin sheath|protein complex|axon terminus|cell body|extracellular exosome|glial cell projection|,"glutamate metabolic process|glutamine biosynthetic process|cell proliferation|cellular response to starvation|response to glucose|positive regulation of insulin secretion|positive regulation of epithelial cell proliferation|protein homooligomerization|positive regulation of synaptic transmission, glutamatergic|",magnesium ion binding|glutamate decarboxylase activity|glutamate-ammonia ligase activity|protein binding|ATP binding|glutamate binding|manganese ion binding|identical protein binding|dynein light chain binding|,1,1,14000000,2.1%
E9Q9C6,0.242548931,0.357916667,12.44053585,-2.4965,0.057009393,-2.360093992,3.7455,1.67,-0.597,-1.131,-0.649,-0.891,E9Q9C6,Fcgbp,E9Q9C6_Fcgbp,E9Q9C6,Fcgbp,1,7,1,1,E9PVG8|E9Q9C6|E9Q0B5,MOUSE,287674,0.3,605,605.1,10.61,10.61,,2583,Fc fragment of IgG-binding protein,proteinaceous extracellular matrix|extracellular exosome|,,,1,7,24200000000,0.3%
P68500,0.26283168,-0.03375,11.68278413,0.915,0.067876836,2.486336866,,,-0.72,0.283,0.273,0.029,P68500,Cntn5,P68500_Cntn5,P68500,Cntn5,1,2,2,2,P68500|E9PYK7,MOUSE,121542.8,4.8,606,606.1,10.61,10.61,,1098,Contactin-5,cytoplasm|plasma membrane|anchored component of membrane|,cell adhesion|sensory perception of sound|,,2,2,277000000,4.8%
Q8R000,0.377571059,0.12375,8.266575849,1.033,0.149053581,1.794580057,,-0.651,,-0.261,0.731,0.676,Q8R000,Slc51a,Q8R000_Slc51a,Q8R000,Slc51a,1,1,1,1,Q8R000,MOUSE,38614.3,2.3,607,607.1,10.57,10.57,,340,Organic solute transporter subunit alpha,endoplasmic reticulum membrane|plasma membrane|integral component of membrane|protein complex|,transport|bile acid and bile salt transport|,transporter activity|protein binding|protein homodimerization activity|protein heterodimerization activity|,1,1,53700000,2.3%
E9Q3E2,0.518066528,0.504083333,5.281851028,-0.8835,0.2963568,-1.145487141,1.9725,-0.812,1.677,-0.224,-0.033,0.444,E9Q3E2,Synpo,E9Q3E2_Synpo,E9Q3E2,Synpo,1,2,2,2,E9Q3E2|Q8CC35|Q8CC35-2|Q8CC35-3,MOUSE,118083.3,2.9,608,608.1,10.52,10.52,,1100,Synaptopodin,actin cytoskeleton|dendrite|axon|,positive regulation of actin filament bundle assembly|,actin binding|,2,2,574000000,2.9%
Q9D6P8,0.415101064,-0.008583333,7.273872396,-1.7675,0.187332341,-1.491261885,0.7775,3.327,-1.479,-0.63,-1.478,-0.569,Q9D6P8,Calml3,Q9D6P8_Calml3,Q9D6P8,Calml3,1,1,1,1,P0DP28|Q9D6P8,MOUSE,16701.1,8.7,609,609.1,10.52,10.52,,149,Calmodulin-like protein 3,extracellular exosome|,,calcium ion binding|,1,1,3520000,8.7%
Q6DFZ1,0.14994666,-0.3291,18.04246451,1.464416667,0.015694719,3.625096606,-0.8075,-1.608,,-0.005,0.695,0.08,Q6DFZ1,Gbf1,Q6DFZ1_Gbf1,Q6DFZ1,Gbf1,1,3,2,2,Q6DFZ1,MOUSE,208832.4,1,610,610.1,10.49,10.49,,1861,Golgi-specific brefeldin A-resistance factor 1,Golgi membrane|mitochondrion|peroxisome|endoplasmic reticulum lumen|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|Golgi stack|cis-Golgi network|trans-Golgi network|plasma membrane|membrane|cell leading edge|trans-Golgi network|,"cell activation involved in immune response|retrograde vesicle-mediated transport, Golgi to ER|Golgi to endosome transport|Golgi organization|regulation of mitotic cell cycle|regulation of cell adhesion|neutrophil chemotaxis|regulation of ARF protein signal transduction|protein localization to Golgi apparatus|retrograde transport, endosome to Golgi|positive regulation of GTPase activity|COPI coating of Golgi vesicle|establishment of monopolar cell polarity|protein localization to endoplasmic reticulum exit site|Golgi disassembly|endoplasmic reticulum-Golgi intermediate compartment organization|reactive oxygen species biosynthetic process|protein localization to endoplasmic reticulum tubular network|regulation of protein localization to cell surface|vesicle-mediated transport|","ARF guanyl-nucleotide exchange factor activity|protein binding|phosphatidylinositol-3,4,5-trisphosphate binding|phosphatidylinositol-3,5-bisphosphate binding|",2,3,641000000,1.0%
Q9R0M0,0.40834567,-0.06,7.500295858,0.642666667,0.177815827,1.633648114,,-0.542,,0.357,-0.046,-0.009,Q9R0M0,NotFound,Q9R0M0_NotFound,Q9R0M0,Celsr2,1,2,2,2,Q9R0M0|A2AEE7|Q9R0M0-2,MOUSE,322437.2,0.9,611,611.1,10.48,10.48,,2920,Cadherin EGF LAG seven-pass G-type receptor 2,cytoplasm|plasma membrane|integral component of membrane|,"neuron migration|cilium movement|regulation of transcription, DNA-templated|homophilic cell adhesion via plasma membrane adhesion molecules|G-protein coupled receptor signaling pathway|Wnt signaling pathway|ventricular system development|neural plate anterior/posterior regionalization|regulation of protein localization|cerebrospinal fluid secretion|cilium assembly|",G-protein coupled receptor activity|calcium ion binding|protein binding|,2,2,5280000000,0.9%
Q80VP2,0.745307288,0.11825,2.338154627,-0.2425,0.58369307,-0.579502261,0.9675,0.313,-0.562,0.101,0.009,-0.119,Q80VP2,Spata7,Q80VP2_Spata7,Q80VP2,Spata7,1,3,2,2,Q80VP2|Q3TTL3|Q3U5D0,MOUSE,66223.9,1.5,612,612.1,10.41,10.41,,582,Spermatogenesis-associated protein 7 homolog,axoneme|microtubule cytoskeleton|photoreceptor connecting cilium|ciliary basal body|,spermatogenesis|visual perception|photoreceptor cell maintenance|response to stimulus|protein localization to photoreceptor outer segment|protein localization to photoreceptor connecting cilium|,,2,3,1750000000,1.5%
Q3V384,0.910370636,0.3715,0.699079215,0.090416667,0.851318514,0.197571532,-0.0745,0.709,,0.929,0.438,-0.144,Q3V384,Afg1l,Q3V384_Afg1l,Q3V384,Afg1l,1,2,2,2,Q3V384|E9Q4K2,MOUSE,54825.7,7.7,613,613.1,10.34,10.34,,480,AFG1-like ATPase,mitochondrion|,,ATP binding|,2,2,15100000,7.7%
E9Q7N9,0.258721385,-0.0837,11.86412592,0.623416667,0.065100962,2.356693487,-0.4525,-0.463,,0.198,0.313,-0.014,E9Q7N9,Dnah11,E9Q7N9_Dnah11,E9Q7N9,Dnah11,1,2,2,2,E9Q7N9,MOUSE,520359.5,0.5,614,614.1,10.33,10.33,,4488,"Dynein, axonemal, heavy chain 11",dynein complex|motile primary cilium|,cilium movement|regulation of cilium beat frequency|determination of left/right symmetry|metabolic process|sperm motility|,microtubule motor activity|ATP binding|ATPase activity|,2,2,23600000,0.5%
Q9QXK7,0.479349419,-0.044916667,5.905948843,0.5785,0.256687734,1.255689492,-1.0155,0.408,-0.395,0.795,-0.2,0.138,Q9QXK7,Cpsf3,Q9QXK7_Cpsf3,Q9QXK7,Cpsf3,1,2,2,2,P79101|Q9QXK7|A0A1Y7VLY3,MOUSE,78131.2,3.6,615,615.1,10.3,10.3,,684,Cleavage and polyadenylation specificity factor subunit 3,mRNA cleavage and polyadenylation specificity factor complex|ribonucleoprotein complex|,"histone mRNA 3'-end processing|nucleic acid phosphodiester bond hydrolysis|RNA phosphodiester bond hydrolysis, endonucleolytic|",RNA binding|endoribonuclease activity|5'-3' exonuclease activity|metal ion binding|,2,2,49500000,3.6%
B1AZP2,0.390133764,-0.17225,8.008845813,0.487833333,0.158166833,1.611947297,0.1075,-0.584,-0.772,0.179,-0.062,0.098,B1AZP2,Dlgap4,B1AZP2_Dlgap4,B1AZP2,Dlgap4,1,3,2,2,B1AZP2|B1AZP2-2|B7ZNS2|B1AZP2-3|E9PUF2|I1E4X0,MOUSE,109004.9,1.9,616,616.1,10.3,10.3,,992,Disks large-associated protein 4,membrane|synapse|,signaling|,protein binding|,2,3,104000000,1.9%
A2BI80,0.745307288,0.5439,2.275594984,-0.208916667,0.592161955,-0.572133734,0.7845,0.554,,0.916,0.012,0.453,A2BI80,Ebf4,A2BI80_Ebf4,A2BI80,Ebf4,1,2,2,2,A2BI80,MOUSE,74942,2.8,617,617.1,10.28,10.28,,696,Transcription factor COE4,nucleus|,"transcription, DNA-templated|regulation of transcription, DNA-templated|multicellular organismal development|",DNA binding|transcription factor binding|metal ion binding|protein dimerization activity|,2,2,720000000,2.8%
Q920R0-2,0.303768038,0.321083333,10.49518226,-0.674833333,0.089224017,-2.0278049,1.2365,0.557,0.182,-0.079,-0.15,0.18,Q920R0,Als2,Q920R0-2_Als2,Q920R0-2,Als2,1,2,1,1,Q920R0-2|Q8C025-2,MOUSE,101241.8,0.8,618,618.1,10.26,10.26,,1651,Isoform 2 of Alsin,ruffle|nucleus|cytoplasm|early endosome|centrosome|cytosol|postsynaptic density|membrane|lamellipodium|axon|dendrite|growth cone|vesicle|neuronal cell body|dendritic spine|protein complex|centrosome|,"behavioral fear response|in utero embryonic development|receptor recycling|response to oxidative stress|endosome organization|lysosomal transport|axonogenesis|neuromuscular junction development|locomotory behavior|protein localization|cell death|vesicle organization|endosomal transport|Rac protein signal transduction|regulation of Rho protein signal transduction|synaptic transmission, glutamatergic|regulation of GTPase activity|positive regulation of GTPase activity|positive regulation of protein kinase activity|neuron projection morphogenesis|regulation of endosome size|protein homooligomerization|positive regulation of protein serine/threonine kinase activity|",GTPase activator activity|protein binding|Rab guanyl-nucleotide exchange factor activity|Rab GTPase binding|Rac guanyl-nucleotide exchange factor activity|identical protein binding|protein homodimerization activity|protein serine/threonine kinase activator activity|Rac GTPase binding|guanyl-nucleotide exchange factor activity|,1,2,17600000,0.8%
P21658,0.083117329,-0.4375,22.9507855,2.195416667,0.00506899,4.819927044,-2.0755,-1.434,,-0.226,0.773,0.775,P21658,Fgf6,P21658_Fgf6,P21658,Fgf6,1,4,1,1,P21658,MOUSE,22912,3.3,619,619.1,10.24,10.24,,208,Fibroblast growth factor 6,extracellular space|sarcolemma|,cartilage condensation|angiogenesis|positive regulation of cell proliferation|fibroblast growth factor receptor signaling pathway|myoblast differentiation|positive regulation of cell division|,fibroblast growth factor receptor binding|growth factor activity|,1,4,1640000000,3.3%
D3YYT1,0.504695138,-0.0477,5.582337482,0.383416667,0.276545281,1.221158088,-0.5845,0.029,,0.183,0.188,-0.054,D3YYT1,Glyr1,D3YYT1_Glyr1,D3YYT1,Glyr1,1,1,1,1,D3YYT1|Q922P9,MOUSE,61061.9,1.2,620,620.1,10.18,10.18,,552,Putative oxidoreductase GLYR1,nucleoplasm|cytoplasm|Golgi apparatus|,oxidation-reduction process|,DNA binding|phosphogluconate dehydrogenase (decarboxylating) activity|methylated histone binding|NAD binding|,1,1,51500000,1.2%
Q8BKN5,0.214239872,-0.4825,13.90519951,1.122083333,0.040689284,2.761015966,-1.6845,-0.627,,-0.23,0.123,0.006,Q8BKN5,Tubgcp5,Q8BKN5_Tubgcp5,Q8BKN5,Tubgcp5,1,2,1,1,Q8BKN5|Q8BKN5-3|Q8BKN5-2,MOUSE,118888,0.5,621,621.1,10.18,10.18,,1024,Gamma-tubulin complex component 5,spindle pole|nucleoplasm|cytoplasm|centrosome|microtubule|gamma-tubulin ring complex|,microtubule nucleation|,microtubule binding|,1,2,482000000,0.5%
P56386,0.254188227,0.57975,12.04579967,-0.9835,0.062433838,-2.293115105,1.6905,1.211,0.313,0.426,-0.337,0.175,P56386,Defb1,P56386_Defb1,P56386,Defb1,1,1,1,1,P56386,MOUSE,8148.4,14.4,622,622.1,10.17,10.17,,69,Beta-defensin 1,extracellular space|extracellular exosome|,innate immune response in mucosa|acute inflammatory response|response to bacterium|antibacterial humoral response|response to testosterone|innate immune response|defense response to Gram-positive bacterium|,,1,1,84500000,14.4%
Q49B93-2,0.254188227,-0.1401,12.01332456,0.798583333,0.062902448,2.384425041,-0.4515,-0.787,,0.025,-0.072,0.585,Q49B93,Slc5a12,Q49B93-2_Slc5a12,Q49B93-2,Slc5a12,1,3,2,2,Q49B93-2|Q49B93,MOUSE,69495.6,2.7,623,623.1,10.16,10.16,,619,Isoform 2 of Sodium-coupled monocarboxylate transporter 2,integral component of membrane|apical plasma membrane|extracellular exosome|,sodium ion transport|lactate transmembrane transport|,lactate transmembrane transporter activity|symporter activity|,2,3,256000000,2.7%
Q6IE21,0.586005351,-0.193416667,4.389271571,-1.231166667,0.36397608,-0.983496755,3.1575,0.115,-2.006,-0.768,-0.971,-0.688,Q6IE21,Otud6a,Q6IE21_Otud6a,Q6IE21,Otud6a,1,1,1,1,Q6IE21,MOUSE,33908.8,2.7,624,624.1,10.15,10.15,,290,OTU domain-containing protein 6A,,protein K29-linked deubiquitination|protein K11-linked deubiquitination|protein K27-linked deubiquitination|protein K33-linked deubiquitination|,ubiquitin-specific protease activity|,1,1,2420000,2.7%
D3YTY6,0.679041452,0.107083333,3.204633826,0.399166667,0.478119677,0.757132693,-0.6055,-0.696,1.024,0.44,-0.085,0.565,D3YTY6,NotFound,D3YTY6_NotFound,D3YTY6,Gm6096,1,12,1,1,D3YTY6,MOUSE,17281.2,7.9,625,625.1,10.04,10.04,,151,Predicted gene 6096,ribosome|,translation|,structural constituent of ribosome|,1,12,3350000000,7.9%
Q80T79,0.176830492,-0.2901,15.67253279,1.108583333,0.027086115,3.096035475,-1.3805,-0.53,,0.27,0.2,-0.01,Q80T79,Csmd3,Q80T79_Csmd3,Q80T79,Csmd3,1,2,2,2,Q80T79|Q80T79-1|Q9D6E4|E9PWJ0,MOUSE,414027.5,0.3,626,626.1,10.03,10.03,,3707,CUB and sushi domain-containing protein 3,plasma membrane|integral component of membrane|,,,2,2,174000000,0.3%
Q80T21,0.402949774,0.43325,7.648555282,-0.663833333,0.171847996,-1.554792442,1.5675,0.729,-0.001,0.157,0.194,-0.047,Q80T21,Adamtsl4,Q80T21_Adamtsl4,Q80T21,Adamtsl4,1,2,1,1,Q80T21,MOUSE,116646.6,1.5,627,627.1,10.01,10.01,,1036,ADAMTS-like protein 4,proteinaceous extracellular matrix|interstitial matrix|,proteolysis|apoptotic process|extracellular matrix organization|positive regulation of apoptotic process|,protease binding|metalloendopeptidase activity|,1,2,1400000,1.5%
P40645,0.353243052,0.165083333,8.853502054,-0.450833333,0.130211636,-1.753027532,0.0425,0.443,0.686,-0.163,0.032,-0.05,P40645,Sox6,P40645_Sox6,P40645,Sox6,1,2,2,2,A0A0U1RNW8|P40645|E9PUW0|A0A0U1RPC1|P40645-2|Q8BSS6|P35710|B2KFM9|Q2TBA9|E9PVR0|P35710-2|B2KFM4|P35710-3,MOUSE,92201,2.9,628,628.1,9.97,9.97,,827,Transcription factor SOX-6,nucleus|nucleoplasm|transcription factor complex|,"negative regulation of transcription from RNA polymerase II promoter|cell morphogenesis|in utero embryonic development|transcription, DNA-templated|regulation of transcription, DNA-templated|post-embryonic development|regulation of gene expression|gene silencing|oligodendrocyte cell fate specification|hemopoiesis|erythrocyte differentiation|positive regulation of chondrocyte differentiation|muscle cell differentiation|cell fate commitment|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|oligodendrocyte differentiation|erythrocyte development|cartilage development|cardiac muscle cell differentiation|positive regulation of cartilage development|cellular response to transforming growth factor beta stimulus|positive regulation of mesenchymal stem cell differentiation|",DNA binding|sequence-specific DNA binding transcription factor activity|protein binding|sequence-specific DNA binding|transcription regulatory region DNA binding|protein heterodimerization activity|,2,2,11400000000,2.9%
O54962,0.087644071,-0.4491,22.45989661,1.601083333,0.005675581,4.636114652,-1.0505,-1.769,,0.267,-0.051,0.358,O54962,Banf1,O54962_Banf1,O54962,Banf1,1,1,1,1,O54962,MOUSE,10330.6,8.9,629,629.1,9.86,9.86,,89,Barrier-to-autointegration factor,nucleus|nucleoplasm|chromosome|cytoplasm|extracellular exosome|,DNA integration|establishment of integrated proviral latency|,DNA binding|,1,1,118000000,8.9%
Q059U7,0.669813064,0.0085,3.311827613,0.32125,0.46646304,0.78920766,-0.6845,0.316,,0.353,-0.139,0.197,Q059U7,Intu,Q059U7_Intu,Q059U7,Intu,1,2,2,2,Q059U7|Q059U7-2,MOUSE,105789,2.6,630,630.1,9.83,9.83,,942,Protein inturned,cytoplasm|cell surface|,nervous system development|regulation of smoothened signaling pathway|negative regulation of keratinocyte proliferation|spinal cord dorsal/ventral patterning|keratinocyte differentiation|hair follicle morphogenesis|cilium assembly|positive regulation of smoothened signaling pathway|negative regulation of cell division|limb development|cilium morphogenesis|,,2,2,209000000,2.6%
Q3UY96,0.081099342,1.1717,23.37806333,-5.053416667,0.004594028,-4.934781722,2.5625,5.845,,-1.267,-0.93,-0.352,Q3UY96,Cfap74,Q3UY96_Cfap74,Q3UY96,Cfap74,1,2,1,1,Q3UY96|Q3UY96-2,MOUSE,180122.9,0.6,631,631.1,9.8,9.8,,1578,Cilia- and flagella-associated protein 74,cytoskeleton|axoneme|,axoneme assembly|,,1,2,123000000,0.6%
P68433,0.084682369,0.812083333,22.7795254,-3.506166667,0.005272875,-4.304631525,2.5975,4.183,0.915,-1.229,-0.964,-0.63,P68433,Hist1h3g,P68433_Hist1h3g,P68433,Hist1h3a,1,1,1,1,A0A1W2P768|P68433|P84228|P84244|P02301|F8WI35,MOUSE,15517.9,5.1,632,632.1,9.76,9.76,,136,Histone H3.1,nuclear nucleosome|nucleoplasm|membrane|extracellular exosome|,chromatin silencing at rDNA|DNA replication-dependent nucleosome assembly|protein heterotetramerization|regulation of gene silencing|,DNA binding|protein binding|histone binding|protein heterodimerization activity|,1,1,64700000,5.1%
P17897,0.271520577,0.17725,11.38474337,-2.3245,0.072698536,-2.181508459,3.3405,1.679,-1.001,-1.007,-1.196,-0.752,P17897,Lyz1,P17897_Lyz1,P17897,Lyz1,1,4,1,1,P17897|P08905,MOUSE,17250.3,6,633,633.1,9.72,9.72,,148,Lysozyme C-1,extracellular space|extracellular exosome|,metabolic process|cytolysis|defense response to Gram-negative bacterium|defense response to Gram-positive bacterium|,lysozyme activity|identical protein binding|,1,4,90100000,6.0%
E9PYT3,0.254188227,0.3413,11.98997545,-1.41575,0.063241543,-2.392724338,2.0915,0.29,,-0.004,-0.25,-0.421,E9PYT3,Atl3,E9PYT3_Atl3,E9PYT3,Atl3,1,2,2,2,E9PYT3,MOUSE,60687,4.6,634,634.1,9.69,9.69,,536,Atlastin-3,endoplasmic reticulum|membrane|integral component of membrane|,endoplasmic reticulum organization|Golgi organization|metabolic process|protein homooligomerization|,GTPase activity|GTP binding|identical protein binding|,2,2,11600000,4.6%
P08249,0.214239872,0.0909,13.71323802,-2.51975,0.042528121,-2.723346559,0.0775,3.128,,-0.804,-1.051,-0.896,P08249,Mdh2,P08249_Mdh2,P08249,Mdh2,1,2,1,1,P08249,MOUSE,36067.2,2.3,635,635.1,9.66,9.66,,338,"Malate dehydrogenase, mitochondrial",nucleus|nucleoplasm|mitochondrion|mitochondrial inner membrane|mitochondrial matrix|plasma membrane|membrane|myelin sheath|extracellular exosome|,carbohydrate metabolic process|tricarboxylic acid cycle|oxaloacetate metabolic process|malate metabolic process|internal protein amino acid acetylation|NADH metabolic process|,malate dehydrogenase activity|L-malate dehydrogenase activity|protein self-association|poly(A) RNA binding|malate dehydrogenase (NADP+) activity|,1,2,5420000,2.3%
Q684R7,0.315406172,-0.7781,10.12001278,1.87775,0.097274436,2.046342741,-3.4075,-0.402,,-0.262,0.122,0.059,Q684R7,Frem1,Q684R7_Frem1,Q684R7,Frem1,1,4,1,1,Q684R7|E9Q5Z7|Q684R7-2|Q684R7-3,MOUSE,246422,0.5,636,636.1,9.65,9.65,,2191,FRAS1-related extracellular matrix protein 1,basement membrane|integral component of membrane|,cell communication|cell-matrix adhesion|craniofacial suture morphogenesis|,carbohydrate binding|metal ion binding|,1,4,9920000000,0.5%
Q61495,0.023108713,0.85275,32.71855031,-3.006166667,0.000534743,-6.795814597,2.9805,2.572,1.515,-0.57,-1.03,-0.351,Q61495,Dsg1a,Q61495_Dsg1a,Q61495,Dsg1a,1,2,2,2,Q61495|Q7TSF1,MOUSE,115622,1.9,637,637.1,9.62,9.62,,1057,Desmoglein-1-alpha,plasma membrane|cytoplasmic side of plasma membrane|integral component of membrane|desmosome|extracellular exosome|cell-cell junction|,homophilic cell adhesion via plasma membrane adhesion molecules|,calcium ion binding|protein binding|gamma-catenin binding|,2,2,14000000,1.9%
Q8C3Y4,0.213452452,0.3895,13.99323138,-0.71125,0.039872812,-2.760671671,0.8455,0.787,,0.148,0.204,-0.037,Q8C3Y4,Kntc1,Q8C3Y4_Kntc1,Q8C3Y4,Kntc1,1,2,2,2,Q8C3Y4,MOUSE,253263.4,2.1,638,638.1,9.62,9.62,,2207,Kinetochore-associated protein 1,condensed chromosome kinetochore|spindle pole|nucleus|cytoplasm|kinetochore microtubule|plasma membrane|actin cytoskeleton|RZZ complex|,mitotic nuclear division|mitotic cell cycle checkpoint|cell division|,,2,2,136000000,2.1%
P18531,0.962840402,0.4327,0.224360582,0.036583333,0.949650807,0.066444781,0.5325,0.289,,-0.354,1.318,0.378,P18531,NotFound,P18531_NotFound,P18531,Ighv3-6,1,2,1,1,P18531|A0A075B5S8,MOUSE,13208.7,5.1,639,639.1,9.61,9.61,,116,Ig heavy chain V region 3-6,,,,1,2,86600000,5.1%
Q3UMU9-3,0.199303152,0.380583333,14.57391832,-2.667166667,0.034882545,-2.728012313,3.5465,2.031,-0.435,-0.922,-1.092,-0.845,Q3UMU9,Hdgfl2,Q3UMU9-3_Hdgfl2,Q3UMU9-3,Hdgfl2,1,1,1,1,Q3UMU9-3|Q3UMU9|Q3UMU9-2|Q3UMU9-4,MOUSE,75472.6,1.4,640,640.1,9.6,9.6,,669,Isoform 3 of Hepatoma-derived growth factor-related protein 2,nucleus|nucleoplasm|mitochondrion|,"transcription, DNA-templated|positive regulation of cell growth|",chromatin binding|protein binding|chromatin binding|,1,1,15500000,1.4%
P56546-2,0.752055167,0.448,2.213787384,-0.32,0.600649696,-0.56882396,,0.688,,0.809,-0.231,0.526,P56546,Ctbp2,P56546-2_Ctbp2,P56546-2,Ctbp2,1,1,1,1,P56546-2|P56546|Q91YZ2,MOUSE,107866.3,2,641,641.1,9.59,9.59,,445,Isoform 2 of C-terminal-binding protein 2,nucleus|transcriptional repressor complex|cell junction|synapse|ribbon synapse|,"transcription, DNA-templated|positive regulation of chromatin binding|negative regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of retinoic acid receptor signaling pathway|white fat cell differentiation|oxidation-reduction process|","chromatin binding|transcription coactivator activity|transcription corepressor activity|protein binding|oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor|retinoic acid receptor binding|NAD binding|",1,1,11100000,2.0%
E9PYL1,0.456433733,0.2223,6.335163667,-0.44575,0.232532485,-1.35829117,0.8415,0.138,,-0.088,0.171,0.049,E9PYL1,Chd5,E9PYL1_Chd5,E9PYL1,Chd5,1,2,2,2,E9PYL1|A2A8L1|E9PYU4|E9QAS5|Q6PDQ2|E9QAS4,MOUSE,224164.2,1.2,642,642.1,9.55,9.55,,1952,Chromodomain-helicase-DNA-binding protein 5,chromatin|nucleus|membrane|,transcription from RNA polymerase II promoter|regulation of transcription involved in cell fate commitment|histone H3-K27 trimethylation|,DNA binding|chromatin binding|ATP binding|ATP-dependent helicase activity|zinc ion binding|H3K27me3 modified histone binding|,2,2,1390000000,1.2%
Q8CGF6,0.940910696,0.1383,0.388049521,0.03925,0.914523875,0.112880988,0.0505,0.179,,-0.104,-0.072,0.638,Q8CGF6,Wdr47,Q8CGF6_Wdr47,Q8CGF6,Wdr47,1,3,2,2,Q8CGF6|A0A0G2JFW8,MOUSE,103908.1,2.1,643,643.1,9.54,9.54,,920,WD repeat-containing protein 47,cytoplasm|microtubule|,multicellular organismal development|,,2,3,219000000,2.1%
Q91UZ1,0.14994666,-0.5821,17.94280298,1.488583333,0.016059045,3.602940267,-2.0025,-0.948,,-0.245,0.131,0.154,Q91UZ1,Plcb4,Q91UZ1_Plcb4,Q91UZ1,Plcb4,1,3,1,1,Q91UZ1,MOUSE,135666.4,0.9,644,644.1,9.44,9.44,,1175,Phosphoinositide phospholipase C,nucleus|smooth endoplasmic reticulum|postsynaptic density|dendrite|,lipid catabolic process|intracellular signal transduction|negative regulation of potassium ion transport|,phosphatidylinositol phospholipase C activity|signal transducer activity|calcium ion binding|protein binding|mitogen-activated protein kinase binding|,1,3,3270000000,0.9%
P70269,0.141445692,0.6218,18.68644409,-1.723666667,0.013531801,-3.770083062,,2.018,1.294,0.474,-0.638,-0.039,P70269,Ctse,P70269_Ctse,P70269,Ctse,1,1,1,1,P70269|D3Z6T3,MOUSE,43336.2,2,645,645.1,9.43,9.43,,397,Cathepsin E,endosome|extracellular exosome|,proteolysis|protein autoprocessing|antigen processing and presentation of exogenous peptide antigen via MHC class II|protein catabolic process|,aspartic-type endopeptidase activity|protein homodimerization activity|,1,1,5960000,2.0%
Q7TRP4,0.203138841,-0.3689,14.32569718,1.088916667,0.036934335,2.837224089,-1.4945,-0.55,,0.282,-0.08,-0.002,Q7TRP4,Olfr667,Q7TRP4_Olfr667,Q7TRP4,Olfr667,1,2,1,1,Q7TRP4,MOUSE,37372.7,1.8,646,646.1,9.42,9.42,,326,Olfactory receptor,plasma membrane|integral component of membrane|,G-protein coupled receptor signaling pathway|sensory perception of smell|detection of chemical stimulus involved in sensory perception of smell|,G-protein coupled receptor activity|olfactory receptor activity|,1,2,438000000,1.8%
Q8BK64,0.175974166,-0.4753,15.76481259,0.99825,0.026516655,3.113068753,-1.3975,-0.751,,-0.245,0.013,0.004,Q8BK64,Ahsa1,Q8BK64_Ahsa1,Q8BK64,Ahsa1,1,3,1,1,Q8BK64,MOUSE,38344.6,3.5,647,647.1,9.4,9.4,,338,Activator of 90 kDa heat shock protein ATPase homolog 1,cytoplasm|endoplasmic reticulum|cytosol|extracellular exosome|,protein folding|response to stress|positive regulation of ATPase activity|,ATPase activator activity|chaperone binding|,1,3,2220000000,3.5%
Q9CXJ1,0.194325351,-0.3717,14.85852316,0.965083333,0.032669891,2.930709177,-1.2725,-0.629,,-0.186,0.21,0.019,Q9CXJ1,Ears2,Q9CXJ1_Ears2,Q9CXJ1,Ears2,1,3,1,1,Q9CXJ1,MOUSE,58724.7,1.1,648,648.1,9.4,9.4,,523,"Probable glutamate--tRNA ligase, mitochondrial",mitochondrion|mitochondrial matrix|,glutamyl-tRNA aminoacylation|tRNA aminoacylation for mitochondrial protein translation|,tRNA binding|glutamate-tRNA ligase activity|ATP binding|glutamate-tRNA(Gln) ligase activity|,1,3,1320000000,1.1%
Q8BWP8,0.840345931,0.1493,1.445668721,-0.142416667,0.716857986,-0.384040546,0.7095,-0.24,,0.128,0.136,0.013,Q8BWP8,B4gat1,Q8BWP8_B4gat1,Q8BWP8,B4gat1,1,2,2,2,Q8BWP8|Q8BWP8-2,MOUSE,47839.9,3.8,649,649.1,9.39,9.39,,415,"Beta-1,4-glucuronyltransferase 1",Golgi membrane|Golgi apparatus|integral component of membrane|extracellular exosome|,protein glycosylation|axon guidance|protein O-linked mannosylation|poly-N-acetyllactosamine biosynthetic process|,"glucuronosyltransferase activity|metal ion binding|N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity|",2,2,18200000,3.8%
D3YTR0,0.55859426,0.1111,4.736719461,-0.27775,0.335991317,-1.064181893,0.1575,0.398,,0.075,0.02,-0.095,D3YTR0,NotFound,D3YTR0_NotFound,D3YTR0,Apc2,1,2,2,2,D3YTR0|Q9Z1K7|G5E832,MOUSE,248334.3,0.8,650,650.1,9.38,9.38,,2303,Adenomatous polyposis coli protein 2,cytoplasm|Golgi apparatus|actin filament|microtubule cytoskeleton|catenin complex|lamellipodium membrane|perinuclear region of cytoplasm|cytoplasmic microtubule|,Wnt signaling pathway|negative regulation of catenin import into nucleus|negative regulation of canonical Wnt signaling pathway|,beta-catenin binding|microtubule binding|,2,2,213000000,0.8%
A0A087WQT6,0.669813064,-0.724916667,3.32638003,1.287166667,0.464902624,0.781159742,0.5255,0.705,-5.336,0.058,-0.233,-0.069,A0A087WQT6,Casp8,A0A087WQT6_Casp8,A0A087WQT6,Casp8,1,3,2,2,A0A087WQT6|O89110,MOUSE,58846.9,4.4,651,651.1,9.32,9.32,,500,Caspase-8,nucleus|nucleoplasm|cytoplasm|mitochondrion|microtubule organizing center|cytosol|Noc1p-Noc2p complex|death-inducing signaling complex|CD95 death-inducing signaling complex|ripoptosome|,angiogenesis|neural tube formation|proteolysis|apoptotic process|activation of cysteine-type endopeptidase activity involved in apoptotic process|heart development|extrinsic apoptotic signaling pathway via death domain receptors|macrophage differentiation|response to tumor necrosis factor|TRAIL-activated apoptotic signaling pathway|positive regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of macrophage differentiation|positive regulation of proteolysis|proteolysis involved in cellular protein catabolic process|negative regulation of necroptotic process|regulation of thymocyte apoptotic process|apoptotic signaling pathway|extrinsic apoptotic signaling pathway|execution phase of apoptosis|activation of cysteine-type endopeptidase activity|hepatocyte apoptotic process|regulation of apoptotic signaling pathway|positive regulation of extrinsic apoptotic signaling pathway|,endopeptidase activity|cysteine-type endopeptidase activity|protein binding|peptidase activity|ubiquitin protein ligase binding|death effector domain binding|protein heterodimerization activity|scaffold protein binding|cysteine-type endopeptidase activity involved in apoptotic process|cysteine-type endopeptidase activity involved in apoptotic signaling pathway|,2,3,53100000,4.4%
A0A140LJ72,0.742574146,-0.0515,2.462752742,0.152916667,0.567184986,0.612247933,-0.1195,-0.167,,0.026,-0.062,0.065,A0A140LJ72,NotFound,A0A140LJ72_NotFound,A0A140LJ72,Muc16,1,2,2,2,A0A140LJ72,MOUSE,911055.7,0.2,652,652.1,9.31,9.31,,8478,Mucin 16,,,,2,2,93000000,0.2%
Q3UHK6-2,0.742574146,0.29325,2.498378491,0.348333333,0.562551324,0.632015394,,0.032,,-0.22,0.696,0.665,Q3UHK6,Tenm4,Q3UHK6-2_Tenm4,Q3UHK6-2,Tenm4,1,2,2,2,Q3UHK6-2|Q3UHK6-4|Q3UHK6|Q3UHK6-3,MOUSE,318101.1,1.1,653,653.1,9.31,9.31,,2771,Isoform 2 of Teneurin-4,nucleus|cytoplasm|integral component of plasma membrane|neuron projection|,gastrulation with mouth forming second|signal transduction|positive regulation of myelination|central nervous system myelin formation|neuron development|positive regulation of oligodendrocyte differentiation|cardiac muscle cell proliferation|cardiac cell fate specification|self proteolysis|positive regulation of gastrulation|,protein homodimerization activity|,2,2,35600000,1.1%
Q8C115,0.322790308,-0.2289,9.892548783,0.778916667,0.102505017,2.002990833,-0.1875,-1.205,,0.195,-0.025,0.078,Q8C115,Plekhh2,Q8C115_Plekhh2,Q8C115,Plekhh2,1,2,2,2,Q8C115|Q8C115-3,MOUSE,169955.2,1.2,654,654.1,9.29,9.29,,1491,Pleckstrin homology domain-containing family H member 2,cytoplasm|plasma membrane|lamellipodium|cortical actin cytoskeleton|,negative regulation of actin filament depolymerization|,actin binding|protein binding|identical protein binding|,2,2,3740000000,1.2%
Q6P1B9,0.437741736,-0.02225,6.702115219,0.534333333,0.213692105,1.477711871,,-0.423,,0.139,0.212,-0.017,Q6P1B9,Bin1,Q6P1B9_Bin1,Q6P1B9,Bin1,1,3,1,1,Q6P1B9|O08539-2,MOUSE,52934.3,3.1,655,655.1,9.28,9.28,,477,Bin1 protein,nucleus|cytoplasm|membrane|axon|lipid tube|,regulation of endocytosis|muscle cell differentiation|positive regulation of apoptotic process|regulation of neuron differentiation|positive regulation of astrocyte differentiation|lipid tube assembly|regulation of cell cycle arrest|,protein binding|identical protein binding|tau protein binding|RNA polymerase binding|,1,3,689000000,3.1%
Q80YY7,0.690196463,0.20825,3.108167455,-0.215833333,0.488858594,-0.737186379,0.2975,0.049,0.602,-0.25,0.09,0.461,Q80YY7,NotFound,Q80YY7_NotFound,Q80YY7,Znf618,1,6,1,1,Q80YY7|F8WIU3,MOUSE,106576.1,1,656,656.1,9.26,9.26,,953,Zinc finger protein 618,nucleus|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",DNA binding|metal ion binding|,1,6,3510000000,1.0%
Q8BI79,0.744838544,0.2779,2.430726905,0.513583333,0.571382993,0.606193179,-1.0595,0.999,,1.466,-0.398,0.382,Q8BI79,Ccdc40,Q8BI79_Ccdc40,Q8BI79,Ccdc40,1,2,2,2,Q8BI79|Q8BI79-2|Q8BI79-3,MOUSE,137283.3,1.6,657,657.1,9.26,9.26,,1192,Coiled-coil domain-containing protein 40,cytoplasm|cilium|axoneme|,heart looping|cilium movement|epithelial cilium movement|regulation of cilium beat frequency|sperm motility|lung development|determination of pancreatic left/right asymmetry|inner dynein arm assembly|motile cilium assembly|epithelial cilium movement involved in determination of left/right asymmetry|axonemal dynein complex assembly|determination of digestive tract left/right asymmetry|determination of liver left/right asymmetry|,,2,2,37500000,1.6%
Q8BUH1,0.233962779,-0.3627,12.84044217,1.060916667,0.051994306,2.554284887,-1.5325,-0.466,,-0.05,-0.082,0.317,Q8BUH1,Txnl4b,Q8BUH1_Txnl4b,Q8BUH1,Txnl4b,1,5,1,1,Q8BUH1,MOUSE,17076.4,8,658,658.1,9.23,9.23,,149,Thioredoxin-like protein 4B,nucleus|spliceosomal complex|U5 snRNP|U4/U6 x U5 tri-snRNP complex|,"spliceosomal complex assembly|mRNA splicing, via spliceosome|mitotic nuclear division|positive regulation of cell proliferation|",,1,5,1510000000,8.0%
Q6ZPY7,0.302051358,0.1125,10.62906916,0.837083333,0.086515333,2.137466958,-0.5675,-0.212,,0.673,-0.121,0.79,Q6ZPY7,NotFound,Q6ZPY7_NotFound,Q6ZPY7,Kdm3b,1,10,1,1,B9EKS2|Q6ZPY7,MOUSE,172583.6,0.8,659,659.1,9.19,9.19,,1562,Lysine-specific demethylase 3B,nucleus|,"transcription, DNA-templated|regulation of transcription, DNA-templated|chromatin modification|oxidation-reduction process|",metal ion binding|dioxygenase activity|,1,10,8610000000,0.8%
A2ARP1,0.757303264,1.4825,2.125323598,-0.75125,0.613010114,-0.539728103,1.7495,2.117,,0.468,-0.72,3.798,A2ARP1,Ppip5k1,A2ARP1_Ppip5k1,A2ARP1,Ppip5k1,1,2,1,1,A2ARP1|A2ARP1-2|A2ARP1-3,MOUSE,161745.4,0.4,660,660.1,9.13,9.13,,1436,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1,nucleoplasm|cytoplasm|cytosol|plasma membrane|,inositol metabolic process|phosphorylation|dephosphorylation|,"inositol-1,3,4,5,6-pentakisphosphate kinase activity|inositol hexakisphosphate 5-kinase activity|acid phosphatase activity|ATP binding|diphosphoinositol-pentakisphosphate kinase activity|inositol hexakisphosphate 1-kinase activity|inositol hexakisphosphate 3-kinase activity|",1,2,283000000,0.4%
Q3TYU2,0.239364851,0.556583333,12.60837344,-1.171833333,0.054848235,-2.38865988,1.2555,1.814,0.358,0.445,-0.694,0.161,Q3TYU2,Atp13a5,Q3TYU2_Atp13a5,Q3TYU2,Atp13a5,1,2,2,2,Q3TYU2|D3YU82|Q3TYU2-2|D6RHM2,MOUSE,138469.1,3.3,661,661.1,9.12,9.12,,1216,Probable cation-transporting ATPase 13A5,integral component of membrane|,cation transport|metabolic process|,ATP binding|ATPase activity|metal ion binding|,2,2,32800000,3.3%
A2AKX3,,1.148666667,,,,,,,,-0.179,1.647,1.978,A2AKX3,Setx,A2AKX3_Setx,A2AKX3,Setx,1,2,1,1,A2AKX3|A2AKX3-2,MOUSE,301805.8,0.2,662,662.1,9.12,9.12,,2646,Probable helicase senataxin,"nuclear chromosome|chromosome, telomeric region|nucleus|nucleoplasm|nucleolus|cytoplasm|axon|growth cone|","MAPK cascade|double-strand break repair|DNA recombination|termination of RNA polymerase II transcription|mRNA splice site selection|cellular response to DNA damage stimulus|spermatogenesis|circadian rhythm|fibroblast growth factor receptor signaling pathway|positive regulation of neuron projection development|positive regulation of RNA splicing|cellular response to oxidative stress|negative regulation of apoptotic process|protein kinase B signaling|cellular response to fibroblast growth factor stimulus|positive regulation of transcription from RNA polymerase II promoter|positive regulation of DNA-templated transcription, termination|cellular response to hydrogen peroxide|cellular response to retinoic acid|positive regulation of DNA-templated transcription, initiation|positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled|",transcription termination site sequence-specific DNA binding|helicase activity|protein binding|ATP binding|identical protein binding|,1,2,14800000,0.2%
P06869,0.44527584,-0.1253,6.545811504,0.434083333,0.221523013,1.396353802,-0.1485,-0.623,,-0.147,0.296,-0.004,P06869,Plau,P06869_Plau,P06869,Plau,1,1,1,1,P06869,MOUSE,49693.4,2.3,663,663.1,9.09,9.09,,433,Urokinase-type plasminogen activator,extracellular space|focal adhesion|cell surface|membrane|extracellular exosome|,angiogenesis|response to hypoxia|spermatogenesis|embryo implantation|positive regulation of cell proliferation|regulation of receptor activity|response to activity|smooth muscle cell migration|regulation of smooth muscle cell migration|positive regulation of smooth muscle cell migration|plasminogen activation|regulation of cell adhesion mediated by integrin|cellular response to hepatocyte growth factor stimulus|regulation of cell proliferation|fibrinolysis|skeletal muscle tissue regeneration|response to hyperoxia|positive regulation of ovulation|neuron death|cellular response to lipopolysaccharide|cellular response to glucose stimulus|cellular response to hypoxia|cellular response to fluid shear stress|cellular response to staurosporine|regulation of smooth muscle cell-matrix adhesion|regulation of hepatocyte proliferation|positive regulation of reactive oxygen species metabolic process|,serine-type endopeptidase activity|,1,1,75500000,2.3%
Q6ZQ93,0.343059017,0.238083333,9.039638548,-0.576166667,0.124748733,-1.784370684,0.2495,0.19,1.139,-0.007,-0.123,-0.02,Q6ZQ93,Usp34,Q6ZQ93_Usp34,Q6ZQ93,Usp34,1,3,1,1,Q6ZQ93|Q6ZQ93-2|Q6ZQ93-3|Q6ZQ93-4,MOUSE,413969.6,0.1,664,664.1,9.07,9.07,,3582,Ubiquitin carboxyl-terminal hydrolase 34,nucleus|cytoplasm|,Wnt signaling pathway|protein deubiquitination|proteasome-mediated ubiquitin-dependent protein catabolic process|regulation of proteasomal protein catabolic process|protein K48-linked deubiquitination|positive regulation of canonical Wnt signaling pathway|,cysteine-type endopeptidase activity|ubiquitin-specific protease activity|,1,3,24700000,0.1%
B1B507,0.742574146,0.0461,2.458073496,-0.156083333,0.567796421,-0.611247746,0.0555,0.224,,0.073,-0.048,-0.074,B1B507,Sell,B1B507_Sell,B1B507,Sell,1,1,1,1,B1B507|P18337|Q3TCF3,MOUSE,45124.3,2.8,665,665.1,9.06,9.06,,387,L-selectin,plasma membrane|external side of plasma membrane|cell surface|,cell adhesion|response to ATP|,protease binding|protein binding|carbohydrate binding|cell adhesion molecule binding|,1,1,2530000,2.8%
Q8BJI1,0.899330297,0.1027,0.805905669,-0.125083333,0.830633482,-0.225587676,1.0205,-0.665,,0.055,0.192,-0.089,Q8BJI1,Slc6a17,Q8BJI1_Slc6a17,Q8BJI1,Slc6a17,1,1,1,1,Q8BJI1|A0A0R4J087,MOUSE,81868.7,1.7,666,666.1,9.04,9.04,,727,Sodium-dependent neutral amino acid transporter SLC6A17,integral component of plasma membrane|synaptic vesicle|cell junction|synaptic vesicle membrane|,neurotransmitter transport|brain development|neutral amino acid transport|glycine transport|leucine transport|proline transport|alanine transport|transmembrane transport|,neurotransmitter:sodium symporter activity|,1,1,1500000,1.7%
E9Q616,0.105031831,-0.3153,21.06982676,1.089083333,0.00781659,4.290138497,-1.0735,-0.864,,0.12,0.121,0.12,E9Q616,Ahnak,E9Q616_Ahnak,E9Q616,Ahnak,1,2,2,2,E9Q616,MOUSE,605040.9,0.5,667,667.1,9.04,9.04,,5656,AHNAK nucleoprotein (desmoyokin),nucleus|cytoplasm|lysosomal membrane|cytosol|plasma membrane|cell-cell junction|focal adhesion|actin cytoskeleton|membrane|vesicle|sarcolemma|costamere|cell-cell contact zone|extracellular exosome|T-tubule|membrane raft|,regulation of RNA splicing|protein oligomerization|regulation of voltage-gated calcium channel activity|,S100 protein binding|poly(A) RNA binding|structural molecule activity conferring elasticity|,2,2,132000000,0.5%
Q5FW85,0.099941315,-0.6449,21.4909563,2.270583333,0.007094215,4.441577414,-2.7515,-1.263,,0.231,0.479,0.08,Q5FW85,Ecm2,Q5FW85_Ecm2,Q5FW85,Ecm2,1,3,1,1,Q5FW85,MOUSE,77644.3,0.8,668,668.1,8.98,8.98,,670,Extracellular matrix protein 2,proteinaceous extracellular matrix|interstitial matrix|,positive regulation of cell-substrate adhesion|extracellular matrix organization|,collagen binding|heparin binding|collagen V binding|,1,3,3540000000,0.8%
E9QN12,0.711200332,0.2719,2.871315071,0.286916667,0.516260019,0.699151628,-0.2915,0.491,,0.691,0.549,-0.08,E9QN12,NotFound,E9QN12_NotFound,E9QN12,Pdgfrb,1,5,1,1,E9QN12|E9QPE2|P05622,MOUSE,124435,1.1,669,669.1,8.92,8.92,,1103,Platelet-derived growth factor receptor beta,cytoplasm|focal adhesion|cell surface|membrane|integral component of membrane|cytoplasmic membrane-bounded vesicle|intrinsic component of plasma membrane|lysosomal lumen|extracellular exosome|,in utero embryonic development|kidney development|tissue homeostasis|nitrogen compound metabolic process|signal transduction|positive regulation of cell proliferation|positive regulation of phospholipase C activity|positive regulation of smooth muscle cell migration|cell migration|peptidyl-tyrosine phosphorylation|adrenal gland development|positive regulation of cell migration|positive regulation of phosphoprotein phosphatase activity|platelet-derived growth factor receptor-beta signaling pathway|positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway|positive regulation of phosphatidylinositol 3-kinase activity|phosphatidylinositol metabolic process|protein autophosphorylation|platelet-derived growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|positive regulation of smooth muscle cell proliferation|skeletal system morphogenesis|smooth muscle tissue development|regulation of peptidyl-tyrosine phosphorylation|cell chemotaxis|positive regulation of ERK1 and ERK2 cascade|,protein tyrosine kinase activity|signal transducer activity|platelet-derived growth factor beta-receptor activity|receptor binding|platelet-derived growth factor receptor binding|ATP binding|kinase activity|protein kinase binding|vascular endothelial growth factor binding|platelet-derived growth factor binding|,1,5,3110000000,1.1%
Q3UHU5,0.759970158,0.03525,2.075067556,0.196333333,0.620144997,0.536453581,,-0.112,,0.23,-0.039,0.062,Q3UHU5,Mtcl1,Q3UHU5_Mtcl1,Q3UHU5,Mtcl1,1,2,2,2,Q3UHU5|Q3UHU5-3|H3BL83|Q3UHU5-2,MOUSE,215456.2,1.3,670,670.1,8.92,8.92,,1945,Microtubule cross-linking factor 1,spindle pole|extracellular space|cytoplasm|cytoskeleton|apical plasma membrane|apicolateral plasma membrane|lateral plasma membrane|midbody|microtubule bundle|,microtubule bundle formation|regulation of autophagy|establishment or maintenance of epithelial cell apical/basal polarity|positive regulation of protein targeting to membrane|positive regulation of microtubule motor activity|,protein binding|microtubule binding|protein homodimerization activity|poly(A) RNA binding|,2,2,932000000,1.3%
P17751,0.857108733,-0.345083333,1.273559054,-0.459166667,0.745837292,-0.339723161,0.5445,2.299,-3.19,-0.51,-0.817,-0.397,P17751,Tpi1,P17751_Tpi1,P17751,Tpi1,1,1,1,1,P17751|H7BXC3,MOUSE,32704.7,5,671,671.1,8.86,8.86,,299,Triosephosphate isomerase,extracellular space|nucleus|extracellular exosome|,glucose metabolic process|gluconeogenesis|glycolytic process|pentose-phosphate shunt|multicellular organismal development|glyceraldehyde-3-phosphate metabolic process|,triose-phosphate isomerase activity|isomerase activity|ubiquitin protein ligase binding|,1,1,2820000,5.0%
Q3U5H1,0.398617191,-0.08475,7.765296203,0.723,0.167290154,1.685644278,,-0.627,,-0.147,0.439,-0.004,Q3U5H1,Tas1r1,Q3U5H1_Tas1r1,Q3U5H1,Tas1r1,1,1,1,1,Q3U5H1,MOUSE,95296.1,3.3,673,673.1,8.8,8.8,,842,Taste receptor type 1 member 1,plasma membrane|integral component of membrane|,G-protein coupled receptor signaling pathway|detection of chemical stimulus involved in sensory perception of taste|sensory perception of umami taste|,taste receptor activity|,1,1,5230000,3.3%
F8WGL3,0.26283168,0.296416667,11.73166273,-1.308833333,0.067117184,-2.239999153,0.4685,2.211,0.173,-0.234,-0.755,-0.085,F8WGL3,NotFound,F8WGL3_NotFound,F8WGL3,Cfl1,1,1,1,1,F8WGL3|P18760,MOUSE,25089.5,5.2,674,674.1,8.79,8.79,,227,Cofilin-1,extracellular space|cytoplasm|cell-cell junction|focal adhesion|membrane|cortical actin cytoskeleton|vesicle|extracellular exosome|,mitotic cytokinesis|neural crest cell migration|neural fold formation|protein phosphorylation|cytoskeleton organization|actin filament organization|response to virus|regulation of cell morphogenesis|establishment of cell polarity|cell projection organization|actin filament depolymerization|positive regulation of actin filament depolymerization|response to amino acid|negative regulation of cell size|regulation of dendritic spine morphogenesis|,actin binding|,1,1,38500000,5.2%
P19157,0.64802674,0.1377,3.572676855,-0.255083333,0.439270779,-0.840007995,0.5095,0.072,,-0.013,-0.151,0.271,P19157,Gstp1,P19157_Gstp1,P19157,Gstp1,1,1,1,1,P19157|P46425,MOUSE,23779.9,3.3,675,675.1,8.79,8.79,,210,Glutathione S-transferase P 1,extracellular space|intracellular|nucleus|cytoplasm|mitochondrion|cytosol|plasma membrane|vesicle|protein complex|extracellular exosome|TRAF2-GSTP1 complex|,response to reactive oxygen species|negative regulation of acute inflammatory response|glutathione metabolic process|xenobiotic metabolic process|response to toxic substance|negative regulation of biosynthetic process|oligodendrocyte development|organ regeneration|response to nutrient levels|response to estradiol|negative regulation of interleukin-1 beta production|negative regulation of tumor necrosis factor production|cellular response to insulin stimulus|regulation of stress-activated MAPK cascade|negative regulation of stress-activated MAPK cascade|positive regulation of superoxide anion generation|response to L-ascorbic acid|common myeloid progenitor cell proliferation|negative regulation of apoptotic process|negative regulation of I-kappaB kinase/NF-kappaB signaling|response to amino acid|negative regulation of MAP kinase activity|negative regulation of JUN kinase activity|response to ethanol|negative regulation of fibroblast proliferation|negative regulation of nitric-oxide synthase biosynthetic process|regulation of ERK1 and ERK2 cascade|negative regulation of ERK1 and ERK2 cascade|negative regulation of leukocyte proliferation|cellular response to lipopolysaccharide|cellular response to epidermal growth factor stimulus|cellular response to glucocorticoid stimulus|cellular response to cell-matrix adhesion|negative regulation of monocyte chemotactic protein-1 production|negative regulation of neutrophil aggregation|negative regulation of peroxidase activity|negative regulation of extrinsic apoptotic signaling pathway|,glutathione transferase activity|protein binding|drug binding|JUN kinase binding|kinase regulator activity|S-nitrosoglutathione binding|dinitrosyl-iron complex binding|,1,1,3540000,3.3%
A0A1D5RLM8,0.242548931,-0.1313,12.45436146,0.911583333,0.056828194,2.471306126,-1.0845,-0.272,,0.416,-0.047,0.331,A0A1D5RLM8,NotFound,A0A1D5RLM8_NotFound,A0A1D5RLM8,Gm11639,1,2,2,2,A0A1D5RLM8|P09041,MOUSE,655392.6,0.2,676,676.1,8.77,8.77,,5808,Predicted gene 11639,,,,2,2,90500000,0.2%
Q3UES3,0.940910696,-0.0899,0.391759589,-0.028583333,0.913742954,-0.113917623,-0.0085,-0.137,,-0.133,-0.126,-0.045,Q3UES3,Tnks2,Q3UES3_Tnks2,Q3UES3,Tnks2,1,3,1,1,Q3UES3,MOUSE,128395.8,0.7,678,678.1,8.77,8.77,,1166,Tankyrase-2,"Golgi membrane|pericentriolar material|chromosome, telomeric region|nucleus|nuclear envelope|cytoplasm|perinuclear region of cytoplasm|","protein polyubiquitination|telomere maintenance|protein ADP-ribosylation|Wnt signaling pathway|multicellular organism growth|regulation of multicellular organism growth|protein localization to chromosome, telomeric region|protein auto-ADP-ribosylation|positive regulation of canonical Wnt signaling pathway|telomere maintenance|",NAD+ ADP-ribosyltransferase activity|enzyme binding|metal ion binding|,1,3,406000000,0.7%
P34884,0.940910696,-0.21375,0.366052022,0.1295,0.919167791,0.105905489,0.1245,1.999,-2.959,0.072,-0.628,0.109,P34884,Mif,P34884_Mif,P34884,Mif,1,1,1,1,P34884,MOUSE,12675.2,7.8,679,679.1,8.74,8.74,,115,Macrophage migration inhibitory factor,extracellular region|extracellular space|nucleoplasm|cytoplasm|cell surface|vesicle|myelin sheath|extracellular exosome|,"prostaglandin biosynthetic process|positive regulation of protein phosphorylation|positive regulation of adaptive immune response|negative regulation of mature B cell apoptotic process|inflammatory response|cell surface receptor signaling pathway|cell aging|cell proliferation|negative regulation of gene expression|positive regulation of protein kinase A signaling|carboxylic acid metabolic process|DNA damage response, signal transduction by p53 class mediator|positive regulation of B cell proliferation|positive regulation of lipopolysaccharide-mediated signaling pathway|negative regulation of cellular protein metabolic process|negative regulation of myeloid cell apoptotic process|positive regulation of peptidyl-serine phosphorylation|regulation of cell proliferation|positive regulation of phosphorylation|negative regulation of apoptotic process|positive regulation of MAP kinase activity|negative regulation of DNA damage response, signal transduction by p53 class mediator|innate immune response|positive regulation of fibroblast proliferation|positive regulation of cytokine secretion|positive regulation of peptidyl-tyrosine phosphorylation|positive chemotaxis|positive regulation of prostaglandin secretion involved in immune response|positive regulation of myeloid leukocyte cytokine production involved in immune response|protein homotrimerization|positive regulation of ERK1 and ERK2 cascade|negative regulation of cell cycle arrest|positive regulation of arachidonic acid secretion|negative regulation of cell aging|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator|positive regulation of chemokine (C-X-C motif) ligand 2 production|",dopachrome isomerase activity|receptor binding|cytokine activity|cytokine receptor binding|chemoattractant activity|phenylpyruvate tautomerase activity|,1,1,5910000,7.8%
Q9ERS4,0.831452937,0.18425,1.523689609,0.230166667,0.704094641,0.39877822,-0.9165,-0.024,1.148,0.695,-0.231,0.434,Q9ERS4,Plekha3,Q9ERS4_Plekha3,Q9ERS4,Plekha3,1,2,1,1,Q9ERS4,MOUSE,33992.9,7,680,680.1,8.73,8.73,,297,Pleckstrin homology domain-containing family A member 3,Golgi apparatus|membrane|,,phospholipid binding|1-phosphatidylinositol binding|,1,2,427000000,7.0%
Q9QVP9,0.254188227,-0.250125,12.10897834,1.0205,0.061532161,2.578741626,-1.0155,,,-0.19,-0.052,0.257,Q9QVP9,Ptk2b,Q9QVP9_Ptk2b,Q9QVP9,Ptk2b,1,1,1,1,Q9QVP9|Q3UDE9|E9Q2A6,MOUSE,117104.6,1.9,681,681.1,8.71,8.71,,1009,Protein-tyrosine kinase 2-beta,nucleus|nucleoplasm|cytoplasm|cytosol|cytoskeleton|focal adhesion|cell cortex|postsynaptic density|N-methyl-D-aspartate selective glutamate receptor complex|lamellipodium|axon|dendrite|growth cone|extrinsic component of cytoplasmic side of plasma membrane|neuronal cell body|cell body|membrane raft|perinuclear region of cytoplasm|apical dendrite|,"MAPK cascade|oocyte maturation|response to hypoxia|positive regulation of cell-matrix adhesion|sprouting angiogenesis|marginal zone B cell differentiation|protein phosphorylation|cellular defense response|response to osmotic stress|cytoskeleton organization|cell adhesion|cell surface receptor signaling pathway|signal complex assembly|epidermal growth factor receptor signaling pathway|positive regulation of cytosolic calcium ion concentration|integrin-mediated signaling pathway|positive regulation of cell proliferation|negative regulation of cell proliferation|regulation of cell shape|response to mechanical stimulus|response to hormone|response to glucose|response to lithium ion|positive regulation of endothelial cell migration|negative regulation of muscle cell apoptotic process|regulation of cGMP-mediated signaling|regulation of macrophage chemotaxis|positive regulation of neuron projection development|glial cell proliferation|cell migration|peptidyl-tyrosine phosphorylation|regulation of cell adhesion|positive regulation of cell growth|positive regulation of cell migration|negative regulation of bone mineralization|regulation of cGMP biosynthetic process|positive regulation of actin filament polymerization|neuron projection development|regulation of inositol trisphosphate biosynthetic process|tumor necrosis factor-mediated signaling pathway|ionotropic glutamate receptor signaling pathway|response to immobilization stress|peptidyl-tyrosine autophosphorylation|response to cocaine|response to drug|response to hydrogen peroxide|activation of Janus kinase activity|negative regulation of apoptotic process|stress fiber assembly|negative regulation of potassium ion transport|positive regulation of JUN kinase activity|negative regulation of neuron apoptotic process|blood vessel endothelial cell migration|positive regulation of phosphatidylinositol 3-kinase activity|innate immune response|regulation of nitric oxide biosynthetic process|bone resorption|response to ethanol|negative regulation of myeloid cell differentiation|positive regulation of translation|positive regulation of angiogenesis|positive regulation of protein kinase activity|positive regulation of JNK cascade|vascular endothelial growth factor receptor signaling pathway|focal adhesion assembly|positive regulation of peptidyl-tyrosine phosphorylation|regulation of calcium-mediated signaling|positive regulation of nitric-oxide synthase activity|regulation of release of sequestered calcium ion into cytosol|response to cAMP|response to calcium ion|positive regulation of synaptic transmission, glutamatergic|long-term synaptic potentiation|chemokine-mediated signaling pathway|positive regulation of ERK1 and ERK2 cascade|cellular response to retinoic acid|cellular response to fluid shear stress|activation of GTPase activity|regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|regulation of establishment of cell polarity|regulation of actin cytoskeleton reorganization|regulation of N-methyl-D-aspartate selective glutamate receptor activity|positive regulation of reactive oxygen species metabolic process|positive regulation of excitatory postsynaptic membrane potential|positive regulation of B cell chemotaxis|",protein kinase activity|calmodulin-dependent protein kinase activity|non-membrane spanning protein tyrosine kinase activity|receptor binding|protein binding|ATP binding|protein complex binding|3-phosphoinositide-dependent protein kinase binding|N-methyl-D-aspartate selective glutamate receptor activity|,1,1,84600000,1.9%
E9PYJ0,0.331936472,0.2575,9.268731344,-0.540416667,0.118338719,-1.884154798,0.6115,0.552,,-0.179,-0.013,0.316,E9PYJ0,Tcp10b,E9PYJ0_Tcp10b,E9PYJ0,Tcp10b,1,3,1,1,E9PYJ0|Q80W76|E9Q2X0,MOUSE,49759.8,1.3,682,682.1,8.69,8.69,,438,T-complex protein 10b,,,,1,3,3020000000,1.3%
Q8BJH1,0.75163864,0.6077,2.225264732,-0.28925,0.59906442,-0.561680083,0.8995,0.663,,1.304,-0.226,0.398,Q8BJH1,Zc2hc1a,Q8BJH1_Zc2hc1a,Q8BJH1,Zc2hc1a,1,1,1,1,Q8BJH1|Q8BJH1-2,MOUSE,35779.1,3.7,683,683.1,8.69,8.69,,324,Zinc finger C2HC domain-containing protein 1A,,,metal ion binding|,1,1,13300000,3.7%
A0A1B0GT72,0.353902242,-0.1795,8.760231382,0.775416667,0.133038354,1.799689585,-1.1405,-0.149,,-0.109,0.539,-0.038,A0A1B0GT72,NotFound,A0A1B0GT72_NotFound,A0A1B0GT72,Gm29133,1,1,1,1,A0A1B0GT72,MOUSE,31614.6,4.1,684,684.1,8.68,8.68,,266,Predicted gene 29133,,,,1,1,14400000,4.1%
Q91Y21,0.888540941,0.2269,0.943883552,-0.083916667,0.804658577,-0.260807027,0.2715,0.283,,0.515,-0.192,0.257,Q91Y21,Pcdha1,Q91Y21_Pcdha1,Q91Y21,Pcdha1,1,2,2,2,Q91Y21|Q641K6,MOUSE,103087.5,3.2,685,685.1,8.68,8.68,,948,Protocadherin alpha 1,endoplasmic reticulum|plasma membrane|membrane|integral component of membrane|,homophilic cell adhesion via plasma membrane adhesion molecules|,calcium ion binding|,2,2,1190000000,3.2%
Q8BK35,0.916739094,0.62275,0.637878227,-0.129666667,0.863400264,-0.183712177,,0.72,,1.346,0.568,-0.143,Q8BK35,Nop53,Q8BK35_Nop53,Q8BK35,Nop53,1,1,1,1,Q8BK35,MOUSE,55849,2,686,686.1,8.64,8.64,,484,Ribosome biogenesis protein NOP53,intracellular membrane-bounded organelle|,,poly(A) RNA binding|,1,1,83000000,2.0%
Q8BX70,0.194325351,0.6065,14.87847648,-1.452916667,0.032520136,-2.954949338,1.7575,1.199,,-0.5,0.79,-0.214,Q8BX70,Vps13c,Q8BX70_Vps13c,Q8BX70,Vps13c,1,2,2,2,Q8BX70|Q8BX70-3|Q8BX70-2,MOUSE,422420.4,0.5,687,687.1,8.64,8.64,,3748,Vacuolar protein sorting-associated protein 13C,intracellular|cell|extrinsic component of membrane|extracellular exosome|,protein targeting to vacuole|protein retention in Golgi apparatus|,,2,2,122000000,0.5%
Q9QYK4,0.555101425,0.0423,4.799014048,0.49925,0.331206305,1.078097457,-0.7745,0.26,,0.737,0.068,-0.079,Q9QYK4,Hs6st3,Q9QYK4_Hs6st3,Q9QYK4,Hs6st3,1,2,1,1,Q9QYK4,MOUSE,55777.7,4.2,688,688.1,8.64,8.64,,470,Heparan-sulfate 6-O-sulfotransferase 3,integral component of membrane|,"heparan sulfate proteoglycan biosynthetic process, enzymatic modification|",heparan sulfate 6-O-sulfotransferase activity|,1,2,233000000,4.2%
Q8C351,0.023108713,0.73925,33.83372012,-2.395166667,0.000413645,-7.070613163,2.5895,1.705,1.516,-0.374,-0.509,-0.492,Q8C351,Layn,Q8C351_Layn,Q8C351,Layn,1,1,1,1,Q8C351|A4QPF5|Q8C351-2,MOUSE,43952.5,2.6,690,690.1,8.62,8.62,,381,Layilin,ruffle|cell surface|integral component of membrane|focal adhesion|,,hyaluronic acid binding|carbohydrate binding|,1,1,5510000,2.6%
Q8BSV3,0.888540941,-0.0139,0.962702144,-0.068583333,0.801179421,-0.265583161,-0.1035,0.158,,-0.023,-0.069,-0.032,Q8BSV3,Bend7,Q8BSV3_Bend7,Q8BSV3,Bend7,1,3,1,1,Q8BSV3|Q8BSV3-3,MOUSE,48849.2,3.6,691,691.1,8.61,8.61,,434,BEN domain-containing protein 7,extracellular exosome|,,,1,3,14300000,3.6%
P04919,0.31416078,0.688416667,10.32118104,-3.2375,0.092871379,-2.003016061,0.6795,0.288,5.954,-0.254,-2.281,-0.256,P04919,Slc4a1,P04919_Slc4a1,P04919,Slc4a1,1,1,1,1,P04919|P04919-2,MOUSE,103475.9,1.3,692,692.1,8.59,8.59,,929,Band 3 anion transport protein,integral component of plasma membrane|membrane|basolateral plasma membrane|Z disc|cortical cytoskeleton|extracellular exosome|blood microparticle|,anion transport|chloride transport|bicarbonate transport|regulation of intracellular pH|anion transmembrane transport|chloride transmembrane transport|,actin binding|inorganic anion exchanger activity|protein binding|protein C-terminus binding|bicarbonate transmembrane transporter activity|chloride transmembrane transporter activity|anion:anion antiporter activity|ankyrin binding|protein homodimerization activity|,1,1,2680000,1.3%
O70372,0.199303152,-0.559583333,14.55982265,1.8765,0.034995946,2.725542187,-0.5245,-0.934,-3.035,0.417,0.688,0.031,O70372,Tert,O70372_Tert,O70372,Tert,1,7,1,1,O70372,MOUSE,129972.7,0.8,693,693.1,8.56,8.56,,1122,Telomerase reverse transcriptase,"telomerase catalytic core complex|chromosome, telomeric region|nucleoplasm|telomerase holoenzyme complex|nucleolus|mitochondrion|RNA-directed RNA polymerase complex|mitochondrial nucleoid|TERT-RMRP complex|PML body|","transcription, RNA-templated|RNA-dependent DNA replication|telomere maintenance via telomerase|mitochondrion organization|negative regulation of gene expression|DNA strand elongation|positive regulation of Wnt signaling pathway|production of siRNA involved in RNA interference|RNA biosynthetic process|positive regulation of hair cycle|positive regulation of nitric-oxide synthase activity|cellular response to hypoxia|DNA biosynthetic process|replicative senescence|positive regulation of pri-miRNA transcription from RNA polymerase II promoter|negative regulation of production of siRNA involved in RNA interference|positive regulation of stem cell proliferation|negative regulation of cellular senescence|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand|",tRNA binding|transcription coactivator binding|DNA binding|telomerase activity|telomeric template RNA reverse transcriptase activity|RNA binding|RNA-directed DNA polymerase activity|protein binding|nucleotidyltransferase activity|telomeric DNA binding|protein homodimerization activity|metal ion binding|telomeric RNA binding|telomeric template RNA reverse transcriptase activity|RNA-directed RNA polymerase activity|,1,7,7090000000,0.8%
Q8C650,0.327678383,-0.2041,9.467879837,0.508583333,0.11303476,1.919917611,-0.3465,-0.672,,-0.041,0.04,-0.001,Q8C650,Sept10,Q8C650_Sept10,Q8C650,Sept10,1,1,1,1,A0A1W2P6J7|Q8C650|A0A0R4J233|Q8C650-2,MOUSE,53220,1.5,694,694.1,8.55,8.55,,452,Septin-10,cytoplasm|cytoskeleton|,cell cycle|cell division|,GTP binding|,1,1,4840000,1.5%
Q99K28-2,0.069673476,-0.4167,24.38398775,1.433416667,0.003644192,5.145954378,-1.4435,-1.11,,0.131,0.318,0.021,Q99K28,Arfgap2,Q99K28-2_Arfgap2,Q99K28-2,Arfgap2,1,1,1,1,Q99K28-2|Q99K28,MOUSE,58508.5,1.4,695,695.1,8.55,8.55,,520,Isoform 2 of ADP-ribosylation factor GTPase-activating protein 2,Golgi membrane|nucleolus|cytoplasm|Golgi apparatus|plasma membrane|,protein transport|vesicle-mediated transport|positive regulation of GTPase activity|,GTPase activator activity|metal ion binding|,1,1,53000000,1.4%
A9Z1V5,0.082718526,0.601416667,23.15014902,-1.6835,0.004841558,-4.384153535,2.1425,1.214,0.973,-0.575,-0.189,0.043,A9Z1V5,Vwa5b1,A9Z1V5_Vwa5b1,A9Z1V5,Vwa5b1,1,5,1,1,A9Z1V5,MOUSE,135567.6,1,696,696.1,8.54,8.54,,1215,von Willebrand factor A domain-containing protein 5B1,extracellular region|,,,1,5,6420000000,1.0%
A2APZ7,0.331936472,0.05725,9.280517852,0.791,0.11801799,1.986852651,,-0.536,,0.337,0.438,-0.01,A2APZ7,Prrx2,A2APZ7_Prrx2,A2APZ7,Prrx2,1,2,1,1,A2APZ7|Q06348|Q9CY80,MOUSE,26556.2,6.4,697,697.1,8.5,8.5,,247,Paired mesoderm homeobox protein 2,nucleus|,"positive regulation of mesenchymal cell proliferation|regulation of transcription, DNA-templated|embryonic limb morphogenesis|inner ear morphogenesis|middle ear morphogenesis|positive regulation of smoothened signaling pathway|embryonic cranial skeleton morphogenesis|embryonic skeletal system morphogenesis|artery morphogenesis|cartilage development|",sequence-specific DNA binding|,1,2,52000000,6.4%